Western University

Scholarship@Western
Canadian Journal of Surgery

Digitized Special Collections

7-1-1987

Volume 30, issue 4
Canadian Medical Association

Follow this and additional works at: https://ir.lib.uwo.ca/cjs
Part of the Surgery Commons

Recommended Citation
Canadian Medical Association, "Volume 30, issue 4" (1987). Canadian Journal of Surgery. 181.
https://ir.lib.uwo.ca/cjs/181

This Book is brought to you for free and open access by the Digitized Special Collections at Scholarship@Western.
It has been accepted for inclusion in Canadian Journal of Surgery by an authorized administrator of
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca.

____

ANUSOL-HC AND TUCKS
TEAM UP FOR RELIEF
Anusol-HC and Tucks team up to effec
tively relieve the discomfort associated
w ith hemorrhoids and other anorectal
disorders.

ANUSOL*-HC
• Relieves pain and itch caused by
inflammation.
• Lubricating petrolatum base mini
m izes friction.
• Colorless ointment and suppositories
protects against personal embarrass
ment.

TUCKS*
• Soothes inflamed hemorrhoidal tissue.
• Eliminates mechanical irritation from
toilet tissue.
• Helps maintain proper hygiene.

TEAM UP FOR RELIEF
PARKE-OAVIS

Parke-Davis Canada Inc., Scarborough, Ontario

*Re«2>. T.M. Parke, Davis & Com pany,
Parke-Davis Canada Inc., Auth. u ser

For prescribing information see page 2 6 5

I

__ i,;AAMi
I c c p i» |

1

JULY 1987 JUILLET

VOLUME 30, NUMBER 4

journal
canadien
de chirurgie
LIST OF CONTENTS
QUILL ON SCALPEL
Survival After Hepatic Resection for Metastatic Disease

225

J.F. Gately

Relationship Between Improved Angina and Left Ventricular Function Change After Aortocoronary Bypass Grafting

226

J.F. Symes

CORRESPONDENCE
227

Fat Embolism and Total Knee Arthroplasty
K.G. Vince; R.R. Richards

227

Surgical Management of Crohn's Disease
D. Aldridge

Determining and Rationalizing the Supply of Physicians

227

D. Nuss

228

Value of Trauma Centres
M.J. Girotti; P.D. Roy

228

Knee Disassembly
T.N. Siller; H.U. Cameron

229

Resection of the Liver for Metastatic Disease
M.J. Wexler, J. Olak

SURGEONS’ UPDATE
Fees and Benefits: a Challenge to Universality of Medicare; QMA Continues Bid to Negotiate Fees;
New Chairman for General Surgery, U of Ottawa; Casualties of War Treated in Canada

232

A. Chouinard

Care of the Ureter in Pelvic Surgery

STATE OF THE ART

234

M.E. Boyd

CANADIAN SOCIETY FOR VASCULAR SURGERY
Symposium on the Perioperative Management of Abdominal Aortic Surgery
1. Preoperative Management of the Patient With Coronary Artery Disease Before Abdominal Aortic Surgery

237

R.D. Weisel

2. Anesthetic Considerations in Abdominal Aortic Surgery

239

R.A. McTaggart

3. Postoperative Management of Patients Who Undergo Aortic Surgery

242

A.D. Callow

ORIGINAL ARTICLES
Biologic Response to Uncemented Madreporic Canine Hip Arthroplasty

245

R.R. Richards, T. Minas, D.W.C. Johnston, J.P. Waddell

Posterior Wall Disruption of the Left Ventricle After Mitral Valve Replacement: Management of
Bleeding and Cardiac Enlargement

249

W.V.A. Vincente, S.V. Lichtenstein, H. El-Dalati, J. Mahoney, T.A. Salerno

VOLUME 30, NO. 4, JULY 1987 / THE CANADIAN JOURNAL OF SURGERY

223

L IS T O F C O N T E N T S C o n t’d

Conservative Management of Renal Lacerations in Blunt Trauma

253

R .A . R o b e rts , P. B e lits k y , S .G . L a n n o n , F.G . M a c k , S.A . A w a d

Simultaneous Occurrence of Chylothorax and Subarachnoid Pleural Fistula After Thoracotomy

256

T .W . R ic e , J.C . K irs h , I B. S c h a c te r, M . G o ld b e rg

Preservation of Platelets and Blood Products by Intravenously Administered Dipyridamole in Patients
Who Undergo Coronary Artery Bypass Grafting

260

P A . R e illy , M. T h o m p s o n , A. B a y e r, F. K a z im , J . R o s e n fe ld , M .F .X . G ly n n

Successful Surgical Repair in a Patient With Mitral Stenosis, Calcified Left Atrium and Severe Tricuspid
Regurgitation With a Giant Right Atrium

264

R .N . M c K e n n e y , K. M e lv in

Repair of Anorectal Incontinence in an Adolescent Boy With Neonatal Anal Atresia

267

H . S te rn , J.R . M a d ro n ic h , N. M c K e e

Do Symptoms Reflect a Change in Left Ventricular Function After Aortocoronary Bypass Grafting in Patients
With Depressed Left Ventricular Function?

269

B .C . M o rto n , M .P . B ra is , D .S . B e a n la n d s , R .J. C h a m b e rs , L .A .J. H ig g in s o n , W .L . W illia m s ,
K .A . A lla n , R .C . N a ir, W .J . K eon

Bacterial Colonization of Intestinal Urinary Conduit Diversion: a Morphologic and Bacteriologic Experimental Study

273

J .C . N ic k e l, M . O ls o n , K. La m , M. M o o d y , J .W . C o s te rto n

Systemic Cystic Angiomatosis in a Woman With Hematuria and Splenomegaly

277

D .M . O ’ B rien, W .R . G h e n t, D .F . D e x te r

Unusual Presentation of a Pancreatic Pseudocyst: a Case Report

281

A .A . A lra b e e a h , M . C a ttra l, J. S ie g e n b e rg

Recognition and Management of Marlex Erosion After Horizontal Gastroplasty for Morbid Obesity

282

D .M . G ra c e

Giant Villous Adenoma of Second Portion of Duodenum: Case Report

287

A . M o lg a t, J .P . S h o e n u t, M. H a m o n ic , A .B . M ic flik ie r

Radiocarpal Osteoarthritis Associated With Bilateral Bipartite Carpal Scaphoid Bones: a Case Report

289

R .R . R ic h a rd s , W .S . L e d b e tte r, E .E . T ra n s fe ld t

St. Anthony’s Fire, Then and Now: a Case Report and Historical Review

291

J .R . T a n n e r
M

A B S T R A C T S — R O Y A L C O L L E G E M E E T IN G 1 9 8 7

«

Canadian Association of General Surgeons

295

Canadian Society for Vascular Surgery

302

Books Received

229

Correction

258

Book Reviews

271

/

4

■*

V
■>-

*

SESAP V Question

280

SESAP V Critique

309

Notice of Change of Address / Avis de changement d’adresse

309

Classified Advertising

310

Advertisers’ Index

310

224

V O LU M E 30, NO. 4, J U L Y 1987 / THE CANAD IAN JOURNAL OF SURGERY

*
T

‘

QUILL ON SCALPEL
This section provides a medium through w hich Canadian
surgeons can declare themselves, briefly and informally, on
the day-to-day affairs of surgery.

Survival After Hepatic Resection
for Metastatic Disease
The article “ Hepatic resection for
metastatic disease” by Olak and col
leagues (Can J Surg 1986; 29: 435-439)
is important for several reasons: it deals
with an issue that is of great interest to
surgeons, it comes from a major aca
demic institution whose credibility should
not be in question, and the authors state
that their data support the position that
selected groups of patients with metastatic
colorectal cancer will obtain long-term
benefit from resection of liver metastases.
The core of the paper is a life-table
analysis of the survival of 25 patients who
had primary colorectal carcinoma and
who underwent hepatic resection for
metastases. For all patients surviving the
hepatic resection, the 5-year survival
projected by the analysis was 50.3%.
The life table is the best method for
handling longitudinal data when patients
enter a study at different times and at its
conclusion have been observed for differ
ent lengths of time. Its efficiency lies in
the fact that the survival experience of all
patients under study is included in the

analysis, not just of those who have died
by the time the study is terminated. H ow 
ever, the authors do not seem to recog
nize the limitations of life-table analysis.
As Peto and colleagues1 pointed out, “ if
few patients are at risk for more than a
certain time and after that time none o f
these few happens to die, there will be an
apparent plateau in the life table. Such
plateaux at the ends of life tables are very
common and should never be taken as
evidence that after a certain time m ost
patients are cured unless there are large
numbers of patients still at risk at the time
of the plateau.” In the Montreal study,
there is a plateau after 30 months with
fewer than five patients followed out to
5 years as shown in Fig. 1 of Olak’s paper
on page 437. The survival of 50.3% at 30
months should therefore not be projected
to 5 years and any comment on long-term
survival is invalid.
Another crucial point is that the prob
ability values that make up the life table
are determinations calculated from a sam
ple of patients. As such they are subject
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to sampling variation that can be meas
ured as standard error. By calculating the
standard erro r of the probability of sur
vival, we can answer the question, “ With
what precision does the survival of our
sample of patients estimate the true sur
vival o f the population from which our
sample is draw n?” The tabulated data
allow us to carry out our own analysis to
include the standard error of the proba
bility o f survival at each event (Table I).
If we include the two operative deaths,
which for some reason were omitted from
the original analysis, the survival estimate
at 36 m onths (the time of the last two
deaths) is 43% with a 95% confidence
interval of 17% to 69%. Thus, with a
small sample o f 25 patients, the estimate
is imprecise and the true survival figure
could be as bad as 17% or as good as
69%.
From the methodologic point of view,
this is a weak study. There is no concur
rent control group of untreated patients
and reliance is placed upon comparison
with historical control groups described
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by other authors. For instance, Adson
and associates2 reported that 20% of
patients with solitary lesions that were not

resected lived for 3 years or more. This
figure falls within the 95% confidence
interval of the estimate at 3 years for

Table 1—Survival Analysis for 25 Patients After Hepatic Resection for Metastatic Colorectal Cancer
(Adapted From Olak and Associates, Table II)
Kaplan—Meier survival analysis*
Time,
mo

0
1
3
4
9
10
11
13
16
20
29
30
33
36
45
53
55
61
82

Died
2
0
0
0
1
0
2
1
1
1
0
0
0
2
0
0
0
0
0

Censored
patients

Survival

0
2
1
1
0
1
1
0
0
1
1
1
1
0
1

0.920
0.920
0.920
0.920
0.872
0.872
0.769
0.714
0 .6 5 9
0 .6 0 4
0 .6 0 4
0 .6 0 4
0 .6 0 4
0 .4 3 2
0 .4 3 2
0.432
0.432
0.432
0.432

1
1
1
1

Standard
error

No. patients
remaining

0.054
0.054
0.054
0.054
0.070
0.070
0.092
0.100
0.107

23
21
20
19
18
17
14
13
12
10
9
8
7
5
4
3
2
1
0

0.111
0.111
0.111
0.111
0.130
0.130
0.130
0.130
0.130
0.130

* All patients have been included (including the 2 operative deaths); 95% confidence intervals - observed
estimate of survival ± 2 standard errors.

patients who underwent surgery in the
Montreal study. Thus, from the purely
statistical standpoint, the survival of the
Montreal patients was not significantly
different from that of Adson’s control
group.
What information, therefore, can we
glean from this paper? Simply that the
survival of patients who undergo hepatic
resection for metastatic disease may be
anywhere between 17% and 69% at 3
years. Whether or not patients will benefit
from resection of liver metastases remains
to be determined by larger studies that
include the survival experience of a com
parable group of untreated patients.
J o h n F . G a t e l y , m b , b c h ir ,
FRCS(EDIN), FRCS, FRCSC
Department o f Surgery,
McMaster University Medical Centre,
Hamilton, Ont.
L8N 3Z5

References
1. PETO R, P ike MC, ARMITAGE P, et al: Design and analy
sis of randomized clinical trials requiring prolonged obser
vation o f each patient. II. Analysis and examples. Br J
Cancer 1977; 35: 1-39
2. ADSON MA, VAN HEERDEN JA, ADSON MH, et al:
Resection o f hepatic metastases from colorectal cancer.
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Relationship Between Improved Angina
and Left Ventricular Function
Change A fter Aortocoronary Bypass Grafting
Coronary artery bypass surgery has
proven to be an effective treatment for
the relief of intractable angina. Improve
m ents in surgical technique and
myocardial protection have made it a safe
and acceptable approach even in poorrisk patients with severe left ventricular
dysfunction.
In this issue (pages 269 to 271), Morton
and colleagues from Ottawa address
the question of whether a correlation
exists between symptomatic improvement
in angina and changes in left ventricular
function following bypass surgery in
patients with moderate to marked left
ventricular dysfunction preoperatively.
They conclude that no such relationship
exists but that substantial relief of angina
can be expected in these patients regard
less o f what happens to left ventricular
function postoperatively.
Although this study has several defi
ciencies (it is retrospective, only a portion
o f the total group were restudied for vary
ing reasons, and the assessment of symp
tom atic improvement is imprecise), it
does makes some important points.
Angina is a result of an acute but tran
sient imbalance between myocardial oxy
gen supply and demand. Fixed, signifi
226

cant coronary artery stenosis leads to
exertional angina when coronary flow
cannot increase to meet oxygen demand.
The goal of bypass surgery is to ensure
an adequate coronary flow reserve. A suc
cessful result is signalled subjectively by
the elimination of exertional angina and
objectively by the ability to achieve a
higher external workload (heart rate mul
tiplied by blood pressure product). Both
goals are usually achieved after success
ful bypass surgery regardless of resting
left ventricular function preoperatively.
Improved left ventricular function
postoperatively has, in contrast, been
more the exception than the rule. As Mor
ton and his colleagues speculate, the
obscurity of this association may relate
in part to perioperative damage to previ
ously normal myocardium. In the present
era of improved myocardial protection,
however, this association is more likely
related to method of assessment. Utiliz
ing serial radionuclide ventriculography,
we were able to demonstrate a modest,
but consistent, improvement in left ven
tricular function in patients with only
mild to moderate impairment preopera
tively.1 Much of the reduction in left
ventricular function seen in patients with

more severe dysfunction, however, is
likely due to myocardial necrosis and will
not change with revascularization. The
case for bypass surgery in these patients,
therefore, depends upon whether or not
there are substantial areas of myocardium
that become ischemic upon exertion. This
rationale is independent of left ventricu
lar function and although the operative
risk in such patients is undoubtedly
greater, with proper selection the benefits
o f surgery are, as M orton’s study con
firms, very real, and the risk is quite
acceptable.
J.F S y m e s , MD, FRCSC
Associate professor of surgery,
Division o f Cardiovascular and
Thoracic Surgery,
McGill University,
Royal Victoria Hospital,
687 Pine Ave. W,
Montreal, PQ
H3A 1A1

Reference
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Improvement in resting ventricular performance follow
ing coronary bypass surgery. Ann Thorac Surg 1985; 39:
340-345

VOLUME 30, NO. 4, JU L Y 1987 / THE CANADIAN JOURNAL OF SURGERY

CORRESPONDENCE
Contributions to the Correspondence section are welcomed.
They should be typewritten and double spaced.

Fat Embolism and
Total Knee Arthroplasty
To the editors.—I read with interest the
article entitled “ Fatal fat embolism dur
ing cemented total knee arthroplasty: a
case report” by Orsini and colleagues in
the September 1986 issue of the journal
(pages 385 and 386). This type of com
plication, although previously described,
certainly warrants reporting. However, I
think it was somewhat misleading to
attribute the complication simply to
“ cemented total knee arthroplasty” as the
title implies. In fact, the fatal fat embo
lus was probably related to the introduc
tion of a long stem into the medullary
canal of the femur. For this reason, such
a complication is more commonly
observed after total hip arthroplasty. The
prosthesis used in this patient, a Guepar
II total knee arthroplasty, is generally
regarded as obsolete. The indications
for fully constrained hinged prostheses
such as this are very limited. Moreover,
modern resurfacing total knee arthro
plasties rarely have intramedullary stems
attached.
Notwithstanding this criticism, I
thought the case was clearly and concisely
reported. It is the title that was mislead
ing, suggesting fat embolism was a com
plication of total knee arthroplasty rather
than the result of introducing a prosthetic
stem into the medullary canal.
Kelly G. Vince, m d , frcsc
Kerlan-Jobe Orthopaedic Clinic,
Ste. 300,
501 East Hardy St.,
Inglewood,
CA 90301,
USA

To the editors.—Dr. Vince correctly
states that the total knee prosthesis
associated with fatal fat embolism in our
case report had a long intramedullary
stem and that most contemporary total
knee prostheses do not utilize intramedul
lary stems. However, research in our
laboratory has clearly demonstrated that
it is the combination of the introduction
of a long intramedullary stem and bone

cement that produces the high intra
medullary pressures associated with fat
embolism.1’2 This evidence, together
with the infrequent association of the fat
embolism syndrome with total knee
arthroplasty, led to our choice of title.
Perhaps a more accurate title would have
been “ Fatal fat embolism during
cem ented long-stem
total knee
arthroplasty” . Nevertheless, we wish to
emphasize that this complication was
associated with the use of bone cement
rather than, as Dr. Vince suggests, sim
ply the introduction of an intramedullary
stem. We thank Dr. Vince for his com
ments.
Robin R. R ichards , md , frcsc
Assistant professor of orthopedic surgery,
University of Toronto,
Ste. 800,
55 Queen St. E,
Toronto, Ont.
M5C 1R6
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Surgical Management
of Crohn’s Disease
To the editors.—The article “ New
options in the surgical management of
Crohn’s disease” (Can J Surg 1987; 30:
133-136) is very helpful and timely.
It is not uncommon to find at opera
tion relatively short and often multiple
strictures, but deciding which strictures to
include and how long an excision should
be has been very difficult in the past.
Strictureplasty makes management much
simpler.
I would recommend a variant of the
technique described in the article. With
relatively short strictures, the Finney tech
nique with a GIA stapler is quick and sim
ple. The technique is similar to that used
for a Finney pyloroplasty, if one

envisages the stricture as the pylorus. I
have used this technique, without any
problems.
D ouglas A ldridge , mb ,
CH B, FRCSC, FACS
Ste. 205,
345 Lakeshore Rd. E,
Oakville, Ont.
L6J 1J5

Determining and Rationalizing
the Supply of Physicians
To the editors.—I was surprised to read
in your March 1987 issue (pages 77 and
78) that there is a move afoot to increase
the number of training slots for general
surgeons in Canada. The reasons given
for this philosophy are twofold — that
there will be an increasing number of
general surgeons retiring in the future and
that “ training takes a minimum of 4
years so there’s no turn on, turn off
mechanism” .
Before embarking on a project with
such long-term ramifications, more than
those two factors should be taken into
consideration. Surgeons have been retir
ing ever since the specialty was first
instituted, so that is nothing new. Even
though it may take 4 years to train a sur
geon, he will stay in the pool for up to
30 years making the “ turn on, turn o ff”
mechanism even m ore difficult to
manage. McPhedran talks of the difficul
ties encountered in trying to increase the
number of training slots. That is mere
child’s play when compared to the
difficulties encountered when trying to
reduce the number of training slots
because of many vested interests.
The figures quoted are based on sim
ple historical population statistics. These
do not take into account the fact that the
number o f surgical procedures is slowly
being reduced. For example, until the
1970s, peptic ulcer surgery was so com
mon that even junior residents were given
an opportunity to perform gastric and
duodenal surgery. Then came H2 block
ing agents. During that same era, rheu
matic heart disease provided cardiac sur
geons with an endless supply of patients
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requiring valve replacements. Today, they
have to content themselves with doing
coronary artery bypass surgery, for rheu
matic heart disease has disappeared. In
our hospital last year, the introduction
and aggressive use of indomethacin
intravenously in neonates with patent
ductus arteriosus has made duct ligation
a rare event. Over the last three decades
the incidence of appendicitis has dropped
to half what it was in the pre-antibiotic
era. Since medical research continues at
an ever-increasing pace, one can antici
pate that the number of diseases requir
ing surgery for their cure will continue to
decline.
In the United States there is now an
oversupply of surgeons. In 1974, the aver
age number of surgical procedures per
formed per individual surgeon was 217.
It had decreased by 1979 to 176 and by
1984 to 161.' This is an average of one
procedure every other day. What an
incredible waste of manpower. How are
junior surgeons going to gain the
experience and proficiency that are such
a necessary part of their profession? It is
stimulating and exhilarating to be busy
and most surgeons are quite capable of
handling a much greater caseload without
difficulty. Concurrently, because of
increased experience and practice, they
may even perform better surgery.
Donald Nuss, mb , ch b, frcsc , facs
Ste. 200,
400 West Brambleton Ave.,
Norfolk,
Va. 23510-1193,
USA
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Several other factors relevant to the
traum a-centre argument should be
explored before any system of regional
trauma care can be established in any
region of Canada:
• An analysis of the morbidity of all
trauma patients treated in trauma centres
versus non-trauma centres.
• Mortality and morbidity of patients
who are not identified as having major
trauma (injury severity score greater than
or equal to 16, trauma score less than or
equal to 12).
• The incremental costs of trauma
care in trauma versus non-trauma centres.
Such factors as these necessarily point
to well-designed before-and-after studies
of trauma patterns, which would then be
followed by the development of regional
trauma units (i.e., a true establishment of
need in a given region).
I wholeheartedly support Dr. Roy’s
argument that accurate well-designed
provincial trauma registries (independent
of hospital medical records) must be
firmly in place to answer all of these ques
tions.
However, I take some exception to Dr.
Roy’s concluding remarks in this other
wise excellent article. Just as there is
inconclusive evidence in the medical liter
ature regarding trauma centre designation
and acutely injured outcomes, so I must
ask the question, “ Is there evidence that
the Advanced Trauma Life Support
Course makes any difference to trauma
care in these situations?” In addition, in
my experience, emergency physicians no
longer need further education in early
trauma care. This needs to be directed to
family physicians who infrequently take
emergency calls in their community hospi
tals, and to general and orthopedic sur
geons who think that their FRCSC auto
matically qualifies them as experts in
resuscitation of traumatized patients.

Value of Trauma Centres

M.J. G irotti, md , frcsc

To the editors.—The recently published
article by Roy (Can J Surg 1987; 30:
17-22), regarding the value of trauma
centres, points out clearly the difficulties
faced by health-care planners, surgeons
and politicians in assessing the impact of
regional trauma centres on the care of the
acutely injured patient. Unfortunately, as
Roy has pointed out, a great deal of the
often-quoted data is anecdotal or publi
cations of case series, with few welldesigned prospective trials. Moreover, an
overwhelming number of these reports
come from the United States where injury
patterns are known to differ from those
in Canada. To a certain extent, similar
disparities already exist in Canada with
respect to injury patterns and outcomes
(e.g., quoted population differences
between Sunnybrook Medical Centre and
St. Michael’s Hospital in Toronto).

Director of trauma services,
Toronto General Hospital,
200 Elizabeth St.,
Toronto, Ont.
M5G 2C4
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To the editors.—All of Dr. Girotti’s
points are well taken. As a group, emer
gency department physicians in university
teaching hospitals are probably the best
providers of advanced trauma life support
in Canada. By “ emergency physicians”
I meant simply the providers of primary
care, particularly at the periphery. This
would, of course, include many family
physicians who only do occasional emer
gency department duty. This should
definitely be the target group in any such
educational program. That is not to say
that an FRCSC should be interpreted as
a licence to resuscitate. Many residency

programs, including our own, offer the
Advanced Trauma Life Support Course
as part of the program, and the McGill
University Medical School offers it to all
medical students at the clinical clerkship
level.
I have no proof that the Advanced
Trauma Life Support Course per se
makes a detectable difference. It is merely
a framework, a cookbook if you like, to
be followed. However, I know of no
other method that will efficiently teach a
group of physicians in a short period the
essentials that I feel are necessary for
optimal resuscitation and treatment in the
“ golden hour” .
P eter D. Roy , md , frcsc
Ste. 4128,
Ambulatory Care Centre,
Victoria General Hospital,
Halifax, NS
B3H 2Y9

Knee Disassembly
To the editors.—The paper entitled “ Role
of total knee replacement in failed knee
fusions” in the January 1987 issue of the
journal (pages 25 to 27) is pioneering.
However, the statement that “ nothing has
yet appeared in the literature on disassem
bly” is not correct.
A case1 treated by Wright was
described as follows: a 26-year-old
woman with previous knee fusion for
tuberculosis at age 13 had a simple
arthroplasty done, followed by spontane
ous ankylosis, then a Walldius total knee
replacement. One year later, loosening
required revision with cementing. At 5
years, the patient passively flexed (by
gravity) to 80°, had no active extension,
but by hand lifted her knee straight when
getting up from a chair. The gait was
acceptable and she was happy with the
result to that point.
T.N. Siller , md , frcsc
Scarborough Grace General Hospital,
3030 Birchmount Rd.,
Scarborough, Ont.
M1W 3W3
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To the editors.—I should like to apolo
gize to Dr. Siller for omitting mention
of the case he describes in Cruess and
Mitchell’s book on degenerative arthritis
of the lower limb.
What is of interest in the case described
by Siller is the lack of active extension.
In the most recent fusion takedown I have
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done, I found the patellar tendon exqui
sitely thin and was very concerned about
the possibility of rupture. I therefore rein
forced it with a couple of wire loops
extending from above the patella to drill
holes in the tibia. This man has powerful
extension, but is very, very slow in gain
ing flexion.
The finding of a very thin patellar ten
don suggests that the patient reported by
Dr. Siller had in fact a patellar tendon
rupture, which would explain her loss of
active extension.
H u g h U . C a m e r o n , m b , c h b , fr csc
Ste. 318,
43 Wellesley St. E,
Toronto, Ont.
M4Y 1H1

Resection of the Liver
for Metastatic Disease
To the editors.—We are grateful for the
opportunity to respond to Dr. Gately’s
editorial.
We all recognize that, ultimately, the
ideal study to decide the relative merit of
alternative forms of therapy, is a prospec
tively randomized double-blind controlled
trial. Unfortunately, this is not a perfect
world!
Since less than 15% of patients with
colorectal cancer and liver metastasis will
be candidates for resection, the experience
of any one institution is going to be
extremely small. Indeed, it was only by
creating a registry and personally review
ing the records and experience of a great
many institutions across the country that
Foster1 was able to suggest this was a
viable and perhaps superior treatment
option in the hands of experienced hepatic
surgeons. The number of subsets to be
analysed is also great. They include: stage
of the primary tumour; age and sex of the
patient; synchronous versus metachro
nous hepatic metastasis; size and number
of liver metastases; extent of hepatic
resection required, etc. A large mul
ticentre (if not multinational) trial with
all its inherent difficulties and tremendous
expense would be necessary. In addition,
the difficulty in generating a concurrent
control group of untreated patients is
real. There is still a place, and indeed a
necessity at this stage, for major institu
tions and hospitals to report their experi
ences to the surgical community at large.
Gately’s suggestion that “ the core of
the paper is a life-table analysis of the sur
vival of 25 patients who...underwent
hepatic resection for metastases” is incor
rect and myopic. Our article was entitled
“ Hepatic resection for metastatic dis
ease” and not “ Survival after hepatic
resection...” as implied in Dr. Gately’s
editorial comments. It was intended to

share and communicate our total experi
ence with hepatic resection for metastatic
disease including types of procedures,
mortality and complications, and to relate
outcome to the various subsets previously
described, looking for apparent differ
ences that might lead to better patient
selection.
In reporting our observed survival, we
have presented data in a form compara
ble to that reported by other authors who
also use life-table methods. Our epidemi
ologists and statisticians at McGill were
consulted before we collected our data
and they agreed that this was the best
method of presentation. We certainly do
recognize the limitations of this method
and have clearly indicated the number of
patients under observation at each
6-month interval on every life table
reported in the article. Furthermore, we
deliberately presented, in Table IV,
“ Observed Survival (in Months)” and
have clearly stated throughout th at the
life-table curves generated only a
“ projected survival figure” . Since
patients were being entered in the study
up to 1985, it goes without saying that
most will not have been observed for 5
years! Dr. Gately himself states that “ the
life table is the best method for handling
longitudinal data when patients enter a
study at different times and at its conclu
sion have been observed for different
lengths of time” . If the life-table method
is not the “ best-fit” m ethod for
representing these data, Dr. Gately has
not told us which method is. We have
been careful to avoid making statistical
conclusions or analyses based on
projected numbers at 5 years.
Dr. Gately correctly notes that the two
operative deaths were omitted from the
original life-table analysis. We are
attempting to look at the effect o f a sur
gical intervention on the biology and
natural history of hepatic metastases.
This is not a cost-benefit analysis and
operative deaths, of necessity, must be
excluded in this context. That is not to say
that operative mortality is unimportant.
It is incumbent upon any surgeon and
institution to prove that this operation
can be accomplished with low morbidity
and mortality and was a greater impetus
for us to review and discuss our own data
than to analyse survival.
With small sample size, estimates of
long-term survival will be imprecise as Dr.
Gately correctly emphasizes. All institu
tions must continually update and report
their survival figures with time and we are
currently in the process of doing so with
18 additional months of follow-up. To
our dismay, recurrences are being seen as
an ongoing event; however, regardless of
the ultimate overall survival data, there
is no question that in some patients sur
vival is being prolonged with a potential
for “ cure” in a few. At no time is “ reli

ance...placed upon comparison with
historical control groups described by
other authors” as Gately states. The fact
that Adson a n d associates2 reported that
20% of patients who had unresected soli
tary lesions lived 3 years or more does not
detract from our report that 13 of 23
patients at risk , taking all subgroups,
were alive and free of disease a mean o f
24 months a fte r hepatic resection. How
better to define and select the subgroup
with greatest potential for gain is the
present interest. This will come with
newer and b etter methods of detecting
subclinical extrahepatic metastasis prior
to undertaking hepatic resection, not by
m ore concurrent control groups o f
untreated patients as suggested by Dr.
Gately.
M arvin J. W e x l e r , m d , fr c sc
J e m i O lak , m d
Department o f Surgery,
Royal Victoria Hospital,
McGill University,
687 Pine Ave. W,
Montreal, PQ
H3A 1A1
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There’s method to our madness here. We’re dramatizing a point about Marcaine:*
The point is, Marcaine lasts a lot longer than other local anaesthetics. Up to
twice as long, in fact. (See Covino, B.G. and Scott, D.B. Handbook of Epidural
Anaesthesia and Analgesia. Grune & Stratton. In Orlando, 1985; 70.)
Since Marcaine lasts twice as long, our ad is twice as long. We understand
that you may not have the time at one sitting to read and digest the amount of
information shown here. But if you’ve read this far, you have the main point
about Marcaine, the reason why it is so well respected and so well used, and later
w e’d like to table some discussion points about additional uses for Marcaine,
and perhaps reacquaint you with its other advantages, such as the degree of
participation it allows the mother in labour, and the fact it is 95% plasma protein
bound which limits the amount of drug transfer across the placental barrier to
th e foetus.
Longer duration is the key benefit of Marcaine to the anaesthetist. It lasts
up to twice as long as lidocaine which means that you can achieve optimum
pain control during surgical procedures. It also saves the obstetric anaesthetist
tim e because fewer top-ups are necessary with Marcaine (see Ostheimer, G.W.,
Regional Anaesthesia Techniques in Obstetrics, Breon Laboratories Inc., 1980,
p.23). But another key point about Marcaine is that it separates sensory from
motor block. Excellent sensory anaesthesia can be obtained with less motor
block than any other local anaesthetic. This separation allows for complete pain
relief during and after surgery, yet lessens immobility in the post-operative
phase. In obstetrics, Marcaine can maintain the mother’s ability to bear down
in labour while providing relief of pain. Greater involvement and cooperation of
the mother are considered desirable in obstetrics for the 80’s. (The reference
material in the above paragraph outlines data on this phenomenon as well as
evidence for the duration of Marcaine.)
Indeed, the long duration of Marcaine (and in actual fact, Marcaine can
last twice as long as other, injectable local anaesthetics) not only reduces the
tim e you spend because of fewer top ups during a procedure, it produces an
extended pain free period in the mother after the birth when perineal repair has
been required. Unlike general anaesthesia, the mother is also conscious during
and immediately after the delivery so bonding and breast feeding can occur
earlier.
What are the advantages of Marcaine and epidural anaesthesia relative to
general anaesthesia? First and foremost is the avoidance of one of the principal
hazards of general anaesthesia, i.e. vomiting and aspiration of stomach contents.
Secondly, consider the area of endocrine stress response to anaesthesia and
surgery (Lindall, S., et al: Endocrine Stress Response during General and Epidural
Anaesthesia for Elective Caesarean Sections, Acta Anaesthesiol Scand. 1983;
27:50-55). With inhalation anaesthesia maternal plasma levels of cortisol and
ACTH - endocrine stress markers - are consistently higher. The foetus may have a
higher endocrine stress response.
And the argument can be effectively summarized by this statement:
“Bupivacaine (Marcaine) is currently established as the safest and most
effective amide-linked local anaesthetic for obstetric anesthesia? (Bromage P.R:
Choice of Local Anesthetics in Obstetrics. In Shnider, S.M. and Levinson, G.
(eds.): Anesthesia for Obstetrics. The Williams & Wilkins Company, Baltimore,
1979,113.) And this statement: “The clear advantages to the post-partum
m other are sufficient grounds for encouraging the teaching and eventually the
routine use of epidural anaesthesia for caesarean section on all suitable patients?
(Morgan B.M., et al: Anaesthetic Morbidity Following Caesarean Section Under
Epidural or General Anaesthesia. The Lancet. 1984: 328-330). We have already
mentioned the longer duration of Marcaine and the additional benefit that
Marcaine is 95% plasma protein bound which limits the amount of drug transfer
across the placenta to the foetus. Marcaine also causes minimal foetal and neo
natal depression of neuro behaviour and muscle tone.
At this point, please allow for a pertinent digression from the discussion
on the longer duration of Marcaine and other benefits.
INDICATIONS: Peripheral nerve block, infiltration, sympathetic blockade,
caudal, epidural, and pudendal blocks.
CONTRAINDICATIONS: Bupivacaine is contraindicated in persons with
known sensitivity to local anesthetics of the amide type. The use of bupivacaine
is contraindicated in the presence of sepsis near the site of proposed injection, in
severe shock and in heart block.
WARNINGS: USAGE IN PREGNANCY: Decreased pup survival in rats and
an embryocidal effect in rabbits have been observed when bupivacaine
hydrochloride was administered to these species in doses comparable to nine
and five times respectively the maximal recommended daily human dose
(400 mg). There are no adequate and well-controlled studies in pregnant women
of the effect of bupivacaine on the developing fetus. Bupivacaine hydrochloride
should be used during pregnancy only if the potential benefit justifies the

potential risk to the fetus. This does not exclude the use of Marcaine 0.25% or
0.50% at term for obstetrical anesthesia or analgesia.
OBSTETRICS: The highest (0.75%) concentration is not recommended for
obstetrical anesthesia. There have been reports of cardiac arrest with difficult
resuscitation or death following its use for epidural anesthesia in obstetrical
patients. Due to the high risk to the fetus, paracervical block is no longer
recommended. The obstetrician is warned that severe persistent hypertension
may occur after administration of certain oxytocic drugs, if vasopressors have
already been used during labor (e.g. in the local anesthetic solution or to correct
hypotension). Until further experience is gained in children younger than 12
years, administration of bupivacaine in this age group is not recommended.
PRECAUTIONS: RESUSCITAnVE EQUIPMENT AND DRUGS SHOULD
BE READILY AVAILABLE WHEN ANY LOCAL ANESTHETIC IS USED.
The safety and effectiveness of local anesthetics depend upon proper dosage,
correct technique, adequate precautions, and readiness for emergencies.
Marcaine (bupivacaine) should be used cautiously in persons with known drug
allergies or sensitivities, particularly to the amide-type local anesthetics. Caution
is advised in administration of repeat doses of bupivacaine to patients with
severe liver disease. The following precautions apply to all local anesthetics:
Select needles of proper length and bevel for the technique employed. Inject
slowly with frequent aspirations and if blood is aspirated, relocate the needle.
Inadvertent intravascular injection may cause serious complications. Absorption
is more rapid when injections are made into highly vascular tissues. In caudal or
epidural anesthesia, abandon the method if the subarachnoid space has been
entered, as shown by aspiration of spinal fluid. The lowest dosage that gives
effective anesthesia should be used, to avoid high plasma levels and serious
systemic side effects. Injection of repeated doses of bupivacaine may cause a
significant increase in blood levels due to accumulation of the drag or its
metabolites or slow metabolic degradation. Tolerance varies with the status of
the patient. Debilitated, elderly and acutely ill patients may require reduced
doses commensurate with age and physical condition. It should be remembered
that solutions containing a vasopressor agent, e.g. epinephrine, should be used
with caution, if at all, in patients who are receiving monoamine oxidase
inhibitors or anti-depressants of the triptyline or imipramine type, because
severe, prolonged hypertension may result. Dose-related cardiac arrhythmias
may occur if preparations containing epinephrine are employed in patients during
or immediately following the administration of chloroform, halothane,
cyclopropane, trichloroethylene or other related agents. In deciding whether to
use these products concurrently in the same patient, the combined action of
both agents upon the myocardium, the concentration and volume of vasocon
strictor used, and the time since injection, when applicable, should be taken into
account. The decision to use a local anesthetic containing a vasoconstrictor in
areas with a limited blood supply or in patients with peripheral vascular disease,
will depend on the physician’s appraisal of the relative advantages and risks.
Local anesthetics which contain preservatives, i.e. those supplied in multiple
dose vials, should not be used for caudal or epidural anesthesia.
EPIDURAL USE: It is advised that a test dose, generally 2-3 mL of 0.5%
bupivacaine (or other amide anesthetic) containing 1:200,000 epinephrine (10-15
micrograms) be administered to check that the spinal canal or a blood vessel has
not been entered while locating the epidural needle or catheter. In the event of
spinal injection clinical signs of spinal block would become evident in a few
minutes. In the event of intravascular injection a transient increase in pulse
rate and possibly momentary increase in systolic blood pressure are usually
detectable with a monitor. The other symptoms and signs of “epinephrine
response” are less dependable. The effects of other medication the patient has
received may modify this response. When reinforcing doses are required the test
dose should be used again to check the catheter location.
ADVERSE REACTIONS: Reactions to bupivacaine are characteristic of those
associated with amide-type local anesthetics. A major cause of adverse
reactions to this group of drags is excessive plasma levels, which may be due to
over-dosage, inadvertent intravascular injection, or slow metabolic degradation.
Other causes of reactions to these local anesthetics may be hypersensitivity,
idiosyncrasy, or diminished tolerance. Excessive plasma levels cause systemic
reactions involving the central nervous system and the cardiovascular system.
The CENTRAL NERVOUS SYSTEM EFFECTS are characterized by
excitation or depression. The first manifestation may be nervousness, dizziness,
blurred vision, or tremors, followed by drowsiness, convulsions, uncons
ciousness, and possibly respiratory arrest. Since excitement may be transient or
absent, the first manifestation may be drowsiness, sometimes merging into
unconsciousness and respiratory arrest. Other central nervous system effects
may be nausea, vomiting, chills, constriction of the pupils, or tinnitus. The
CARDIOVASCULAR MANIFESTATIONS of excessive plasma levels may
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include depression of the myocardium, blood pressure changes (usually
hypotension), and cardiac arrest. Recent clinical reports and animal studies
suggest this may be more likely to occur with the long acting amide local
anesthetics such as bupivacaine. .
ALLERGIC REACTIONS are characterized by cutaneous lesions (e.g.
urticaria, edema) and other manifestations of allergy. Reactions following
epidural or caudal anesthesia may include: high or total spinal block, urinary
retention; fecal incontinence, loss of perineal sensation and sexual function;
persistent analgesia, paresthesia, and paralysis of the lower extremities;
headache and backache; and slowing of labor and increased incidence of forceps
delivery. It should be noted that reactions due to systemic absorption may be
slow or rapid in onset. Those of rapid onset include respiratory depression,
cardiovascular collapse and cardiac arrest. This type of reaction necessitates a
high degree of preparedness since it can occur with little warning.
In co-ordinated studies of 3200 procedures carried out by 15 investigators,
there were 2 severe systemic reactions. Both patients experienced convulsions
as a result of inadvertent vascular injection. Fetal bradycardia has been
observed with the use of bupivacaine. Most cases, including a few fatalities,
occurred when the paracervical route was used (see “Warnings”).
In some subjects bupivacaine may produce marked peripheral vasoconstric
tion in unanesthetized areas which may last for several hours.
TREATMENT OF OVERDOSE AND SEVERE REACTIONS: Toxic effects of
local anesthetics require symptomatic treatment; there is no specific cure. The
physician should be prepared to maintain an airway and to support ventilation
with oxygen and assisted or controlled respiration as required. Supportive
treatment of the cardiovascular system includes intravenous fluids and, when
appropriate, vasopressors (preferably those that stimulate the myocardium).
Convulsions may be controlled with oxygen and intravenous administration, in
small increments, of a barbiturate or muscle relaxant, as follows: preferably, an
ultra short-acting barbiturate such as thiopental or thiamylal, if this is not
available, a short-acting barbiturate (e.g. secobarbital or pentobarbital) or a
short-acting muscle relaxant (succinylcholine). Intravenous muscle relaxants
and barbiturates should only be administered by those familiar with their use.
DOSAGE AND ADMINISTRATION: As with all local anesthetics, the dosage
varies and depends upon the area to be anesthetized, the vascularity of the
tissues, the number of neuronal segments to be blocked, individual tolerance,
and the technique of anesthesia. The lowest dosage needed to provide effective
anesthesia should be administered.
In recommended doses, bupivacaine produces complete sensory block,
but the effect on motor function differs between the three concentrations.
0.25% when used for caudal, epidural, or peripheral nerve block, produces
incomplete motor block. Should be used for operations in which muscle re
laxation is not important, or when another means of providing muscle relaxation
is used concurrently.
0.5% provides motor blockade for caudal, epidural, or nerve block, but
muscle relaxation may be inadequate for operations in which complete muscle
relaxation is essential.
0.75% produces complete motor block. This concentration is recommended
only for epidural block (single dose) in abdominal operations requiring complete
muscle relaxation without the aid of other medication. It is not recommended for
epidural block in obstetrical patients.
The duration of anesthesia with bupivacaine is such that, for most pro
cedures, a single dose is sufficient. Maximum dosage limit must be
individualized in each case after evaluating the size and physical
status of the patient, as well as the usual rate of systemic absorp
tion from a particular injection site. Most experience to date is
with single doses of bupivacaine up to 225 mg with epinephrine
1:200,000 and 175 mg without epinephrine; more or less drug
may be used depending on individualization of each case. At
present there is insufficient clinical evidence with multiple
dosage or intermittent dose techniques to permit precise re
commendations for such procedures to be given. However
limited clinical experience in this area of use indicates that
bupivacaine may be repeated in 3 to 6 hours up to a maxi
mum dose of400 mg in 24 hours. In most cases the duration
of anesthetic effect"is prolonged by the addition of epine
phrine. The following table is presented as a guide to the use
of bupivacaine. The doses shown have generally proved
satisfactory for the average adult. They may require adjust
ment in relation to age and the physical condition of the
patient.
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RECOMMENDED CONCENTRATIONS AND DOSAGE FOR ADULTS
Type of Block
Local Infiltration
EpiduraP

EpiduraP
Test Dose

Peripheral Nerves
Sympathetic

Concentration

mL

0.25%
0.75% 2
0.50%
0.25%
0.50%
w/epi

up to max
10-20
10-20
10-20
2-3

0.50%
0.25%
0.50%
0.25%
0.25%

mg
up to max
75-150
50-100
25- 50
10- 15
(10- 15/ig
epinephrine)
75-150
37.5- 75
25-150
12.550-125

15-30
15-30
5-30
5-60
20-50

Motor Blockl

Complete
Moderate to Complete
Partial to Moderate

Moderate to Complete
Moderate
Moderate to Complete
150
Moderate
to Complete

1. With continuous (intermittent) techniques in caudal and epidural block using 0.25 and 0.5% solutions,
repeat doses increase the degree of motor block. The first dose of 0.5% may produce complete motor block
in most intercostal nerve blocks for intra-abdominal surgery, the 0.25% concentration has produced
satisfactory motor blockade.
2. For single dose use not for intermittent technique.
3. Use of an appropriate test dose is recommended prior to injecting the full epidural dose (see “Precautions”)

AVAILABILITY: ISOTONIC SOLUTIONS:
0.25%-10 mL single dose vials (without preservative), (boxes of 5).
-20 mL single dose vials (without preservative) with and without
epinephrine (boxes of 5).
-50 mL multiple dose vials (containing methylparaben as preservative)
without epinephrine (boxes of 1).
0.50% - 3 mL single dose ampuls (without preservative) with epinephrine (boxes of

10).
-10 mL single dose vials (without preservative), (boxes of 5).
-20 mL single dose vials (without preservative) with and without
epinephrine (boxes of 5).
-50 mL multiple dose vials (containing methylparaben as preservative)
without epinephrine (boxes of 1).
0.75% - 3 mL single dose vials (without preservative) without epinephrine (boxes
of 5).
The solutions are made isotonic with NaCl and the pH is adjusted with
NaOH or HC1. The pH range for solutions without epinephrine is 4.0-6.5 and
for solutions with epinephrine is 3.4-4.5. Plain solutions may be autoclaved but
those containing epinephrine may not. Each mL of solution with epinephrine
contains 0.0091 mg epinephrine bitartrate with 0.5 mg sodium metabisulfite.
0.001 mL monothioglycerol, and 2 mg ascorbic acid as antioxidants, 0.002 mL
60% sodium lactate buffer and 0.1 mg edetate calcium disodium as stabilizer.
Product Monograph is available on request.
Marcaine allows better participation of the mother in labour. Marcaine is
95% plasma protein bound which limits the amount of drug transfer across the
placenta to the foetus.
But first and foremost, Marcaine offers longer duration of pain control
needed for surgical and obstetrical procedures.
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Marcaine.
The local anaesthetic

that lasts twice as long.
W in th ro p L ab o ra to ries
D ivision o f S terling D rug Ltd.**
A u ro ra , O n ta rio L 4G 3H 6
• Reg. Trade Mark
“ Registered User

What's new in surgery is the subject of this column. The short items are designed to let readers know
who's doing what and why. Surgeons are interested in what other surgeons are doing in
research, education, practice and administration. Surgery is a vibrant specialty, and, as
its practitioners, you must be the source as well as the readers of this column.

Fees and Benefits:
a Challenge to Universality of Medicare
The schedules of benefits paid for by
provincial health insurance plans across
Canada are likely to change markedly in
the next few years, as Alberta joins BC
as provinces that have disallowed some
payments previously supported.
In Alberta in mid-May, the government
cut back its list of “ basic health services”
in an effort to save $40 million and asked
the public to help save another $25 mil
lion. When the Alberta government
announced that it would no longer auto
matically pay for, among others, gas
troplasty, eye examinations, circumcision,
sterilization (and reversal operations) or
blepharoplasty, the country turned
toward Ottawa to hear the federal
response. Health and Welfare Minister
Jake Epp replied a few days later that
such cutbacks would not endanger trans
fer payments as long as the services were
not medically necessary.
In an open letter to Albertans, the
Minister of Hospitals and Medical Care
said, “ Since 1980 costs have more than
doubled...we have seen the price tag for
health-related services rise from $1.1 bil
lion in 1980 to approximately $3 billion
in 1986, or from under $600 for every
Albertan...to $1300....” The letter, signed
“ Marv Moore” , solicited public help: “ In
order to meet our budgetary target of
having no increase in the present expen
diture of $694 million for the Alberta
Health Care Insurance Plan, it will be
necessary to save a further $25 million.
If we all help by using our health care sys
tem in a responsible manner and perhaps
using the system one time less, then I
believe we can save even more and suc
ceed in preserving the quality of our serv
ices for years to come.”
Contributions to this column are welcome.
Please send your material to: Mrs. Amy
Chouinard, Canadian Journal o f Surgery,
PO Box 8650, Ottawa, Ont. K1G 0G8.
232

The news release accompanying the
announcement said, “ ...a new restruc
tured Utilization Committee is being
formed and will be working particularly
in the area of reducing unnecessary med
ical tests and x-rays which have escalated
dramatically in recent years” .
At present, the concern about rising
costs may be the only universal element
in the provinces’ health systems despite
the Canada Health Act. Efforts to
increase the funds available to pay the bill
included New Brunswick’s official ban of
extra-billing at the end of March, thus
making that province the last to become
eligible for transfer payments withheld by
the federal government.
Earlier this year the Manitoba govern
ment refused a medical fee increase that
was recommended by a three-lawyer
arbitration team. The government later
changed its position, citing ambiguity in
the arbitrators’ report as the reason for
its reticence in accepting the 5.6%
increase in fees and the 0.9% increase
anticipated for growth in utilization. The
refusal came during the first test of an
agreement between the province and the
medical association to put an end to extra
billing.
The recent move by Alberta, now given
the federal nod, is likely to become
popular.
A look at the different schedules for
fees and benefits shows that some
provinces have more freedom to maneu
ver than others. For example, Ontario
and Alberta have agreed to pay for one
complete annual health examination for
each resident, whereas this is not a benefit
in many other provinces; Newfoundland
has a clause permitting payment for con
sultations required by law or statute
“ presumably in the best interest of
patients and hospitals” , but other
provinces specifically forbid such pay
ments.

The differences in benefits are likely to
be closely scrutinized in future, as is the
lack of parity in payments to practi
tioners. Theoretically, accessibility is at
risk for patients who come from a
province where practitioners have fallen
far behind in their fee increases.
A sampling of surgical procedures
(Table I) for which payment is allowed
in all the provinces indicates the great var
iation in amounts paid; the preambles for
the schedules in some instances offset the
differences, in others increase them.
Regular “ business” hours for physicians
vary from 9 hours in Alberta, Newfound
land and Saskatchewan to a high of 13
for GPs in Quebec, where Saturday is
considered part of the work week.
The fee for most surgical procedures in
Quebec includes 90 days of preoperative
care and 15 days of postoperative care.
Although all the other provinces also
include some preoperative and postoper
ative care in the price of the procedure,
most allow surgeons to charge a fee for
the major consultation, include some
premium for performing the procedure
outside normal business hours or add a
surcharge for special visits.

QMA Continues Bid
to Negotiate Fees
The discrepancies in Quebec physi
cians’ reimbursements when compared
with practitioners in the rest of Canada
prompted the Quebec Medical Associa
tion to draft a new schedule for GPs in
an attempt to gain negotiating power for
the province’s physicians. Last year, the
QMA’s bid for negotiating power for
specialists was rejected by government
primarily because it was presented dur
ing fee negotiations with the Federation
des medecins specialistes du Quebec. The
QMA is appealing the decision, maintain
ing that negotiations are continuous and
text continued on page 307
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Table 1- S elected D iffe re nces in the Pream bles and Fees Listed in Provincial S ch edu les
Quebec
GP

Ontario

Specialist

New

New-

Prince

Nova

Saskat-

Bru nsw ick

foundland

Edward Island

S co tia

chewan

M anitoba

A lb e rta

Colum bia

PREAM BLE
W orking hours

0 8 : 0 0 -2 1 :0 0 0 7 :0 0 -1 9 :0 0 0 7 : 0 0 -1 7 :0 0

0 8 :0 0 -1 8 : 0 0

0 8 :0 0 -1 7 :0 0

0 8 : 0 0 -1 9 :0 0

0 8 : 0 0 -1 9 : 0 0

0 8 : 0 0 -1 7 :0 0

nm

0 8 : 0 0 - 1 6 : 5 9 0 8 : 0 0 -1 8 : 0 0

$ 15

$ 23.35

$ 2 8 .2 5

1 7 : 0 0 -2 4 : 0 0

nm

1 7 :0 0 -2 2 : 5 9 1 8 : 0 0 -2 3 :0 0

$ 23.25

$ 3 9 .7 5

S pecia l trip charge
Evenings

-

Premium

+33%

S pecia l vis it fee
Night premium

-

-

1 9 :0 0 -2 4 :0 0 1 7 :0 0 -2 4 :0 0

+ 50%

1 7 :0 0 -2 4 :0 0

1 9 :0 0 -2 4 :0 0

+ 30%

+ 30%

+ 25%

_

1 7 :0 0 -2 4 :0 0

-

$ 36 .2 0

$8.45

$ 3 2 .2 2

$ 22

+ 50%

+ 25%

_

+50%

+ 25% (mini-

-

$ 2 9 .4 0

mum $25 .8 0 )
S pecia l vis it fee
W o rk w eek
S urg ical a s sista n t's fee

$ 31.85
M o n -S a t

M o n -Fri

M o n -F ri

M o n -F ri

$ 5 4 .3 0

-

$ 3 2 .2 2

$22

$ 23.35

$ 7 9 .5 0

$ 4 1 .3 0

M o n -F ri

M o n -F ri

M o n -F ri

M o n -F ri

M o n -F ri

M o n -F ri

M o n -F r i

$ 6 6 .2 5 for

Procedures

21% of

25% of

$ 8.47 /1 5 min to

35% of

20% (min-

25% (minimum

major fee

major fee

2 h; $16.94/

surgeon fee

2 h; $19.34/

imum $27 .4 5 )

$15)

+ 10% of

+ 10% of

15 min thereafter

thereafter + units

25% if sur-

others

others

+ units for

fo r procedure

$ 9.67 /1 5 min to

procedure

$ 62.80/1 h;

Procedures of

$18 /15 min

< $ 1 3 2 .7 5 -

1 h; $ 1 6 .5 0 / < $ 9 7 . 5 0 -

thereafter

$ 5 2 .9 0 (+

1 5 min

geon/referring

$ 1 7 .9 0 fo r every

thereafter

GP

$88.05)

$ 41.10;
$ 9 7 .5 0 -2 9 1 $ 7 6 .5 0 ; $291
- 485 - $105

A s st, special trip

-

-

$ 2 8 .5 0

-

-

_

$ 3 2 .2 2

$15

$ 23 .3 5

Evening

$ 4 2 .8 0

$ 3 6 .2 0

$ 3 2 .2 2

$22

$ 23.35

$ 3 9 .7 5

$ 2 9 .4 0

Night

$ 4 2 .8 0

$ 5 4 .3 0

$ 3 2 .2 2

$30

$ 23.35

$ 7 9 .5 0

$ 4 1 .3 0

Prem ium , evening

-

-

night

+40%

_

+ 50%

Preoperative care
in clu ded in

All:

A ll except

All:

90 d

major consul-

30 d

procedural fee

tation

Po stoperative care
in clu ded in fee

+40%

_

_

+ 50%
A ll except

A ll except

All:

major consul-

major consul-

30 d

tation

tation

A ll except

A ll unless

All:

All:

major consul-

documented

30 d

30 d

tation

All:

All:

All:

All:

All:

All:

All:

All:

All:

All;

15 d

42 d

42 d

8 wk

30 d

30 d

42 d

42 d

42 d

42 d

S U B S E Q U E N T PRO CED UR ES, % of normal fee
Sam e anesthesia,

50

50

85

50

85

50

50

75

50

75

50

50

50

85

75

85

50

65

75

75

75

75

nm

100

nm

nm

nm

100

nm

nm

100

1 00

100

nm

nm

85

nm

nm

100

nm

nm

A rthroscopy, hip

1 06 .1 0

150

82.50

1 3 3 .4 4

1 04 .7 5

1 3 3 .5 5

179

1 05

9 9.75

121

93

W ith biopsy

+ 2 6 .5 0

175

+ 9 .25

2 5 8 .2 4

325

3 5 6 .1 5

3 1 3 .2 5

265

2 93

362

351

sam e incision
S am e anesthesia.
n ew incision
S am e anesthesia,
diffe ren t surgeon
N e w condition,
w ith in 14 d

PR O CED UR ES, S

W ith foreign

200

body removal
Arthrotom y, hip

2 3 8 .7 0

225

256

Reduction, hip
Closed

1 03.95

98

2 27 .2 5

1 47 .8 4

2 8 8 .5 0

1 3 3 .5 5

1 3 4 .2 5

1 33

83

1 5 7 .5 0

256

Open

2 0 6 .8 5

195

3 44 .6 0

2 95 .6 8

4 3 7 .5 0

3 1 1 .6 5

3 1 3 .2 5

292

2 93

518

428

Bladder, cystectom y
Partial

2 6 5 .2 0

2 50

3 1 3 .5 0

2 9 5 .6 8

398

3 5 6 .1 5

358

299

427

249

341

W ith reimplant

3 7 1 .3 0

350

4 5 3 .7 0

3 9 8 .4 0

576

4 4 5 .2 0

4 8 3 .3 0

362

514

405

499

6 36 .5 5

600

6 0 2 .6 0

nm

7 65

nm

nm

nm

514

572

3 0 .9 5

50

2 9 .1 0

1 2 9 .5 0

9 6 .5 0

6 4 .2 0

4 4 .1 6

75

1 40 .2 0

1 10 .4 0

1 0 3 .5 0

9 6 .5 0

493

474

558

o f ureter
W ith reimplant
o f ureters
Urethroscopy
W ith biopsy

+ 10.05

W ith foreign

7 7 .4 0

4 4 .1 6

37
8 1 .5 0
178

71.20

5 3 .3 0

5 3 .6 0

29.85

71.20

5 3 .3 0

nm

nm

1 33 .5 5

1 3 3 .2 5

92

1 19.50

body removal
Gastroscopy

5 1 .6 0

50

7 4 .8 0

88.32

95

1 33.55

1 3 4 .2 5

83

9 7.25

W ith biopsy, photo

+ 15.50

+ 15

74.80

88.32

95

1 33.55

1 3 4 .2 5

83

9 7.25

W ith foreign

+ 32

+35

8 1 .1 0

1 47 .8 4

103

nm

nm

128

230

230

3 3 0 .8 0

2 92 .8 0

420

3 2 0 .4 5

3 3 1 .1 5

542

T otal gastrectom y

620

620

7 7 3 .5 0

6 5 0 .8 8

982

7 12 .2 5

6 2 6 .5 0

669

618

921

826

Gastroduodenostomy/

2 5 4 .6 0

260

3 3 0 .8 0

2 9 2 .8 0

420

3 2 0 .4 5

3 2 2 .2 0

327

3 70

542

315

3 5 0 .1 0

370

+ 130

4 0 7 .0 4

+ 165

4 4 5 .2 0

4 2 9 .6 0

467

+ 8 8 .5 0

758

461

body removal
Wedge resection
fo r ulcer

gastrojejunostomy
W ith vagotomy
Pericardiectom y
One side open

2 97 .0 5

350

5 1 9 .9 0

IC

660

3 5 6 .1 5

358

542

688

610

582

Both sides open

4 8 8 .0 5

460

8 1 9 .2 0

IC

104 0

5 3 4 .1 5

537

nm

nm

nm

nm

428

Cardiotomy
W ith exploration

2 6 5 .2 0

250

4 3 0 .1 0

IC

546

4 4 5 .2 0

537

440

558

469

W ith foreign

3 28 .9 0

310

5 1 9 .9 0

IC

660

4 4 5 .2 0

4 4 7 .5 0

444

nm

836

body removal

nm -

not mentioned; 1C -

independent consideration.
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Care of the Ureter in Pelvic Surgery
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Maintaining the integrity of the ureter is
crucial in pelvic surgery. The ureter is
best safeguarded by routine intraopera
tive exposure, which will also allow
immediate recognition of injury to it. If
doubts over possible injury persist, it is
best to open the bladder. The flux of
urine from the ureteric orifices or the
retrograde passage of catheters will then
confirm or deny clinical suspicions. If
specialist help is unavailable, the pelvic
surgeon must be able to perform simple
ureteric repairs or temporize in a way
that allows the safe delay of definitive
surgery. End-to-end ureteric anastomosis
and ureteroneocystostomy are straight
forward procedures that all pelvic sur
geons should be familiar with. If they
cannot be performed safely, the situa
tion may be salvaged by draining the
proximal ureter through the lateral
abdominal wall; later, definitive surgery
can be performed.
En chirurgie pelvienne, il est crucial de
maintenir I'integrite de I'uretere. Le meilleur moyen de sauvegarder I'uretere consiste a I'exposer de routine durant I'operation, ce qui permet egalement de
reconnaltre les lesions qui pourraient
I'affecter. Si le doute persiste quant a
des lesions possibles, mieux vaut ouvrir
la vessie. L'ecoulement d'urine a partir
des orifices ur^teraux ou le passage
retrograde de catheters permettront alors
de confirmer ou d'infirmer les soupcons
cliniques. Si on ne peut compter sur
Taide d'un specialiste, le chirurgien pel
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vien doit etre capable d'effectuer des
reparations simples des ureteres ou de
temporiser de facon a permettre de retar
der I'operation definitive en toute secu
rity. Les anastomoses ureterales bout-about et les ureteroneocystostomies sont
des interventions simples que tout chirur
gien du bassin devrait connaTtre. Si elles
ne peuvent etre pratiqu£es sans risque,
on peut sauver la situation en drainant
I'uretere proximale via le cote de la paroi
abdominale; la chirurgie definitive pouvant etre remise a plus tard.

Pelvic surgeons are concerned with main
taining the integrity of the ureter, for,
should injury occur, the postoperative
course will often be complicated and fre
quently secondary surgery will be needed.
This review will detail the circumstances
surrounding the occurrence of ureteric
injury and its management. The discus
sion of repair will be confined to that
undertaken at the time of surgery; treat
ment of ureteric injuries that are first
recognized in the postoperative period
need not be immediate, and there will be
time to obtain specialist help.1"3
The Injury

Two-thirds of all iatrogenic ureteric
trauma occurs during gynecologic sur
gery, most often for abdominal hys
terectomy or the excision of uterine
adnexa.1,4 The hysterectomy is fre
quently described as “ straightforward”
and “ uncomplicated” .5 Pelvic inflam
matory disease, endometriosis, uterine or
ovarian tumours may displace the ureter
and contribute to injury but not to the
extent generally believed. Less common
sources of injury are abdominoperineal
or anterior resection of the rectum; the
ureters are at risk near the point where
the in ferior m esenteric artery is
ligated.6’7 Vascular surgery also accounts

for a number of ureteric injuries.1
Hyperangulation and obstruction of the
ureter may result from placing vaginal
sutures more laterally than recommended
during a Burch urethropexy.
The ureter is frequently injured while
hemostasis is being obtained. Therefore,
the more common sites of injury are deep
in the pelvis, close to the point where the
uterine artery crosses over the ureter and
at the brim of the pelvis, where the ure
ter and ovarian vessels converge. The
usual mechanism of injury is a crush or
cut of a small portion (less than 1.0 cm)
of an otherwise normal ureter. In gyneco
logic surgery for benign disease, the ure
ter is never “ stripped” and thus its blood
supply is rarely interrupted.8’9
Prevention

The traditional means of avoiding
operative injury to the ureter is to stay
well clear of it. For example, at hysterec
tomy, dissection is confined to the area
in close proximity to the uterus. There
are, however, difficulties with this
approach. At times, pelvic lesions may so
distort the ureter’s pathway that a dissec
tion, believed to be far from the ureter,
may place it in jeopardy, or a pelvic mass
may limit the surgeon to dissection in
areas where direct contact with the ure
ter is unavoidable. At other times, the
ureter may be in its usual position, but
landmarks are lost and the ureter is inad
vertently clamped, incised or ligated.
The best way to avoid ureteral injury
is to expose it through a retroperitoneal
dissection.5 This dissection is not
difficult and it allows an easier approach
to pelvic surgery. A further advantage is
the immediate discovery of any ureteric
damage.1011
Retroperitoneal dissection is initiated
by cutting the round ligament at its mid
point. The peritoneum is incised in a cau
dal direction for 4.0 cm and the incision
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extended cranially well above any pelvic
disease. This cranial-directed incision is
placed lateral to the ovarian vessels
(infundibulopelvic ligament).
The medial edge of the cut peritoneum
is grasped with two or three small curved
forceps and elevated medially. Immedi
ately beneath the peritoneum a conden
sation of the endopelvic fascia will be
seen; the small blood vessels in this layer
are best cauterized on sight. This prevents
staining of tissues and enhances the dis
section. The endopelvic fascia is then
incised for 3 to 4 cm, giving access to
loose retroperitoneal tissue that is charac
teristically free of adhesions. The
retroperitoneum in this location can eas
ily be divided with the forefingers.
It is emphasized that dissection must be
directed both medially and posteriorly to
avoid the common and internal iliac
blood vessels. As the surgeon proceeds
along the medial leaf of the peritoneum,
the ovarian vessels are first encountered;
just deep to them, the ureter will be found
attached to the peritoneum. The ureter is
usually easy to identify by the peristaltic
movements, its “ macaroni-like” appear
ance and the fine blood vessels that cover
it. The ureter runs from the brim of the
pelvis (which it enters by crossing above
the bifurcation of the common iliac blood
vessels) downward to the medial aspect
of the lateral cervical ligament. It then
enters the ureteric canal and passes
beneath the uterine artery, advancing
through the vesicouterine ligament into
the bladder.
The whole course of the ureter (from
the pelvic brim to the ureteric canal) can
be traced, with little bleeding, in a few
moments. A further advantage is that the
location of the ovarian and uterine ves
sels has been established.

be established by opening the bladder
through a vertical cystotomy and noting
the escape of jets of blue urine from the
ureteric orifices.
If uncertainty persists, the suspect ure
ters should be catheterized; a no. 8 French
infant feeding tube serves this purpose
admirably. The catheterization may not
be easy, for a mucosal flap can prevent
passage of the catheter. In such an event,
tension applied to a suture, temporarily
placed in the middle of the interureteric
bar, will straighten the intramural ureter
and permit the catheter’s passage.
Repair of the Injury

Usually only a small portion of a nor
mal ureter is damaged, but there is a
regrettable tendency to underestimate
such injuries.13’14 Segments crushed by
suture or forceps should be excised and
partial transections should be treated as
though they were complete. Another mis
take is failure to ensure that the repair
performed is well clear of any pelvic
disease.
End-to-End Anastomosis

This method of repair is an uncompli
cated procedure that restores anatomy
and preserves the normal vesicoureteric
junction. Some years ago it was dis
couraged because stenosis frequently
occurred at the site of repair. This
problem can be minimized by enlarging
the anastomotic site and preventing the
pooling of urine in the retroperitoneal
space. Urine in this location excites a
fibrotic response; this fibrosis outside the
ureter and the scarring of the ureter itself
at point of injury may result in obstruc
tion of the ureter.
To reduce pooling of urine, the anasto
Recognition
mosis is made as watertight as possible
and the area is drained with a JacksonIt should be emphasized that most ure Pratt drain. Years ago it was taught that
teral injuries occur after uncomplicated urine must be diverted away from the
surgery when injury to the ureter has not anastomotic site by a vertical relieving
been considered.5 Less than one-third of incision.15 It is now argued that in the
injuries are recognized intraoperatively; absence of radiation injury or infection
delay compounds the potential complica diversion is unnecessary.16
tions. Immediate repair is usually
A recent introduction is the internal
straightforward and the postoperative splint that not only provides a conduit for
result is generally good.1'7-12
the urine and thus diminishes leakage but
During surgery injury may be suspected also gives support to the anastomosis
if an unusual collection of fluid is noted itself. The malleable double-J ureteral
in the pelvis or if dissection was especially catheter is particularly attractive because
difficult in the vicinity of the ureter.
it is inert and retains its place in both the
When the surgeon suspects injury but renal pelvis and the bladder. The use of
is not willing to expose the ureters, fear such a stent can be seen as an added safety
ing dissection may in turn cause injury, the measure and its use is encouraged.
use of indigo carmine or methylene blue
The following technique of anastomo
dye is called for. After the administration sis is suggested. The ureter is first
of 40.0 mg of furosemide (Lasix), a 5-ml debrided to ensure viability and mobilized
intravenous injection of the dye is given. to prevent excessive tension on the suture
Discolouration of the fluid in the pelvis line. The opposing ends are spatulated to
indicates ureteric injury. If the concern enlarge the circumference of the anasto
is one of ureteric occlusion, patency can mosis, and a double-J ureteral catheter is

inserted. A watertight anastomosis is then
performed using interrupted 5-0 polyglycolic acid sutures through the full
thickness of the ureteral wall. A
Jackson-Pratt drain is placed close to the
anastomotic site and brought out through
a separate incision.
Ureteroneocystostomy
The ureteral injuries that occur at hys
terectomy are most often deep in the
pelvis where limited access makes end-toend anastomosis technically difficult and
increases the risk of ischemic damage to
the distal segment of the ureter. In these
circumstances ureteroneocystostomy,
using an antireflux technique, is advised.
Urologists have become increasingly con
fident with this technique as a result of
their renal transplant experience.
The principles of repair are similar to
those already mentioned. The ureter must
be viable and the anastomosis with the
bladder must be tension-free and tun
nelled, but need not be in the region of
the trigone. Tension-free anastomosis is
best achieved by mobilizing the bladder,
as in the Burch procedure, but dissection
of the proximal portion of the ureter
should be limited. After viability of the
ureter is ensured by resection of the
damaged end, it is brought through the
muscle wall of the bladder by means of
a submucous tunnel — the length of the
tunnel should be five times the diameter
of the ureter. A mucosa-to-mucosa
anastomosis is performed between the
ureter and bladder. A double-J ureteral
catheter is inserted and a Jackson-Pratt
drain placed retroperitoneally, close to the
anastomotic site.
Anastomotic disruption is usually
caused by tension, which can be avoided
by mobilizing the bladder, but if adequate
mobilization is not possible, a psoas hitch
or the Boari-Ockerblad flap should be
used.17 Both procedures permit upward
extension of the bladder so it comforta
bly reaches the injured ureter. Because of
its simplicity and better results, the psoas
hitch has generally replaced the BoariOckerblad flap.1418 The hitch is per
formed by first mobilizing the bladder,
and with two fingers in its interior, a horn
is created which is sutured to the iliopsoas
fascia. The site chosen is lateral to and
above the external iliac artery; care is
taken not to injure the genitofemoral
nerve which overlies the psoas muscle in
that area. Anastomosis with the ureter is
carried out as described.
Other Maneuvers
There are circumstances in which the
suggested repairs are not possible; for
example, a large segment of ureter may
be missing and a urologist is not availa
ble. A procedure that allows renal
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drainage but does not place the other kid
ney in jeopardy or compromise later
definitive repair, is needed. In these cases,
a double J ureteral catheter or an infant
feeding tube is inserted into a linear ure
terostomy well above the site of injury.
The catheter or tube is secured and
brought out through the abdominal wall.
The ureterostomy is closed in a watertight
m anner and the retroperitoneum
drained.14
Experienced urologists have other
options, including transureterouretero
stomy, ureteral replacement by a segment
o f ileum, mobilization o f the kidney,
renal autotransplantation and nephrec
tomy. These procedures should not be
attempted by the less-experienced sur
geon, as further damage to the urinary
tract may result.19 Simple ligation o f the
ureter for autonephrectomy should rarely
be done, for infection and fistula forma
tion frequently result.20
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Coronary artery disease accounts for
more than half of the morbidity and mor
tality associated with abdominal aortic
surgery. To improve the results of vascu
lar surgery, the risk of perioperative
cardiac ischemia should be evaluated in
each patient. Routine coronary angiogra
phy demonstrated severe correctable
coronary artery disease in 14% of
patients who had no history or elec
trocardiographic evidence of coronary
artery disease. Exercise testing before
abdominal aortic aneurysm repair will
identify patients at high risk of cardiac
ischemia. Dipyridamole-thallium imaging
will identify high-risk patients before sur
gery for aortoiliac occlusive disease.
Some patients with symptomatic coro
nary disease who are at extremely high
risk should undergo preoperative coro
nary revascularization. Others should
have their vascular surgery deferred,
because their cardiac risk may exceed
the anticipated benefit of the vascular
surgery. Patients at moderate risk may
need more intensive intraoperative
monitoring. Patients without evidence of
cardiac ischemia with stress may
undergo vascular surgery with a low risk
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of perioperative cardiac ischemia. Finally,
patients who have evidence of ischemic
heart disease should be considered for
coronary revascularization following suc
cessful vascular repair in order to
prolong their survival.

La maladie arterielle coronarienne repre
sente plus de la moitie de la morbidity et
de la mortalite associees a la chirurgie
aortique abdominale. Pour ameliorer les
resultats de la chirurgie vasculaire, le ris
que d'ischemie cardiaque perioperatoire
doit etre evalue chez chaque patient.
L'angiographie coronarienne de routine
demontre une severe et corrigible mala
die arterielle coronarienne chez 14% de
patients sans antecedents ni evidence
electrocardiographique de maladie arte
rielle coronarienne. Des tests d'exercice
avant correction de I'anevrisme aortique
abdominal permettent d'identifier les
patients presentant un risque elev&
d'ischemie cardiaque. La visualisation au
dipyridamole thallium permet d'identifier
les patients a hauts risques avant chirur
gie lors de maladie occlusive aortoiliaque. Certains patients atteints de mala
die coronarienne symptomatique et
presentant un risque extremement eleve
doivent subir une revascularisation coro
narienne preoperatoire. D'autres doivent
avoir ieur chirurgie vasculaire retardee
car le risque cardiaque peut exceder le
benefice escompte apres la chirurgie vas
culaire. Les patients a risque modere
necessitent une surveillance intraoperatoire plus intensive. Les patients sans
evidence d'ischemie cardiaque lors de
stress peuvent subir la chirurgie vascu
laire avec un risque minime d'ischemie
cardiaque perioperatoire. Finalement, les
patients presentant des evidences de
maladie cardiaque ischemique doivent
etre retenus pour une revascularisation
coronarienne, suite a une chirurgie vas
culaire reussie, afin de prolonger Ieur
survie.

More than half the perioperative mor
bidity and mortality associated with
abdominal aortic surgery results from
coronary artery disease.1-5 In addition,
the poor long-term survival after success
ful abdominal aortic surgery usually
results from coronary artery disease.6-11
The vascular surgeon must carefully
assess the risks of perioperative cardiac
ischemia in each patient before elective
vascular surgery is carried out.
Improved techniques of intra- and
postoperative m anagement have
decreased the risks of abdominal aortic
surgery and have reduced the frequency
of perioperative deaths from cardiac
ischemia. However, the incidence of
myocardial infarction postoperatively
remains substantial,5 and a perioperative
myocardial infarction may limit long
term survival after vascular surgery.6’7
Perioperative cardiac injury may also
induce persistent cardiac symptoms
postoperatively. Vascular surgeons there
fore should attempt to minimize perioper
ative myocardial ischemic injury.
Extent of Coronary Artery Disease

Hertzer and colleages12 performed
routine preoperative coronary angiogra
phy in 1000 patients who presented at the
Cleveland Clinic between 1978 and 1983
for consideration of elective vascular
reconstruction. In patients with an
abdominal aortic aneurysm, 6% had nor
mal coronary arteries, 29% had mild to
moderate coronary artery disease, 29%
had compensated coronary artery disease,
31 % had severe correctable coronary dis
ease and 5% had severe inoperable dis
ease. The Cleveland Clinic group care
fully reviewed the coronary angiograms
and the ventriculograms to develop these
complex categories. They classified coro
nary artery disease as mild when no lesion
in a major coronary artery exceeded 70%
stenosis. Coronary artery disease was
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advanced but compensated when a major
coronary artery was stenosed but there
was no im m ediate indication for
m yocardial revascularization either
because the region at risk was adequately
perfused by collateral vessels, or because
it had already been replaced by a scar
from a previous myocardial infarction.
Coronary artery disease was considered
severe but correctable when a severe coro
nary artery stenosis supplied a region of
functioning myocardium which was at
risk for a myocardial infarction. They
classified disease as severe and inoper
able when there was diffuse distal disease
or inadequate ventricular function.
The Cleveland Clinic group compared
these results of coronary angiography to
their suspicion of coronary artery disease
from clinical examination (Table I).
Among the 1000 patients (263 with
abdominal aortic aneurysms, 381 with
lower limb ischemia, 295 with cerebrovas
cular disease and 61 with other vascular
problems), 554 were suspected of having
coronary artery disease before angiogra
phy because of a history of myocardial
infarction or angina pectoris and elec
trocardiographic evidence of a previous
infarction, ST- and T-wave changes or a
left bundle-branch block. Severe correc
table coronary artery disease was found in
34% of those suspected of having coronary
artery disease before angiography (Table
I) compared with 14% of the patients who
had no clinical evidence of coronary
artery disease. Therefore, the patient’s
history and an electrocardiogram may not
provide a reliable guide to those at highrisk for perioperative ischemic injury.
At the Cleveland Clinic, 250 patients
underwent coronary angiography before
abdominal aortic aneurysm repair. Eighty
patients (32%) had severe correctable
coronary artery disease. Of the 250
patients, 76 underwent coronary artery
bypass grafting and 4 (5.3%) died; 206
patients then underwent abdominal aor
tic aneurysm repair and 7 (3.4%) died.
Overall there were 282 operations, result
ing in 11 deaths (3.9%). In the entire ser
ies only one of the patients who had
undergone coronary bypass grafting
preoperatively died during or after
peripheral vascular surgery.
From their experience, Hertzer and
colleagues12 recommended a modified

approach to identify patients with severe
but correctable coronary artery disease.
They recommended preoperative coro
nary angiography for those with clinical
indications of coronary artery disease. If
a major cardiac region was jeopardized
by a critical stenosis, inadequately per
fused by collaterals and not damaged by
a previous infarction, they recommended
preoperative coronary revascularization.
In patients who had no clinical indication
of coronary artery disease, they recom
mended extensive noninvasive testing to
identify the 14% of patients who will have
severe correctable coronary artery disease.

suffered cardiac ischemia perioperatively.
Four patients had a myocardial infarction
perioperatively and three of them died.
Four had angina and transient elec
trocardiographic changes and two under
went successful coronary bypass surgery.
T h erefore, exercise testing or
dipyridamole-thallium imaging may iden
tify patients who are at high risk for
cardiac ischemia perioperatively, but the
management of these high-risk patients
remains controversial.

Noninvasive Testing

Figure 1 illustrates the preoperative
management protocol that we have used
at the Toronto General Hospital to evalu
ate patients before performing abdomi
nal aortic surgery. After a complete his
tory, a physical examination and an
electrocardiogram, most patients can be
divided into one of three groups: (a) a his
tory of previous cardiac events, (b) likely
to have a cardiac condition or (c) unlikely
to have a cardiac condition. Preoperative
evaluation should attempt to identify
patients who are at high risk of ischemic
injury perioperatively (severe stenosis in
a vessel supplying a large segment of
functioning myocardium) rather than
identify patients with a cardiac condition.
Those who have severe ventricular dys
function but do not show evidence of
ischemia with stress will require intensive
monitoring intraoperatively, but they may
not be at risk of ischemic events perioper
atively and may not benefit from preoper
ative coronary revascularization. Patients
who have angina that is poorly controlled
with full medical therapy should proba
bly undergo coronary angiography
preoperatively. The remaining patients
should probably undergo noninvasive
testing that includes an exercise test (with
electrocardiographic m onitoring or
nuclear ventriculography) or a

Two-dimensional echocardiography
will identify wall-motion abnormalities
from a previous myocardial infarction but
will not detect regions at risk of ischemia
or infarction with stress. Patients with an
abdominal aortic aneurysm can undergo
exercise testing to evaluate their risk of
perioperative ischemic injury. Exercise
testing with or without thallium imag
ing13 may identify the extent of inade
quately perfused cardiac regions during
exercise. Rest and exercise nuclear ven
triculography will identify global or
regional ventricular dysfunction with
exercise suggesting severe correctable
coronary artery disease.
Patients with aortoiliac occlusive dis
ease usually cannot undergo standard
exercise testing. Thallium imaging before
and after intravenous administration of
dipyridamole may identify patients at
high risk of perioperative ischemic injury.
Boucher and colleagues14 at the Mas
sachusetts General Hospital evaluated 54
patients with suspected coronary artery
disease before they underwent peripheral
vascular surgery. Six had abnormal thal
lium test results and underwent coronary
bypass surgery before the abdominal aor
tic procedure, with no cardiac complica
tions. Twenty patients had normal thal
lium scans and 12 had persistent thallium
defects (suggestive o f a previous
myocardial infarction); all 32 underwent
vascular surgery without cardiac ischemic
complications. Sixteen patients had evi
dence of ischemia (thallium redistribu
tion) with stress (dipyridamole) and 8

Table I—Angiographic Classification of Coronary Artery Disease
ICAD) Before Vascular Surgery at the Cleveland Clinic
Suspected CAD,*
Angiographic classification
%
4
Normal
18
Mild
34
Compensated
34
Severe, correctable
10
Severe, inoperable
"Suspected CAD = cardiac history or an abnormal electrocardiogram.
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No indication
of CAD, %
14
49
22
14
1
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FIG. 1—Preoperative management pro
tocol. Careful history, physical examination
and electrocardiogram will determine likeli
hood of cardiac disease, but noninvasive evalu
ation may be required preoperatively to iden
tify those patients who have evidence of cardiac
ischemia with stress and severe, correctable
coronary artery disease. Management of these
patients requires careful assessment of risks and
benefits of abdominal aortic surgery.
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dipyridamole-thallium test (for those who
cannot exercise). An echocardiogram may
identify regional abnormalities of wall
motion or dysfunction of the cardiac
valve. A cardiology consultation may help
in selecting the appropriate tests. Noninvasive testing may identify the 14% who
have severe correctable coronary artery
disease without a history of a cardiac con
dition and the 34% with a history of a
cardiac condition who have severe correc
table coronary artery disease.
After preoperative noninvasive evalu
ation, most patients can be classified into
one of three groups: low, moderate and
high probability of suffering cardiac
ischemia perioperatively. Patients with a
low probability should undergo routine
abdominal aortic surgery. Those with a
moderate probability may require exten
sive intra- and postoperative cardiac
monitoring. Experienced anesthetists
employing intensive monitoring can pro
vide excellent hemodynamic stability dur
ing operation that may reduce possibil
ity of cardiac ischemia. Patients who have
evidence of myocardial ischemia with
stress should have the risks and benefits
of the vascular procedure carefully
reviewed. Some should undergo vascular
surgery with intensive monitoring. Some
should be considered for coronary
angiography and preoperative coronary
bypass surgery. For some patients with
severe coronary artery disease, the risks
of the vascular procedure may outweigh
the potential benefits. In these patients
vascular surgery should be delayed.
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ment the roles of the cardiologist and
vascular surgeon. Identification of risk
factors and assessment of the degree of
functional impairment of vital organs
allows the anesthetist the best opportu
nity to provide the vascular patient with
as stress-free a surgical experience as
possible.
Patient profiles, monitoring, induction
and maintenance phases in the adminis
tration of the anesthetic, and concerns
of the early postoperative period are dis
cussed from the anesthetist's perspec
tive. General principles are emphasized.
Specific details of assessment and
management must be guided by local
experience and resources.
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completer les roles du cardiologue et du
chirurgien vasculaire. L'identification des
facteurs de risques et I'etablissement du
degr£ de deterioration fonctionnelle des
organes vitaux permettent a I'anesthesiste de fournir au patient de meilleures
garanties d'absence de complications
lors de la chirurgie vasculaire.
Les profils des patients, le monitoring,
les phases d'induction et de maintien
lors de ('administration de I'anesthesique,
ainsi que la surveillance du stade precoce postoperatoire sont discutes sous la
perspective d'un anesthesiste. Les principes generaux sont degages. Les details
specifiques devaluation et de controle
doivent etre guides par ('experience
locale et les ressources disponibles.

Mutual understanding of the respective
contributions of medicine, surgery and
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anesthesia can benefit the patient who
presents with abdominal aortic disease.
Advances in technique and aggressive
monitoring have become the benchmarks
of anesthesia’s contribution.
This discussion will outline the extent
of anesthesia’s role. I shall begin with
some comments on patient profile and
monitoring, then consider induction,
maintenance and the early postoperative
period.

Patient Profile
The medical profile of a patient sched
uled to undergo abdominal aortic surgery
has been well documented. Given its
generalized nature and the host of
predisposing factors contributing to its
onset, patients with atherosclerosis who
require abdominal aortic surgery may
present with disease and functional
impairment of the heart, lungs, kidneys
and brain.
By interviewing the patient preoperatively and reviewing the investigative data
on the chart, the anesthetist can assess the
functional reserve of the vital organs.
Myocardial function has repeatedly
been demonstrated to be the most impor
tant factor in determining patient out
come after aortic surgery. Through a his
tory of congestive failure or limited
physical activity, the patient with func
tional impairment of the left ventricle will
be relatively easy to identify. The patient
without an abnormal cardiac history
presents a more difficult problem. Here,
the extent of coronary artery disease is
unknown, as is the likely response of the
left ventricle to the critical events of the
perioperative period. A normal resting
electrocardiogram and an exercise elec
trocardiogram that is limited by the phys
ical constraints of peripheral vascular dis
ease leave the question of functional
reserve and myocardial ischemic risk
unanswered. The expense and risks of
coronary angiography preclude its routine
use in patients scheduled for vascular sur
gery. Dipyridamole-thallium scanning as
reported by Boucher and associates1
appears to offer a solution to this major
gap in our knowledge. Patients may be
separated, preoperatively, into low- and
high-risk categories for myocardial ische
mia and dysfunction. Their management
would differ, but the objective of vascu
lar surgery completed successfully with
the least risk of perioperative myocardial
ischemia and its sequelae could be
achieved in a larger percentage of
patients. If this imaging technique proves
reliable, it may become a routine investi
gation before major vascular surgery.
With the high rate of smoking in this
group of patients, pulmonary dysfunction
is common and may complicate the peri
operative period. Altered response to
240

fluctuations in hydrogen-ion concentra
tion and arterial oxygen content coupled
with the depressant effects of anesthetic
agents and narcotics can place these
patients at greater risk than others.
Increased pulmonary secretions and dis
turbances in chest-wall mechanics con
tribute to morbidity.
To cope with the stresses imposed dur
ing the perioperative period, the kidneys
must maintain three functions — a
glomerular filtration rate adequate to
maintain nonuremic blood chemistry, the
ability to autoregulate intrarenal blood
flow over a range of blood pressures and
have tubules capable of controlling water
and electrolyte fluxes. Consequently, the
anesthetist will review the creatinine
index, a range of the patient’s bloodpressure determinations and the specific
gravity on a urine specimen taken before
surgery.

Preinduction
Application of currently available
monitoring techniques to patients who
undergo abdominal aortic surgery allows
the anesthetist to follow closely physio
logical functioning intraoperatively. Limi
tations of these monitoring techniques
require extrapolation from actual infor
mation provided and is accepted clinical
practice in the management of such
patients.
During electrocardiographic monitor
ing, lead II will be adequate to interpret
simple dysrhythmias but is considered
inadequate for ischemia as only inferior
wall events are chronicled. At a mini
mum, leads II and V5 must be displayed.
Addition of an esophageal lead would
allow the posterior myocardium to be
monitored for ischemia. One must real
ize that ST depression is a late indicator
of myocardial ischemia, and such changes
on the oscilloscope are preceded by the
following: regional myocardial dysfunc
tion, decreased ventricular compliance
with the appearance of new V waves on
the wedge- or occlusion-pressure tracing,
myocardial lactate production and angina
pectoris in the awake patient.
Catheterization of the radial artery is
universally accepted for monitoring, but
its limitations must be appreciated in that
both false high and false low pressures
may be presented. For example, reverber
ation in an inadequately damped system
will give false high systolic pressures and,
similarly, low pressures may be artefactual. The electronically derived mean
arterial pressure is more consistent in
representing true events. Devices are now
available to adjust damping in the
catheter-transducer system without alter
ing natural resonating frequencies.
Right atrial catheterization should be
performed to determine right ventricular

filling pressures. It also allows access to
the central venous circulation for the infu
sion of vasoactive drugs.
Pulmonary artery catheterization is
now common in monitoring patients who
undergo major vascular procedures, and
multifunction catheters are available. The
catheter should be placed in the awake
but sedated patient, preferably several
hours before the scheduled surgery. This
allows time to observe the response of the
left ventricle to volume challenging as well
as the degree of relationship between the
pulmonary artery diastolic pressure and
the pulmonary artery occlusion pressure.
Convincing arguments have been made to
justify the use of the pulmonary artery
catheter in patients with good left ventric
ular function. Waller and associates2
have shown that many hemodynamic epi
sodes were missed or misinterpreted
without the use of the catheter. Conners
and colleagues3 showed that the
hemodynamic status of critically ill
patients could not be predicted on the
basis of clinical signs. The occlusion pres
sure was predicted correctly in only 42%
of cases and the cardiac index in only
44%. Further, in 48% of cases correct
information obtained from the pulmo
nary artery catheter monitoring prompted
a change in drug therapy. Preoperative
knowledge of the left ventricular ejection
fraction appears not to predict a relation
ship between central venous pressure and
pulmonary artery occlusion pressure in
patients who undergo abdominal aortic
surgery. Ansley and colleagues4 sug
gested that both pressures must be
independently measured to assess the ven
tricular filling pressures.
Ongoing assessment of renal function
by observation of urine output is gener
ally followed on an hourly or half-hourly
basis. By convention, renal function is
assumed to be normal if hourly flows
greater than 0.5 ml/kg are maintained.
During infrarenal cross-clamping, a rever
sible, functional oliguria commonly
develops. Frequently observed and inade
quately explained, this oliguria is selfcorrecting if adequate intravascular
volume and systemic pressures are main
tained throughout the procedure and into
the recovery period.

Induction
Induction of anesthesia leading up to
surgery is the first critical event in
intraoperative management of the
patient. It is a time requiring the closest
attention to any alteration in functions.
With careful titration of selected induc
tion agents and with airway management,
the patient is prepared for intubation. By
observing individual responses to a series
of graded stimuli, ranging from loss of
sympathetic tone with lapse into uncons-
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ciousness to the degree of pressor
response to laryngoscopy without intuba
tion, the anesthetist can judge both the
level of anesthesia and degree of
hemodynamic control. Dysrhythmias and
severe hemodynamic changes are most
likely to occur at this stage. Once intu
bation is complete, stimulation is minimal
until the surgical incision is made.
Throughout the induction sequence it is
essential that the anesthetist have availa
ble the drugs necessary to treat detrimen
tal alterations in hemodynamics (e.g.,
nitrates, inotropes, /3-blockers and cal
cium antagonists).
Maintenance

The maintenance phase brings concerns
in addition to preserving myocardial oxy
gen balance, such as fluid replacement,
rate of decline in body temperature,
degree of accumulation of anesthetic
agents and alterations of ventilationperfusion ratios in the lungs. It is during
the maintenance period that two other
critical events take place — cross
clamping and declamping of the aorta.
Fluid replacement for the majority of
these patients requires a rigorous response
to marked alterations in extracellular fluid
and blood volume. Rate of replacement
is guided by serial central venous and
occlusion pressure readings, changes in
the morphology of arterial waveform,
urine output and ongoing estimates of
blood loss. Crystalloid in the form of
Ringer’s lactate solution or normal saline
is employed initially and replaced with a
more osmotically active solution, such as
hetastarch or stored plasma, later in the
procedure. It is common to administer
more than 1 L /h of crystalloid. Oxygen
carrying capacity is supported with
packed cells as indicated, on the basis of
initial hematocrit value and blood loss.
A second problem, hypothermia, has
numerous adverse effects that include
alterations in functioning of the follow
ing: anesthetic agents, the coagulation
system, the oxyhemoglobin dissociation
curve, performance of the myocardium
and the ability to buffer or metabolize lac
tic acid. Maintenance of normal body
temperature is difficult in the intraoper
ative period. The rate of decline of body
temperature can be slowed by active
warming of inhaled gases and intravenous
fluids and must be considered part of the
standard intraoperative care of these
patients.
A third concern is the accumulation of
anesthetic agents. Tissue uptake of fixed
and volatile drugs, especially lipid-soluble
drugs is a well-characterized component
of anesthetic pharmacokinetics. The two
main determinants of the rate and degree
of tissue uptake are tissue blood flow and
drug storage capacity. Constant doses of

fentanyl citrate or isoflurane throughout
the operation will result in a large tissue
store requiring metabolization and excre
tion in the early postoperative period.
Problems accompany mechanical ven
tilation of the lungs. Monotonous fixedvolume ventilation will allow a progres
sive deterioration in ventilation-perfusion
ratios, resulting in a progressive intrapulmonary shunt and subsequent impaired
oxygenation. High peak airway pressures
may result in a reduction in venous return
to the heart. Positive end-expiratory pres
sure may alter pulmonary artery pressures
and position of the intraventricular sep
tum, thereby disturbing left ventricular
stroke volume, but ongoing attention by
the anesthetist will minimize these haz
ards. The anesthetist can manipulate ven
tilator settings to provide optimum gas
exchange with a minimum of deleterious
effects, aided by either a mass spectrom
eter or stand-alone oximeter and capnometer in conjunction with serial arterial
blood-gas measurements.
Two critical events — cross-clamping
of the aorta and subsequent declamping
— require close cooperation between the
anesthetist and the surgeon. Anticipation
of these events allows for appropriate
action to be taken to minimize the phys
iologic sequelae to sudden drastic altera
tions in peripheral vascular resistance and
venous return. It is impossible to predict
precisely the degree of response of either
the myocardium or the myocardial oxy
gen supply-demand ratio to aortic cross
clamping. With information supplied by
systemic and pulmonary pressure lines
and close attention at the time of clamp
ing, intervention with vasodilators or
volume replacement, or both, will effec
tively counter adverse hemodynamic con
ditions. Declamping will again result in
marked alterations in hemodynamic func
tion. Vigorous volume replacement
preceding declamping will counteract the
hypotension commonly observed.
Early Postoperative Period

The hours immediately after abdomi
nal aortic surgery are viewed by the
anesthetist as a continuation of intraoper
ative management. Requirements for
volume replacement, warming and the
administration of analgesia and sedation
continue.
Problems such as oliguria, coagulopa
thy or “ breakthrough” hypertension may
occur in the later stages of the main
tenance period or de novo in the early
postoperative period.
Renal failure developing perioperatively can seriously complicate the out
come in these patients. Prompt aggressive
dialysis may improve results, although the
death rate remains exceptionally high.
Prevention seems the best course, so the

anesthetist must constantly be concerned
about renal function during the opera
tion. Mechanisms available to prevent
renal failure are similar, regardless of the
etiology. These preventive measures
include maintenance of renal blood flow,
glomerular filtration rate and tubular
flow. Urine volume remains the standard
monitor of renal function intraoperatively. The quality of this urine is not rou
tinely measured (e.g., specific gravity,
sodium concentration, urine-plasm a
ratios). In addition, a mental checklist of
the major determinants of urine volume
(mean systemic arterial pressure, antidi
uretic hormone, sympathetic tone, tubu
lar osmotic load and plasma oncotic pres
sure) should be reviewed at intervals by
the anesthetist. In response to a fall in
urine output this checklist may suggest
appropriate therapy (e.g., increase mean
arterial pressure, crystalloid infusion or
“ renal dose” dopamine).
As with other major problems asso
ciated with this type of surgery, emer
gence of a bleeding disorder is often
predictable. Rarely is intraoperative
coagulopathy due to an isolated defect in
the clotting system; it is usually multifac
torial. Early signs of trouble such as per
sistent oozing from previously dry raw
areas or failure to see clot formation in
pooled blood will prompt the anesthetist
to alert the blood bank to an anticipated
increased need for blood and blood com
ponents. Tests to be performed might
include prothrom bin, partial throm 
boplastin and activated coagulation
times, platelet count and measurement of
fibrinogen and fibrinogen-split products.
Early consultation with the hematology
service can facilitate a prompt response
from laboratory and blood bank. More
importantly, expertise will be provided
should the problem persist or worsen,
although the mainstay of therapy for
acquired coagulopathies in the perioper
ative period remains infusions of freshfrozen plasma and platelets.
The appearance of an exaggerated
hyperdynamic phase with hypertension
and tachycardia early in the recovery
period indicates that the patient has
“ broken through” the sedation and
analgesia. Prom pt appropriate use of
vasodilators, narcotics, /3-blockers and
sedative hypnotics will prevent the poten
tially deleterious effects of increased
m yocardial work and oxygen con
sumption.
Conclusions

Postoperative care of the patient who
has undergone abdominal aortic surgery
will frequently pass from the anesthetist’s
hands upon transfer to the intensive care
unit. By virtue of the preoperative evalu
ation and, more importantly, through
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several hours of direct observation and
care, the anesthetist has accumulated con
siderable information about each pa
tient’s response to various physiologic
stresses. A great deal of information on
the intraoperative course of the patient is
contained in the anesthetic record. Unfor
tunately, interpretation of this record in
the postoperative period is often difficult
and sometimes impossible to those un
familiar with the symbols and shorthand
it contains. The result is either a poten
tially hazardous misinterpretation of

intraoperative events or a disregard for
information that may have a positive
bearing on a postoperative problem. I
would emphasize the need for direct com
munication among all specialties involved
in care of the patient in the perioperative
period.
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3. Postoperative Management of Patients
Who Undergo Aortic Surgery
Because patients with occlusive or
aneurysmal disease of the aorta fre
quently have coexisting disease in other
important organ systems, complications
after aortic surgery usually relate to the
heart, lungs and kidneys. Postoperative
care thus requires attention, in an
intensive-care milieu, to respiratory,
cardiac, renal and gastrointestinal sys
tems, coagulation and, in rare instances,
psychiatric problems.

Du fait que les patients souffrant
d'occlusion ou d'anevrisme aortique sont
frequemment atteints de maladies au
niveau d'autres organes vitaux, les com
plications apres chirurgie aortique sont
g^neralement reliees au coeur, poumons
et reins. La surveillance postoperatoire,
en milieu de soins intensifs, necessite
une attention particuliere aux systemes
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respiratoire, cardiaque et gastro
intestinal, a la coagulation et, dans de
rares cas, aux problemes psychiatriques.

The patient with occlusive or aneurysmal
disease of the aorta is generally in an age
group in which coexisting disease in one
of several organ systems is common and,
hence, complications after aortic surgery
usually relate to the heart, lungs and kid
neys, rather than to the arterial recon
struction itself. Although the measure
ment of central venous pressure is a
relatively reliable guide to cardiac func
tion and volume status under normal cir
cumstances, it is often inaccurate during
stress and in the presence o f cardiac and
pulmonary disease. Swan-Ganz catheteri
zation is therefore relied upon in these
patients for more precise measurement of
fluid and blood replacement.
Postoperative complications associated
with intraoperative problems include the
following: injury to the inferior vena cava
and iliac veins, ureteral injury, intraoper
ative and postoperative thrombosis,
intimal embolism, postoperative hemor
rhage, stenosis or occlusion of an anasto
mosis, spinal cord ischemia and paraple
gia and ischemia of the left colon. These
are specific problems that are usually eas
ily recognized and, except for spinal cord
ischemia, amenable to correction.
Postoperative care requires attention to
the following: intensive care monitoring,
respiratory, cardiac, renal and gastroin
testinal (stress ulceration) systems, bleed
ing and psychosis.

Monitoring
Initially the patient should be stabilized
in an intensive care or recovery room
where vital signs, urine output, cardiac
rhythm and respiratory status can be con
tinuously monitored for as long as neces
sary. Systemic blood pressure, heart rate
and rhythm and arterial blood gases
should be measured promptly and a chest
x-ray film obtained to check endotracheal
tube position and adequate lung expan
sion. Pre- and postoperative 12-lead elec
trocardiograms should be compared. If
myocardial ischemia or infarction is sus
pected, blood samples should be submit
ted for measurement of cardiac isoen
zymes, hematocrit, serum electrolyte
values, blood glucose, prothrombin and
partial thromboplastin times and platelet
count. The most commonly mismanaged
postoperative problem involves fluid
administration. This must be meticulous,
for these patients do not tolerate fluid
overload. During aortic surgery, the
patient often requires a large amount of
fluid, which is retained postoperatively.
Much of this is sequestered in the inter
stitial spaces where it remains until gradu
ally mobilized and excreted in 48 to 72
hours. Inappropriate secretion of antidi
uretic hormone results in sodium and
water retention. Therefore, intravenous
fluids for maintenance should be limited
to approximately 80 m l/h or 1 ml/kg
body weight of 5% dextrose and half
normal saline with 20 to 30 mmol/L of
potassium chloride.
On arrival in the recovery room, these
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patients are usually cold and vasoconstricted, and additional fluid may be
necessary as rewarming and vasodilata
tion occur. A decreasing urine output,
reduced blood pressure, tachycardia and
lower cardiac filling pressures indicate a
need for additional fluids together with
packed red cells or whole blood, if avail
able, if the hematocrit is less than 30%.
A balanced salt solution, such as Ringer’s
lactate, is helpful.
We do not believe in early ambulation
of patients after aortic or peripheral
arterial reconstruction since many of
them are hemodynamically unstable for
several days. Incisional pain may be
severe, causing tachycardia and hyperten
sion, thus increasing the burden on the
heart, and with the mobilization of excess
fluid occurring 48 to 72 hours postoperatively, there may be expansion of the
intravascular volume creating additional
cardiac stress. It must be remembered that
myocardial infarction occurs most com
monly 3 days after major surgery.1 Leg
exercises against a foot board or other
resistance-generating equipment improve
venous emptying from calf muscles,
increase blood flow to the legs and thus
through the graft, maintain muscular tone
and probably serve as prophylaxis against
deep venous thrombosis.
Respiratory System

Support by a volume ventilator is
generally necessary for several hours and
sometimes several days. For the patient
unable to breathe, controlled mechanical
ventilation provides a preset tidal volume
at a controlled frequency. For the patient
who must remain intubated, an assistcontrol technique allows spontaneous
breathing supplemented by assisted ven
tilations, thus preventing hypoventilation
and respiratory acidosis. Intermittent
mandatory ventilation provides good
assistance and control. Between manda
tory ventilations, the patient may breathe
spontaneously, so that the mandatory
ventilations can be progressively
decreased as the patient’s mechanics
improve. Occasionally, those with
reduced functional residual capacity will
require continuous positive airway pres
sure or positive end-expiratory pressure
as well as assisted ventilation. It must be
remembered that high pressures (more
than 15 cm H20 ) can decrease cardiac
output.2 Deep breathing and coughing
are essential after extubation. Intermittent
positive-pressure breathing is rarely neces
sary unless bronchodilators or mucolytic
agents are to be given. If endotracheal
stimulation and suction are necessary,
adequate oxygenation should be assured
and the pulse be monitored because of the
occasional occurrence of arrhythmias.

Cardiac System

Incisional pain, increased sympathetic
tone, and some as-yet-unaccounted-for
elevation of the renin angiotensin activity
may explain why hypertension is fre
quently associated with postoperative
cardiac problems, producing excessive
cardiac work. Cardiac work is the
product of stroke volume, rate and sys
tolic blood pressure. Thus, if hyperten
sion is inadequately controlled,
myocardial ischemia with failure may
supervene. A useful guideline is to main
tain systolic blood pressure within 15%
above or below the preoperative level.
Because arterial lines tend to record
higher pressures than the sphygmo
manometer, a comparison between the
two should be made before an antihyper
tensive medication is administered. Often,
the relief of pain by a small dose of mor
phine (2 to 5 mg) will moderate the hyper
tension and the tachycardia.
For more immediate action, sodium
nitroprusside may be given — 50-mg
doses in 250 ml of 5% dextrose in water
at a rate of 0.5 to 1.0 /ig/kg-min-1.
This may be increased to a maximum of
10 ^g/kg m in"‘.3 Blood pressure must
be monitored continuously, for, although
this drug has a short duration of action,
possibly not more than 10 minutes, it is
a potent vasodilator. It must be used cau
tiously in those with hepatic or renal
insufficiency, either chronic or transient,
inasmuch as it is metabolized to
thiocyanate. Prolonged infusion or exces
sively high doses may lead to cyanide
intoxication.
The combination of tachycardia and
hypertension is particularly stressful on
the myocardium. Hypovolemia may be
detected by decreased urine output, fall
ing blood pressure, especially with deep
inspiration, and low heart filling pres
sures. If hypovolemia is not the cause,
persistent tachycardia may be due to
cardiac failure or increased sympathetic
tone. A pulmonary capillary wedge pres
sure greater than 18 to 20 mm Hg sug
gests left ventricular failure for which
digoxin may be administered. In the
absence of hypovolemia and evidence of
cardiac failure, tachycardia may be con
trolled by the adm inistration of
propranolol 0.1 to 1.0 mg. Again, con
tinuous electrocardiographic and bloodpressure monitoring should be main
tained, for rapid slowing of the heart rate
may occur. An occasional side effect, par
ticularly in patients with chronic obstruc
tive airway disease, is bronchospasm; this
is less likely to be produced when patients
are given the /3-blocker metoprolol
(Lopressor), 50 mg orally twice daily. It
should be used with care in the insulindependent diabetic for /3-blockade may
mask sympathetic signs of hypoglycemia.
Low cardiac output and hypotension

must also be considered in association
with hypovolemia, for pump failure or
cardiogenic shock is a main cause of low
cardiac output. Severe chronic cardi
omyopathy or an intraoperative myo
cardial infarction makes it a likely possi
bility. So, too, must septic shock and
cardiac arrhythmias be considered in
determining the cause of low output.
Cardiac output is a product of heart rate
and stroke volume.4,5 The principal
determinants of stroke volume are
preload, afterload and myocardial con
tractility.
Preload is the end-diastolic filling pres
sures of the right and left hearts. Stroke
volume is directly related to preload.
Afterload is the resistance against which
the left ventricle contracts — the forceresisting fibre contraction. It is inversely
related to stroke volume.
Contractility describes factors such as
/3-adrenergic agonists and antagonists that
modify the force of contraction indepen
dent of pre- and afterload. Systemic
blood pressure depends directly on
cardiac output and peripheral vascular
resistance.
In the low-perfusion state, both blood
pressure and urine output drop, one fre
quently sooner or to a greater extent than
the other. A 5- to 10-ml/kg bolus of fluid
may^improve perfusion. Preload is meas
ured by ventricular filling pressure at end
of diastole, which means central venous
pressure for the right ventricle and pul
monary capillary wedge or left atrial pres
sure for the left. Filling pressures should
be brought into the normal range before
administering drugs or mechanical sup
port. The best drugs to improve cardiac
output are the inotropic and /3-adrener
gic group — isoproterenol or dopamine/dobutamine. Mechanical support
may be necessary if these drugs fail.
Cardiac output can also be increased by
use of vasodilators to decrease afterload.
A pulmonary capillary wedge pressure
above 18 to 20 mm Hg may lead to pul
monary congestion and a rise above 30
mm Hg to frank pulmonary edema. It
must be remembered that excessive posi
tive end-expiratory pressure may falsely
elevate central venous and pulmonary
artery pressures, thus masking the true
cause — hypovolemia. Nitroprusside or
nitroglycerin, administered intravenously,
may help to reduce afterload by vasodila
tation. It may be maintained on a more
sustained basis later in the postoperative
period with hydralazine, captopril,
nitrates and other parenteral vasodila
tors.6 Myocardial contractility is most
effectively enhanced by the inotropic
drugs dobutam ine, dopamine and
digitalis. In acute cardiac failure, dobuta
mine is the agent of choice, acting rapidly
to decrease both preload and afterload.
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If bradycardia is the cause of the low out
put state, the use of atropine may accen
tuate the arrhythmias, making cardiac
pacing necessary. Coronary perfusion
may fall as a consequence of cardiac
arrhythmias, and there may be associated
diminished flow in other organ systems.
There are a number of mechanisms that
produce arrhythmias in the immediate
postoperative course; hypothermia (quite
common), hypoxia, hypo- or hyper
kalemia, disturbances of acid-base
metabolism and, of course, myocardial
infarction. When premature ventricular
contractions are common (often in the
cold and acidotic patient) and occurring
at a rate of more than 6/min, or
associated with runs of ventricular
tachycardia or bigeminy, treatment is
required. Lidocaine (50 to 100 mg
intravenously) administered as a bolus
will often solve the problem. Rarely is a
continuous infusion necessary.
Renal System

testinal tract associated with reconstruc
tive surgery revolve around peptic ulcer
ation. Sepsis, prolonged hypotension,
widespread tissue trauma, respiratory
insufficiency, renal failure and advanced
age are all risk factors.8,9 Usually, the
body of the stomach is involved, but the
small bowel, including duodenum, as well
as the colon have suffered such ulcera
tions. In most instances, nonoperative
methods for controlling the bleeding are
suitable but will not be effective if the
underlying cause, as for example sepsis,
continues. It should be remembered that
the surgical death rate for stress hemor
rhage in the stomach exceeds 50%.9 Fre
quent administration of antacids through
a nasogastric tube if necessary, with
hourly check of gastric residuals to avoid
the possibility of aspiration pneumonia,
plus monitoring of the gastric juice pH,
are all essential in prophylaxis and
treatment.

Hemorrhage

Renal failure in the absence of chronic
renal insufficiency can usually be avoided
by careful fluid management. The dia
betic patient who has chronic renal
insufficiency or is dehydrated is more
likely to suffer failure postoperatively
than the normal individual. An output of
less than 15 ml/h in the presence of ris
ing blood urea nitrogen and creatinine
values makes for early recognition. In the
high-risk patient, adequate preoperative
hydration in the intensive-care unit,
Swan-Ganz monitoring on the night
before surgery and the administration of
mannitol before infrarenal aortic clamp
ing have been most effective in limiting
this problem.7 The ideal urine output in
the normal patient is 30 to 60 m l/h. Highoutput renal failure (more than 60 ml/h)
in an intravascular-volume-depleted
patient is occasionally seen and can be
confirmed by the finding of a urine
plasma-creatinine ratio of less than 10.
Because the normal kidney retains sodium
(urine value 20 to 40 m mol/L), a urine
sodium value of 80 to 100 mmol is a
second indicator of renal failure. Finally,
failure to concentrate urine (specific
gravity of 1.010) or a urine-plasma
osmolarity ratio of less than 1.3 is an
additional sign. Prerenal failure is usually
due to inadequate intravascular volume
or low cardiac output. Actual renal causes
are usually a consequence of toxic
influences such as antibiotics, other medi
cations or the dye used at arteriography.
Obstruction of the urinary collection sys
tem is a cause of postrenal failure.

Early reoperation is mandatory in the
management of bleeding from an anasto
mosis or an area of dissection such as the
bed of an aortic aneurysm. Complications
of bleeding are the development of infec
tion in a hematoma and the late forma
tion of a pseudoaneurysm at the anasto
motic line. If more than two units of
blood are needed to m aintain a
hematocrit in the range of 30% ± 2%
during the first 6 to 12 hours, intra
abdominal hemorrhage must be consi
dered. The usual causes of persistent perior postoperative bleeding are inadequate
surgical hemostasis, a failure to reverse
or excessive amounts of anticoagulants
and, rarely, defects in clotting factors
such as disseminated intravascular coagu
lation and dilutional thrombocytopenia.
Fresh-frozen plasma (10 ml/kg body
weight) should be used to counteract the
effect of heparin or Coumadin. The
administration of large amounts of
stored, packed, red blood cells may lead
to dilutional thrombocytopenia, and fresh
platelets should be available and
administered with every six units of plate
let concentrate. Spontaneous bleeding is
rare with a platelet count of above 20.0
x 109/L.
Massive blood transfusions, major
transfusion reaction, widespread tissue
trauma, extensive ischemia and sepsis are
the most common causes of consumptive
coagulopathy. Rarely, it is seen as an idi
osyncratic reaction to systemically
administered heparin.10 Disseminated
intravascular coagulation involves con
sumption of platelets and coagulation
Factors VIII and V as well as fibrinogen.
Gastrointestinal System
Thrombocytopenia, prolonged prothrom
Postoperative problems in the gastroin bin time and depressed fibrinogen levels
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are the criteria for the development of dis
seminated intravascular coagulation. The
use of heparin should be reserved for
when other efforts such as administration
of platelets in fresh-frozen plasma fail to
correct the problem.
Psychosis

The patient who undergoes reconstruc
tive aortic surgery is generally elderly, in
an age group susceptible to postoperative
psychosis. Agitation, confusion, halluci
nations, even combative behaviour are
frequently seen. These changes are mild
and generally resolve with no specific
treatment. Sleep deprivation, unfamiliar
surroundings, disturbances in physiology,
such as hypoxia, hypoglycemia and
hyponatremia, and the consequences of
sepsis all play a role. A few may be suffer
ing alcohol withdrawal. Narcotics may
intensify the problem. Cimetidine has
been implicated. Normal waking and
sleeping patterns should be re-established
if possible, normal sensory input provided
and sedation, if used, must be carefully
monitored. Haloperidol in doses of 0.5
to 2 mg orally or intramuscularly may be
useful as is Librium."
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Biologic Response to
Uncemented Madreporic Canine Hip Arthroplasty
The M adreporic hip a rth ro p la sty has
provided encouraging clin ica l results. The
surface o f the prosthesis is unlike other
uncem ented prostheses since th e rough
surface is form ed by m u ltip le 1-mm
diam eter beads th a t are ca st as an
integral part o f the prosthesis and
increase its surface area fo u r tim es.
Seven M adreporic hip a rth ro p la sties were
im planted in adult m ale m ongrel dogs.
Specim ens w e re harvested 5, 6, 9, 12,
20 and 52 w e e ks a fte r in se rtio n . One
specim en became se p tic and loosened.
The prosthesis w as stabilized in itia lly by
fric tio n f it b e tw e en th e p ro sth e sis and
the endosteal c o rte x o f th e proxim al
fem ur. Dense, u n ifo rm ly organized,
fib ro u s tissue surrounded th e prosthesis
at 5 w eeks. The fib ro u s tissu e appeared
sim ilar to S h a rp ey's fib re s. C ircum feren
tia l bone c o n ta c t increased fro m 2 6 % at
5 w eeks to 6 0 % a t 52 w e e ks. Fluores
ce n t labelling revealed a ctive n e w bone
fo rm a tio n w ith in th e in te rstice s o f the
prosthesis w ith o u t evidence o f an in te r
vening s o ft-tis s u e m em brane. Firm
m echanical anchorage o f th e M adreporic
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fe m o ra l prosthesis w a s de m o n strate d in
th is study.
L 'a rth ro p la stie M adreporique de la han
d le a fo u rn i des re su lta ts cliniques
encourageants. La surface de la prothese
d iffe re des autres p rotheses non consolides par le fa it que la su rfa ce rude est
fo rm e e de m u ltip le s grains de 1 m m de
d iam etre c o n s titu a n t une partie integ rante de la p rothese et a u g m e n ta n t de
q uatre fo is sa su p e rficie . S ept a rth ro p la s
tie s M adreporique de la hanche fu re n t
im plantees chez des chiens m ongrel
a dultes males. Des e ch a ntillo ns fu re n t
recoltes 5, 6, 9, 12, 20 e t 52 semaines
apres in se rtio n . Un ech a ntillo n d e vin t
septique et se decom posa. La prothese
fu t stabilisee in itia le m e n t par a justem ent
e n tre la prothese e t le co rte x endosteal
du fe m u r p ro xim a l. Du tissu fib re u x,
dense, u n ifo rm e m e n t organise, entoura la
prothese au b o u t de 5 semaines. Ce
tissu fib re u x ressem blait aux fib re s de
Sharpey. Le c o n ta c t osseux peripherique
augm enta de 2 6 % apres 5 semaines. a
6 0 % apres 52 sem aines. Le m arquage
flu o re sce n t revela une nouvelle fo rm a tio n
osseuse a ctive dans les in te rstice s de la
prothese sans evidence d ’ apparition
d 'u n e m em brane de tissu mou. Un
assem blage m ecanique ferm e de la p ro 
th e se fem orale M adreporique a ete
dem ontre au co u rs de c e tte etude.

The long-term success of an arthroplasty
depends on permanent anchorage of the
prosthetic components within bone.
Smooth-surfaced prostheses require bone
cement for fixation. In spite of recent
modifications in the use of methylmetha
crylate to improve mechanical lon
gevity,1'2 cemented arthroplasties fre
quently loosen with time.3,4 Uncemented
prostheses have been developed as an
alternative. Rough-surfaced components

may allow biologic fixation that can
respond to mechanical stresses over a long
period without loosening.
There has been extensive clinical
experience with the Madreporic (Benoist
Girard, Paris; French manufacturing divi
sion of Howmedica Inc.) hip arthroplasty
developed by Lord.5' 7 This prosthesis
utilizes a rough surface of 1-mm diameter
beads that are cast as an integral part of
the femoral component. The Madreporic
surface increases the surface area of the
prosthesis by a factor of four. The beads
are cast in a single layer with an interbead
space of between 1 and 3 mm. This differs
from other uncemented prostheses which
generally have the rough surface secon
darily attached to the smooth prosthetic
core by sintering or a similar process.8
This surface takes the form of wire mesh,
atomized alloy metal or a composite
structure. The interbead distance of the
Madreporic prosthesis far exceeds the 50
to 400 /tm pore size recommended for
porous coated prostheses.9 For these rea
sons, the Madreporic surface cannot be
compared to porous coated prostheses
which have received a great deal of
experimental investigation.10-15
Prosthetic canine hip arthroplasties

FIG. 1—Canine prosthetic hip arthroplasty
components consisting of polyethylene
acetabular component and femoral component
with Madreporic surface.
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were used to study the biologic response
to the Madreporic surface. The prosthe
sis had an identical surface to that of the
components used in human Madreporic
hip arthroplasty. The purpose of the
study was to determine the response of
the proximal femur to the implantation
of the prosthesis. Specifically, we sought
to investigate the character of the inter
face between the prosthesis and the sur
rounding bone, and the presence of new
bone formation within the proximal
femur after insertion of the prosthesis.
Materials and Methods

Seven Madreporic hip arthroplasties
were performed in adult mongrel dogs.
The canine femoral component was tri
angular in cross-section with the base
medially and the apex laterally (Fig. 1).
This differs from the circular crosssection of the human prosthesis. This
design difference gave immediate rota
tional stability without circumferential
cortical contact.
The hip was exposed through an
anterolateral incision. After capsulectomy, the joint was dislocated and the
femoral head resected. The acetabulum
was reamed and irrigated, and an
acetabular prosthesis cemented in place
using methylmethacrylate. The femur was
reamed and the femoral component in
serted, producing a snug fit to give ini
tial mechanical stability (Fig. 2). Antibi
otics were administered prophylactically
for 48 hours postoperatively. The animals
were not immobilized.
The dogs were given a single
intravenous dose of xylenol orange,16 90
m g/kg, 1 week before sacrifice by Nem-

butal overdose. Both the acetabulum and
the proximal femur were harvested, but
only the femoral components were
studied. Specimens were obtained 5, 6, 9,
12, 20 and 52 (two specimens) weeks fol
lowing insertion.
The proximal femur was dehydrated,
defatted and embedded in methyl
methacrylate using a method similar to
that of Jowsey and associates.17 Modifi
cations in the technique were necessary
due to the large size of the specimens.18
Cross-sections 1-mm thick were cut
through the proximal, middle and distal
portions of the prosthesis using a Buehler low-speed low-deformation saw. Finedetail roentgenograms were obtained
using Kodak XTL-2 mammography film
and a Faxitron 805 (Hewlett Packard,
Mississauga, Ont.). The sections were
mounted on petrographic slides and
ground with a rotary grinder to a thick
ness of 250 /an. The sections were ana
lysed by light, polarized and fluorescence
microscopy.
The extent of bone ingrowth was meas
ured for the proximal, middle and distal

In general, the animals were ambula
tory within 48 hours of surgery. One
animal stopped walking on the operated
leg 6 weeks postoperatively. Radiologic
examination did not reveal any abnormal
ity, but the specimen was loose when har
vested 52 weeks after insertion and puru
lent material was present within the
pseudocapsule of the hip joint. No other
specimens could be manually extracted at
the time of sacrifice. An undisplaced frac
ture of the proximal femur occurred
intraoperatively in two dogs whose speci-

Fig. 3a

Fig. 3b

cross-section of each prosthesis. A 20 x
25-cm photographic enlargement was
made of a whole-mount polarized pho
tomicrograph of each entire cross-section
(original magnification x 4). An area
analyser was then used to determine the
percentage of the prosthetic perimeter
that lay in direct contact with bone. Since
the prosthesis has a rough surface rather
than a porous coating, it was possible to
make these measurements accurately.
Results

FIG. 3—(a) Polarized photomicrograph of proximal cross-section 5 weeks after insertion
of prothesis. In this area there is no direct bone contact between prosthesis and endosteal cor
tex. Intervening space is filled with fibrous tissue. Immature woven bone is advancing toward
prosthesis. Intramembranous ossification is occurring within fibrous tissue (original magnifi
cation x 20). (b) Polarized photomicrograph showing junction betw een woven bone and fibrous
tissue surrounding prosthesis. Fibrous tissue is well organized and resembles Sharpey’s fibres,
suggesting that it may be important for load transference while bone ingrowth occurs (original
magnification X 52).
T a b le l - P r o s t h e t ic P e rim e te r W ith B one C o n ta c t (% )
W eeks

FIG. 2—Postoperative view of canine
Madreporic hip arthroplasty. Acetabular com
ponent is cemented in place. Femoral compo
nent is inserted without cement and is initially
stabilized by friction fit.
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mens were harvested 6 and 9 weeks after
implantation; there was no difference in
the recovery rate of these animals postoperatively.
Evaluation o f the 5-week specimen
demonstrated immature woven trabecu
lar bone being formed along the endosteal
cortical surface (Fig. 3a). Only a small

portion o f the prosthesis had direct
endosteal bone contact (Table I). The
trabeculae ranged from 50 to 200 /tm in
thickness (average 150 /mi). The trabec
ulae were oriented at right angles to the
prosthetic stem. Dense, fibrous tissue,
oriented obliquely to the cross-section o f
the femoral component, filled the space

between the prosthesis and the endosteal
cortical bone. The fibrous tissue was well
organized with parallel fibres that resem
bled Sharpey’s fibres (Fig. 3b). A longitu
dinal section demonstrated that the
fibrous-tissue fibres sloped downward
from the endosteal bone to the prosthesis.
At 6 and 9 weeks the prosthetic

Fig. 4a

Fig. 5a

F'g- 4b

Fig. 5b

FIG. 4—(a) Polarized photomicrograph of cross-section of mid
stem of prosthesis at 20 weeks. Fifty percent of prosthetic perimeter
has direct bone contact. Bone growth into interstices of prosthesis and
trabecular hypertrophy are both advanced at apices of prosthesis (origi
nal magnification x 4). (b) High-power fluorescent photomicrograph
of bone-prosthesis interface. New bone is forming within interstices
of prosthesis and immediately adjacent to prosthesis without any evi
dence of intervening soft tissue (original magnification x 52).

FIG. 5—(a) Polarized photomicrograph of cross-section of mid
dle portion of specimen at 1 year. Mature trabecular bone lies in inti
mate contact with prosthesis (original magnification x 20). (b) Highpower fluorescent photomicrograph of bone-prosthesis interface 1 year
after im plantation. Active new bone formation continues deep within
interstices of prosthesis without any evidence of intervening soft tissue
(original magnification x 52).
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perimeter with direct bone contact had
increased to 43% and 39% respectively.
Predominantly woven bone was observed
around the prosthesis. The intervening
fibrous tissue remained well organized.
The bone formation was concentrated at
the proximal and distal ends of the
prosthesis and also in cross-section at the
apices of the triangular prosthesis. The
split in the femur had healed in both
specimens. At 12 weeks, 37% of the
prosthetic perimeter had direct bone con
tact. The lateral apex of the prosthesis
demonstrated the greatest bone ingrowth
and hypertrophy.
F ifty percent of the prosth etic
perimeter had direct bone contact at 20
weeks (Fig. 4a). Bone ingrowth and
trabecular hypertrophy were maximal at
the apices of the prosthesis. New bone
formation was observed in many of the
interstices of the prosthesis (Fig. 4b). In
these areas, the new bone formation
approximated the prosthesis without evi
dence of an intervening soft-tissue mem
brane.
At 52 weeks, 60% of the prosthetic
perimeter had direct bone contact.
Mature trabecular bone was in contact
with the prosthesis in many areas without
intervening soft tissue (Fig. 5a). Fluores
cent labelling demonstrated continued
new bone formation deep within the inter
stices of the prosthesis without interven
ing soft tissue (Fig. 5b).
The septic specimen demonstrated no
fibrous or bone ingrowth (Table I). The
prosthesis was encircled by a reactive
1-mm thick shell of endosteal new bone
formation located approximately 2 mm
from the edge of the prosthesis. The cor
tical bone of the proximal femur had
undergone cancellous change.
Discussion

Our study demonstrates that the
Madreporic surface provided firm fixa
tion of the femoral component of the
prosthesis both initially and throughout
the 1 year o f the study. Immediately
postoperatively, the prosthesis was
anchored by friction fit. With time, wellorganized fibrous tissue and new bone
surrounded the prosthesis to stabilize it.
Bone form ation around the prosthesis
was progressive, and in many areas no
soft tissue intervened between areas
o f new bone and the prosthesis.
O thers11,19,20 have noted that initial
friction fit is of paramount importance
in allowing bone ingrowth. Micromotion
is acceptable, but macromotion is not.
This concerned us in our study since two
undisplaced femoral fractures occurred at
the time the prosthesis was inserted. The
fractures healed without displacement,
and bone ingrowth was not adversely
affected. Longitudinal splitting of the
femur at the time of prosthetic insertion
248

did not appear to have a deleterious effect
on the quality or quantity of bone in
growth, providing the initial friction fit
was maintained.
Since the prosthesis was triangular and
the canine endosteal canal is circular, only
a portion of the prosthesis had direct con
tact with the endosteal cortex at the time
of insertion. In areas where the prosthe
sis was in direct contact with the endosteal
cortex, new bone formation was ob
served, but fibrous tissue, fibrocartilage
and hyaline cartilage were absent. Bone
ingrowth was maximal at the apices of the
prosthesis, which were often in direct con
tact with the endosteal cortex. Progres
sive trabecular maturation and hyper
trophy were observed in the 20- and
52-week specimens.
Fibrous tissue, which was obliquely
oriented to the longitudinal surface of the
prosthesis, formed in areas where the
prosthesis did not touch the endosteal cor
tex. This fibrous tissue attached to the
endosteal bone and had the appearance
of Sharpey’s fibres. This tissue, also
similar in appearance to periondontal
ligam ent, has been observed by
others9,11,14,15,20,21 and was particularly
prominent in the 5-, 6- and 9-week speci
mens. We speculate that this wellorganized fibrous tissue plays a role in
load transference initially, while bone
ingrowth occurs. Its presence did not indi
cate loosening, since new bone formation
was occurring within the interstices of the
prosthesis in areas immediately adjacent
to those with fibrous tissue.
Cameron and colleagues22 demon
strated the inhibitory influence of early
sepsis on bone ingrowth. Chen and
colleagues13 observed a lack of bone
growth into a cementless canine hip
arthroplasty when non-weight bearing
occurred secondary to a dislocation. We
observed a total absence of tissue
ingrowth of any kind in the single animal
with sepsis. We are uncertain whether the
absence of tissue ingrowth was due to a
direct effect of sepsis or was secondary
to the dog’s inability to bear weight. We
think it was probably secondary to sep
sis, because of the total absence of any
type of tissue ingrowth.
The Madreporic prosthesis is not sub
ject to damage by the shear forces that
occur during insertion and that may dis
rupt porous sintered surfaces.23 Sinteredparticle migration does not occur and the
large surface irregularities allow for the
development of new bone between the
endosteal bone and the prosthesis even in
areas where there is no bone contact ini
tially. Active new bone formation was
observed at the bone-prosthesis junction
throughout the study. Although only a
small number of animals were studied and
the important issue of stress shielding in
the proximal femur was not addressed,
this canine study demonstrates a favoura

ble response to implantation of a femoral
hip arthroplasty component with a
Madreporic surface.
We acknowledge the assistance of Mrs.
Isabella Urquhart, chief technologist in histol
ogy, Princess Margaret Hospital, Toronto and
Mr. A.K. Collins, director of medical photog
raphy, St. Michael’s Hospital, Toronto.

References
1. Burke DW, G ates El, H arris WH: Centrifugation as
a method of improving tensile and fatigue properties of
acrylic bone cement. J Bone Joint Surg [Am] 1984; 66:
1265-1273
2. P anjabi M, C im ino W, G oel V, et al: Enhancement
of bone-cement composite by cement pressurization.
Trans Orthop Res Soc 1984; 9: 129
3. GRUEN TA, MCNEICE GM, AMSTUTZ HC: “ Modes of
failure” of cemented stem-type femoral components: a
radiographic analysis of loosening. Clin Orthop 1979;
141: 17-27
4. Sutherland CJ, W ilde AH, Borden LS, et al: A tenyear follow-up of one hundred consecutive Muller curvedstem total hip-replacement arthroplasties. J Bone Joint
Surg [Am] 1982; 64: 970-982
5. LORD GA, H ardy JR, KUMMER FJ: An uncemented
total hip replacement: experimental study and review of
300 madreporique arthroplasties. Clin Orthop 1979; 141:
2-16
6. LORD G, Bancel P: The madreporic cementless total
hip arthroplasty. New experimental data and a seven-year
clinical follow-up study. Clin Orthop 1983; 176: 67-76
7. J ohnston DWC, Waddell JP , M c C ulloch JA, et
al: Non-cemented total hip arthroplasty (abstr). J Bone
Joint Surg [Br] 1984; 66: 300
8. GALANTE J, ROSTOKER W, LUECK R, et al: Sintered
fiber metal composites as a basis for attachment of
implants to bone. J Bone Joint Surg [Am] 1971; 53:
101-114
9. Bobyn JD, PlLLlAR RM, CAMERON HU, et al: The
optimum pore size for the fixation o f porous-surfaced
metal implants by the ingrowth o f bone. Clin Orthop
1980; 150: 263-270
10. P illiar RM, C ameron HU, Binnington AG, et al:
Bone ingrowth and stress shielding with a porous surface
coated fracture fixation plate. J Biomed Mater Res 1979;
13: 799-810
11. Bobyn JD, P illiar RM, C ameron HU, et al: Osteo
genic phenomena across endosteal bone-implant spaces
with porous surfaced intramedullary implants. Acta
Orthop Scand 1981; 52: 145-153
12. R hinelander FW, Stew art CL, W ilson j w , et al:
Growth of tissue into a porous, low modulus coating on
intramedullary nails: an experimental study. Clin Orthop
1982; 164: 293-305
13. CHEN PQ, T urner TM, RONNIGEN H, et al: A canine
cementless total hip prosthesis model. Clin Orthop 1983;
176: 24-33
14. ENGH CA: Hip arthroplasty with a Moore prosthesis
with porous coating. A five-year study. Ibid: 52-66
15. Spector M, Davis RJ, LUNCEFORD EM, et al: Porous
polysulfone coatings for fixation of femoral stems by
bony ingrowth. Ibid: 34-41
16. R a h n BA, PERREN SM: X ylenol orange, a
fluorochrome useful in polychrome sequential labeling
of calcifying tissues. Stain Techno! 1971; 46: 125-129
17. J owsey J, P hil D, Kelly PJ, et al: Quantitative
microradiographic studies of normal and osteoporotic
bone. J Bone Joint Surg [Am] 1965; 47: 785-806
18. R ichards RR, O rsini EC, Mahoney JL, et al: The
influence of muscle flap coverage on the repair of devascularized tibial cortex: an experimental investigation in
the dog. Plast Reconstr Surg (in press)
19. C ameron HU, P illiar RM, Ma c N ab I: The effect of
movement on the bonding of porous metal to bone. J
Biomed Mater Res 1973; 7: 301-311
20. PILLIAR RM, C ameron HU, w el sh RP, et al: Radi
ographic and morphologic studies of load-bearing porous
surfaced structured implants. Clin Orthop 1981; 156:
249-257
21. Bobyn JD, C ameron HU, A bdulla D, et al: Biologic
fixation and bone modeling with an unconstrained canine
total knee prosthesis. Clin Orthop 1982; 166: 301-312
22. C am eron HU, Yoneda BT, P illiar RM, et al: The
effect o f early infection on bone ingrowth into porous
metal implants. Acta Orthop Belg 1977; 43: 71-74
23. Buch ert PK, Vaughn BK, M allory TH, et al:
Excessive metal release due to loosening and fretting of
sintered particles on porous-coated hip prostheses. Report
o f two cases. J Bone Joint Surg [Am] 1986; 68: 606-609

VOLUME 30, NO. 4, JU L Y 1987 / THE CANADIAN JOURNAL OF SURGERY

W a l t e r V .A . V in c e n t e , m d ;* J S a m u e l V. L ic h t e n s t e in , m d , f r c s c ;* H a y s a m E l -D a l a t i ,
J a m e s M a h o n e y , m d , f r c s c ;! T o m a s A . S a l e r n o , m d , f r c s c *

m b , c h b ;*

Posterior Wall Disruption of the
Left Ventricle After Mitral Valve Replacement:
Management of Bleeding and Cardiac Enlargement
Two patients who underwent mitral
valve replacement sustained posterior
left ventricular disruption postoperatively
and survived. Management consisted of
repair from outside the heart without
removal of the mitral prosthesis. This
was achieved with a running Prolene
suture in the atrioventricular junction in
one patient and pledgeted sutures in the
other who had transverse midventricular
disruption. Biologic glue was crucial in
controlling hemorrhage after the repair in
both cases. The patient with transverse
midventricular disruption required place
ment bilaterally of pectoralis muscle
flaps to close the sternal wound because
of swelling and dilatation of the heart.

Deux patients qui avaient eu un remplacement de la valvule mitrale ont subi en
postoperatoire une desunion ventriculaire gauche posterieure et ont survecu.
Le traitement a consiste a reparer de
I'exterieur du coeur sans enlever la prothese mitrale. Ceci a ete accompli chez
une patiente a I'aide d'une suture courante de Prolene et, chez I'autre, qui
avait une desunion meso-ventriculaire
transverse, a I'aide de sutures en tam
pon. Dans les deux cas, ('utilisation
d'une colle biologique fut cruciale pour
juguler I'hemorragie apres I'operation. La
patiente qui avait subi une desunion
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meso-ventriculaire transverse a necessity
des greffes bilaterales de lambeaux de
muscles pectoraux pour refermer la plaie
sternale a cause d'une inflammation et
d'une dilatation du myocarde.

Ventricular disruption is a dreaded com
plication of mitral valve replacement and
is associated with a high death rate.1-4
Most deaths are due to bleeding5-7 and
heart failure.5,8 We have encountered
two such cases and achieved successful
surgical repair without removing the
prosthesis. Besides suturing the disruption
from outside the heart, biologic glue was
found to be crucial in controlling residual
hemorrhage. Bilateral pectoralis muscle
flaps9 and bolstered skin traction of the
sternal edges were used in one patient to
accommodate the dilated heart in the
pericardial cavity.

applied to the atrioventricular region avoiding
the circumflex coronary artery. Biologic glue,
made up of thrombin, cryoprecipitate, plasma
and calcium,11 was applied to the area after
suturing. The patient was weaned from bypass
without difficulty. She made a smooth recov
ery and was well on follow-up 15 months later.

Case 2

An obese 65-year-old woman underwent
replacement of a 29-mm Omniscience mitral
valve prosthesis which had been implanted 8
months before for mitral stenosis and insuffi
ciency. Malfunction of the prosthesis was evi
dent; at catheterization the coronary arteries
appeared normal. After opening the sternum,
only the right side of the heart was dissected
due to very dense adhesions over the left ven
tricle. There was tissue ingrowth into the
prosthesis with pannus formation in the atrial
and ventricular sides of the prosthetic valve.
The valve was removed and replaced with a
29-mm lonescu-Shiley prosthesis using pledg
eted sutures. A left ventricular vent was not
Case Reports
used. The operation was difficult but weaning
from bypass posed no problems. Two hours
Case 1
after surgery, she had severe hemorrhage with
shock and was immediately explored. Profuse
A thin 75-year-old woman underwent mitral bleeding was observed from behind the heart.
valve replacement with a 27-mm Ionescu- By the time bypass was instituted she had been
Shiley prosthesis for calcific mitral stenosis and hypotensive for approximately 30 minutes.
insufficiency. Cardiac catheterization before After induction of cardioplegic arrest and dis
surgery revealed normal coronary arteries, section of the remaining pericardial adhesions,
severe mitral stenosis with a gradient of 17 mm a 3- to 4-cm longitudinal disruption was found
Hg across the mitral valve at rest, grade 3 on the posterior midventricular region of the
mitral insufficiency and calcific mitral annu left ventricle (type III10). Finger exploration of
lus with calcification extending posteriorly into the ventricular cavity through the tear revealed
the left ventricular myocardium. The annulus that the struts of the prosthesis did not appear
was decalcified but the posterior papillary mus to be the cause of the tear, so we elected to
cles were calcified and were left adherent to the repair the tear without removing the prosthe
ventricular myocardium. Pledgeted sutures sis. The defect was closed with pledgeted
were used to secure the mitral prosthesis. A left sutures of 3-0 Prolene placed longitudinally.
ventricular vent was not used. The operation Bleeding, which occurred after unclamping and
was uncomplicated. Three hours after the heart ejection, ceased when biologic glue was
procedure she suffered a severe hemorrhage applied to the posterior surface of the heart.
requiring immediate exploration. A site of pro She was weaned from bypass with the aid of
fuse bleeding was identified at the back of the the intra-aortic balloon pump. Due to pro
heart. Under cardiopulmonary bypass the dis found hypotension when attempts were made
ruption was pinpointed at the atrioventricular to close the sternum or skin, both were left
junction (type I disruption10). In view of the open. Temporary closure of the latter was
heavy calcification noted at the time of the ini achieved with a Vidrape. The morning after
tial operation, removal of the mitral prosthe surgery she was returned to the operating room
sis and repair from within the ventricle were and several attempts were made to close the
considered unwise. After induction of cardi- sternum and skin, again without success due
oplegic arrest, a running 4-0 Prolene suture was to profound hypotension. Three days later
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another attempt to close the sternum failed, but
the skin was approximated. A final attempt at
sternal closure was made 4 days later without
success, so pectoralis muscle flaps were deve
loped to fill the sternal wound. Stay sutures
were needed to hold the sternal edges apart to
prevent a tamponade-like effect while the mus
cle flaps were applied to the sternotomy inci
sion. They were removed 7 days postoperatively. The intra-aortic balloon was removed
a day later. She required prolonged ventilatory
support and eventually a tracheostomy was
performed 32 days after operation. The
wounds healed without problems, but bactere
mia occurred due to infection in a subclavian
line used for hyperalimentation. She made a
satisfactory recovery, with excellent cosmetic
appearance o f the sternotomy incision. The
follow-up is short (9 months), but she remains
well and has had the tracheostomy tube
removed.
Discussion

Left ventricular disruption after mitral
valve replacement is rare (0.5% to 2% of
all mitral valve replacements) and carries
a high death rate.2-4 The condition was
first reported by Roberts and Morrow in
1967.12 Its cause is not completely under
stood.10'12-15 Although spontaneous dis
ruption o f the left ventricle without
antecedent trauma may occur,15 most
reports implicate a preceding traumatic
event.16-23 Several hypotheses have been
advanced to explain this complication.
The atrioventricular groove is a “ weak”
area in th at the mitral annulus is only in
continuity with the endocardium of the

left atrium4 without muscular continuity
between atrium and ventricle. Thus,
aggressive debridement or decalcification
of this region may lead to atrioventricu
lar separation. Similarly, insertion of
sutures that penetrate the ventricular mus
cle and are tied vigorously may result in
tearing of the ventricular muscle with
resultant weakening and subsequent sepa
ration. This may explain type I injury. It
has been suggested that type II injury is
due to zealous excision of the papillary
muscles with thinning of the ventricular
wall followed by trauma from an adja
cent prosthetic valve strut.8,10 Cobbs and
colleagues15 and Spencer and associates8
have hypothesized that type III injury is
related to disruption of the posterior
chordal attachments, predisposing the
ventricle to a stretch injury, exacerbated
by excessive ventricular relaxation during
cardioplegic arrest. They suggest that
preservation of the posterior mitral valve
apparatus may eliminate this complica
tion. In fact, the patient in our case 2 with
a type III separation, did have excision
of the posterior leaflets and chordae dur
ing the original operation, thus predispos
ing the ventricle to this type of separation.
It must be noted, however, that confir
mation of the mechanism of injury
usually eludes the surgeon and, in view
of this, particular care should be taken
in the patient with a small ventricle, in the
elderly and in the patient with previous
mitral valve replacement who has had
excision of the mural leaflet. Treatment

includes removal of the prosthesis and
suture repair with or without a patch5 or
repair of the tear without removal of the
prosthesis.8 Bleeding5-8 and heart
failure5,8 appear to be the most common
complications leading to death after
repair.
In our patients, repair was achieved
from outside the heart either by running
sutures in the atrioventricular groove
avoiding the circumflex coronary artery
(case 1) or with pledgeted sutures on the
ventricular myocardium (case 2). In both
cases, profuse bleeding in inaccessible
areas occurred after repair. Biologic glue
allowed complete hemostasis after the
repair and was life-saving. This type of
physiologic glue11 is readily available in
any operating room.
Bleeding, edema and dilatation of the
heart in the patient with type III disrup
tion posed a considerable problem.
Although bleeding was eventually con
trolled with biologic glue, cardiac swell
ing and dilatation precluded approxima
tion of the sternum and skin. This
problem was solved by the use of bilateral
pectoralis muscle flaps to accommodate
the heart in the pericardial cavity.9 The
sternal edges had to be held apart with
bolster sutures to prevent cardiac com
pression when the flaps were laid over the
sternal defect.
Conclusions

Bleeding and cardiac edema are major
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problems when posterior left ventricular
disruption occurs after mitral valve
replacement. The surgeon should consider
repair without removal of the prosthesis
and the use o f biologic glue to achieve
hemostasis subsequently. Mobilization of
muscle flaps to accommodate an edema
tous dilated heart should also be consi
dered if sternal closure is impossible. It
may become necessary to hold the ster
nal edges apart with stents or suture bol
sters to avoid compressing the heart until
swelling decreases with time.
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Conservative Management of Renal Lacerations
in Blunt Trauma
Controversy in the treatment of blunt
renal trauma is largely focused on
immediate surgery versus conservative
management for parenchymal lacera
tions. A retrospective analysis of 133
cases of blunt renal trauma at the Vic
toria General Hospital in Halifax over a
10-year period revealed 26 cases of
renal laceration. The conservative
approach to radiologic diagnosis and
treatment options is discussed. Our
experience confirms a low rate of
both nephrectomy and secondary compli
cations using conservative management.
Le debat entourant le traitement des
traumatismes renaux fermes oppose surtout les tenants d'une chirurgie imme
diate a ceux qui preconisent un traite
ment conservateur des lacerations du
parenchyme. L'analyse retrospective de
133 cas de contusions renales vus au
Victoria General Hospital d'Halifax au
cours d'une periode de 10 ans a revele
26 cas de lacerations renales. On commente I'approche conservatrice avec le
diagnostic radiologique et les diverses
options therapeutiques. Selon notre
experience, on constate que le traite
ment conservateur est accompagne d'un
faible taux de nephrectomie et de com
plications secondaires.

Despite increased experience over the last
30 years with the treatment of renal lacer
ations from blunt trauma, the issue of
immediate surgery versus conservative
management remains controversial.
Advocates of immediate surgical debride
ment maintain that primary repair and
drainage allow for primary healing and
early rehabilitation of the patient.1-4
Advocates of a conservative approach
think that a high percentage of renal inju

ries will heal spontaneously, precluding
the need for any renal surgery.5-10
At our institution, clinically stable
patients with severe renal lacerations have
been managed conservatively and a
review of our experience appeared ger
mane to the controversy of immediate
versus expectant surgery.
Patients and Methods
A retrospective analysis at the Victoria
General Hospital in Halifax of 133
patients who had suffered blunt renal
trauma between 1975 and 1984 revealed
26 cases of severe renal lacerations. Rou
tine intravenous pyleography was done on
admission for all patients with suspected
renal injury, except those requiring emer
gency surgery. Renal arteriography was
performed when no renal lesion or a
poorly defined one was seen on intra
venous pyelography or, occasionally, as
part of aortography to delineate intra
abdominal bleeding. Nuclear scanning
and intravenous pyelography were used
on follow-up to assess renal function.
Renal lesions were classified in two
groups — parenchymatous and hilar.
Under parenchymatous lesions, contusion
was diagnosed when there was minimal
functional or anatomical change on
intravenous pyelography; laceration was
defined as a deep parenchymal tear
extending at least to the corticomedullary

junction, with or without calyceal disrup
tion (Fig. 1); a shattered kidney implied
multiple lacerations. Hilar injuries were
subdivided into pedicle injury, referring
to renal arterial occlusion or laceration
resulting in nonvisualization and failure
of kidney perfusion, and pelvic injury,
referring to a disrupted renal pelvis.
The clinical state of the patient decided
the initial management of a renal lacera
tion. If the patient was hemodynamically
unstable because of severe renal hemor
rhage at the time of admission, despite
resuscitation, laparotomy was performed
immediately. The clinically stable patient
was treated conservatively with bed rest,
frequent abdominal examinations and
monitoring of vital signs, hydration, anal
gesics, serial complete blood count and
follow-up renal scanning or intravenous
pyelography. Renal exploration was done
if there was persistent severe hemorrhage,
massive or increasing urinary extravasa
tion or renal sepsis.
Findings
Renal lacerations accounted for 18%
of blunt renal injuries in our institution
and 80% of them resulted from traffic
accidents (Table I). In this adult popula
tion, 75% of the patients were under 30
years of age and 90% were men (Fig. 2).
Emergency intravenous pyleography was
performed on 25 patients; emergency
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FIG. 1—Intravenous pyelogram and corresponding arteriogram of renal laceration.
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laparotomy precluded one patient from
undergoing intravenous pyelography and
the laceration was diagnosed at surgery.
Fifteen patients had renal arteriography
for more accurate definition of the renal
laceration. There were three additional
cases in which arteriography, used to
define an associated abdominal injury,
outlined the renal laceration. The
intravenous pyelogram and arteriogram
were congruous except in three patients
in whom the intravenous pyelogram was
suggestive of a contusion but the arterio
gram showed a renal laceration.
Three patients required immediate
renal exploration and nephrectomy for
severe hemorrhage. Surgery (nephrec
tomy) was indicated in four other patients
initially treated conservatively, three for
persistent severe bleeding and one for
renal sepsis. All kidneys removed immedi
ately or after expectant treatment showed
shattering.
Two (8% of the group of 26 with lacer
ations) patients requiring nephrectomy
had associated renal anomalies. One had
a pelvic kidney and required immediate
nephrectomy for severe hemorrhage. The
other had a hydronephrosis secondary to
an obstruction at the ureteropelvic junc
tion; the obstruction initially was
managed expectantly, but persistent severe
bleeding necessitated nephrectomy.
There were no postoperative complica
tions in the three patients requiring
immediate nephrectomy. One patient
with a delayed nephrectomy required re
exploration of the renal bed 24 hours after
operation because of hemorrhage, seem
ingly from a slipped ligature.
In addition to the renal laceration,
major associated injuries (Table II) were
present in 17 patients, an average of 1.8
injuries per patient. There were three
deaths but none due to renal causes.
Excluding the three patients who died of
non-renal causes and three patients who
required immediate nephrectomies, 20
patients were managed expectantly. Four
(20%) later needed nephrectomy. Those
managed successfully showed improved
renal function on follow-up renal scan
ning or intravenous pyelography by the
time of discharge. For patients with major
injuries associated with the renal lacera
tion, the average time in hospital was 20
days. When the renal laceration was the
main injury responsible for hospitaliza
tion, the average stay was 10 days. Six
patients underwent intravenous pyelogra
phy at 6 months and one at 3 years; all
showed completely healed kidneys. None
suffered hypertension during a follow-up
of 2 to 6 years. The remaining 13 could
not be traced because of the transient
patient population.
Discussion
In blunt renal trauma, renal contusion
accounts for 80% of the injuries; the con
254

arteriography and the lesion seen at explo
ration.14' 16 Unfortunately, tomography
is not available to every emergency
department, and intravenous pyelography
alone is said to have a correlation of 50%
to 7 0% .14,15,17 In this series, the
intravenous pyelogram provided adequate
information about the renal laceration in
22 of 25 cases for a false-negative result
of 12%. On the other hand, arteriogra
phy confirmed the diagnosis of renal
laceration whenever it was suspected on
intravenous pyelography.
Renal arteriography is the most
accurate study for defining the nature of

tusions are treated conservatively as heal
ing usually occurs without complica
tions.11 Immediate surgical intervention
is advised for hilar pedicle and pelvic inju
ries and renal laceration in patients who
are hemodynamically unstable.12 The
controversy in the management of blunt
renal trauma is thus focused on the less
than 20% of patients with renal trauma
who present with parenchymal lacera
tions.1' 10,13
In accurately delineating the renal
injury, infusion intravenous pyelography
with tomography has an excellent (90%)
correlation with both selective renal
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the renal injury. Lang18 recommended its
use in all patients with hematuria and
renal trauma, citing its low morbidity,
accuracy and assessment of associated
intra-abdominal injury. However, it can
be argued that if a conservative approach
to managing renal laceration is the policy
and the indication to explore is based on
clinical criteria, establishing a function
ing kidney on the intravenous pyelogram
is all that is necessary, since knowing the
extent of laceration will not influence the
course of management. Arteriography
should, therefore, be reserved for possi
ble surgical intervention when there is
clinical deterioration. Advocates of a
more liberal use of renal arteriography
could argue that the procedure may be
unsafe or not feasible by the time clini
cal deterioration has occurred. It should
be emphasized that the arteriographically
defined renal injury may be more exten
sive than the patient’s clinical condition
indicates and the severity of the anatom
ical injury per se should not be an indi
cation for surgery.
Recent reports19'20 suggest that com
puterized tomography provides precise
anatomical details of renal injuries and
has been used in preference to renal arteri
ography. Computerized tomography has
been advocated as the primary diagnos
tic modality in patients suspected of sus
taining major renal and other organ inju
ries.21 Although there is a possibility that
a laceration may be missed because the
slice taken by the scanner may not go
through the site of the renal injury,
enhancement of the renal parenchyma has
the added advantage of ruling out a major
vascular injury. Routine intravenous pye
lography and selective use of arteriogra
phy still have their merits, particularly if
renal surgery is contemplated.
In reviewing various series (Table
III2-4’9’10’13'14’22) in which the policy of
immediate surgical repair for all renal
lacerations is applied, even with the tech
nique of controlling the vascular pedicle
before renal exploration, the nephrec
tomy rate is equivalent to that of conser
vative management. The merits of either

approach thus seem to centre on immedi
ate and long-term patient morbidity. Our
experience and that of others indicate
spontaneous healing and resolution
without side effects in a large proportion
of cases even when the laceration seems
severe on arteriography. Immediate sur
gical management has been recommended
for shattered kidneys with multiple lacer
ations in order to avoid morbidity, but
invariably a nephrectomy is neces
sary.4'23 Even in these most severe paren
chymal injuries, a conservative approach
has been used successfully with minor
complications7 and is recommended for
the patient who can be stabilized clini
cally.
Classification of renal injuries has
varied from a simple categorization into
mild and severe to one of 15 subdivisions
based on anatomic and topographic
criteria.11 We prefer the classification
that separates the parenchymatous from
the hilar lesions and attempts to catego
rize the extent of the parenchymatous
lesion. In our opinion such classifica
tion is practical and has therapeutic
implications.
There is a good correlation between the
extent of trauma and the severity of the
associated injuries. These extrarenal inju
ries frequently dictate the immediate
management and account for the m or
bidity and mortality. The incidence of
associated injuries in this study is com
parable to those of previously reported
series.4'13’24 Mendez12 reported that shock
was present in 14% to 30% of trauma
patients with renal injuries compared
with 20% in our series. The frequency of
associated major injuries could make the
conservative approach more desirable.
Advocates of immediate surgical inter
vention have suggested that the expectant
approach prolongs the hospital stay.1'13
The length of stay in our series was found
to be more a reflection of the associated
injuries. For patients whose renal lacera
tion was the main injury, we believe an
average length of stay of 10 days is an
acceptable figure when compared with
that from surgical series.

Table Ill-Frequency of Nephrectomy in Series of Renal
Lacerations Caused by Blunt Trauma
No. of patients

Series
Immediate surgery
Cass and Ireland, 19733
Peters and Bright, 197713
Cass, 19792
Cass and Luxenberg, 19834
lacerations
shattered
Expectant treatment
Morrow and Mendez, 197014
Cass and Ireland, 1973s
Thompson and associates, 19779
Wein and associates, 197710
Gibson and associates, 198222
Present series

%

22
?
17

68
18
15

31
14

6.5
100

21
16
44
42
28
20

22
6
2
2
19.6
20

Conclusions
Emergency intravenous pyelography
with renal arteriography in selected cases
continues to be the method o f choice in
the initial evaluation of patients with renal
injury. Conservative management of
renal lacerations carries a low morbidity,
an acceptable nephrectomy rate and we
believe may obviate the need for surgery
in many such cases. M ajor associated
injuries frequently play an important role
in the management of patients with renal
lacerations.
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Simultaneous Occurrence of Chylothorax and
Subarachnoid Pleural Fistula After Thoracotomy
A left chylothorax complicated elective
left posterolateral thoracotomy and emer
gency decompressive laminectomy car
ried out on a 32-year-old woman with a
benign neurofibroma. Failure of conser
vative therapy necessitated ligation of
the thoracic duct and this in turn
unmasked the concomitant subara
chnoid-pleural fistula. Surgical repair and
lumbar subarachnoid drainage were
required to close the second fistula. The
clinical setting, diagnosis and manage
ment of this uncommon condition are
reviewed.
Un chylothorax gauche est venu compliquer une thoracotomie posterolaterale
gauche non urgente et une laminectomie
de decompression d’urgence pratiquees
chez une femme de 32 ans souffrant
d'un neurofibrome benin. L'echec d'un
traitement conservateur a necessity une
ligature du canal thoracique qui, a son
tour, mit en evidence une fistule pleurosous-arachnoidien. La reparation chirurgicale et le drainage sous-arachnoldien
lombaire ont du etre pratiques pour refermer la seconde fistule. Le tableau Clini
que, le diagnostic et le traitement de
cette rare affection sont passes en
revue.

Chylothorax and subarachnoid-pleural
fistula are uncommon complications of
thoracotomy. Their simultaneous occur
rence, a rare event,1 must be considered
in certain settings when treatment of a
chylothorax is unsuccessful.

found to have an asymptomatic left posterior
mediastinal mass on a routine chest film. Com
puterized tomography demonstrated its origin
from the left T6 nerve root, erosion of the outer
lip of the interverteral foramen and no dumb
bell extension into the spinal canal (Fig. 1). At
another hospital a benign plexiform neuro
fibroma was electively excised through a left
posterolateral thoracotomy. The patient awoke
with a left Brown-Sequard syndrome, which
progressed rapidly and required emergency
decompressive laminectomy late that night.
Excessive serous pleural drainage was noted
postoperatively. The chest tubes were eventu
ally removed and the patient transferred to our
hospital 2 weeks after operation for treatment
and rehabilitation of a left lower extremity
paralysis.
On admission, the clinical diagnosis of a
large left pleural effusion was confirmed radiologically. Thoracentesis was done, and exami
nation of the milky fluid revealed a triglycer
ide content eight times that of plasma. A
low-lying left intercostal drainage tube was
inserted. The patient was placed on an elemen
tal diet, but dietary intolerance required the
institution of total parenteral nutrition (TPN).
In spite of re-expansion of her left lung, ade
quate dependent drainage and “ thoracic duct
rest” , the fistulous drainage persisted at a rate
of 600 to 1200 m l/d. The left chest tube was
repositioned and then replaced, with no effect.
A contrast lymphangiogram (Fig. 2) and a
nuclear lymphangiogram (Fig. 3) demonstrated
disruption o f the thoracic duct with extrava
sation into the left pleural space. A left sub
clavian venogram confirmed a patent subcla
vian vein, thus ruling out venous occlusion as

a cause for the persistent chylothorax. Twentyseven days after admission, after the patient
was given 200 ml of cream 6 hours preoperatively by nasogastric tube, supradiaphragmatic
ligation of the thoracic duct was performed
through a right posterolateral thoracotomy.
Postoperatively, the chest tube drainage
decreased to 200 to 600 ml/d. A repeat nuclear
lymphangiogram showed successful treatment
of the chylothorax. However, persistent leftchest-tube drainage necessitated a left
posterolateral thoracotomy 3 weeks later. A
subarachnoid-pleural fistula was identified at

FIG. 2—Contrast lymphangiogram demon
strates chylous leak in vicinity of T6 vertebra
(closed white arrow). Contrast material then
flows freely into left pleural space after travers
ing paramediastinal cavity containing air-fluid
level (open white arrow).
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A previously healthy 32-year-old woman was
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FIG. 1—Computerized tomogram (coronal view) of T6 vertebra showed neurofibroma aris
ing from left T6 nerve root (closed white arrows). Erosion of superior and inferior lips of inter
vertebral foramen can be seen (open white arrows), but no dumb-bell extension into spinal canal.
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the site of the previous excision. Dural closure
could not be obtained, so a pedicled pleural
patch was sutured to the tissue edges about the
intervertebral foramen, using interrupted 3-0
silk sutures. The left lung was decorticated, the
parietal pleura abraded and the subarachnoid
space decompressed by continuous closed lum
bar subarachnoid drainage. Postoperatively,
the patient remained on bed rest with limited
elevation of the head of the bed. The left-chesttube drainage diminished considerably. Four
days postoperatively the lumbar drain was

removed and the chest tube drainage promptly
increased to 200 to 400 m l/d. A nuclear myelo
gram (Fig. 4) demonstrated a persistent left
subarachnoid-pleural fistula. Continuous
closed lumbar subarachnoid drainage was rein
stituted and after 1 week the fistula had closed.
When the lumbar drain was removed the
patient became febrile and had the signs and
symptoms of meningitis. Culture of the
cerebral spinal fluid grew Pseudomonas aer
uginosa. The infection promptly responded to
ceftazidime, which was continued in a dosage
of 2 g every 8 hours for 2 weeks. The patient
was transferred to our rehabilitation unit and
was discharged home 14 weeks after transfer
to our hospital, walking unaided with a
minimal left foot drop. Fler discharge chest xray film showed left pleural thickening (Fig. 5).

Comments
Chylothorax

FIG. 3—Nuclear lymphangiogram demon
strates left chylothorax (closed black arrows).
Some contrast material reaches supraclavicu
lar nodes (open black arrows). Infradiaphragmatic uptake is in liver and spleen.

The anatomy of the thoracic duct is
extremely variable. Its “ normal” course
is rarely seen (Fig. 6). The thoracic duct
originates as the efferent vessel of the
cisterna chyli, adjacent to the L3-T10 ver
tebral bodies. It lies to the right of the
aorta, passing into the posterior mediasti
num through the aortic hiatus. Here, in
possibly the most constant location in the
thorax, it is situated anterior to the ver
tebral bodies, posterior to the esophagus,
to the left of the azygos vein and to the
right of the aorta. At approximately the
level of the T5 vertebral body, the duct
passes behind the aorta, to lie on its left.
At the apex of the thorax (root of the
neck) the duct passes behind the carotid
sheath and then arches anteriorly to enter
the venous system at the junction of the

left internal jugular and left subclavian
veins. Along this course there are rich col
laterals and anastomoses. This allows for
safe ligation without sequelae.
Injury to the thoracic duct occurs most
frequently during surgery about the
thoracic aorta or esophagus but can com
plicate any thoracic procedure. Aware
ness of the variable anatomy o f the duct
is most im portant in preventing a
chylothorax. Careful dissection about the
probable course of the duct and
meticulous control of suspected chylous
leaks at operation are essential. If
damaged, the duct may be safely ligated2
or repair attempted.3 In our hands liga
tion has been simple, safe and effective.
The diagnosis of a chylothorax is well
documented.2 Fluid analysis measuring
total lymphocyte count, chylomicrons
and triglyceride and cholesterol concen
trations is helpful. Contrast studies are
the mainstay of diagnosis. We have found
nuclear lymphangiography, using technetium-99m antimony colloid to be a
new, but useful, diagnostic tool. It is easy
to adm inister, well to lerated and
eliminates the potential pulmonary com
plications of standard contrast lymphan
giography. In this case, nuclear lymphangiograms verified the presence of the
chylous fistula and recorded its closure.
Precise localization of the fistulous site
can be difficult but if required, as in our
case, standard contrast lymphangiogra
phy should be done.
N onoperative m anagem ent o f a
chylothorax includes an elemental diet or
total parenteral nutrition. Administration
o f total parenteral nutrition through the
left subclavian vein can be complicated

L E F T JU G U L A R VEIN

FIG. 4—Nuclear myelogram demonstrates
left subarachnoid-pleural fistula (closed black
arrow). Contrast material drains through chest
tube into reservoir on patient’s chest (open
black arrow).

L E F T S U B C L A V IA N VEIN
L E F T IN N O M IN A TE VEIN
A O R TA

S YM P A TH E TIC N.

A Z Y G O S VI

LESSER & G R E A TE R
S P L A N C H N IC N.
H E M IA Z Y G O S VEIN
A O R TA

AZYGOS
V EIN

ESOPHAGUS
T H O R A C IC
DUCT

C IS TER N A C H Y L I

R IG H T LUMBAR TR UN K
L E F T LUMBAR TR U N K

FIG. 5—Chest film at time of discharge
from hospital shows minimal left pleural thick
ening, blunting of right costophrenic angle and
surgical clips at site of fistulas.

FIG. 6—Typical course of thoracic duct. Its most constant portion within thorax is depicted
on right.
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by venous thrombosis and paradoxically
delayed fistula closure. For this reason we
try not to use the left subclavian vein
when treating a chylothorax and perform
subclavian venography when conservative
therapy fails.
We prefer the supradiaphragmatic
approach for ligation of the thoracic
duct.2 Generally, a right thoracotomy is
used; however, concomitant or persistent
disease in the left pleural space may neces
sitate a left thoracotomy. In our case, an
unsuspected subarachnoid-pleural fistula
was masked by the chylous fistula, which
was managed by a right-sided approach.
Later, a left thoracotomy was needed to
manage the subarachnoid-pleural fistula.
Subarachnoid-Pleural Fistula
This fistula is an uncommon entity. It
occurs most frequently after blunt or
penetrating trauma1,4-9 but is rarely seen
after thoracotomy.10' 12 The fistula may
be suspected on plain films of the
skull,12 thoracic spine or chest. It may be
demonstrated by myelography,4,5,7,8,10
but if high-viscosity material is used there
may not be free flow throughout the
subarachnoid space, thus precluding the
dem onstration o f a small fistu la .13
R adionuclide m yelography is use
ful.4’9,10’12,13 Analysis of the cerebrospi
nal fluid collected from the pleural space
may be misleading, for a “ dialysis effect”
may alter its typical composition.
Treatment of a subarachnoid-pleural
fistula by intercostal tube drainage alone
may be successful.6,7'11 Operative
management may be conducted through
a posterior laminectomy4,5,8,10 or thora
cotomy, or both.1,4,9,12 Direct suture
closure,4,8,10 fascial grafting,5 placement
of a pleural flap,1,4 intercostal and other
muscle grafting (free or pedicled),4 use
of thrombin-soaked Gelfoam4 or methyl
methacrylate seal,9 and thoracoplasty12
have all been successful. The use of
subarachnoid drainage is controversial.14
In this case the continuous closed lumbar
subarachnoid drain was a major factor in
obtaining fistula closure. However, a
Pseudomonas meningitis was uncovered
on removal of the drain. This dreaded
complication, which previously carried a
55% to 85% death rate, was successfully
treated with ceftazidime.15
The simultaneous occurrence of a
chylothorax and a subarachnoid-pleural
fistula has been described after blunt
traum a,1 the diagnosis being made at
thoracotomy. In our case, which occurred
after thoracotomy, the diagnosis was
made in stages. The simultaneous occur
rence of these two fistulas should be con
sidered in a patient with a chylothorax
and a persistent neurologic defect, who
presents after suffering trauma or under
going thoracic neurosurgery. When the
chylothorax fails to respond to standard
258

therapy, in this setting, a diagnosis of a
sim ultaneous subarachnoid-pleural
fistula should be considered. Diagnosis by
analysis of thoracentesis fluid is difficult
because of contam ination o f the
cerebrospinal fluid by chyle. Contrast and
nuclear studies of each individual fistula
are most useful. Staged surgical manage
ment was successful in our case; however,
a single procedure is desirable.

(^Mefoxiri I/Wy
(sterile cefo xitin sodium, Frosst Std.)

ANTIBIOTIC
ACTION
In v itro studies dem onstrate that the

bactericidal action of cefoxitin, a cephamycin
derived from cephamycin C, results from the
inhibition of bacterial cell wall synthesis.
Evidence suggests that the methoxy group in
the 7a position is responsible for the
resistance of cefoxitin to degradation by
bacterial beta-lactamases.

INDICATIONS AND CLINICAL USES
TREATMENT
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Correction
In the May 1987 issue, page 220, there
was a printing error in the book review
entitled “ Treatment of shock” . The
short fourth paragraph of this review
should read “The text is in three parts:
treating the microcirculatory lesions,
supporting the vital organs and treat
ing the underlying cause.” We apolo
gize to Dr. Downs, the reviewer, for
this error.

The treatment of the following infections when
due to susceptible organisms:
1 - Intra-abdominal infections such as
peritonitis and intra-abdominal abscess
2 - G ynecological in fe ction s such as
endometritis and pelvic cellulitis
3 - Septicemia
4 - Urinary tract infections (including those
caused by Serratia m arcescens and
Serratia spp.)
5 - Lower respiratory tract infections
6 - Bone and joint infections caused by
Staphylococcus aureus

7 - Soft tissue infections such as cellulitis,
abscesses and wound infections
Appropriate culture and susceptibility studies
should be performed to determine the
susceptibility of the causative organism(s) to
MEFOXIN*. Therapy may be started while
awaiting the results of these tests, however,
modification of the treatment may be required
once these results become available.
Organisms particularly appropriate for
therapy with MEFOXIN* are:
Gram positive

Staphylococci, penicillinase producing and
non-producing
Streptococci excluding enterococci

Gram negative (beta-lactamase producing
and non-producing strains)

£. coli
K l e b s i e l l a sp e cie s ( in c lu d in g
pneumoniae)
Proteus, indole positive and negative
Haemophilus influenzae
Providencia species

K.

Anaerobes

Bacteroides fragilis

MEFOXIN* may also be appropriate for the
treatment of infections involving susceptible
strains of both aerobic and anaerobic bacteria.
Clinical experience has demonstrated that
MEFOXIN* can be administered to patients
who are also receiving c a rb e n ic illin ,
gentamicin, tobramycin, or amikacin (see
PRECAUTIONS and ADMINISTRATION).
Intravenous Administration

The intravenous route is preferable for
p a tie n ts w ith ba cterem ia, b a c te ria l
septicemia, or other severe or life-threatening
infections, or for patients who may be poor
risks because of lowered resistance resulting
from such d e b ilita tin g co n d itio n s as
malnutrition, trauma, surgery, diabetes, heart
failure, or malignancy, particularly if shock is
present or impending.
PROPHYLACTIC USE

MEFOXIN* may be administered perioperatively (preoperatively, intraoperatively and
postoperatively) to patients undergoing
vaginal or abdominal hysterectomy and
abdominal surgery when there is a significant
risk of postoperative infection or where the
occurrence of postoperative infection is
considered to be especially serious.
In patients undergoing cesarean section,
intraoperative (after clamping the umbilical
cord) and postoperative use of MEFOXIN*
may reduce the incidence of surgery related
postoperative infections.
Effective prophylactic use depends on the
time of administration. MEFOXIN* usually
should be given one-half to one hour before
the operation. Prophylactic administration
should usually be stopped within 12 hours. It
has been generally reported that continuing
administration of any antibiotic beyond
*®Trademark

24 hours follow ing surgery increases the
possibility of adverse reactions but, in the
majority of surgical procedures, does not
reduce the incidence of subsequent infection.
If signs of postsurgical infection should
appear, specimens for culture should be
obtained for identification of the causative
organism(s) so that appropriate therapy may
be instituted.

CONTRAINDICATIONS
MEFOXIN* is contraindicated in persons who
have shown hypersensitivity to cefoxitin or to
the cephalosporin group of antibiotics.

WARNINGS
Before therapy with MEFOXIN* is instituted,
careful inquiry should be made to determine
whether the patient has had previous hyper
s e n s it iv it y r e a c tio n s to M E F O X IN ',
cephalosporins, penicillins or other drugs.
MEFOXIN* should be given with caution to
penicillin-sensitive patients.
There is some clinical and laboratory evidence
o f p a rtia l c ro s s -a lle rg e n ic ity betw een
cepham ycins and the other beta-lactam
antibiotics, penicillins and cephalosporins.
Severe reactions (including anaphylaxis) have
been re p o rte d w ith m ost b e ta -la cta m
antibiotics.
Pseudomembranous colitis has been reported
with virtually all antibiotics. This colitis can
range from mild to life threatening in severity.
Antibiotics should therefore be prescribed
with caution in individuals with a history of
gastrointestinal disease, particularly colitis. It
is im portant to consider a diagnosis of
pseudomembranous colitis in patients who
develop diarrhea in association with antibiotic
use. While studies indicate that a toxin
produced by Clostridium difficile is one
primary cause of antibiotic-associated colitis,
other causes should also be considered.
Any patient who has demonstrated some form
of allergy, particularly to drugs, should receive
antibiotics including MEFOXIN* with caution.
If an allergic reaction to MEFOXIN* occurs,
a d m in is tra tio n o f th e d ru g s h o u ld be
d is c o n tin u e d . S erious h y p e rs e n s itiv ity
re a c tio n s may re q u ire tre a tm e n t w ith
epinephrine and other emergency measures.

PRECAUTIONS
The total daily dosage should be reduced
when MEFOXIN* is administered to patients
with transient or persistent reduction of
urinary output due to renal insufficiency (see
DOSAGE AND ADMINISTRATION) because
h ig h and p ro lo n g e d serum a n tib io tic
concentrations can occur from usual doses.
In patients treated with MEFOXIN* a false
positive reaction to glucose in the urine may
occur with Benedict’s or Fehling’s solutions
but not with the use of specific glucose
oxidase methods.
Using the Jaffe Method, falsely high creatinine
va lu e s in serum m ay o c c u r if serum
concentrations of cefoxitin exceed 100 ug/mL.
Serum samples from patients treated with
MEFOXIN* should not be analyzed for
creatinine if withdrawn within two hours of
drug administration.
Increased nephrotoxicity has been reported
follow in g concom itant adm in istratio n of
c e p h a lo s p o rin s and a m in o g ly c o s id e
antibiotics.
The safety of MEFOXIN* in the treatment of
infections during pregnancy has not been
e s ta b lis h e d . If th e a d m in is tr a tio n of
MEFOXIN* to pregnant patients is considered
necessary, its use requires that the anticipated
benefits be weighed against possible hazards
to the fetus. Reproductive and teratogenic
studies have been performed in mice and rats
and have revealed no evidence of impaired
fertility or harm to the fetus due to MEFOXIN*.
Cefoxitin has been observed in the milk of
nursing mothers receiving the drug.
Prolonged use of MEFOXIN* may result in the
overgrowth of non-susceptible organisms.
Repeated evaluation of the patient's condition
is essential and if super-infection occurs
during therapy, appropriate measures should
be taken. Should an organism become
resistant during antibiotic therapy, another
antibiotic should be substituted.
In children 3 months of age or older, higher
doses of MEFOXIN* (100 m g/kg/day and
above) have been a sso cia te d w ith an
increased incidence of eosinophilia and
elevated SGOT.

ADVERSE REACTIONS
MEFOXIN* is generally well tolerated. Adverse
re a ctio n s ra re ly re q u ire d ce ssa tio n of
treatment and usually have been mild and
transient.
Local Reactions
T h r o m b o p h le b itis has o c c u rre d w ith
intravenous administration. Some degree of
pain and tenderness is usually experienced
after intramuscular injections using water.
Induration has occasionally been reported.
Allergic
M acu lo p a p u la r rash, u rtica ria , p ru ritu s,
eosinophilia, fever and otherallergic reactions
have been noted.
Gastrointestinal
Symptoms of pseudomembranous colitis can
appear during or after antibiotic treatment.
Nausea and vomiting have been reported
rarely.
Blood
T r a n s ie n t e o s in o p h ilia , le u k o p e n ia ,
neutropenia, hemolytic anemia, and thromboc y to p e n ia have been re p o rte d . Some
individuals, particularly those with azotemia,
may develop positive direct Coombs tests
during therapy with MEFOXIN*.
Liver Function
Transient elevations in SGOT, SGPT, serum
LDFI, and serum alkaline phosphatase have
been reported.
Kidney
Elevations in serum creatinine and/or blood
urea nitrogen levels have been observed. As
with the cephalosporins, acute renal failure
has been re p o rte d ra re ly. The role of
MEFOXIN* in changes in renal function tests
is d i f f i c u l t to asse ss, s in c e fa c to rs
predisposing to prerenal azotemia or to
im paired renal fun ctio n have often been
present.

TREATMENT OF OVERDOSE
Other than general supportive treatment, no
specific antidote is known. MEFOXIN* can be
eliminated by dialysis in patients with renal
insufficiency.

DOSAGE AND ADMINISTRATION
MEFOXIN* may be a d m inistered in tra 
venously or intramuscularly when required.
(See complete monograph for full details on
ADMINISTRATION and RECONSTITUTION.)
TREATMENT DOSAGE
Adults
The usual adult dosage is 1g o r 2g of
MEFOXIN* every 6 to 8 hours. Dosage and
route of administration should be determined
by severity of infection, susceptibility of the
causative organisms, and condition of the
patient. The usual adult dosages are shown in
the Table below.
Usual Adult Dosage
Type of
o f infe ctio n

Daily
IDosage

Frequency
and Route

U ncom plicated
form s* o f in
fectio ns such as
pneum onia,
urinary tract
infection, soft
tissue infection

3-4 g

M oderately
severe or severe
infections

6-8 g

1 g every 4 h
or
2 g every 6-8 h I.V.

Infections
com m only
needing a n ti
bio tic s in higher
dosage (e.g. gas
gangrene)

12 g

2 g every 4 h
or
3 g every 6 h I.V.

’ I n c lu d in g p a tie n ts
a b s e n t o r u n lik e ly

in w h o m i b a c t e r e m ia

1 g every 6-8 h
I.V. o r I.M.

should be employed and it is advisable to
monitor serum levels in patients with severe
impairment.
In adults with renal insufficiency, an initial
loading dose of 1 g to 2 g should be given.
A fte r a lo a d in g d o s e , th e f o llo w in g
recommendations for maintenance dosage
may be used as a guide:
RENAL
FUN CTIO N

Mild
im pairm ent
M oderate
im pairm ent
Severe
im pairm ent
Essentially
no fu n c tio n

C R E A TIN IN E
CLE ARA NC E
m L /m in

DOSE

50-30

1-2 g

every 8-12 h

29-10

1-2 g

every 12-24 h

9-5

0.5-1 g

every 12-24 h

<5

0.5-1 g

every 24-48 h

FREQUENCY

In the patient undergoing hemodialysis, the
loading dose of 1 -2 g should be given after
each hemodialysis, and the maintenance dose
should be given as indicated in the Table
above.
Neonates (Including Prem ature Infants),
Infants and Children (See WARNINGS for
Neonates under ADMINISTRATION in the
complete monograph.)
P re m a tu re In fa n ts
w ith B o d y W e ig h ts
A bove 1500 g

20-40 mg/kg every 12 h I.V.

N e o n a te s

01-

1 week of 20-40
age mg/kg every 12 h I.V.
4 weeks of20-40
age mg/kg every 8 h I.V.

In fa n ts

1 month to 2 years
of age

20-40 mg/kg every 6 h or
every 8 h I.M. or I.V.

C h ild re n

20-40 mg/kg every 6 h or
every 8 h I.M. or I.V.

In severe infections, the total daily dosage in
infants and ch ildren may be increased to
200 mg/kg, but not to exceed 12 g per day.
MEFOXIN* is not recommended for the ther
apy of meningitis. If meningitis is suspected,
an appropriate antibiotic should be used.
At present there is in s u ffic ie n t data to
recommend a specific dosage for children
with impaired renal function ."However, if the
administration of MEFOXIN* is deemed to be
essential the dosage should be m odified
consistent with the recom m endations for
adults (see Table above).
PROPHYLACTIC USE
For prophylactic use, a three-dose regimen of
MEFOXIN is recommended as follows:
Vaginal or abdom inal h yste re cto m y and
abdominal surgery
2 g a d m in is te re d in t r a m u s c u la r ly o r
in tr a v e n o u s ly ju s t p r io r to s u r g e r y
(approximately one-half to one hour before
initial incision).
The second and third 2 g doses should be
administered at 2 -6 hour intervals after the
initial dose.
Cesarean Section
The first dose of 2 g should be administered
intravenously as soon as the umbilical cord
has been clamped. The second and third
2g doses should be given intravenously or
intramuscularly four hours and eight hours
after the first dose.

AVAILABILITY
MEFOXIN* (sterile cefoxitin sodium, Frosst
Std.) is supplied as sterile powder in boxes of
10 vials:
No. 3356 1 g cefoxitin as sodium salt
No. 3357 2 g cefoxitin as sodium salt
Storage
MEFOXIN* in the dry state should be stored
below 30° C.

PRODUCT MONOGRAPH AVAILABLE
ON REQUEST

is

Therapy may be started while awaiting the
results of susceptibility testing.
Antibiotic therapy for group A beta-hemolytic
streptococcal infectionsshould be maintained
for at least 10 days to guard against the risk of
rheumatic fever or glom erulonephritis. In
staphylococcal and other infections involving
a collection of pus, surgical drainage should
be carried out where indicated.
Adults with Impaired Renal Function
MEFOXIN* may be used in patients with
reduced renal function but a reduced dosage
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Preservation of Platelets and Blood Products
by Intravenously Administered Dipyridamole in Patients
Who Undergo Coronary Artery Bypass Grafting
The combination of dipyridamole and
acetylsalicylic acid has been proven
effective in preventing coronary artery
bypass graft occlusion, but the benefits
of dipyridamole alone have not yet been
evaluated. In order to assess the value of
dipyridamole alone, the authors ran
domized 24 patients (age range from 47
to 76 years) who underwent coronary
artery bypass grafting to treatment with
either dipyridamole (120 mg/d) by cons
tant intravenous infusion or isotonic dex
trose solution. They recorded platelet
counts and aggregates, hemoglobin
levels, total blood loss, blood products
and intravenous fluids given and
dipyridamole plasma levels, starting 8
hours before operation and continuing
for 3 days after.
The two groups were similar with
respect to pump time, cross-clamp time
and baseline demographic factors. Plate
let counts during cross-clamping and 1
hour postoperatively were similar, but
those on days 1, 2 and 3 postoperatively
were significantly (p = 0.01 to 0.02)
higher in the dipyridamole group. Mean
blood losses in this group were 22% to
3 0 % lower, but the difference was not
significant. However, administration of
erythrocytes and plasma was 49% to
58% less in the dipyridamole group (p =
0.005 to 0.048) over the same period.
Dipyridamole plasma concentrations
varied from 0.37 /ig/ml before and during
bypass to 1.5 ;tg/ml in the 3 days after.
The authors conclude that dipyridamole
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administered intravenously to patients
who undergo coronary artery bypass
grafting may preserve hemostatically
effective platelets so that fewer blood
products are required.
L'association dipyridamole/acide acetylsalicylique a demontre son efficacite
dans la prevention de I'occlusion des
pontages aortocoronariens. Toutefois,
I'utilite du dipyridamole seul n'a pas ete
evaluee. Dans le but d'evaluer I'effet du
dipyridamole, les auteurs ont soumis au
hasard 24 patients (ages de 47 d 76
ans) qui ont subi un pontage aortocoronarien a un traitement qui renfermait soit
du dipyridamole (120 mg/j) en perfusion
intraveineuse continue, soit une solution
de dextrose isotonique. Ont 6te enregistres: le decompte et I'agregation plaquettaires, le taux d'hemoglobine, la perte de
sang total, les derives sanguins et les
solutes intraveineux administres et les
concentrations plasmatiques de dipyrida
mole, de la 8e heure jusqu'au 3e jour
apr£s I'operation.
Les deux groupes etaient comparables
en ce qui a trait au temps de pompe, au
temps de clampage et aux facteurs
demographiques de depart. Les decomptes plaquettaires ont ete similaires pen
dant la clampage et a la premiere heure
apres I’operation; toutefois aux jours 1,
2 et 3 apres I'operation, ils etaient significativement plus eleves (p = 0.01 a
0.02) dans le groupe dipyridamole. Les
pertes sanguines dans ce groupe ont ete
de 22% S 3 0 % inf^rieures mais cette
difference n'est pas significative. Cependant, pendant cette meme periode
I'administration de sang entier et de
plasma a ete de 49% a 58% moindre
dans le groupe dipyridamole (p = 0.005 a
0.048). Les concentrations plasmatiques
de dipyridamole ont varie de 0.37 ^g/ml
avant I'operation jusqu'a 1.5 /ig/ml dans
les 3 jours qui suivirent.
Les auteurs concluent que I'administra
tion intraveineuse de dipyridamole aux
patients qui subissent un pontage aortocoronarien peut sauvegarder I'hemostase
des plaquettes, reduisant de la sorte les
besoins en derives sanguins.

Dipyridamole (Persantine; Boehringer
Ingelheim [Canada] Ltd., Burlington,
Ont.) is an inhibitor of platelet function
and has been used in combination with
warfarin and acetylsalicylic acid to pre
vent thromboembolism associated with
cardiac valve prostheses,1 stroke,2 coro
nary bypass graft occlusion3 and myo
cardial infarction.4 However, there have
been little data establishing the effective
ness of dipyridamole alone. Claimed bene
fits over acetylsalicylic acid alone rest on
indirect evidence4 or have yet to be sub
stantiated.5,6 In order to determine
whether dipyridamole alone affects plate
lets in coronary artery bypass grafting, we
gave the drug as an intravenous infusion
and measured the number of platelets and
degree o f hemostasis in patients who
underwent elective coronary artery bypass
grafting.

Patients and Methods
The study population comprised 24
patients (19 men, 5 women), ranging in
age from 47 to 76 years, scheduled to
undergo elective coronary artery bypass
grafting. All had platelet counts in the
normal range, had had no concomitant
antiplatelet or anticoagulant treatment for
at least 1 week before surgery and had no
evidence of heart failure. Each patient
gave informed consent. The protocol and
consent forms were approved by the
institutional Human Experimentation
Committee. Only one o f the authors,
responsible for randomization and study
organization, had access to the study
code. Surgery, sam ple collection,
postoperative patient management and
assays were all carried out under blinded
conditions.
The patients were randomized to two
groups of 12 patients. One group received
dipyridamole (120 m g/d), the other iso
tonic dextrose. Intravenous dipyridamole
or the placebo was started at least 8
hours before operation and continued
for 2 or 3 days postoperatively. The
drug ampoules (Boehringer Ingelheim
[Canada] Ltd., Burlington, Ont.) were
mixed in a 5% dextrose in water solution
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and infused at a rate of 12 m l/h to a dose
of dipyridamole of 120 m g/d. The iso
tonic dextrose was infused at a rate of 12
m l/h. Based on pharmacokinetic con
siderations and oral bioavailability,7 we
estimated that this regimen would yield
plasm a concentrations interm ediate
between peaks and troughs after oral dos
ing of 75 mg three times daily and
minimize variation due to absorption.
Anesthesia and cardiopulm onary
bypass procedures were standardized.
Anticoagulation intraoperatively was with
heparin (3 mg/kg), cardioplegia was by
cold potassium solution (25° to 28°C) and
the bypass pump was primed asanguineously and operated with a bubble oxygen
ator. The heparin effect was neutralized
postoperatively with protamine sulfate (1
mg/kg).
After operation all patients were
managed routinely in the intensive care
unit by the regular staff who had no
knowledge of patient randomization.
Hemoglobin concentrations were main
tained at 100 g /L or greater by the trans
fusion of packed cells. Plasma, albumin

or crystalloid was used for volume
replacement to maintain the left atrial
pressure at 8 to 10 mm Hg. No patient
in either group required reoperation or
infusions of platelets or cryoprecipitate to
manage bleeding.
Various venous blood samples were
taken pre- and postoperatively and by
a rte ria l catheter in trao p erativ ely .
Erythrocyte counts, platelet counts and
hematocrit and hemoglobin levels were
analysed by an automatic counter. Cir
culating platelet aggregates were deter
mined by the method of Wu and H oak,8
and the aggregation index was calculated
as the platelet count in plasma plus ethy
lene diamine tetra-acetic acid (EDTA) and
formalin divided by the platelet count in
plasma plus EDTA. Blood samples were
taken 24 hours preoperatively (before
infusion), immediately preoperatively
(after infusion achieved a steady level),
intraoperatively (during cross-clamping),
1 hour postoperatively (in the recovery
room) and 24, 48 and 72 hours postoper
atively. Intraoperative blood loss,
postoperative fluid balance, blood losses

Table I - Surgical P ro file *
Variable
Age, yr
Preoperative
hemoglobin, g/L
Preoperative
p latele t counts,
X 1 0 9IL
Preoperative
aggregate ratio
Num ber of bypassed
vessels
Tim e on pump, min
A ortic cross-clamp
tim e, min
Intraoperative
fluids given, m lt
Intraoperative
blood loss, ml
Postoperative fluid
balance, m l§

Dipyridam ole
(n - 12 , 2 women)

(n -

Placebo
12 , 3 w om en)

5 4 .5
(4 7
142
(1 2 9
2 2 8 .3
(1 6 6

±
±
±
-

6 .6
67)
1 0 .3
157)
3 8 .5
286)

5 8 .4
(4 8
133
(1 1 3
2 4 3 .2
(1 6 8

±9.12
- 76 )
± 12.1
- 154)
± 5 6 .1
- 379)

1 .0 0
(0 .7 6
3 .0 0
(2
8 9 .9
(5 4
3 5 .3
(9
4205
(3 5 0 0
683
(2 5 0
4330
(2 5 5 0

±
±
±
±
±
±
±
-

0 .1 4
1.16 )
0 .9 5
4)
2 5 .0
131)
1 8 .9
57)
514
4900)
510
1900)
1166
6750)

1 .0 7
(0 .8 9
2 .6 0
(2
8 3 .0
(6 0
3 7 .1
(1 0
3717
(2 2 5 0
648
(3 0 0
3562
(2 4 0 0

± 0 .1 4
- 1 .2 8 )
± 0 .5 1
- 4)
± 1 8 .8
- 110)
± 1 8 .7
- 60)
± 1104
- 5300)
± 332
- 1400)
±1172
- 6050)

p value fo r
group d iffe re n c e t
0 .5 8
0 .0 8
0 .4 6

0 .2 1
0 .2 6
0 .4 9
0 .8 3
0 .2 5
0 .8 7
0 .1 6

'V a lu e s are means w ith standard deviations, num bers in brackets are value ranges.
tT e s t of differences is unpaired /-te s t.
tS u m of asanguineous pump prime plus packed cells.
§Blood products and crystalloids given minus blood loss and urine output.

Table II— Hemoglobin C oncentrations (g /L)*
Sam ple
Preoperative, 2 4 h
Post drug, 1 h preop
Intraoperative, on
cross-clam p
Postop, 1 h
Postop, 2 4 h
Postop, 4 8 h
Postop, 7 2 h

Placebo

p v a lu e t

1 4 2 ± 1 0 .3
1 4 0 ± 1 0 .3
8 2 .5 ± 1 0 .8

1 3 3 ± 12.1
131 ± 1 3 .5
7 5 .7 ± 1 3 .0

0 .0 8
0 .0 7
0 .2 0

111
111
115
116

0 .9 1
0 .5 0
0 .2 8
0 .0 4

± 1 5 .0
± 6 .2
± 1 6 .5
± 9 .7

'V a lu e s are m ean ± standard deviations.
t p value is based on unpaired M e s t.

±
±
±
±

Statistical Analyses
Statistical analyses were carried out
using the BMDP statistical program s.10
Analyses of variance techniques for a
two-factor repeated-measures design with
one grouping factor (drug) were em
ployed. Unpaired f-tests were used for
comparisons of individual time points and
clinical variables. Absolute and percen
tage changes from baseline were used as
a measure of drug effect, when baseline
measurements were comparable.
Results
Table I presents details of the bypass
procedure. Hemoglobin and hematocrit
values and erythrocyte count were all
slightly higher in the dipyridamole group
but were similar to the placebo group by
1 hour postoperatively (Table II).
Changes in platelet counts and circulat
ing platelet aggregates are plotted in Fig.
1. Overall analysis of change from base
line for platelet counts was significantly
different (p = 0.023) for the two treat
ment groups, but pairwise comparison of
the time points confirms the impression
from Fig. 1 that this is primarily due to
differences at 1, 2 and 3 days postopera
tively (p = 0.024, 0.019 and 0.020,
respectively). There was no significant
change in circulating aggregates.
Cumulative blood losses over 48 hours
postoperatively and blood products
administered are given in Table III, and
losses in the first 12 hours are shown in
Table IV. Only 18 patients had complete
data. Patients treated with dipyridamole
lost 20% to 30% less blood than the
placebo-treated patients, but the differ
ence was not statistically significant.
Nevertheless, the am ount o f blood
products needed by the treated group to
maintain the standard hemoglobin level
after operation was significantly less.
Dipyridamole plasma concentrations are
shown in Fig. 2.
Discussion

Dipyridamole

111
108
108
104

at 0 to 12 hours, 12 to 24 hours and 24
to 48 hours postoperatively, and blood
products (plasma, packed cells) and fluids
given in the same postoperative periods
were recorded. Dipyridamole plasma con
centrations were determined by highpressure liquid chromatography.9

1 6 .0
1 3 .2
1 3 .7
1 5 .3

Activated by the traum a o f cardiopul
monary bypass, platelets adhere avidly to
injured endothelium and synthetic sur
faces. Once platelets have adhered, the
sequence of activation, adhesion and the
internal generation and release o f bioac
tive materials begins. The widespread
platelet consumption and partial activa
tion of other platelets deplete their abso
lute number and leave many impaired
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residual platelets in the circulation. These
residual circulating platelets respond
abnormally when tested in vitro and thus
may contribute, as does the diminished
number of platelets, to postoperative
hem orrhage.11
In our study, mean (± standard error)
hemoglobin concentrations dropped
42.2% ± 1.7% (dipyridamole) and
43.9% ± 2.8% (placebo) during aortic
cross-clamping compared with baseline
values, and platelet counts dropped
47.3% ± 2.8% and 49.2% ± 3.8%
respectively. The proportionately greater
loss of platelets confirms platelet seques
tration or consumption. In patients
treated with dipyridamole, the recovery
of platelet counts was more rapid
postoperatively than in patients not so
treated. The time course of new platelet
synthesis from megakaryocytes is in the
order o f 3 to 7 days after a thrombocyto
penic stimulus, so that a stimulus to
thrombopoiesis by dipyridamole is less
likely than direct platelet-sparing.12
Intraoperative blood losses and blood
products used (Table I) were quite simi
lar in the two treatment groups, in agree
ment with the findings of Chesebro and
colleagues.3 During this period, patients
received heparin anticoagulation, so the
effects of an antiplatelet agent might not
be detectable. After heparin reversal with
protam ine, both variables of platelet
counts and usage of blood products
separate by treatment group. A previous
rep o rt13 studied postoperative blood
losses and blood products given for 15
hours after open-heart surgery in patients
on dipyridamole and in a control series
but detected no differences. However, the
dipyridamole dose was 0.5 m g/kg given
as a single dose into the heart-lung
machine, about one-quarter of the dose
given in this study.
The pattern of blood products used and
blood losses in the recovery period mir
ror the observations on platelet counts.
This implies that the platelets preserved
by dipyridamole are functional. The
platelet-sparing and improved hemosta
sis by dipyridamole in this study stands
in marked contrast to the effects of simi
lar drugs such as acetylsalicylic acid and
prostacyclin, which may preserve plate
lets but at the expense of increased risks
of hemorrhage and bleeding complica
tions.14'15
Other groups have recorded elevations
of platelet counts after dipyridamole
treatm ent and the thrombocytopenic
effect of surgery, in both animals16'17
and m an.13’18 Miyauchi and Isomura18
also used an intravenous dose (1 to 2
m g/kg daily) preoperatively, apparently
without postoperative drug administra
tion. None of these groups, however,
monitored the postoperative use of blood
products for 2 days. In one study in
dogs,17 the difference in platelet counts
262

in dipyridamole versus control animals
was paralleled by lower indium -Illlabelled platelet deposition in the
myocardial tissues of the dipyridamole
group. This supports the suggestion of
decreased platelet consumption in our
study. In another animal study, Becker16
obtained good results by adding dipyrida

mole to the pump prime. The plasma con
centrations of dipyridamole were not
monitored in any of these studies, but all
the positive results were associated with
intravenous use of the drug.
The infusion rate of dipyridamole was
calculated to produce plasma concentra
tions near 0.5 g/ml and preoperative
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PIG. 1—Platelet counts are shown as percentage of baseline in dipyridamole (solid circles)
and placebo (open circles) groups. Values are means with standard-error bars for 11 or 12 patients
in each group. Asterisks indicate significant differences between treatments (*p = 0.02, **p
= 0.01). Change in platelet aggregate ratio from baseline (means with standard errors) for
dipyridamole (solid squares) and placebo (open squares) groups. Positive deviation indicates
decrease in presence of circulating aggregates. None o f differences between treatments are statisti
cally significant.
Table III--Cumulative Blood Losses and Blood Products Given Postoperatively*
Placebo
Dipyridamole
Postop
(n - 8)
(n = 10)
time, h
Measurement
526 ± 294
366 ± 194
0-12
Blood loss, ml
841 ± 406
638 ± 198
0 -2 4
950 ± 511
738 ± 242
0-48
688 ± 291
290 ± 222
0 -1 2
Blood products
909 ± 351
465 ± 493
0 -2 4
given, ml
1065 ± 459
515 ± 494
0-48

p value
0.183
0.183
0.261
0.005
0.048
0.28

'Values are mean ± standard deviations.

Table IV--Data for Transfusion and Blood Loss (ml) in
the First 12 Hours Postoperatively
Control
b24
P22
P19
P16
+ 14
P13
P12
P10
P8
P5
P3
P1

Dipyridamole
Transfusion
500
50
200
200
500
300
200
250
200
200
40
50

Losses
315
750
750
Nil
775
525
340
125
400
100
325
450

Control
23B
21
20
18
17
15
11
9
7
6
2

Placebo
Transfusion
250
500
500
500
250
250
250
250
500
—
—

Losses
300
450
750
925
430
380
450
600
425
525
325
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concentrations were in this range (Fig. 2).
This is in the middle range of concentra
tions attained with a dose of 75 mg three
times daily,19'20 a regimen used in long
term trials of bypass graft occlusion3 and
secondary prophylaxis of myocardial
infarction.4 The variation among
individuals with the intravenous infusion
method here is much less than the 50 to
100-fold range observed with the peaks
and troughs of oral dosing. If one con
siders the preoperative dose of 100 mg
four times a day used by Cheseboro and
colleagues,3 then infusion rates must be
at least doubled over our regimen to
attain dipyridamole concentrations in the
1.0 fig/ml range.20
The postoperative changes in platelet
counts in our study were associated with
two to three-fold increase in dipyridamole
concentrations. This accum ulation
phenomenon may be due to a post-bypass
redistribution of fluid (there is a large
positive fluid balance postoperatively), an
acute phase increase in the production of
cq-acid glycoprotein,21 which avidly
binds dipyridamole, or a decreased biliary
excretion of dipyridamole. From our
data, we are unable to explain the
mechanism of the accumulation and we
cannot conclude whether the platelet and
blood-product effects are due to the
increased concentrations or to intraoper
ative platelet preservation. We could find
no correlation in this study between drug
concentration and platelet effects. Others
have correlated both aggregation and

platelet Factor IV in plasma with
dipyridamole concentrations.22
The lack of significant effects on plate
let aggregates is disappointing, but, since
the publication of Wu and H oak’s
method,8 there have been only isolated
demonstrations of antiplatelet effects of
a drug using this end point.23 Dipyrida
mole is particularly devoid of antiaggre
gation effects using conventional platelet
aggregation models.24 This is thought to
be owing to the need for an intact in-vivo
preparation for its mechanism of action
to be seen. This mechanism has been var
iously proposed as adenosine uptake inhi
bition,24 prostacyclin production25 and
phosphodiesterase inhibition.24 The ini
tial observation of antiplatelet effects in
man occurred at dipyridamole concentra
tions of 3.75 jtig/ml after oral dosing.26
Extremely high doses in ex-vivo animal
models have been required to decrease
platelet aggregation or adhesion.27
Clinical evaluations of dipyridamole
have yielded variable results. A combina
tion of dipyridamole and warfarin signifi
cantly decreased the thromboembolic
complications in patients with prosthetic
heart valves compared with warfarin
alone.1 The combination of dipyrida
mole and acetylsalicylic acid significantly
decreased the incidence of coronary
occlusion for 2 years in patients suffer
ing a previous infarction,4 but compari
son with acetylsalicylic acid alone has not
shown added benefit. The power of the
latter comparison to detect an increase of

TIM E, h
FIG. 2—Plasma concentrations of dipyridamole determined in II patients. Error bars show
standard deviations. Drug levels rise consistently in postoperative period.

50% in effectiveness of acetylsalicylic acid
alone is about 20%, so lack of benefit
cannot be established in this indication.
Chesebro and Fuster28 have used previ
ous human data to establish the relevance
of dipyridamole in bypass graft occlusion
and H arajola and colleagues29 have
shown separate and additive effects of
acetylsalicylic acid and dipyridamole on
occlusion rates of peripheral bypass
g rafts. In c o n tra st, Brown and
colleagues6 have shown no added effect
of dipyridamole in coronary bypass graft
occlusion, but both acetylsalicylic acid
and dipyridamole were not started until
2 days after operation.
Our data show that dipyridamole
alone, infused preoperatively and for 3
days postoperatively, preserves platelets
and may thus decrease the necessity for
transfusion of blood products in the
postoperative period. The platelet-sparing
activity of dipyridamole may well have
important implications for reducing coro
nary graft occlusion and the severity of
perioperative myocardial ischemia.
We acknowledge the assistance of the sur
geons in the Department of Cardiovascular
Surgery, Toronto General Hospital, especially
Dr. R.D. Weisel. We also thank Mrs. C.
Legault and Mrs. L. Deeming for data han
dling and computer entry and Miss Fiona Mat
thew for the dipyridamole analyses.
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Successful Surgical Repair in a Patient With Mitral Stenosis,
Calcified Left Atrium and Severe Tricuspid Regurgitation
With a Giant Right Atrium
Successful mitral valve replacement and
tricuspid annuloplasty were performed on
a 66-year-old woman who had a calci
fied left atrium, giant right atrium, calci
fied mural thrombus and normal pulmo
nary pressures. Successful repair in such
cases depends on an adequate preopera
tive investigation and a surgical approach
tailored to the individual.
On a pratique avec succes un remplacement de valvule mitrale et une annuloplastie tricuspidienne chez une femme de
66 ans qui avait une calcification de
I'oreillette gauche, une hypertrophie de
I'oreillette droite, un thrombus mural calcifie et des pressions pulmonaires normales. Dans de tels cas, le succes de la
reparation depend d'un examen preoperatoire adequat et d'un abord chirurgical
individualise.

Calcification o f the left atrium was first
described by Oppenheimer in 19121 as
seen at the autopsy o f a patient who died
of heart failure secondary to mitral valve
disease. The literature was reviewed by
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Harthorne and colleagues2 in 1966,
bringing the number o f reported cases to
88. A further computer search has turned
up only 17 more cases — probably
because the condition is no longer a med
ical curiosity.3-5
There are several classic features of left
atrial calcification:
• It is usually found in women (75%).
• With the exception o f one reported
case,6 it is associated with mitral steno
sis secondary to rheumatic valve disease.
• Atrial fibrillation is almost uni
versal.
• Most patients have long-standing
symptoms averaging 15 to 20 years.
• The frequency o f embolism (pul
monary or systemic) is about 50%.
The calcification is believed to result
from one of two causes — repeated bouts
o f endocarditis with deposition of calcium
or a regurgitant jet striking the posterior
portion of the atrium (McCallum’s patch)
causing deposition o f lime salts in this
area.
The overall incidence o f left atrial cal
cification is estimated to be 1% to 2%
o f patients with rheumatic valvular
disease.7
The death rate from surgery has been
reported at 25%2 and it is stressed that
the outcome o f surgery is greatly
improved by preoperative recognition of
the disease. The major problems encoun
tered are control o f hemostasis, difficulty
entering the atrium and postoperative
embolism.

We report an unusual case in which a
huge right atrium, calcified left atrial
thrombus and normal pulmonary artery
pressures were all present in association
with complete left atrial calcification.
Case Report
A 66-year-old woman had rheumatic fever
as a child and first became symptomatic at 40
years of age, requiring commissurotomy in
1959. She was well maintained on low-dose
digoxin until 1977 when mild pulmonary edema
developed. A diuretic was added to her regi
men. She refused to undergo surgery on several
occasions and in 1983 presented with biventric
ular failure. She was managed medically but
in 1985 consented to a surgical opinion.
At that time she had severe dyspnea on mild
exertion. She had a blood pressure of 130/80
mm Hg and atrial fibrillation. Her jugular vein
pressure was elevated to the angle of the jaw
and prominent fibrillating waves were noted.
A hepatojugular reflux was present. The
cardiac apex was laterally displaced and heart
sounds were variable with an occasional S3
murmur. There was a grade 3/6 pansystolic
murmur in the tricuspid area and a milder sys
tolic murmur in the mitral area. The liver was
palpable 8 to 10 cm below the costal margin.
The lung fields were clear and the rest of the
physical examination was unremarkable.
Preoperatively the hemoglobin level was 123
g/L with normal indices. The alkaline phos
phatase level was mildly elevated (134 U/L),
the electrocardiogram showed left ventricular
hypertrophy, right bundle branch block and
atrial fibrillation at a rate of 80 beats/min.
A chest x-ray film revealed cardiomegaly with
a huge right atrium and enlarged left atrium
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with irregular dense calcification in the left
atrial cavity (Fig. 1).
Angiography demonstrated mitral stenosis
and regurgitation. Her pulmonary artery pres
sures were 36/19 mm Hg. The left atrial cal
cification was not thought to involve the mitral
annulus and surgical treatment was advised.

Surgical Approach
The heart was exposed through a midline
sternotomy. The large right atrium was very
thin and the left atrium was totally calcified.
The aorta and both venae cavae were cannulated and the patient was placed on cardiopul
monary bypass. Through the right atrium a
Dubost incision was performed to expose both
the tricuspid and mitral valves, the former
being grossly dilated but with no structural
abnormalities. A calcified mass was removed
from the left side of the interatrial septum and
reported as a calcified mural thrombus. The
mitral valve was replaced with a no. 29
Ionescu-Shiley bioprosthesis. Tricuspid
annuloplasty using a no. 34 CarpentierEdwards ring was then performed. The patient
was weaned from cardiopulmonary bypass
without complication. The clamp time was 134
minutes and bypass time 216 minutes.
Postoperatively, the woman required treat
ment for heart failure. She responded well and
was transferred from the intensive care unit on
postoperative day 3. Later a symptomatic
pleural effusion was removed by thoracente
sis and she was discharged home to the care
of her family physician on day 14.
Follow-up 6 months later revealed residual
class II symptoms (New York Heart Associa
tion classification). The patient complained of
only mild dyspnea and there was no evidence
of cardiac failure on the chest film.

Discussion
Our patient was unique in several ways.
Although all o f the following have been
reported in association with left atrial cal
cification, there are no reports o f all three
coexisting simultaneously.

• A giant right atrium was reported
by Roberts and associates8 in a series o f
three patients. All died intraoperatively
or soon after.
• Left atrial thrombus is not uncom
mon in this condition, although complete
calcification is less common.
• Pulmonary artery pressures were
normal. Although occurring in 20% o f
patients, this has never before been
reported in a patient with a hugely dilated
right atrium.
Proper preoperative evaluation is para
mount in these patients. It must include:
(a) A chest x-ray film. The left atrium
is seen just inferior to the carina. Wellpenetrated films are best, and oblique and
lateral projections most useful.
(b) Fluoroscopy. This is a more sen
sitive modality, especially in delineating
the extent o f calcification.
(c) Catheterization, which will help
differentiate calcification in the coronary
arteries.
The information gained from these
investigations allows the surgeon to plan
alternative approaches, two of the more
common being a right thoracotomy with
an incision through the posterior inter
atrial groove and a Dubost incision
through the right atrium and interatrial
septum.
The high incidence o f em bolism
postoperatively can be minimized by
removal o f thrombus and by long-term
anticoagulation.
We may, therefore, conclude that with
proper preoperative investigation and an
individualized surgical approach, severe
calcification and enlargement o f the atria
are not contraindications to surgery in
patients with severe left atrial calcifi
cation.
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Repair of Anorectal Incontinence in an
Adolescent Boy With Neonatal Anal Atresia
Fecal continence, the ability to retain
intestinal contents until evacuation is
desired, requires the complex interaction
of several factors. They include: the
motor action of the sphincters, sensibil
ity of skin and sphincters and function of
the rectum and central nervous path
ways. Appropriate and effective manage
ment is available to treat many disorders
of continence. However, the success of
these treatments depends on careful
delineation of the various contributing
factors. The authors present the case of
an 18-year-old boy with disabling fecal
incontinence, secondary to neonatal anal
atresia and its primary management, in
order to illustrate the importance of care
ful assessment of each of the contribut
ing factors. His staged surgical treatment
has been successful in returning him to a
more normal state.
La continence anale, soit la capacity de
retenir le contenu intestinal jusqu'E son
Evacuation volontaire, exige I'interaction
complexe de nombreux facteurs. Parmi
ceux-ci, on compte Taction motrice des
sphincters, la sensibilitE de la peau et
des sphincters et le fonctionnement du
rectum et des voies de transmission du
systEme nerveux central. II existe des
traitements appropriEs et efficaces pour
paliier a plusieurs troubles de la conti
nence. NEanmoins, le succEs de ces trai
tements dEpend de ('identification
soigneuse des divers facteurs en cause.
Les auteurs dEcrivent le cas d'un jeune
homme de 18 ans handicapE par une
incontinence anale secondaire E une atrEsie anale nEonatale et a son traitement
initial. Ce cas leur permet d'illustrer
('importance d'une Evaluation soigneuse
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de chacun des facteurs impliquEs. Un
traitement chirurgical par Etape a permis
E ce jeune homme un retour E une vie
normale.

Complex derangements o f anal inconti
nence can be managed in such a way as
to benefit the patient. We describe the
case o f a teenage boy who presented with
a severe sociosexual disability resulting
from fecal incontinence. The derange
ment o f the continence mechanism was
complex and related to neonatal anal atre
sia which was managed by dilatation. His
condition was substantially improved by
careful delineation of the abnormalities
and an operative strategy to correct each
one.

67% of the anterior quadrants and anal
manometry using three radially placed strain
gauges (Narco Digitized Manometer; Narco
Scientific Ltd., Health Dyne Co., Downsview,
O nt.) (Table I).
A combined approach to the sphincter
mechanisms and skin defects was designed.
With the patient in the prone, jack-knife posi
tion, a curvilinear incision was made in the
anterior anal verge for approximately 180°.
The healthy lateral margins of normal sphinc
ter were first dissected out to a depth of

Case Report
An 18-year-old boy had congenital anal atre
sia and an anal dimple. Treatment at birth had
consisted of insertion of a probe through the
dimple and dilatation. The sphincter was not
incised. His mother was instructed to continue
dilatations through his early childhood. His
continence through childhood and adolescence
was marginal. Control was achieved largely
through buttock squeeze, dietary manipulation
and frequent reconnoitering of accessible toi
let facilities. Frequently he was unaware of the
seepage. When we saw him his major problem
was sociosexual, relating to his frequent leak
age and fear of accidents. He refrained from
all physical activities and had withdrawn from
establishing any female relationships.
There were no obvious physical abnormali
ties other than that pertaining to the anorectum. The anus was extremely patulous with a
large anterior “ keyhole” defect and no observ
able anoderm. The anal canal was 6 cm long,
but the rectal mucosa was loose and an
ectropion prolapsed 3 cm into the anal canal
(Fig. 1). On digital examination a thickened
rigid canal was noted which could easily admit
two fingers. Squeeze was present in the
posterior 120° of the puborectalis and exter
nal sphincter. No squeeze could be effected
anteriorly. Sigmoidoscopy and barium studies
gave normal findings. Further investigations
included intravenous pyelography which iden
tified a horseshoe kidney, standard anal elec
tromyography using a needle electrode which
showed posterior activity but no activity in

FIG. 1—Combination of defects including
keyhole effect and mucosal ectropion.
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approximately 3 cm, the deep dissection was
carried anteriorly to the scar. No intraopera
tive electromyography was used since our
preoperative results had been precise and the
demarcation between healthy sphincter and
scar was clear. The latter was quite attenuated
and difficult to dissect, but once dissection was
completed the scar was divided at its midpoint
in preparation for a wrap as described by Gold
berg and colleagues1 (Fig. 2). The scar ends
were overlapped and sutured to the con
tralateral healthy sphincter with interrupted
absorbable sutures (Fig. 3).
After sphincter-muscle repair, the next stage
was to re-establish the anoderm of the anal
canal. This was accomplished by S-shaped skin
and subcutaneous flaps, approximately 5 cm
x 10 cm in dimension, which were created in
the lateral quadrants and rotated into the anal
canal. They were anchored with absorbable
sutures and the lateral subcutaneous spaces
drained with a small plastic suction apparatus
(Fig. 4).
One week after operation the patient was
continent to solid stools and at 6 weeks he was
continent to both solid and loose movements,
with occasional loss of control of flatus.
Subsequently, he experienced seepage of
liquid stools and was operated upon again to
remove a persistent mucosal ectropion.
He is now generally continent to solid stools
but still has some difficulty with loose stools
and flatus, although this occurs fairly infre
quently and he is aware of the seepage. Con
fidence in his continence mechanisms has been
restored enabling him to begin an active social
life. Despite significant clinical improvement,
manometric improvement was minimal —
approximately 20 mm Hg higher squeeze pres
sures, radially.

Discussion
The frequency of anorectal atresia is
between 1 in 1500 and 1 in 5000 live births
and is more common in males.2-4 It is
usually the result of incomplete separa
tion by the urogenital septum of the
cloaca into urogenital and anorectal com
ponents. Less frequently it is caused by
failure of the anal membrane to perforate
normally at the end of 8 weeks’ gesta
tio n .2 Murken and Albert4 found a
family history of anorectal atresia in 1 of
169 patients with the abnormality.
The international classification of
anorectal anomalies separates these
defects into low (translevator), intermedi-

ate and high (supralevator), with many
subdivisions according to sex and
associated fistulas.5
Problems commonly associated with
anorectal atresia include urinary inconti
nence and sexual dysfunction which
present a major psychosocial problem for
the patient. Associated congenital
genitourinary and skeletal anomalies are
frequent.6,7 In 1272 children with imper
forate anus Hasse6 found 323 urogenital
malformations, 12 of which included
horseshoe kidney.
The initial management of complete
atresia has been directed at decompress
ing the obstructed bowel and subse
quently producing a socially necessary
degree of fecal continence.8 In incom
plete atresias, with an anal dimple,
preliminary colostomy may not be neces
sary. An early dilatation with repeated
dilatations by one parent has been a com
mon approach.5,9-13 Many other ap
proaches have been advocated for higher
fistulas, all of which are beyond the scope
of this paper.8,14,15
The common factor in all forms of
treatment is to provide long-term conti
nence. Continence can be defined as the
ability to retain intestinal contents until
evacuation is desired. It requires the com
plex interaction of several factors.
Scharli16 has identified five main factors
as the passive forces of continence: the
motor action of the sphincters, the sensi
bility of the skin and the sphincters, the
function of the rectum and the central
nervous pathways, which produce cons
cious and unconscious coordination.
Continence requires the ability to sense
the need to defecate and to use the volun
tary musculature to redirect stool proximally.17 A rigid anorectum may impede
normal continence. Stelzner18 noted the

importance of the hypersensitive skin of
the anal canal in sensing the intestinal
contents.
Millard and Rowe15 identified the
absence of a skin-lined anal canal from
mucosal ectropion or rectal prolapse as
common complications of early repair of
imperforate anus, as in our patient. They
noted that there is not enough skin avail
able by push or pull to construct an ample
skin-lined canal. They advocated skin
flaps to eliminate tension at the border
of mucosa and skin to correct the
problem. They further suggested replace
ment of insensitive ectropic mucosa with
cutaneous sensory epithelium created by
local flaps to provide essential perianal
sensation. Our experience with gracilis
muscle replacement for damaged sphinc
ter muscle has been unrewarding.
Although we performed manometric,
electromyographic and radiologic studies,
we and others14 have found them in
general to be of less benefit than clinical
assessment. The one test of clinical use
in our patient was electromyography
which identified normal muscle and the
extent of scar tissue.
We identified three deficiencies in our
patient: a cutaneous sensory defect caused
by the mucosal ectropion; anterior defi
ciency of the anal sphincter, possibly
caused by the initial dilatation “ missing”
the anterior fibres; and anterior scarring
of the anal canal, presumably due to
repeated dilatations. O ur surgical
approach was designed to correct each of
these deficiencies and was successful in
restoring the young man to a near-normal
state. Although we could find no similar
reports using this combined approach, we
speculate that, given the frequency of this
problem, other patients exist who might
benefit from such an approach.
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FIG. 2—Type of anterior dissection of exter
nal sphincter (adapted from Goldberg SM,
Gordon PH, Nivatvongs S1).
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FIG. 3—Completed wrap of external sphinc
ter with suture tags.

FIG. 4—Completed wrap and graft 2
months postoperatively.
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Do Symptoms Reflect a Change in Left Ventricular Function
After Aortocoronary Bypass Grafting in Patients
With Depressed Left Ventricular Function?
Seventy-nine patients with moderate to
severe left ventricular dysfunction who
underwent aortocoronary bypass grafting
between 1971 and 1977 had follow-up
heart catheterization at a mean interval
of 3 years. Thirty-three patients (42%)
had angiographic improvement in left
ventricular function at follow-up and 18
(25% ) had a decrease in left ventricular
end-diastolic pressure. Fifty-eight
patients (73%) had improvement in
angina of at least one New York Heart
Association class at follow-up. There
was no correlation between late
improvement in left ventricular function
and improvement in angina. Improvement
in left ventricular function did not corre
late with preoperative indices of severity
of coronary disease or with indices of
completeness of surgical repair.
Soixante-dix-neuf patients qui avaient
souffert de dysfonctionnement ventricu-

From the University o f Ottawa Heart Insti
tute, Ottawa Civic Hospital, Ottawa, Ont.
Presented at the 38th annual meeting o f the
Canadian Cardiovascular Society, Halifax,
NS, Oct. 24, 1985
Accepted for publication Jan. 29, 1987
Reprint requests to: Dr. B.C. Morton,
University o f Ottawa Heart Institute,
Ottawa Civic Hospital, 1053 Carling Ave.,
Ottawa, Ont. K1Y 4E9

laire gauche moyen ou severe et qui ont
subi un pontage aortocoronarien entre
1971 et 1977 ont passe un catheterisme
cardiaque de controle apres un intervalle
moyen de 3 ans. Trente-trois patients
(42% ) montraient au suivi une ameliora
tion angiographique de la fonction ventriculaire gauche et 18 (25%) avaient une
diminution de la pression telediastolique
du ventricule gauche. Cinquante-huit
patients (73% ) presentaient une amelio
ration de I'angine d'au moins une classe
a I'echelle de la New York Heart Asso
ciation. On n'a constate aucune correla
tion entre une amelioration tardive de la
fonction ventriculaire gauche et une
amelioration de I'angine. L'amelioration
de la fonction ventriculaire gauche n'a
pas montre de rapport avec les indices
preoperatoires de la severite de la maladie coronarienne ou avec les indices
d'achevement de la reparation chirurgicale.

It has become clear over the past 15 years
that symptoms of angina are relieved by
aortocoronary bypass grafting for a long
time in most patients,1 but the effect of
such surgery on left ventricular function
is contentious. Published studies have
reported improvement,2'3 no improve
ment4'5 and variable change6'7 in resting
left ventricular function after successful
bypass to myocardial segments with re
versible ischemia.

One problem in analysing the results of
grafting is that latent dysfunction of
ischemic segments may be brought out
only by stress such as exercise or pacing
at study before or after surgery.5'8
Another is that segments with normal
contraction preoperatively cannot be
expected to show better resting function
postoperatively, but there is thf; potential
for a loss of function due to periopera
tive infarction. In our own experience, a
comparison of segmental wall motion in
50 patients before and after operation
showed a decline in resting wall motion
in 29 ventricular segments, improvement
in 47 and no discernible change in 174.
Mean ejection fraction for the group did
not differ preoperatively and postopera
tively (0.48 versus 0.49).9 On average,
there appears to be modest improvement
in ventricular function from aortocoro
nary bypass grafting alone, but there is
considerable individual variation.
We surveyed the results in our hospi
tal of aortocoronary bypass grafting
along with aneurysm repair in patients
with depressed left ventricular function
before operation. This subgroup admit
tedly carries the greatest potential for a
gain in ventricular function after surgery
and we first wished to learn how fre
quently such improvement occurred. We
tried to assess whether functional
improvement in such patients at follow
up was manifested by better left ventricu-
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lar function. Further, we questioned
whether improvement in systolic and
diastolic left ventricular function neces
sarily went together. When improvement
did occur, we examined whether it could
be predicted by, or associated with, cer
tain characteristics of the patient or the
operation.
Patients and Methods

Of 1831 patients who underwent aor
tocoronary bypass grafting at the Ottawa
Civic Hospital between 1971 and 1977,
263 were considered to have class III or
IV left ventricular dysfunction preoperatively. This classification is a subjective
and semiquantitative assessment of dys
function used by our group that relates
to the number of 25 percentiles of nor
mally contracting ventricular circumfer
ence at angiography (right anterior
oblique projection). A class I ventricle has
75% of the circumference contracting
normally and a class II ventricle 50%.
Thus, a class III ventricle has only 25%
of its circumference with normal inward
systolic motion and a class IV ventricle
has no entire segment that contracts nor
mally. Although subjective, the system
has become fairly reproducible within our
group. Where such measurements are
available, patients with class III left ven
tricles usually have ejection fractions
between 0.25 and 0.45 and those with
class IV ventricles less than 0.25.
This report is a survey of 98 of the 263
patients who returned for a second heart
catheterization at least 1 year after sur
gery. In the first few years, many such
patients returned because of recurrent
symptoms. After 1978 some were studied
in response to an invitation extended to
all surviving patients. Complete pre- and
postoperative catheterization data were
available for 79 of the 98 patients. The
interval between surgery and restudy was
2.9 ± 1.4 years (mean ± SD). Compari
sons were made of ventricular function
preoperatively and postoperatively for
each patient. Ventricular angiograms
were reviewed by an experienced cardiac
radiologist without knowledge of the clin
ical results. Because left ventricular ejec
tion fractions for both studies were avail
able for only a few patients, systolic
function was reported in terms of the
above-noted classification. Left ventric
ular end-diastolic pressure was measured
before angiography through fluid-filled
catheters, at the nadir of the “ a” wave.
Change in ventricular function between
the tw o studies and sym ptom atic
improvement at follow-up were cor
related, along with a number of preoper
ative clinical and operative factors (Table
I). Tests of statistical significance used
were x2 analysis, Student’s t-test and
Fisher’s exact test.
270

Findings

Of the 79 patients, 73 (92%) were men
and the mean age at the time of surgery
was 49 ± 8 years. Fifty patients (63%)
had class III left ventricular dysfunction
preoperatively and 29 (37%) class IV. No
patient had a normal electrocardiogram
before surgery; 64 (81%) manifested one
or more previous infarctions, and the
remainder had left bundle-branch block
or ischemic ST abnormalities. Almost
90% of patients had angina but only 18%
had symptoms of uncompensated conges
tive heart failure (Table II). At the time
of operation, 17 patients (22%) had pli
cation or resection of a ventricular
aneurysm and the mean number of
bypass grafts placed was 3.4 ± 1.1 per
patient. These figures all closely resem
ble those of the parent group, suggesting
that patients restudied were a reasonably
representative sample. The operative
(30-day) death rate for the entire group
of 263 patients was 8%.
Thirty-three patients (42%) were
judged to have shown improvement,
between studies, of at least one angio
graphic class of ventricular contraction
(Table III). The remainder did not
improve or became worse.
Changes in left ventricular end-diastolic
pressure between studies are outlined in
Table IV. Although the mean value for
the group overall did not change, there
were subgroups in which there was a
physiologically and statistically significant
change in end-diastolic pressure. These
groups were (somewhat arbitrarily)
defined — one in which the pressure was
more than 16 mm Hg preoperatively and
fell by at least 6 mm Hg postoperatively
(18 patients) and another in which the left
ventricular end-diastolic pressure was
more than 16 mm Hg postoperatively and
at least 6 mm Hg more than the preoper
ative level (21 patients). These subgroups
o f patients we have designated as
“ LVEDP better” and “ LVEDP worse”
respectively. In the remaining 40 patients
there was no significant change.
A univariate analysis of preoperative
clinical and operative factors thought
likely to have a bearing on improved ven
tricular function was done for the 33
patients with improvement of one or
more angiographic classes of left ventric
ular function and the 18 “ LVEDP bet
ter” patients. In no instance did any of
these factors have a significant correla
tion with such improvement (p > 0.10).
Improvement in angina at late follow
up was compared with angiographic or
hemodynamic improvement in left ven
tricular function. The incidence of symp
toms of uncompensated heart failure
before surgery was too low (18%) for a
meaningful difference to be present after
surgery. Thus, improvement in angina
was studied instead. Of the 18 “ LVEDP

better” patients, 10 (56%) had improve
ment in angina of one or more NYHA
class. However, 16 (76%) of the 21
“ LVEDP worse” patients and 32 (80%)
of the 40 whose left ventricular enddiastolic pressure did not change signifi
cantly had similar degrees of improve
ment. Similarly, 24 (73%) of the 33
patients whose angiographic systolic left
ventricular function improved had angi
nal improvement while 34 (74%) of the
46 whose left ventricular function was not
better had similar improvement at
follow-up.
Discussion

Many cardiac centres have avoided aor
tocoronary bypass grafting in patients
Table I—Univariate Analysis of Hemodynamic
or Angiographic Improvement
Preoperative factors
Presence of angina
Presence of congestive heart failure
Angiographic class of left ventricular
function
Cardiomegaly
Hypertension
Extent of coronary disease
Use of digoxin
Use of diuretics
Operative factors
Number of grafts
Graft patency at angiographic follow-up
Aneurysm repair
p > 0.10 for all factors.

Table II—Preoperative Clinical Status of Patients
Angina,
Heart failure,
NYHA class
no. (%)
no. |%)
1
65 (82)
9 (11)
II
22 (28)
9 (ID
III
3 (4)
28 (35)
IV
2 (3)
20 (25)

Table III--Change in Angiographic Class
of Left Ventricular Function
Class
Postop
Preop
—
2
Normal
1
Class I
—
14
Class II
42
50
Class III
29
20
Class IV
Improvement in one or more class - 33 (42%).

Table IV-Change in Left Ventricular
End-diastolic Pressure
(LVEDP) (mean value ± SD)
Postop,
Preop,
Group
mm Hg
mm Hg
Total group (n = 79)
15 ± 8 16 ± 8
LVEDP worse (n - 21)
12 ± 7 25 ± 6
LVEDP same (n - 40)
13 ± 7 13 ± 7
LVEDP better (n - 18) 24 ± 6 12 ± 4

VOLUME 30, NO. 4, JU L Y 1987 / THE CANADIAN JOURNAL OF SURGERY

with severely depressed left ventricular
function, especially those with a left ven
tricular ejection fraction of less than 0.25
(equivalent to our class IV). The ration
ale has been that the high operative death
rate and high attrition rate over the sub
sequent few years negate the value o f such
surgery. This has not been our philosophy
at the Ottawa Heart Institute and the
acceptable surgical mortality and late sur
vival figures for patients with depressed
left ventricular function bear this out.
However, the changes in left ventricular
function after grafting are much less
clear-cut. That 42% of patients had a dis
cernible improvement in angiographic left
ventricular function must reflect reversi
ble ischemia as a major component of
hypokinesia preoperatively. It is surpris
ing that none of the factors reflecting clin
ical severity o f coronary heart disease
were predictive o f improvement; it sug
gests that patients need not be denied sur
gery on that basis. It is more sobering that
improvement in left ventricular function
did not relate to those factors that usually
express adequacy of surgery — number
of grafts performed, number o f grafts
patent at follow-up and repair of an
aneurysm when present. It is possible that
the beta error imposed by the number of
patients in this study is responsible for the
apparent lack o f correlation and that

results in a much larger study might be
different.
Of interest is the discrepancy between
rates o f improvement in systolic left ven
tricular function (33 patients) and in
diastolic function (18 patients, including
9 o f the above 33). As left ventricular enddiastolic pressure reflects not only enddiastolic volume but also end-diastolic
chamber compliance, some ventricles
must have experienced improved contrac
tion without improvement in “ stiffness”
upon filling. This may be the consequence
of resid, al scarred myocardium or an
absolute reduction in chamber size.
Lastly, it was interesting that 73% o f
patients had persisting improvement in
angina at follow-up regardless of whether
left ventricular function had observably
improved, even when severely depressed.
In particular, anginal improvement was
equally likely to be present when the rest
ing left ventricular end-diastolic pressure
was higher after surgery than when it was
lower. This attests to the complexity o f
reasons for improvement in symptoms
and, most importantly, implies that relief
o f angina following surgery in such
patients does not necessarily indicate
improvement in left ventricular function.
Clearly, aortocoronary bypass grafting
can relieve angina in a majority o f
patients with depressed left ventricular

function. Improvement in left ventricu
lar function per se is variable and not
readily predictable; it cannot be inferred
from improvement in angina alone.
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BOOK REVIEWS
ACUTE PERIPHERAL VASCULAR SUR
GERY. Michael Staudacher. 165 pp. Must.
Springer-Verlag New York, Inc., New
York, 1985. $38.50 (US). ISBN 0-38781874-X.

This monograph is designed for the general sur
geon who may occasionally be required to pro
vide emergency care for the patient with acute
vascular problems.
The contents are well organized and the
procedures well illustrated with coloured
schematic diagrams. A very brief description
is given of the pathologic features of some vas
cular emergencies including arterial embolism,
arterial thrombosis, venous thrombosis and the
tourniquet syndrome. The descriptions of
aneurysms and trauma are extremely brief.
Emergency instruments required for simple
vascular repairs are adequately listed, but the
description of the use of air in the Fogarty
catheter will not be acceptable to most vascu
lar surgeons.
The basic vascular surgical techniques are
nicely illustrated, although the use of two stay
sutures instead of the standard three triangu
lation stay sutures for arterial end-to-end
anastomosis is not generally practised. There
are specific illustrations for the management
of embolectomy, simple arterial puncture
wound, severe femoral artery and vein injury
and false aneurysm. Venous thrombectomy is
described, but I do not think this is often indi

cated and should not be done by the occasional
operator.
Repair of the popliteal aneurysm is clearly
described but oversimplified. Resectional ther
apy is now seldom used. Iatrogenic vascular
injuries are identified in hernia repair, mastec
tomy and pelvic surgery. Although the manage
ment is illustrated briefly, the prevention of
these injuries is not addressed.
For the occasional vascular surgeon, it seems
inappropriate to include a description of the
extra-anatomical repair for an infected vascu
lar wound in the groin.
The bibliography is limited to some German
and American textbooks.
This monograph may be of value to the stu
dent or junior resident as an introduction to
vascular emergencies. The description of the
basic vascular techniques of repairing arteries
and veins will be of value to the general sur
geon, but I think the operative descriptions of
the emergency procedures lack the detail neces
sary for the general surgeon who may be called
upon to treat patients with these problems.

A.R. Downs, md , frcsc , facs
Professor of surgery,
University of Manitoba,
Head of Vascular Surgery Service,
GC405 Health Sciences Centre,
820 Sherbrook St.,
Winnipeg, Man.
R3A 1R9

COLORECTAL CANCER. Current Concepts
in Diagnosis and Treatment. Edited by
Glenn Steele, Jr. and Robert T. Osteen. 366
pp. Must. Marcel Dekker, Inc., New York,
1986. $59.59 (US). ISBN 0-8247-7372-1.
COLORECTAL TUM ORS. Edited by Oliver
H. Beahrs, George A . Higgins and Jacob
J. Weinstein. 334 pp. Must. J.B . Lippincott Company, Philadelphia, 1986. $57.50
(US). ISBN 0-397-50677-5.

Approximately 138 000 new cases o f colorec
tal cancer were diagnosed in the United States
in 1985. About half this number of people died
of the disease in the same year. These statis
tics establish colorectal cancer as the second
most common cause of cancer-related deaths,
and certainly a worthy subject for a compre
hensive review in textbook form. Interestingly,
two separate books on the subject, each with
a quite different approach, have appeared on
the market at the same time. Since even the
most dedicated physician is unlikely to require
or desire both books, a review of the individual
and relative merits o f the two would seem
appropriate.
Beahrs and colleagues in their book Colorec
tal Tumors have chosen a multiple-author for
mat, with 42 contributors writing on their own
areas of expertise, I gather, within the frame-
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COUMADIN
(Warfarin sodium) ANTICOAGULANT
INDICATIONS: The prophylaxis and/or treatment of venous throm bosis and its extension, pulm onary
embolism, atrial fibrillation with embolization, and as an adjunct in the prophylaxis of systemic embolism
after myocardial infarction. Some of the more common clinical disorders which may be associated with
or predispose patients to the above indications are: Thrombophlebitis; Congestive heart failure; Surgical
procedure or trauma associated with a high risk of throm boem bolism ; Myocardial infarction; Cerebral
e m bolism . It may also be useful as an adjunct in the treatment of transient cerebral ischem ic attacks due
to intravascular clotting.
CONTRAINDICATIONS: Any localized or general physical condition or personal circumstance in which
the hazard of hemorrhage might be greater than the potential clinical benefits of anticoagulation, such
as: Pregnancy: C O U M A D IN ' is contraindicated in pregnancy because the drug passes through the
placental barrier and may cause fatal hemorrhage to the fetus in utero. Also, there have been reports
of birth malformations in children born to mothers who have been treated with warfarin during pregnan
cy. Women of childbearing potential who are candidates for therapy should be carefully evaluated and
the indications critically reviewed with the patient. If the patient becomes pregnant while taking this drug,
she should be apprised of the potential risks to the fetus, and the possibility of termination of the pregnancy
should be discussed in light of those risks. Hemorrhagic tendencies or blood dyscrasias. Recent or
contem plated surgery of: 1. central nervous system; 2. eye; 3. traum atic surgery resulting in large
open surfaces. Bleeding tendencies associated with active ulceration or overt bleeding of:
gastrointestinal, genitourinary or respiratory tracts; cerebrovascular hemorrhage; aneurysms - cerebral,
dissecting aorta; pericarditis and pericardial effusions; bacterial endocarditis. Threatened abortion,
eclam psia and preeclampsia. Inadequate laboratory facilities or unsupervised senility, alcoholism,
psychosis, or lack of patient cooperation. Spinal puncture and other diagnostic or therapeutic procedures
with potential for uncontrollable bleeding. Miscellaneous: major regional, lumbar block anesthesia and
m alignant hypertension.
WARNINGS: The most serious risks are hemorrhage in any tissue or organ and, less frequently, necrosis
and/or gangrene of skin and other tissues. Risk of hemorrhage is related to the level of intensity and duration
of therapy. Hemorrhage and necrosis have in some cases been reported to result in death o r permanent
disability. Necrosis appears to be associated with local thrombosis and usually appears within a few days
of the start of therapy. In severe cases of necrosis, treatment through debridement or am putation of the
affected tissue, limb, breast or penis has been reported. Careful diagnosis is required to determine whether
necrosis is caused by an underlying disease. Therapy should be discontinued when warfarin is the
suspected cause of developing necrosis and heparin may be considered. Although various ones have
been attempted, no treatment for necrosis has been considered uniform ly effective. See below for infor
mation on predisposing conditions. These and other risks must be weighed against the risk of throm 
bosis or embolization in untreated cases. COUMADIN is a potent drug with a half-life of 2.5 days; therefore
effects may become more pronounced as daily maintenance doses overlap. It cannot be emphasized
too strongly that treatment of each patient is a highly individualized matter. Dosage should be con
trolled by periodic determinations of prothrombin time or other suitable coagulation tests. Determina
tions of whole blood clotting and bleeding tim es are not effective measures for control of therapy. Heparin
prolongs the one-stage prothrombin time. When heparin and COUMADIN are administered concomitantly,
refer to CONVERSION FROM HEPARIN THERAPY for recommendations. Caution should be observed
when COUMADIN is administered in any situation or in the presence of any predisposing condition where
added risk of hemorrhage o r necrosis is present. Administration of anticoagulants in the following con
ditions w ill be based upon clinical judgement in which risks of therapy are weighed against the risk of
throm bosis or embolization in untreated cases. The following may be associated with these increased
risks: Lactation. Severe to moderate hepatic or renal insufficiency. Infectious diseases o r distur
bances of intestinal flora - sprue, antibiotic therapy. Trauma which may result in internal bleeding.
Surgery or trauma resulting in large exposed raw surfaces. Indwelling catheters. Severe to moderate
hypertension. Known or suspected deficiency in protein C: This hereditary or acquired condition,
which should be suspected if there is a history of recurrent episodes of throm boem bolic disorders in the
patient o r in the family, has been associated with an increased risk of developing necrosis following war
farin administration. Tissue necrosis may occur in the absence of protein C deficiency. It has been reported
that concurrent anticoagulation therapy with heparin for 5 to 7 days during initiation of therapy with
COUMADIN may minimize the incidence of this reaction. Warfarin therapy should be discontinued when
it is suspected to be the cause of developing necrosis, and heparin may be considered. Miscellaneous:
polycythem ia vera, vasculitis, severe diabetes, severe allergic and anaphylactic disorders. Patients with
congestive heart failure may become more sensitive to COUMADIN, thereby requiring more frequent
laboratory m onitoring, and reduced doses. Concurrent use of anticoagulants with streptokinase or
urokinase is not recommended and may be hazardous. (Please note recommendations accompanying
these preparations.)
PRECAUTIONS: Periodic determination of prothrombin tim e or other suitable coagulation test is
essential. Numerous factors, alone or in combination, including travel, changes in diet, environ
ment, physical state and medication may influence response to anticoagulants. It is good practice
to monitor the response with additional prothrombin time determinations in the period immediately
after discharge from the hospital, and whenever other medications are initiated, discontinued or
taken haphazardly. The following factors are listed for your reference; however, other factors may
also affect the anticoagulant response.
The following factors, alone or in combination, may be responsible for INCREASED pro
thrombin time response: ENDOGENOUS FACTORS: cancer, collagen disease, congestive heart failure,
diarrhea, elevated temperature, hepatic disorders: (infectious hepatitis, jaundice), poor nutritional state,
steatorrhea, vitamin K deficiency. EXOGENOUS FACTORS: a lco h o l,t allopurinol, aminosalicylic acid,
amiodarone HCI, anabolic steroids, anesthetics, inhalation, antibiotics, bromelains, chloral hydrate,! chlor
propamide, chymotrypsin, cimetidine, clofibrate, COUMADIN overdosage, dextran, dextrothyroxine, diazoxide, diflunisal, d iuretics,! disulfiram, ethacrynicacid, fenoprofen, glucagon, hepatotoxic drugs, ibuprofen,
influenza virus vaccine, mefenamic acid, methyldopa, methylphenidate, metronidazole, miconazole,
m onoam ine oxidase inhibitors, nalidixic acid, naproxen, narcotics, prolonged, pentoxifylline,
phenylbutazone, phenytoin, pyrazolones, quinidine, quinine, ranitidine ,! salicylates, sulfinpyrazone,
sulfonam ides, long-acting, sulindac, thyroid drugs, tolbutamide, trimethoprim /sulfamethoxazole, other
medications affecting blood elements which may modify hemostasis. Also: dietary deficiencies, prolonged
hot weather, unreliable prothrombin time determinations.
The following factors, alone or in combination, may be responsible for DECREASED prothrom
bin tim e response: ENDOGENOUS FACTORS: edema, hereditary coumarin resistance, hyperlipemia,
hypothyroidism . EXOGENOUS FACTORS: adrenocortical steroids, a lcoh o l,! antacids, antihistamines,
barbiturates, carbamazepine, chloral hydrate,! chlordiazepoxide, cholestyramine, COUMADIN under
dosage, diuretics,! ethchlorvynol, glutethimide, griseofulvin, haloperidol, meprobamate, oral contracep
tives, paraldehyde, primidone, ra n itidine ,! rifampin, vitamin C. Also: diet high in vitamin K, unreliable PT
determinations. Because a patient may be exposed to a combination of the above factors, the net effect
on PT response may be unpredictable. More frequent laboratory monitoring is, therefore, advisable.
Coumarins may also affect the actions of other drugs. Hypoglycemic agents (chlorpropamide, tolbutamide
and glyburide) and anticonvulsants (phenytoin and phenobarbital) may accumulate in the body as a result
of interference with either their metabolism or excretion.
ADVERSE REACTIONS: Potential adverse reactions may include: • Hemorrhage from any tissue or organ.
This is a consequence of the anticoagulant effect. Signs and symptoms w ill vary according to the loca
tion and degree or extent of bleeding. Therefore, the possibility of hem orrhage should be considered
in evaluating the condition of any anticoagulated patient with complaints which do not indicate an ob
vious diagnosis. Bleeding during anticoagulant therapy does not always correlate with prothrombin activity.
(See SYMPTOMS AND TREATMENT OF OVERDOSAGE.) B leeding which occurs when the prothrom 
bin tim e is w ithin the therapeutic range warrants diagnostic investigation, since it may unm ask a

previously unsuspected lesion, e.g. tumor, ulcer, etc. • Necrosis of skin and other tissues. (SEE WARN
INGS). • Other adverse reactions are infrequent and consist of alopecia, urticaria, dermatitis, fever, nausea,
diarrhea, abdominal cramping, a syndrome called "purple toes,” cholestatic hepatic injury, and hypersen
sitivity reactions. • Priapism has been associated with anticoagulant administration, however, a causal
relationship has not been established.
DOSAGE AND LABORATORY CONTROL: Administration: Administration and dosage must be
individualized. Adjust the dosage according to results of the one-stage prothrombin time (PT) with
commonly used rabbit brain thromboplastin. There is ample evidence that prolongation of the prothrombin
time 1.2 to 1.5 tim es control is sufficient for prophylaxis and treatment of venous thromboembolism,
minim izing the risk of hemorrhage associated with more prolonged PT values. Where the risk of throm
boembolism is great, such as with recurrent systemic embolism, a PT of 1.5 to 2.0 times control should
be maintained. A ratio greater than 2.0 appears to provide no additional therapeutic benefit in most patients
and is associated with a higher risk of bleeding.
Table of Recommended Therapeutic PT Ranges*
Clinical State

Rabbit Brain PT Ratio**

Prophylaxis - venous throm boem bolism
High-risk surgery
Hip surgery
Treatment-deep vein thrombosis or pulm onary embolism
Prevention of systemic embolism in patients with:
• atrial fibrillation,
• tissue heart valves, or
• acute myocardial infarction
Recurrent systemic embolism

1.2-1.4
1.3-1.5
1.2-1.5

1.2-1.5
1.5-2.0

'M odified from Chest, ACCP-NHLBI National Conference on Antithrombotic Therapy, volume 89,
num ber 2, page 14S, 1986.
**For the three thromboplastins currently used in North America, a PT with rabbit brain thrombo
plastin of 1.3 to 2.0 is equivalent to an International Normalized Ratio (INR) of 2.0 to 4.0. For other
throm boplastins the INR can be calculated as: INR = (observed PT).ISI The ISI (International
Sensitivity Index) is available from the manufacturers of thromboplastin.
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Bacterial Colonization of Intestinal Urinary Conduit Diversion:
a Morphologic and Bacteriologic Experimental Study
Cutaneous diversion of the urine through
intestinal conduits results in bacteriuria
with uropathogenic organisms in up to
80% of patients, many of whom suffer
pyelonephritis. Analysis of the bacterio
logic data from daily sampling at multiple
sites and scanning and transmission elec
tron microscopic studies of sequential
loop and autopsy specimens in rabbits
with functioning colonic conduits indi
cate that the pyelonephritis evolves in
sequential stages of microbial coloniza
tion. Using these data on the natural
progression of bacterial infection, we can
rationally test the ability of strains of
bacteria indigenous to the conduit of this
animal model to prevent uropathogenic
colonization of the conduit.

types de bact£ries indigenes stabilisees
dans le canal intestinal de ce modele
animal pour arreter les pathog&nes
potentiels.

introduced into the conduit can be
assessed. In this investigation we deve
loped an animal model for colonic con
duit urinary diversion and undertook
detailed microbiologic, ultrastructural
and morphologic studies of the model to
determine the etiology and natural
progression of urinary conduit infections
from the development of bacteriuria in
the sterile conduit to the appearance of
destructive pyelonephritis.

Cutaneous diversion of the urine is used
to treat a variety of conditions that
require surgical excision of the lower uri
nary tract. The ileal loop, which uses an
ileal segment into which both ureters are
implanted for draining urine to the
abdominal wall,1 has been used exten Material and Methods
sively for the past 30 years. However, the
operative procedure results in later Operative Procedure
development of infection; 80% of
After partial cystectomy colonic con
patients are reported to have bacteriuria
caused by uropathogens.2-6 Acute and duits were created in 10 young, female,
chronic pyelonephritis is common among New Zealand rabbits, each weighing 4 to
the patients because of reflux of infected 5 kg, using a modification of the trigonal
urine into the kidney resulting in progres patch technique of Pond and Texter.12
La derivation cutanee de I'urine dans les
sive renal deterioration.4'7,8 Colonic con The animals were starved for 24 hours
canaux intestinaux resulte en une bacduits incorporating a nonrefluxing ure- preoperatively and received saline infu
teriurie avec organismes uropathogeterocolic anastomosis have recently sions preoperatively, intraoperatively and
niques pour un pourcentage de malades
become popular. Long-term follow-up of for 36 hours postoperatively. A single
allant jusqu'a 8 0 % ; de plus beaucoup de
patients having a colonic conduit revealed dose of veterinary penicillin-streptomycin
malades sont ensuite atteints de pyGthat there is still a high incidence of pye was administered parenterally 12 hours
lonephrite. Les analyses des donnees
lonephritis and renal deterioriation.9 To before the operation. The animals were
bacteriologiques de pr£l6vements quotireduce this incidence, antibiotics have anesthetized with ketamine and the abdo
diens provenant d'emplacements multi
men was opened through a midline inci
ples, ainsi que des etudes utilisant micro been given preoperatively and postoperatively, sometimes resulting in infection sion. A 3 to 5-cm segment of descend
scopes electroniques a balayage et a
with yeast and resistant bacteria.2_6,l° ing and sigmoid colon was mobilized and
transmission avec de specimens d'anses
Because of widespread clinical use of isolated by sharply transecting the prox
successives et de specimens d'autopsie
antibiotics, the natural history and imal and distal margins, being careful to
chez des lapins ayant des canaux du
progression of the bacterial populations preserve the mesenteric blood supply.
colon en bon etat, indiquent que revolu
associated with the intestinal urinary con Continuity of the colon was re-established
tion de la pyelonephrite se fait par
duit is unknown.
by a one-layer anastomosis with inter
etages successives de colonisation
Rozee and colleagues" have shown rupted 4-0 chromic catgut sutures. The
microbienne progressive. Si I'on se sert
that the bacteria associated with the intes bladder, along with the ureters and the
de ces donnees sur la progression
tinal surface are trapped within the mucus inferior vesical blood supply, was care
naturelle des etages successives de I'inblanket. In a recent study, Bruce and fully dissected free. A subtotal cystectomy
fection bacterienne, il est possible de
colleagues10 showed virtually no bacteria was performed, preserving the ureteral
faire des essais rationnels de I'usage de
adhering 13 the columnar cells of an intes insertions into the trigone. The proximal
I'interference bacterienne en utilisant des
tinal urinary conduit, even though the urethra was oversewn with 4-0 chromic
conduit mucus was heavily colonized with catgut. The isolated segment of colon was
bacteria. It was suggested that use of irrigated, first with a dilute piperacillin
From the *Department o f Urology,
Queen’s University, Kingston, Ont., and
indigenous bacteria to colonize the mucus solution and then copiously by phos
the tDivision of Microbiology, Department
of intestinal conduits might pre phate-buffered saline. The proximal end
of Biology, University of Calgary, Calgary, biofilm
vent uropathogenic colonization. Before was spatulated and anastomosed to the
Alta.
such a concept can be tested, a model trigonal patch with a running 4-0 catgut
Accepted for publication Jan. 27, 1987
must be developed to study the natural suture. A circular plug of abdominal wall
microbiologic progression of urinary con was excised at the preselected stomal site
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layers, the rabbits were placed in incu
bators with supplemental oxygen, in
creased hum idity and a tem perature of
29°C for 12 hours, after which they were
returned to their cages. They received
fluids parenterally for 36 hours postoperatively, and then a regular diet.

Specimen Sampling and Preparation
Catheterized specimens o f urine (with
or without mucus) were taken daily from
the stom a (distal 1 cm of conduit) and
deep conduit (m ore than 1 cm proximal
to stoma). Aliquots (0.1 ml) o f urine were
spread plated on brain-heart infusion agar
an d sh e ep -b lo o d ag ar p la te s and
incubated aerobically and anaerobically
for 24 to 48 hours. Bacteria were quanti
tated, isolated and identified using stan
dard techniques. Bacterial counts greater
than 104/m l were considered significant.6
Mucus specimens extracted aseptically
from the deep conduit were cultured in
a similar fashion and were also prepared
for transm ission electron microscopy as
described below.
All animals eventually became ill,
stopped eating and drinking, became
lethargic and had some degree o f flank
tenderness. W ith these symptoms a clini
cal diagnosis o f pyelonephritis was made
and the rabbit was killed. At autopsy,
urine was aseptically aspirated from the
proximal conduit and the renal pelves of
both kidneys and was cultured. Speci
mens were taken from the stom a, prox
imal and distal conduit, conduit mucus,
ureters and kidneys for scanning and
transm ission electron microscopy. Renal
cortical tissue was sectioned and bisected;
one portion was homogenized and cul
tured and the other stained with hematox
ylin and eosin for histologic examination.
The specimens collected for scanning
electron microscopy were fixed in 5%
glutaraldehyde in cacodylate buffer (0.1
M, ph 7.0) with 0.15% ruthenium red for
2 hours at room tem perature (22°C). The
preparations were washed three times in
the buffer and then “ m etallized” , using
o sm iu m te tro x id e a n d th io c a rb o h y d ra z id e .13 This was follow ed by
dehydration in ethanol and freon-113
before critical point drying.14 The speci
mens were then examined with a H itachi
S450 scanning electron microscope at an
accelerating voltage o f 20 kV.
The specimens collected for transm is
sion electron microscopy were fixed as for
scanning electron microscopy. They were
then washed five times in buffer, postfixed in 2% osmium tetroxide in buffer
and dehydrated through a series of ace
tone washes. All of the solutions used in
processing the specimen, from the washes
after gluteraldehyde fixation to dehydra
tion with 70% acetone solution, con
tained 0.05% ruthenium red. After fu r
ther dehydration in propylene oxide, the
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FIG. 1—Bacteriologic data from stoma (S), deep conduit (C) and kidney (K) in seven rab
bits after colonic conduit urinary diversion. Identification of organisms demonstrates sequen
tial microbiologic colonization after operation, starting with stomal area and progressing to
deep conduit and finally to kidney.

FIG. 2—Rabbit no. 7. Transmission electron photomicrograph of proximal portion of intes
tinal conduit 7 days after operation. Note absence of bacterial colonization of both microvillar
surface of colon and overlying mucus layer. Bars on all photomicrographs indicate 1 ^m.
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specimen was embedded in Spurr15 lowviscosity embedding resin. Sections were
cut and stained with uranyl acetate and
lead citrate,16 reinforced with evaporated
carbon and examined with a Hitachi 6000
transmission electron microscope at an
accelerating voltage of 60 kV.
Results

The postoperative death rate was 30%
— one animal died as a result of the
anesthetic, another of pneumonia and the
third of a pelvic abscess. In the remain
ing seven rabbits a definite pattern of
microbiologic colonization and infection
was demonstrated. In all, there was a

progression from stomal colonization to
deep conduit infection, followed by pye
lonephritis. Table I shows the postoper
ative time lapse until demonstrable
colonization (greater than I04 bacteria/ml) of stomal and deep conduit
urine and clinical occurrence of pye
lonephritis. The stomal urine was
colonized by more than 104 bacteria/ml
in a mean time ( ± SD)of5.1 ± 4.6 days,
deep conduit urine infection followed
3.7 ± 2.6 days later (range from 1 to 7
days) and clinical evidence of pye
lonephritis was confirmed a mean of
4.3 ± 2.8 days (range from 1 to 9 days)
after that. The clinical impression of pye
lonephritis was confirmed in all cases by

FIG. 3—Rabbit no. 4. Transmission electron photomicrograph of bacterial microcolony
in mucus at site of stoma 16 days after surgery. Although cultures grew Staphylococcus epider
midis, and many gram-positive cocci were seen, microcolonies of this gram-negative organism
were commonly found in mucus. Ruthenium-red staining has revealed fine fibrous glycocalyx
material surrounding these cells which also have thin electron-dense concentric element outside
outer membrane of their cell walls.

autopsy cultures of renal pelvis urine and
homogenized cortical tissue.
Identification of the organisms isolated
from the urine specimens showed that in
all animals bacteriuria developed with one
or more of the following organisms:
Staphylococcus epidermidis, Staphylo
coccus aureus, Staphylococcus xylosus,
Streptococcus faecalis, Pseudomonas
aeruginosa, Corynebacterium pyogenes,
Escherichia coli, Pasteurella pneumotropica, Acinetobacter Iwoffi, Enterobacter cloacae, Flavobacterium meningosepticum and Bacteroides sp. (Fig. 1).
Analysis of the progressive data (Fig. 1)
showed that organisms present in the
stomal urine in the first stages of
microbial colonization were usually
involved in the further stages of conduit
infection and pyelonephritis. In most
animals polymicrobial populations deve
loped in the later stages.
Scanning and transmission electron
microscopic studies of sequential mucus
specimens and autopsy biopsies of the
conduits and kidneys again demonstrated
the various stages of microbiologic
colonization. For several days after the
operation no microorganisms were found
in the intestinal tissues or the mucus
blanket (Fig. 2), but within a period of
5 ± 4.6 days, the stomal area, including
the mucus (Fig. 3) and cells from the
mucocutaneous junction (Fig. 4), was
heavily colonized by glycocalyx-enclosed
microcolonies of bacteria. Within days
the deep-conduit mucus and urine became
thickly colonized with a similar mucusassociated population of bacteria, includ
ing both gram-positive and gram-negative
bacteria (Fig. 5). There was virtually no
bacterial attachment to the microvillar
surface of the columnar cells of the con
duit (Fig. 6); however, bacterial coloni
zation of the nearby mucus blanket was
clearly demonstrated (Fig. 7). In all the
animals, pyelonephritis (proven at
autopsy) eventually developed. The inva
sive and destructive nature of the renal
infection was confirmed by positive cul
tures of homogenized cortical tissue and
histologic sections of the renal paren
chyma.
Discussion

FIG. 4—Rabbit no. 4. Transmission electron photomicrograph of epidermal cells from
stoma 16 days after surgery. Cultures grew 5. epidermidis and direct microscopy showed that
spaces between cells in this squamous epithelium were filled by gram-positive cocci growing
in coherent glycocalyx-enclosed biofilm.

The development of pyelonephritis
with renal deterioration is the major long
term complication of intestinal conduit
urinary diversion.2' 10 Our data indicate
that the evolution of pyelonephritis fol
lows sequential stages of progressive
microbial colonization. Entry of bacteria
into the conduit undoubtedly occurs when
pathogenic bacteria adhere to the
mucocutaneous junction of the stoma,
and this is followed quickly by coloniza
tion of the mucus and urine of the distal
stomal zone. It took approximately 4 days
in our animal mode! for the mucus and
urine layer of the deep conduit to become

VOLUME 30, NO. 4, JU LY 1987 / THE CANADIAN JOURNAL OF SURGERY

275

colonized with a polymicrobial popula
tion of pathogenic bacteria. It is likely
that bacteria gain access to the kidneys
through reflux of the infected urine from
the conduit because reflux is present in
this reconstructed urinary system.
It was interesting to note that a deep
conduit urine infection did not develop
immediately after colonization of the
mucus and urine of the stomal zone of the
conduit. The bacteria in the distal con
duit were all present in the mucus/urine
layer and none were seen attached to the
intestinal cells. It would appear that the
mucus produced by the goblet cells of the
colonic conduit forms a dense flowing
biofilm that entraps invading organisms
and continuously forces them toward the
stoma and out of the conduit. The mucus
blanket might also be involved in prevent
ing bacterial attachment to the conduit
cell surface by pathogenic organisms.
High levels of secretory immunoglobulin
A within the conduit urine may also con
stitute a host-defence mechanism against
urinary tract infection in patients with
conduits.17 However, this proposed
defence mechanism is not totally effec
tive, and pathogenic organisms eventually
invade and reside in the mucus layer of
the deep conduit. The presence of these
pathogenic organisms in the proximal
conduit exposes the animals to the risk of
upper tract infection, which eventually
develops in those subjected to this surgi
cal modification.
Clinical studies2-10 appear to confirm
our morphologic and bacteriologic inves
tigation, although progression through
the described stages is, of course, not
documented. In most patients who
undergo urinary diversion, bacteriuria
develops within the conduit and this
appears to precede the eventual develop
ment of renal infection. The conduit
mucus recovered from patients with ileal
conduit bacteriuria also appears to be
heavily colonized by uropathogens.10 It
has been suggested10 that the establish
ment of a nonpathogen (normal flora)
within the urinary conduit may competi
tively exclude pathogenic organisms from
the conduit. Bacterial interference using
indigenous strains of bacteria to inhibit
potential pathogens has been successful
in the intestines of human neonates,18 in
the bovine udder,19 in the digestive tracts
of newborn ruminants (unpublished data)
and in the human vagina.20
In this investigation, the natural
progression of the sequential stages of
bacterial infection in the colon urinary
conduit has been established in an animal
model. We are planning to use this model
in an attempt to stabilize indigenous bac
teria such as Lactobacillus sp. in the
mucus biofilm of the urinary conduit. In
turn, we hope this may prevent subse
quent stages of uropathogenic coloni
zation.
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FIG. 5—Rabbit no. 6. Transmission electron photomicrograph of mucus from deep (prox
imal) area of colonic conduit 20 days after surgery. Both gram-positive and gram-negative bac
teria were seen in mucus from this site, which grew wide variety of bacteria on culture. Gram
negative rod-shaped cells are embedded in fine glycocalyx fibres and coarse fibres of dehydrationcondensed mucus.

FIG. 6—Scanning electron photomicrograph of intestinal tissue from same proximal site
as mucus sample seen in Fig. 5. When mucus is removed during processing, extensive examina
tion of tissue surface shows very few bacteria and tissue appears normal in all morphologic
respects.

FIG. 7—Rabbit no. 7. Transmission electron photomicrograph of tissue-mucus sample from
deep (proximal) site in ileal conduit. Deep portion of this conduit was rapidly colonized 8 days
after surgery and this sample grew both Pasteurella pneum otropica and Staphylococcus aureus
on culture. Microcolonies of both gram-positive and gram-negative (seen here) bacteria were
seen in mucus layer but tissue surface was not colonized.
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Systemic Cystic Angiomatosis
in a Woman With Hematuria and Splenomegaly
Cutaneous hemangiomas are frequently
found on routine clinical examination and
generally are not important. But when
internal organs are involved, these vas
cular tumours assume greater importance
because of associated morbidity. A case
is presented of multiple organ involve
ment by angiomas in a woman with a
history of flank hemangioma who was
investigated for hematuria and
splenomegaly. She subsequently under
went splenectomy. The uncommon sys
temic syndromes characterized by vascu
lar tumours are discussed, and the case
reported is appropriately classified. The
clinical picture, pathologic features and
investigations appropriate for systemic
cystic angiomatosis are briefly reviewed.
The authors recommend conservative
management when there is splenic
involvement unless the size of the spleen
makes its rupture likely or when there
are hematologic complications.

L'hemangiome cutane est frequemment
retrouve a I'examen Clinique de routine
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et il est generalement sans importance.
Toutefois, quand il y a atteinte des visceres, ces tumeurs vasculaires prennent
une importance plus considerable a
cause de la morbidity qui y est associee.
On presente ici le cas d'une femme
ayant des antecedents d'hemangiome du
flanc, examinee pour hematurie et splenomegalie, et chez qui on decouvrit de
multiples atteintes angiomateuses viscerales. Elle subit par la suite une splenectomie. On commente les syndromes
systemiques rares caracterises par les
tumeurs vasculaires et les cas signale s'y
trouve classifie. On passe brievement en
revue le tableau clinique. les caracteristiques pathologiques et les examens
appropries dans les cas d'angiomatose
kystique systemique. Les auteurs recommandent un traitement conservateur
quand il y a atteinte de la rate & moins
que la taille de celle-ci fasse soupconner
une rupture possible ou quand il y a des
complications hematologiques.

Although cutaneous hemangiomas are
common and usually innocuous, they can
be associated with a number of uncom
mon systemic syndromes of potentially
serious nature. In the latter context, they
may serve as a clue to an underlying
pathologic condition. We describe a case
of the rare syndrome of systemic cystic
angiomatosis, emphasizing the general
ized nature of the disorder and the
unusual presenting complaint o f
hematuria.

Case Report
A 44-year-old woman was admitted with a
5-day history of painless hematuria and mild
left-flank pain. Her medical history included
surgical removal of a large left-flank heman
gioma as a child.
Physical examination revealed mild leftflank tenderness and scarring and an enlarged
spleen, palpable near the umbilicus medially.
No other abnormalities were noted.
Laboratory investigations, including com
plete blood count, differential count, platelet

FIG. 1—Abdominal x-ray film showing cal
cific density near L3-4, splenomegaly with cal
cifications and irregularity of heads of ribs at
T10 and T il, consistent with arteriovenous
malformations.
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count, blood smear, coagulation studies, liver
transaminase determinations and creatinine
measurement, were within normal limits. Uri
nalysis showed 150 red blood cells per highpower field with negative cytologic findings
and cultures. Intravenous pyleography showed
no urinary tract abnormality, but there was
radiologic evidence of splenomegaly, abdomi
nal wall calcifications and enlargement of ver
tebrae L3 and L4 (Fig. 1), findings consistent
with arteriovenous malformation, and the left
ribs appeared larger than the right on a chest
x-ray film. Abdominal ultrasonography rev
ealed multiple diffuse cystic lesions of the
spleen and retroperitoneal area, believed to be
hemangiomas (Fig. 2).
During cystoscopy, blood was seen to ooze
from the left ureteric orifice, but a left retro
grade pyelogram was normal. The hematuria
stopped spontaneously after 5 days. Angiog
raphy showed hemangiomatous involvement of
the left chest wall and splenomegaly without
evidence of hemangioma formation. A diag
nosis of splenic hemangioma was made and
splenectomy advised as a prophylactic meas
ure, because its enlarged size made rupture
resulting from minor trauma a possibility. At
laparotomy a large spleen, mottled by calcifi
cation, was removed. A large confluent heman
gioma involved the left retroperitoneal area and
encroached upon the left kidney. The liver and
right kidney felt normal. No postoperative
difficulties were encountered.

giomatosis and multiple lymphangiectasis.1 The underlying pathologic features
have remained similar, consisting of a net
work of multiple cystic vascular and lym
phatic channels.2 The rarity with which
they occur as a multiorgan problem has
prevented a uniform nomenclature.
In our case, pathologic changes
involved the spleen, bones, skin,
retroperitoneum and the left kidney. This
involvement suggests the syndrome of
systemic cystic angiomatosis, described by
Seckler and associates.1 The differential
diagnosis includes Klippel-Trenaunay
syndrome (osteohypertrophic varicose
nevus) characterized by hypertrophy of
affected limbs, Osler-Weber-Rendu dis
ease (multiple hereditary hemorrhagic
telangiectasia), Sturge-Weber disease
(encephalofacial hemangiomatosis), von

Flippel-Lindau disease (hemangiomato
sis of the retina, brain stem and other
organs) and M affucci’s syndrome
(cutaneous hemangioma and enchondroma of the bones). Similar splenic fea
tures may be seen in lymphangioma of the
spleen,3 lymphangioendothelioma of the
spleen,4 and peliosis of the spleen (never
found without coexisting peliosis hepatis).5 These all have features of our case
and are a part of the differential diagno
sis in patients with hemangioma.
Systemic cystic angiomatosis is a
benign vascular tumorous formation that
may be locally invasive. Only one case of
truly malignant lymphangioma of the
spleen has been described.6 Involved
organs may include spleen, liver, lung,
pleura, subcutaneous tissues (especially
the neck and axilla), thymus, mediasti-

Pathological Findings
The spleen measured 16 x 13 x 7 cm
and weighed 750 g. Multiple cystic and
anastomosing vascular channels could be
seen grossly, filled with blood and
serosanguineous fluid (Fig. 3). These were
lined by thin endothelium and surrounded
by dense fibrous tissue. Some contained
erythrocytes, others only proteinaceous
material. Foci of calcification were
present. The surrounding red and white
pulp was displaced and distorted (Fig. 4).
The diagnosis was lymphohemangioma.

F1G. 3—Capsule of spleen (left) showing roughened pebble surface. Cut surface (right)
shows cystic transformation by numerous blood-filled cavities.

Discussion
Vascular tumours have been described
under a variety of names and syndromes:
metastasizing benign angioma, angioma
tosis, generalized lymphangioma, heman-

FIG. 2—Sonogram of enlarged spleen with
multiple cysts of varying sizes, some with cal
cific foci.
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FIG. 4—Spleen shows numerous cysts lined by thin fibrous septae, some containing pro
teinaceous fluid (upper right), others red blood cells. Splenic red and white pulp is displaced,
distorted and diminished (hemalum-phloxine-saffron stain, initial magnification x 60).
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num, breast, retroperitoneum, kidney,
skin and virtually any bone including the
skull.1 The multisystem involvement may
reflect the congenital origin of these
tumours.7 The involvement of both lym
phatic and vascular channels is more fre
quent than either alone, and different
organs may contain different types of
lesions. The congenital nature is suggested
by the severe neonatal forms of the dis
ease such as diffuse neonatal heman
giomatosis, generally a fatal condition.8
In the older patient, the disease seems to
progress more slowly.9
The absence of any family history and
the age of our patient are not remarka
ble, as she had had a cutaneous heman
gioma as a child, suggesting that the other
lesions may have been present since then.
Hematuria is an unusual presentation in
this syndrome, but hemangiomas are a
well-described cause of urinary bleed
ing.10 Although no lesion was identified
radiologically, a hemangioma is assumed
because of the other lesions present and
the proximity of the pathologic changes
in the left retroperitoneal area. Bleeding
in this syndrome normally does not result
from thrombocytopenia; only one such
case has been reported.11 Despite the fre
quent finding of splenomegaly (50%),
hypersplenism is not usual. Bleeding
usually results from local tumour effects
such as bruising with a pathologic frac
ture, hemoptysis with a lung lesion,9
hemoperitoneum or bloody ascites from
pleural or peritoneal angiomas.
No specific laboratory findings are
present. However, various imaging proce
dures, while not always in agreement, are
on the whole diagnostic, as in this case.
The skeletal survey may demonstrate the
extent of disease. A simple abdominal xray film may reveal a soft-tissue density
from splenic enlargement with cyst-wall
calcifications or bony involvement.
Technetium-99m-labelled heat-damaged
erythrocytes for radioisotope scanning
provide a specific splenic imaging
agent.12 Ultrasonography may be espe
cially helpful in splenic angioma, typically
showing multiple echo-free lesions of var
ious sizes. This is recommended as the
method of choice for splenic imaging.13
Some reviewers suggest angiography for
definitive diagnosis, as a characteristic
swiss-cheese appearance is pathogno
monic. In our case, such an appearance
was not seen. A picture o f well-defined
avascular lesions of varying size scattered
throughout the spleen with no neovas
cularity, arteriovenous shunting or
venous pooling is typical.14
Splenic involvement in this case was the
reason for surgery, and perhaps other
patients with apparently isolated splenic
lesions have multiorgan involvement that
is not recognized. Angiomas of the spleen
are uncommon even if isolated, and the

pathologic characteristics are essentially
the same as in systemic angiomatosis.3
The recognition of other lesions is not just
of academic interest, as patients observed
over time may show an increase in num
ber and size of lesions.11 Four of 13
patients in Seckler’s study1 died o f local
space-occupying effects and complica
tions, including cervical cord compres
sion, hepatosplenomegaly and chylous
pleural effusion.
Therapy is primarily for local lesions
and is surgical. Systemic therapy includ
ing chemotherapy is ineffective. The ques
tion of when to perform splenectomy
might be guided by Halgrimson’s obser
vation that these lesions are frequently
calcified and thought to represent a late
dormant stage in the natural history of
hemangioma, suggesting that they are
unlikely to lead to new symptoms, and the
patient can safely be observed without
surgery.15 Splenectomy is indicated when
the spleen is greatly enlarged and trau
matic rupture is considered likely with
minor trauma, or if hematologic compli
cations occur.
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SESAP V Question

315. A baby boy born with an imperforate anus treated by sigmoid colostomy has intermittently required admission for watery diarrhea. Each hospitalization lasts three to five days,
and typical serum electrolytes are serum sodium, 135 mEq/L; serum potassium, 5.5 mEq/L;
serum chloride, 120 mEq/L; serum carbon dioxide content, 19 mEq/L, and pH, 7.27. The
contrast radiograph shown above was performed by injection of the distal colostomy stoma
when the baby was one year old. The most likely cause of this clinical picture is
(A)

obstructive uropathy

(B)

excessive loss of electrolytes due to gastroenteritis

(C)

malabsorption caused by long-term administration of antibiotics

(D)

excessive intake of liquids related to treatment of diarrhea

(E)

urinary tract infection associated with passage of urine through the
rectourethral fistula

1 A

* *
„
. ^

4- V

For the incomplete statement above, select the one completion that is best of the five given.
For the critique of Item 315 see page 309.
*

v
K

(Reproduced by permission from SESAP V Syllabus; Surgical Education and Self-Assessment
Program No. 5. For enrolment in the Surgical Education and Self-Assessment Program No. 5,
please apply to the American College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
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Unusual Presentation of a Pancreatic Pseudocyst:
a Case Report
Although pancreatic pseudocysts are
usually found in the vicinity of the pan
creas, there are reports of them ruptur
ing into the peritoneal cavity, fistulizing
into the thorax or bowel and occupying
unusual sites such as the mesentery,
mediastinum and spleen.
This is a report of a patient with pan
creatitis and a pancreatic pseudocyst
presenting as a swelling of the left thigh
due to dissection of the pseudocyst into
the psoas muscle.

Meme si les pseudokystes pancreatiques
sont habituellement retrouves dans la
region du pancreas, on retrouve des arti
cles signalant leur rupture dans la cavite
peritoneale, leur fistulisation dans le tho
rax ou I'intestin ou leur presence dans
des endroits inhabituels tels que le
mesentere, le mediastin et la rate.
On signale ici le cas d'une patiente
souffrant d'une pancreatite et d'un pseudokyste pancreatique qui est apparu
sous la forme d'une tumefaction de la
cuisse gauche, a cause de la dissection
du pseudokyste dans le psoas.

A complication of pancreatitis is the for
mation of pseudocysts, known to resolve
spontaneously in about 41% of cases
within 6 weeks.1 However, a substantial
number may cause complications or
appear at unusual sites. Weaver and
colleagues2 noted that 80% of cases of
pancreatic ascites resulted from pan
creatic pseudocyst leakage. The pseu
docysts were reported to rupture or track
through the mediastinum into a pleural
cavity3 or perforate into the colon and
duodenum.4 They can present at unusual
sites such as the spleen5 and dissect into
the groin.6 We report another unusual
presentation of pancreatic pseudocyst.
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Case Report

appeared to communicate with the pancreatic
duct. An intraoperative pancreatogram rev
ealed an ectatic duct with free flow of the dye
into the duodenum and no extravasation. The
duct was suture-ligated and the pancreatic
stump oversewn. Penrose and sump drains
were placed in the pancreatic bed and left psoas
sheath.
Pathological examination of the pancreas
showed chronic nonspecific pancreatitis.
Postoperatively the patient had an external
pancreatic fistula that drained, at its peak, 1400
ml over 24 hours. Nasogastric suction and
parenteral nutrition resulted in a substantial
decrease in drainage. Three weeks postopera
tively a left subphrenic fluid collection was
drained surgically. She was discharged 3 weeks
later in good condition, but with a persistent
fistula draining up to 10 ml/d. The swelling
of the left thigh had resolved at the time of dis
charge.

A 42-year-old woman was admitted with a
swollen and painful left thigh; the symptoms
had developed 1 month earlier. She was known
to be an alcoholic with chronic pancreatitis.
Previous operations included cholecystectomy
and gastrojejunostomy with vagotomy for gas
tric outlet obstruction secondary to pancrea
titis, later converted to Roux-en-Y drainage
because of bile reflux gastritis.
At examination the patient was in no distress
but appeared older than her stated age. No
mass or tenderness was detected on abdomi
nal examination. Her left thigh was tender and
markedly enlarged, with a circumference of 47
cm at the mid-thigh level, compared with 41
cm on the right side. The swelling was nonpitting and the skin had a bluish discoloura
tion, most prominent near the groin.
Her hemoglobin level was 110 g/L, serum
amylase level was 539 IU/L (normal 20 to 120
IU/L), alkaline phosphatase level was 498
IU/L (normal 100 to 275 IU/L) and the serum
albumin level was 25 g/L (normal 30 to 50
g/L). The leukocyte count and blood urea,
bilirubin, creatinine and aspartate aminotrans
ferase levels were all normal.
A left lower limb venogram and lymphangiogram were normal. A computerized tomo
gram of the abdomen demonstrated diffuse
pancreatic calcification and multiple radiolucent areas in an enlarged left psoas muscle (Fig.
1). In the thigh, all muscle groups and adja
cent soft tissue were enlarged, with oblitera
tion of the tissue planes (Fig. 2).
At laparotomy, the whole left psoas sheath
appeared distended. It contained 1500 ml of
straw-coloured fluid having an amylase con
tent of 37 800 units/L. With the fluid removed,
a communication between the left psoas sheath
and pancreatic bed was discovered. The pan
creas was fibrotic and thickened with chronic
inflammatory changes. A splenectomy and dis
tal pancreatectomy were performed well medial
to the site where the pseudocyst clinically

Pancreatic pseudocysts are uncommon
but well-recognized complications of
acute and chronic pancreatitis. They have
the ability to enlarge and migrate,6 form
an internal fistula3 and present in
unusual locations.5,6
Our case illustrates a unique complica
tion of pancreatitis. Although not radiologically demonstrated, an internal fistula
between the left psoas sheath and the pan
creatic duct was presumably formed
either directly or by way of a pseudocyst.
Over time, pancreatic secretions collected
in, and slowly enlarged, the psoas mus
cle and sheath, eventually dissecting into
the left thigh where the fluid diffused into
the compartments causing swelling and
pain.
The computerized tomogram was
instrumental in diagnosing this particu-

FIG. 1—Discrepancy in size between left (a)
and right (b) psoas muscles.

FIG. 2—Swelling and increased size of left
thigh muscles.

Discussion
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lar problem. Ideally, endoscopic retro
grade cholangiopancreatography would
have been helpful in demonstrating the
fistula between the pancreatic duct and
pseudocyst, but unfortunately the previ
ous surgery precluded this examination.
We elected to perform distal pancreatec
tomy because at laparotomy we believed
that the changes in the psoas sheath were
closely related to the posterior aspect o f

the distal pancreas with a communication
between the left psoas sheath and pan
creatic bed even though no definite duc
tal disruption was visualized.
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Recognition and Management of Marlex Erosion
After Horizontal Gastroplasty for Morbid Obesity
B e tw e e n 1979 and 1 9 8 2 , 1 6 2 pa tie nts
u n d e rw e n t horizontal g a stro p la sty in
w h ic h polypropylene m esh (M arlex) w as
used to support th e greater cu rve ch a n 
nel. T he re were no de a th s and early
w e ig h t loss was g o o d . The operation
w a s sto p pe d because o f late w e ig h t
gain. M arle x erosion w a s recognized by
e n d o s c o p y in 10 (6 % ) p a tie nts b etw een
2 7 and 6 0 m onths a fte r operation. T w o
o th er pa tie nts w ith M arlex erosion had
th e g a stro p la sty p e rfo rm e d elsew here.
T he p a tie nts' s y m p to m s w ere a b d om i
nal p a in , vom iting o r w e ig h t gain. The
M arle x w a s often d iffic u lt to resect
because th e in fla m m a to ry m ass was
a d h e re n t to spleen or pancreas. Recon
s tru c tio n by Roux-en-Y g a stric bypass or
v e rtic a l banded g a s tro p la s ty a llo w e d co n 
tin u e d w e ig h t loss and gastrogastro s to m y , although te ch n ica lly easier,
re s u lte d in weight gain. The a u th o r co n 
c lu d e s th a t long-term fo llo w -u p is neces
sa ry a fte r any g a s tro p la sty or g a stric
b yp a ss procedure espe cia lly w h e n fo r
eign m a te ria l is used to su p p o rt the
sto m a .
De 1 9 7 9 a 1982, 1 6 2 p a tie nts o n t subi
une g a stroplastie h o rizo n ta le au cours de
la q u e lle de la toile de po lyp ro p yle n e
(M a rle x) a ete utilisee pour m ainte n ir le
canal de la grande co u rb u re . On n 'a
e n re g is tre aucun deces e t la perte de
p o id s in itia te fut bo n ne . On m it fin a
c e tte o p e ra tio n & cause du gain de poids
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subsequent. A I'endoscopie, on a id e n ti
f y une erosion de la to ile M arlex chez
10 (6% ) des pa tie nts de 27 a 6 0 m ois
apres (’ o p eration. Deux autres pa tie nts
qui avaient subi leur gastroplastie dans
un autre centre presentaient aussi une
erosion de la to ile M arlex.
Les sym pto m e s co n sista ie nt en douleur
abdom inale, vom issem ents ou gain ponderal. La to ile M arlex fu t souvent d iffic ile
a resequer a cause de la masse in fla m m atoire qui adherait a la rate ou au pan
creas. Une re co n stru ctio n par d erivation
gastrique de Roux-en-Y ou par g a stro 
plastie a se ctio n s verticales a perm is de
poursuivre la perte de poids alors que la
ga stro -g astro sto m ie , bien que techniquem ent plus fa cile , a resuite en un gain de
poids. L 'a u te u r co n c lu t a la necessity
d'un e surveillance prolongee apres to u te
in te rve n tio n de gastroplastie ou de d eri
vation g astrique, specialem ent quand des
m ateriaux e trangers so n t utilises pour
soutenir le stom a.

Gastroplasty for morbid obesity is now
a common operation, performed in many
hospitals in North America. Late weight
gain, often due to stomal dilatation, has
been a problem after many types o f gas
troplasty and has led surgeons to support
the stoma with materials such as poly
propylene mesh (Marlex).
Over the last 5 years, Marlex erosion
occurred in 12 of 162 patients who under
went horizontal gastroplasty. The late
appearance o f this problem suggests that
such cases will continue to be seen for a
long time.
This report emphasizes the potential
problems in the use of foreign materials
around gastric stomas. Long-term follow
up of patients who have had gas
troplasties is recommended.

Patients and Methods
Between September 1979 and October
1982, 162 consecutive gastroplasties were
performed in 140 women and 22 men,
using the technique illustrated in Fig. 1
and described elsewhere.1 One double
staple line was placed in 10 patients; in
all the others, two double staple lines were
placed 1 cm apart. Gastric pouch volume
was less than 100 ml. Three staples were
removed from the greater curve end of the
long staple line and two from the same
end o f the short staple line. The stapler
was applied across the entire stomach.
The resultant stoma was wrapped with a
2 x 6-cm strip of Marlex mesh held in
place with a 2-0 Prolene suture passed
through the mesh 5 mm from each end
and through the stomach just above and
below the greater curve o f the staple line.
The suture was tied snugly but not tightly,
effectively closing the blind space between
the staple lines and securing the mesh to

FIG. X—Transverse gastroplasty as per
formed between 1979 and 1982.
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the stomach. Omentum was placed over
the mesh. A no. 18 nasogastric tube with
extra holes above and below the staple
line was passed through the opening and
left in place for 48 hours.
Patients were at least 45 kg above ideal
weight (mean 134 ± 20 kg) and between
the ages of 17 and 58 years (mean 36 ±
8 years). Treatable endocrine disorders
were excluded by preoperative assess
ment. Most of the 162 patients had poten
tially reversible disorders related to
obesity, such as diabetes, hypertension,
osteoarthritis and infertility. All patients
were assessed preoperatively by an inter
nist and were required to stop smoking
as a condition of acceptance for gas
troplasty. Heparin (5000 units) was given
subcutaneously to all patients before
operation and cefazolin (1 g) was given
intravenously once before and twice after
operation. A fluid and pureed diet was
advised for the first month postoperatively and a soft diet for the second
month. Patients were seen at monthly

intervals for the first 6 months and every of operation. They required a gastrogas3 months thereafter.
trostomy. In these patients Marlex was
Revision gastroplasty was usually per not removed. Recovery was excellent but
formed by the techniques illustrated in the patients gained weight.
The late problems with Marlex are
Figs. 2 and 3. The GIA or TA-55 staplers
were used for wedge excision of the documented in Table I. Ten of the 12
eroded Marlex, and Roux-en-Y gastric patients were from our series while 2 had
bypass was performed by the technique the initial operation elsewhere; 11 were
of Pories and colleagues.2 For two of the women. Eight of the 12 patients had
later cases of staple-line disruption, ver nausea and vomiting, 3 of these had com
tical banded gastroplasty3 was per plete stomal obstruction, 6 had weight
formed after Marlex resection. No gas gain and 5 abdominal pain. An upper gas
trostomy was carried out.
trointestinal series after a barium meal
demonstrated stomal obstruction or
enlargement but not Marlex erosion,
Results
endoscopy being the most useful proce
dure. Eroded Marlex could be seen as a
Weight loss at 1 year was 33% of the black mass adherent to the greater curve
initial weight. The low early failure rate of the stomach. In three patients the
rose progressively with time. There were stoma was completely obstructed. In
no postoperative deaths. One leak eight, the staple line adjacent to the
occurred 5 days after gastroplasty and the Marlex had disrupted leaving a large
patient recovered after drainage and stoma, explaining the weight gain. Gas
removal of the Marlex. Five (3%) patients tric ulceration adjacent to the Marlex was
had stomal obstruction within 2 months unusual but was observed in one patient.
In several cases, attempts were made to
remove the Marlex with forceps and trac
tion but it was too tightly adherent to the
gastric wall.
Although stomal obstruction often
occurred suddenly, other symptoms often
persisted for months before the diagno
sis of Marlex erosion followed by reoper
ation. In several patients weight gain was
the major sign and eroded Marlex was
observed adjacent to a dilated stoma.
Reoperation was carried out a mean of
44 months after initial gastroplasty (range
from 27 to 60 months). Since only
patients with major weight gain or severe
symptoms underwent endoscopy, it is
possible that the frequency of this
problem has been underestimated.
Preparation for reoperation was rou
tine except in the three patients with
stomal obstruction. They required
nasogastric decompression and one
patient with severe weight loss was given
HG. 2—Method of reconstruction in most patients after Marlex erosion.
parenteral nutrition preoperatively.
Stomal dilatation was attempted as previ
ously described4 but was unsuccessful.
At operation, the eroded Marlex was part
of an inflammatory mass that was often
difficult to resect. Although the Marlex
had been covered by omentum in most
cases, the mass was often adherent to
pancreas or spleen. Careful dissection was
necessary and bleeding was sometimes
troublesome. In patient 6, splenectomy
was necessary and discharge was delayed
by hematoma formation in the left upper
quadrant. Patient no. 10 underwent the
original gastroplasty at another hospital.
The Marlex did not appear to have been
covered with omentum; it had retracted
upward and was adherent to the
diaphragm. The Marlex was left in place
without apparent ill effect and the patient
was well 4 months later. He requested the
safest operation and underwent only a
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gastrogastrostomy. Stomach adjacent to
the eroded Marlex was often thickened
and inflamed. Care was necessary to get
a secure staple line, and staple lines were
usually oversewn. In two o f the later cases
the transverse staple line had disrupted
almost completely allowing a vertical

banded gastroplasty to be performed.
Care was taken to avoid constriction or
obstruction o f the stomach at the point
where transverse and vertical staple lines
intersected. The appearance o f the eroded
Marlex is shown in Figs. 4 and 5. In
patient 12, Marlex erosion was diagnosed

recently by endoscopy. Although the
patient had been vomiting, the stoma was
patent. So far, she has been willing to
accept her symptoms because o f the risks
o f reoperation and the potential for
weight gain.
Although the operations were often

Table I—Data for Patients With Marlex Erosion After Gastroplasty
Patient
no.
1

Preop
Age,
weight,
kg
yr Sex
28

F

147

Symptoms/
signs
Vomiting,
stomal
obstruction

Months
to reoperation

Minimum
weight,
kg

Revision
weight,
kg

34

76

76

103

45

Findings
Marlex
erosion,
no stoma
Large
stoma

Treatment

Present condition,
weight (kgl/duration
Complications of follow-up (mo)

Marlex
resection,
gastrogas
trostomy
Gastric
bypass

None

Weight gain, 103111

None

Good, 85135

2

49

F

123

Vomiting,
stomal
obstruction

45

57

57

Marlex
erosion,
stomal
obstruction

Marlex
resection,
Roux-en-Y,
gastric
bypass

None

Good, 82136

3

49

F

125

Left upper
quadrant pain,
weight gain

27

93

104.5

Marlex
erosion,
staple-line
disruption

Marlex
resection,
Roux-en-Y,
gastric
bypass

None

Good, 86124

4

31

F

115

Abdominal
pain

46

76

76

Marlex
erosion,
gastric
ulceration,
staple-line
disruption

Marlex
resection
(refused
gastric
bypass)

Hematemesis,
gastrectomy
1 yr later
(elsewhere)

Good, 61121

5

34

F

120

Vomiting,
abdominal
pain, weight
gain

37

72

107

Marlex
erosion,
staple-line
disruption

Marlex
resection,
gastric
bypass

None

Good, 80118

6

38

F

102.5

Vomiting

49

63

63

Marlex
erosion,
small stoma

Marlex
resection,
gastric
bypass

Left upper
quadrant
bleeding,
splenectomy

Good, 69)14

7

33

F

119

Vomiting,
abdominal
pain, weight
gain

35

81

103

Marlex
erosion,
staple-line
disruption

Marlex
resection,
gastric
bypass

None

Good, 84113

8

52

F

115.5

Nausea,
weight gain

60

88

107

Marlex
erosion,
staple-line
disruption

Marlex
resection,
gastric
bypass

None

Good, 75112

9

37

F

111

Weight gain,
abdominal
pain, burping

47

77

93

Marlex
erosion,
staple-line
disruption

Marlex
resection,
vertical
banded
gastroplasty

None

Abdominal pain,
71)12

10

37

M

227

Vomiting,
stomal
obstruction

36

84

84

Marlex
erosion,
no stoma

Gastrogastrostomy

None

Good, 9114

11

54

F

177

Heartburn,
weight gain

58

89

145

Marlex
erosion,
staple-line
disruption

Marlex
resection,
vertical
banded
gastroplasty

None

Good, 129.5)3

12

36

F

139

Vomiting

60

60

Marlex
erosion

None yet

44.4
± 10.5

76.3
± 11.1

Means 39.9
± 9.1

135.0
± 36.8

92.3
± 25.1*

83.0 ± 17.71
17.5 ± 11.3t

•Initial revision weight only for patient 1.
tFinal weight and follow-up date only for patient 1.
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difficult, recovery was uncomplicated
apart from the case of left upper quad
rant hematoma after splenectomy.
Weight loss was good with gastric bypass
and satisfactory with vertical banded gas
troplasty. Patient 1 with a gastrogastrostomy had substantial weight gain
which was controlled by gastric bypass.
Patient 10 is doing well after gastrogastrostomy although weight gain is
expected.
Discussion

Erosion of the gastrointestinal tract by
foreign materials ranging from sump
drains to the Angelchik prosthesis5 has
been described. It is not surprising that
Marlex sutured to the stomach should
sometimes erode, and our data suggest
that erosion may not be recognized for
many years after the initial operation.
Symptoms and signs may vary widely
from complete and surprisingly sudden
stomal obstruction to abdominal pain and
weight gain. Erosion of the Marlex at the
end of a staple line appears to weaken it
and may initiate the disruption. It is pos
sible that erosion has occurred without
symptoms in other patients who have not
been subjected to endoscopy. The act of
fixing the Marlex to the stomach with
sutures penetrating the gastric wall may
lead to erosion. In vertical banded gas
troplasty the Marlex is passed through the
circular window and fixed to itself. The

lack of fixation to the stomach may
reduce the likelihood of erosion.3
The reoperations proved difficult
although there were no serious complica
tions. The major problem was removal of
the Marlex which was obscured by an
inflammatory mass adherent to spleen or
pancreas. The lack of symptoms after
leaving the Marlex in place in one patient
with stomal obstruction suggests that
Marlex need not always be removed as
long as obstruction is relieved. Even in
those with a large stoma it may be possi
ble to leave the Marlex below new staple
lines, although staples may not hold well
when placed in or near an inflammatory
mass. Gastric bypass or vertical banded
gastroplasty allow continued weight loss
and can be performed safely, although
gastrogastrostomy is a much easier oper
ation for the high-risk patient and when
technical difficulties occur. We did not
use gastrostomy or jejunostomy but
would recommend either procedure if the
revision operation was particularly
difficult.
Erosion of Marlex is not the only fac
tor that can cause late obstruction and
vomiting. Other possible causes include
inflammatory adhesions to the Marlex
mesh with torsion of the stomach, stomal
ulceration, impaired emptying of the
pouch due to pooling of contents in a
large dependent pouch or poor motility
and stricture formation under the mesh.
Dilatation is the easiest way to manage
stomal obstruction, but this may not be
possible when the stoma is wrapped with
Marlex.4
Summary and Conclusions

FIG. 4—Appearance of eroded Marlex after
resection.

Marlex erosion has been detected as a
late complication in 12 patients after
transverse gastroplasty for morbid
obesity. The symptoms included vomit
ing, abdominal pain and weight gain. The
problem was identified by endoscopy but
not by upper gastrointestinal series. The
patients were managed by Marlex resec
tion and Roux-en-Y gastric bypass or ver
tical banded gastroplasty, with good
results. Horizontal gastroplasty is an
unsatisfactory operation, and any patient
with a gastric partition or gastric bypass
requires long-term follow-up, especially
when foreign materials are used to sup
port the stoma.
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Giant Villous Adenoma of Second Portion of Duodenum:
Case Report
Villous adenomas of the duodenum are
rare. In this report the authors describe
the case of a 75-year-old woman who
had an extensive adenoma involving the
second portion of the duodenum and
ampulla of Vater. The patient was suc
cessfully managed by a pancreaticoduo
denectomy. The authors describe the
histopathology of the lesion and suggest
guidelines for surgical consideration.
Les adenomes villeux du duodenum sont
peu frequents. Ce rapport decrit une
lesion tr6s etendue comprenant toute la
deuxieme partie du duodenum ainsi que
I'ampoule de Vater chez une femme de
75 ans. L'investigation ayant mene au
diagnostic, le traitement chirurgical et les
conclusions histo-pathologiques sont
presentes. Quelques pensees au sujet de
la tenue a prendre envers ces lesions
sont offertes.

Villous adenomas, although they are
found throughout the gastrointestinal
tract, are rare in the duodenum. Fewer
than 75 such cases have been reported in
the English medical literature since
1893.1 These lesions have a propensity
for malignant transformation, especially
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when they involve the duodenum and the
ampulla of Vater simultaneously,1'2 and
their detection is often incidental. The size
of villous adenomas may or may not
correlate with malignant change.3-5
Jaundice,6 obstruction1 and bleeding7
are the most frequent clinical features in
patients with villous adenomas of duode
num and ampulla of Vater.
The patient whose case is described in
this paper was referred to the gastroin
testinal service with vague abdominal dis
tress and was found to have a large duo
denal and ampullary villous adenoma,
containing foci of both in-situ and inva
sive adenocarcinoma.
Case Report
A 75-year-old white woman complained that
she had had a vague gnawing sensation in the
abdomen for more than 2 years. Physical
examination and results of hematologic and
biochemical studies failed to provide a diag
nosis, but ultrasonography demonstrated a
1.5-cm dilatation of the common bile duct. She
underwent endoscopic retrograde cholangiopancreaticography (ERCP), which demon
strated an extensive lesion involving the entire
mucosa of the second portion of the duode
num and the ampulla of Vater, the orifice of
which was obscured, preventing cannulation.
Multiple biopsies were taken and later a bar
ium study was performed to determine the
extent o f the lesion. Results o f liver function
tests and amylase levels were normal. A com
puterized tomogram demonstrated a thicken
ing of the wall of the second part of the duode
num and dilatation of the common bile duct.
Selective celiac and mesenteric arteriograms
showed a lesion of the second portion of the
duodenum with increased vascular supply from
branches of the gastroduodenal artery.
At laparotomy a diffuse soft mass was pal
pated, filling the second portion of the duode
num. There was no proximal dilatation. The
gallbladder was thickened and distended, but
the pancreas felt normal. The second portion
of the duodenum and head of the pancreas
were mobilized medially. Lymph nodes from
the retroperitoneal space were examined by
frozen section and no malignant cells were
found. Once the common duct, portal vein and
vena cava had been exposed, a pancreaticoduo
denectomy was feasible and safely performed.
The postoperative course was uncomplicated
and the patient was discharged 11 days later.

Pathological Findings

The operative specimen showed a cir
cumferential mucosal villous tumour, 8
cm long, extending equidistant from the
ampulla in the second portion of the
duodenum. The wall of the ampulla of
Vater was thickened, its orifice narrowed
and the common duct distended to 1.5 cm
in diameter (Figs. 1 and 2).
The tumour, a villous adenoma, was
characterized by folds of hyperplastic sur
face epithelium protruding into and nar
rowing the duodenal lumen (Fig. 3). Mul
tiple sections (32) revealed one focus of
adenocarcinoma in situ, as demonstrated
by a cribriform proliferation of the sur
face epithelium with cellular atypism (Fig.
3). In another zone of the adenoma was
an area of submucosal invasive adenocar
cinoma with marginal intramucosal car
cinoma (Fig. 4).
The villous adenoma involved the

FIG. 1—Duodenal villous tumour involving
entire circumference of mucosa of second por
tion of duodenum and ampulla of Vater.

FIG. 2—Villous tumour located equidistant
from papilla. Papilla and ampulla of Vater are
thickened and common duct lumen (C) is
slightly widened.
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ampulla of Vater (Fig. 5). No metastasis
was noted in the 20 lymph nodes iden
tified.
Discussion
Although villous adenomas have been
observed in the first and third parts of the
duodenum,3’6'8 the majority are located
in the second portion,8-9 the number pos
sibly being inflated by the inclusion of
localized ampullar adenomas. Some
observers believe that the incidence of
malignant transformation in villous ade
nomas of the duodenum and small intes
tine parallels their increase in size. In a
recent review, Perzin and Bridge5
detailed a retrospective study of 51
patients with adenomatous lesions of the

small bowel among 392 000 surgical
pathological examinations. The benign
adenomas were observed to have an aver
age diameter of 2.65 cm versus 3.7 cm for
adenomas incorporating a malignant
component.
The type of surgical resection chosen
for villous tumours of the duodenum
depends on a number of factors: the
demonstration of a focus of invasive
adenocarcinoma within an existing
predominantly villous adenoma, the loca
tion and confines of the adenoma in the
duodenum, the size and type (peduncu
lated versus sessile), and on the simultane
ous involvement of the duodenum and
ampulla of Vater.
Although preoperative biopsies of the
lesion in our case did not demonstrate

malignant change, the surgical procedure
selected was a pancreaticoduodenectomy,
a decision based on the size and extent of
the tumour, its sessile rather than pedun
culated nature, the involvement of the
ampulla of Vater with radiologic evidence
of luminal narrowing and, finally, the
difficulty in demonstrating by frozen sec
tion a possible site of invasive carcinoma
in a lesion of this size.
Our case demonstrated the coexistence
of focal, in situ, intramucosal and inva
sive carcinoma, a finding that has fre
quently been observed in large villous ade
nomas of the duodenum.
In our patient the difficulty in making
an early diagnosis related to a paucity of
symptoms. The narrowing of the duo
denal lumen did not lead to obstruction,
the increased vascularity of the tumour
did not cause bleeding and the ampullary
involvement did not result in jaundice or
cholangitis.
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Radiocarpal Osteoarthritis Associated With
Bilateral Bipartite Carpal Scaphoid Bones:
a Case Report
Bipartite carpal scaphoid is a rare con
genital anomaly. The authors report on a
56-year-old man who presented with
bilateral wrist pain without a history of
trauma. X-ray films demonstrated
bilateral symmetric bipartition of the
scaphoid into a large distal ossicle and a
smaller proximal ossicle. There was
degenerative change in the articulation
between the distal ossicle and the radial
styloid. The joint space between the
proximal ossicle and the scaphoid fossa
was preserved. The absence of periscaphoid degenerative change has been
suggested as a criterion for the diagnosis
of congenital bipartite scaphoid. This
patient fulfilled all other criteria for the
diagnosis and the authors suggest that
degenerative change developed due to
abnormally high contact force between
the distal ossicle and the radial styloid.
An identical pattern of degenerative
change has been observed in long
standing nonunion of the scaphoid, likely
due to a similar mechanism. Radiocarpal
osteoarthritis can develop in patients
with congenital bipartition of the
scaphoid and is similar to that observed
in long-standing nonunion of the
scaphoid.

Le scaphoi'de carpien bipartite est une
anomalie conggnitale rare. Les auteurs
commentent le cas d'un homme de 56
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ans vus souffrant de douleurs bilaterales
aux poignets alors qu'il n 'y avait pas
d'ant6c6dent de traumatisme. Les radiographies ont d6montr6 une division en
deux parties sym£trique bilaterale du
scaphoi'de donnant lieu d un osselet
proximal gros et a un osselet distal plus
petit. On constatait une modification
ddgdndrative de Tarticulation entre
I'osselet distal et le styloide radial.
L'espace articulaire entre I'osselet proxi
mal et la fossette scaphoi'de n'dtait pas
touchd. L'absence de changement ddgdneratif periscaphoide a etd proposee
comme critdre diagnostique du scaphoi'de
carpien bipartite. Le malade qui nous
occupe remplissait tous les autres e n ti
res diagnostiques et les auteurs suggferent que les changements ddgeneratifs
observes dtaient dus a la force de con
tact 6lev6e entre I'osselet distal et le
styloide radial. Une Evolution identique
des modifications ddgdndratives a deja
et£ observde dans des cas d’absence
d'ossification de longue date, probablement & cause de mdcanismes similaires.
Une arthrose radio-carpienne peut apparaftre chez les patients souffrant de sca
phoi'de bipartite congenital et celle-ci
ressemble a cede qu on observe quand il
y a absence prolongde d'ossification du
scaphoi'de.

Many authors113 have reported bipartite
carpal scaphoid as a rare congenital
anomaly. The condition may be isolated
or it may occur in conjunction with other
congenital anomalies of the hand or fore
arm.14 The differentiation of scaphoid
bipartition from nonunion of the
scaphoid is important so that unnecessary
immobilization and surgery can be
avoided.13 Furthermore, accurate recog
nition of the condition is important in
compensation cases in order to avoid
inappropriate judgements. The absence of
periscaphoid degenerative change has
been suggested as a criterion for the
diagnosis of congenital bipartite
scaphoid.10'1314 We recently treated a
patient who had radiocarpal osteoarthri

tis in association with bilateral bipartite
carpal scaphoid bones.
Case Report
A 56-year-old right-handed male factory
worker complained of bilateral wrist pain. The
pain had developed spontaneously 2 years
earlier. There was no history of trauma or other
joint problem. On specific questioning, the
patient denied any history of even trivial injury
to or immobilization of either wrist joint. There
was no family history of a joint problem in
general or of the wrist in particular. The pain
was aching in nature, exacerbated by activity
and localized to the dorsal radial aspect of both
wrists. The patient had been employed at a
foundry for 15 years where he regularly had
to push a heavy hopper down a track.
There was tenderness over the dorsal radial
aspect of both wrists. The range of motion was
45° dorsiflexion, 40° volar flexion, 15° ulnar
deviation and 10° radial deviation bilaterally.
Pronation and supination were full. Discom
fort was felt at the extremes of motion. Maxi
mum grip strength measured with a Jaymar
dynanometer was at the third setting and meas
ured 28 kg on the right and 18 kg on the left.
Other findings on examination were within
normal limits.
X-ray films demonstrated identical findings
in both wrists (Fig. 1). The scaphoid consisted
of two separate ossicles with smooth margins.
The distal ossicle was larger than the proximal
one. There was no evidence of cyst formation,
increased density or osteoporosis. Lateral radi
ographs (Fig. 2) showed no evidence of inter
calary instability. The joint space between the
radial styloid and the distal ossicle was narrow
and the subchondral bone was sclerotic. The
joint space between the proximal ossicle and
the scaphoid fossa was preserved. A bone scan
(Fig. 3) showed increased activity in the region
of the scaphoid and lunate bilaterally consis
tent with a degenerative process. Use of a non
steroidal antinflammatory agent partially
relieved the patient’s symptoms. Bilateral
leather wrist gauntlets were prescribed to be
worn at work. One year later the patient still
complained of pain, but he had not changed
his occupation.

Discussion

Bipartite carpal scaphoid is a rare con
genital anomaly. Gruber15 found four
bipartite scaphoid bones among 3007 dis-
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sections and Pfitzner1 found nine in
1456. It has been proposed that scaphoid
bipartition results from failure of the dis
tal (radial) and proximal (ulnar) compo
nents of the scaphoid to fuse. However,
the very existence o f scaphoid bipartition
has been questioned.16 In view of the
absence of a history of trauma and the
symmetrical radiologic findings, we
believe that our patient had congenital
bilateral bipartition of the scaphoid. He
fulfils Bunnell and Boyes’ criteria10 for

the diagnosis, with the exception of
degenerative change within the radiocar
pal articulation. However, the presence
of degenerative change in association with
scaphoid bipartition is consistent with
current knowledge of carpal biome
chanics and the patient’s long history of
manual labour. Others5,9,11’17 have stated
that arthritic changes may occur with
bipartite scaphoid.
Radiocarpal osteoarthritis is usually
associated with chronic ligamentous insta
bility,18 malunion of displaced intraarticular fractures19 and nonunion of the
scaphoid.20,21 Watson and Brenner18
noted that degenerative arthritis of the
carpus develops when small cartilaginous
contact surfaces are subjected to high
shear loading. They also noted that the
process of degenerative arthritis asso
ciated with long-standing nonunion of the
scaphoid begins between the radial styloid
and the distal scaphoid fragment. In con

trast, the proximal pole fragment in the
scaphoid fossa is always spared. This
radiographic pattern was observed in our
patient, suggesting that degenerative
arthritis associated with bipartition of the
scaphoid develops by a mechanism simi
lar to that observed in nonunion of the
scaphoid. We suggest that scaphoid
bipartition increased the contact force on
the articulation between the radial styloid
and the distal ossicle resulting in the
development of degenerative arthritis.
The radiographic pattern of arthritic
change was identical to that observed in
long-standing nonunion of the scaphoid.
Bone grafting of the scaphoid was not
recommended in our patient because of
the relatively advanced arthritic changes
present when we saw him. It has been
clearly shown that long-standing nonun
ion of the scaphoid leads to progressive
degenerative carpal arthritis.20,21 Since
degenerative change also developed in our

Fig. 2a

Fig. 2b

FIG. 2—Lateral views o f (a) left and (b) right carpi do not show evidence of intercalary
instability.

Fig. lb
F IG . 1—Posteroanterior views of (a)
left and (b) right wrists of patient. Both
scaphoids are bipartite. Distal ossicles are
larger than proximal and edges are rounded.
There is joint-space narrowing and subchon
dral sclerosis between each distal ossicle and
radial styloid. Joint space between proximal
ossicle and scaphoid fossa is preserved.
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FIG. 3—Delayed technetium-99m bone scan demonstrating increased uptake affecting
radioscaphoid articulation. Pattern of uptake is consistent with degenerative process.
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patient, bone grafting might be consi
dered for patients with symptomatic
scaphoid bipartition who present without
degenerative changes. Although differen
tiation of nonunion of the scaphoid from
scaphoid bipartition is important diag
nostically, it would appear, on the basis
of this case report, that both conditions
can result in identical patterns of carpal
arthritis.
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St. Anthony’s Fire, Then and Now:
a Case Report and Historical Review
A rare case of morbid vasospasm,
together with striking angiographic find
ings, is described secondary to the
ingestion of methysergide by a 48-yearold woman. A brief review of the litera
ture on similar cases is presented.
A discussion of the history of ergot
includes its original discovery, the epi
demics of gangrene that it has caused
through the ages and its past and
present role in the management of
migraine headache. Despite the advent
of calcium channel blockers and 0adrenergic antagonists, ergot prepara
tions continue to play a major role in
migraine therapy, so that the danger of
St. Anthony's fire persists.
On decrit un cas rare de vasospasme
pathologique survenant de concert avec
des modifications angiographiques mar
quees chez une femme de 48 ans qui
avait pris du methysergide. On fait une
breve revue d'articles traitant de cas
similaires.
Le commentaire sur I'histoire de I'ergot
de seigle, porte sur sa decouverte originale, les epidemies de gangrene dont il
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fut la cause a travers les ages et son
role passe et actuel dans le traitement de
la migraine. Malgre I'avenement des bloqueurs calciques et des antagonistes 0adrenergiques, les preparations de deri
ves de I'ergot continuent de jouer un role
majeur dans la therapie de la migraine de
sorte que, encore de nos jours, le danger
du feu de Saint-Antoine persiste.

Epidemic gangrene has been recorded
since the 9th century AD and a “ noxious
pustule in the ear of grain” (i.e., ergoty
rye) was described on an Assyrian tablet
in 600 BC.1 Written records of epidemic
gangrene appeared in the 10th and 11th
centuries AD. The Greeks and Romans
did not eat rye; it was the conquering Teu
tons who popularized its consumption,
and thus were responsible for the spread
of ergotism throughout Western Europe.
The connection with St. Anthony of
Egypt (251-356 AD), “ patriarch of
monks and healer of both men and
animals” , developed some time later,
probably with the translation of his relics
and the establishment of a shrine at La
Motte in the southeast of France around
1100 AD.2 Victims of ergotism likely
obtained relief at the shrine because o f a
change of diet. On modern French maps,
there are two spots marked “ La M otte”
in the Dauphinee region. Synonyms for
the disease, such as “ mal des ardents” ,
“ ignis sacer” and “ feu sacre” , reflect this

French influence. Houses of the Order of
St. Anthony, devoted to the care o f the
victims of epidemic gangrene, apparently
had flame-red walls. Alternatively, the
“ fiery” pain of peripheral vasospasm,
which prompted sufferers to expose their
limbs to the open air, and the subsequent
development and bloodless separation of
charcoal-like lesions on the extremities
(i.e., dry gangrene) may also be respon
sible for the name of the disease, St.
Anthony’s fire.
In 1676, it was proven that epidemic
gangrene was caused by the sclerotium of
the fungus Claviceps purpurea (Fig. 1),
which grows on rye, particularly in wet
weather, and is now subject to strict pub
lic health regulations. Despite these, the
problem has persisted into the 20th
century.
Isolated instances of morbid vaso
spasm, on the other hand, may occur
through the use of ergot preparations for
treating migraine. They tend to follow
one of three patterns:3
• Long-term ingestion with gradual
increase to toxic levels.
• Acute excessive ingestion.
• Acute idiosyncrasy to a small dose.
The first pattern is the most common,
and ergotamine usually is the causative
agent.
Methysergide, a semisynthetic drug
that is structurally related to the natural
ergot compound, has a relatively weak
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vasoconstrictive action and is less often
implicated in vasospasm than ergotamine.
Methysergide has some pharmacologic
antiserotonin activity, which may account
for its clinical prophylactic value against
migraine. Moreover, vasospasm with
methysergide has been overshadowed in
importance by a graver complication —
retroperitoneal fibrosis.4 The following
report describes a case of methysergideinduced vasospasm, documented both by
angiography and by noninvasive studies,
which suggest that significant ergot-like
activity is present in methysergide, in spite
o f synthetic alteration.

Case Report
A 48-year-old woman was referred with a
1-month history of rest pain in the feet. One
year before, pentoxifylline (Trental) had been
prescribed for claudication, primarily in the
left calf. For 2 years she had been taking
methysergide as prophylaxis for migraine
headache. Dosage ranged up to 16 m g/d, but
she had two 3-month periods of abstinence on
the advice of her physician. At the time of
referral, however, she was taking close to her
maximum dose. She had stopped smoking 5
years before. Her history included hysterec
tomy for fibroids in 1966 and an allergy to
codeine.
The patient was a tired, anxious woman of
medium build, who was having much difficulty
walking. Carotid pulses were normal without
bruits, femoral pulses were weak with bruits
and there were no distal pulses in the lower
limbs. The feet were pale, cold and slightly
mottled, with elevation pallor and dependent
rubor; ankle pressure was 30 mm Hg on the
right, with no recordable Doppler signal on the
left. Angiography (Fig. 2) demonstrated severe
symmetrical narrowing in the superficial
fem oral and popliteal arteries, and multiple
areas o f occlusion in the distal leg vessels.
Methysergide was discontinued. Within 48
hours the feet were warm and pink, with
bounding pulses and ankle pressure of 150 mm
Hg (brachial pressure 145/80 mm Hg). Angiog
raphy was not repeated. On follow-up 2
months later, ankle pressures were normal,
although there was some numbness in the dis
tal part of the right foot. She was having inter
mittent nocturnal headaches, satisfactorily con
trolled with ice packs.

vulsions, psychoses and death occurred in
rural France in the early 1950s when a
baker used contaminated illegal rye to cir
cumvent taxation, and, as recently as
1979, an epidemic was reported in Ethio
pia.6 Agriculture Canada7 grades rye on
the basis of ergot content, from no. 1
(0.05%) to no. 3 (0.33%). Higher con
tents than this are labelled ergoty rye; this
usually involves less than 1% of rye in a
normal year but up to 36% in a wet year.
Other cereal and feed grains that are less
susceptible to ergot infection than rye
have similar limitations imposed by the
Canadian Grain Commission.
The effect of ergot in pregnancy has
been known for at least 2000 years. A
quote from the sacred book of the Parsees, written between 400 BC and 300 BC,
translates as follows; “ Among the evil
things created by Angro Maynes are nox
ious grasses that cause pregnant women
to drop the womb and die in childbed” .1
The M oorish physician A vicenna
(980-1037) apparently knew of ergot’s
potential, although there is no direct men
tion of it in his writings. In 1582,
Lonicerus wrote of the painful effect of
ergot on the uterus. In the early 1800s,
Stearns, Akerly and Spalding described
the use of ergot in parturition, and by
1822 an enquiry into it? misuse resulting
in stillbirth was conducted for the Medi
cal Society of New York.5
In 1884, Dr. William H. Thomson of
New York City described the use of fluid
extract of ergot for frequent periodic
headache.8 The dosage was 2 to 4 mg
orally or rectally every hour for 3 hours
or until effective, accompanied by quinine
for nausea. According to Dr. Thomson,

Discussion
Because, historically, epidemic gan
grene involved such a large population,
the epidemiology of ergotism was difficult
to define. It became apparent that poor
farmers were particularly vulnerable and
that wet weather could be followed by an
outbreak. The fact that ergot loses its
potency with storage probably also con
fused the picture. Once the connection
was established between St. Anthony’s
fire and ergoty rye, preventive public
health measures were introduced. They
have not met with unmitigated success:
betw een 1889 and 1890, K ortneff
observed over 2000 cases of ergot poison
ing.5 A spectacular outbreak with con
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FIG. 1—Three ears of rye on left of this
early 19th-century drawing contain ergots,
sclerotia of fungus Claviceps purpurea. First
two ears contain great number of ergots, more
detailed examples of which are shown in
detached ergots. Third ear of stout rye contains
only one large ergot. Ear at right, which also
bears one ergot, is wheat, grain rarely contami
nated by fungus. (From Prescott, O Jr: A Dis
sertation on the Natural History and Medici
nal E ffects o f the Secale Cornutam, or Ergot,
Cummings and Hilliard, Boston, 1813).

FIG. 2—Four films of translumbar aortogram demonstrate typical picture of ergotinduced vasospasm: symmetrical and diffuse
narrowing, principally in superficial femoral,
popliteal and limb arteries. Collateral vessels
are frequently larger than main channels. Aorta
and iliac arteries appear normal.

VOLUME 30, NO. 4, JU LY 1987 / THE CANADIAN JOURNAL OF SURGERY

it “ rarely fails” . Twentieth-century
reports of ergotamine use in migraine
appeared first in the French8 and
German5 literature, but the definitive
proposal for the mechanism of ergot’s
beneficial effect was by Graham and
Wolff9 in 1938: the long-acting vasocon
striction produced by ergot prevents the
vasodilatation of arteries of the scalp,
which gives rise to the pain of migraine.
H arriso n ’s P rinciples o f Internal
Medicine10 cites ergotamine as the prin
ciple therapeutic agent for aborting an
acute attack of migraine, and methysergide as the most useful drug in the
prophylaxis of migraine. With such a tes
timonial from one of the most popular
and widely read medical textbooks in the
world, one might infer extensive prescrip
tion of ergot compounds.
Some of the most important investiga
tions related to the actions and chemis
try of the ergot alkaloids were carried out
by Dale" and coworkers in the early
1900s. Using the receptor protection tech
nique, Innes12 demonstrated that ergota
mine acts both as an a-adrenergic
antagonist and as a partial agonist, in a
variety of in-vitro animal smooth-muscle

FIG. 3—Structural formulae of ergotamine
(left) and methysergide (right).

Table I—Iatrogenic Ergotism:
Sites of Involvement15
Carotid vessels
Retina
Upper limb
Coronary vessels
Mesentery
Kidney
Lower limb

preparations. The a-adrenergic blocking
effect was confirmed by Mikkelsen and
associates13 who showed that ergotamine
could block the effect of norepinephrine
in human in-vitro mesenteric arteries har
vested at cancer surgery. The partial
agonist activity has been corroborated
both in migraine patients and in normal
volunteers,14 in whom there is a reprodu
cible fall in ankle-to-brachial pressure
ratio with intravenous administration of
0.5 mg of ergotamine.
Goodman and Gilman1 have described
ergot as a “ veritable treasure house of
pharmacology” . As well as ergot, the
sclerotium of Claviceps purpurea contains
amines such as histamine, tyramine and
acetylcholine; also quarternary ammonia
bases, amino acids, carbohydrates,
sterols, glycerides and inorganic com
pounds. Ergot itself can be classified as
follows: amino-acid alkaloids, amine
alkaloids, and dihydrogenated com
pounds of the above.
Ergotamine is an amino-acid alkaloid,
whereas methysergide, which is more
easily absorbed through the gastrointes
tinal tract, is an amine alkaloid (Fig. 3).
Dihydrogenation of ergotamine reduces
its vasoconstrictive effect. All these com
pounds are structurally related to lyser
gic acid diethylamide (LSD).
The problem of iatrogenic ergotism,
particularly in migraine sufferers, was
first brought to the attention of the med
ical community by Labbe and colleagues
in 1929.5 Since then, over 100 case
reports have appeared describing morbid
vasospasm with the therapeutic use and
abuse of ergot compounds.15 Table I
outlines documented sites of involvement.
A partial review of these case reports sug
gests that the majority of patients recover
completely. A few suffer minor tissue
loss, the rare patient requires a major
amputation, and when death ensues there
is a complicating factor such as recent

Table II--Treatments for Iatrogenic Ergotism15
Anticoagulation
Vasodilatation (pharmacologic)
Heparin
a-adrenergic block
Streptokinase
Phenoxybenzamine
Dextran (?)
Phentolamine
Tolazoline
Prazosin
Reserpine
^-adrenergic block
Propranolol
Direct action
Papaverine
Nitroglycerin
Nitroprusside

Volume expansion
Dextran
Mannitol
Crystalloid

Calcium channel block
Nifedipine

Vasodilatation (mechanical)
Fogarty
Griintzig

Ganglionic block
Epidural bupivacaine
Cervical ganglionectomy
Lumbar sympathectomy

major surgery. In a few cases, such as the
one we described, the only treatment was
withdrawal of the medication, but most
physicians have felt obliged to institute at
least some additional care (Table II).
Since all these reports are anecdotal, the
only control has been in patients in whom
a constant intravenous infusion of
nitroglycerin16 or nitroprusside17 has
been interrupted with return of symptoms
and signs. Otherwise, it is impossible to
determine whether the relief of vasospasm
is spontaneous or treatment-induced.
Migraine headache is an extremely
common phenomenon, and its manage
ment can be time-consuming, frustrating
and moderately dangerous, as illustrated
by this review. More recently there has
been a trend to the use of /3-blocking
agents18 and calcium channel blockers19
in migraine therapy, although the sale of
ergot preparations seems to be continu
ing relatively unabated (Sandoz Ltd,
M ontreal: Personal com m unication,
1986). Thus, the potential for St.
Anthony’s fire is still with us, and likely
will be for the forseeable future. It is
important that the practising physician be
aware of morbid vasospasm from ergot
drugs, so that disasters can be averted.
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D a la c in C Phosphate Sterile Solution

(clindamycin phosphate)

* Superinfection is a complication of antibiotic therapy in general and is not necessarily a true side
effect of clindamycin phosphate.
* Due to underlying myocarditis in this patient.

Antibiotic
Recommended Applications
Action: Clindamycin exerts its antibacterial effect by causing cessation of protein synthesis and also by
causing a reduction in the rate of synthesis of nucleic acids.
Indications: Dalacin C Phosphate (clindamycin phosphate) is indicated for the treatment of infections
where the oral route is not indicated or feasible.
Dalacin C Phosphate is indicated in the treatment of serious infections due to sensitive anaerobic
bacteria, such as Bacteroides species, peptostreptococcus, anaerobic streptococci, Clostridium
species and micro-aerophilic streptococci.
Dalacin C Phosphate is also indicated in serious infections due to sensitive Gram-positive organisms
(staphylococci, including penicillinase-producing staphylococci, streptococci and pneumococci)
when the patient is intolerant of, or the organism resistant to other appropriate antibiotics.
Contraindications: The use of Dalacin C Phosphate (clindamycin phosphate) is contraindicated in
patients previously found to he hypersensitive to this compound, the parent compound, clindamycin, or
clindamycin palmitate. Although cross-sensitization with Lincocin® (lincomycin hydrochloride) has not
been demonstrated, it is recommended that Dalacin C Phosphate not be used in patients who have
demonstrated lincomycin sensitivity.
Until further clinical experience is obtained, Dalacin C Phosphate is not indicated in the newborn (in
fants below 30 days of age), or in pregnant women.
Warnings: Some cases of severe and persistent diarrhea have been reported during or after therapy
with Dalacin C Phosphate (clindamycin phosphate). This diarrhea has been occasionally associated with
blood and mucus in the stools and has at times resulted in acute colitis. When endoscopy has been
performed, some of these cases have shown pseudomembrane formation.
If significant diarrhea occurs during therapy, this drug should be discontinued or, if necessary, con
tinued only with close observation. Significant diarrhea occuring up to several weeks post-therapy
should be managed as if antibiotic-associated.
If colitis is suspected, endoscopy is recommended. Mild cases showing minimal mucosal changes
may respondtosimpledrugdiscontinuance.Moderatetoseverecases.includingthoseshowing ulcera
tion or pseudomembrane formation, should be managed with fluid, electrolyte, and protein
supplementation as indicated. Corticoid retention enemas and systemic corticoids may be of help in
persistent cases. Anticholinergics and antiperistalticagents may worsen the condition. Other causes
of colitis should be considered.
Studies indicate a toxin(s) produced by Clostridia (especially Clostridium difficile) may be a principal
cause of clindamycin and other antibiotic-associated colitis. These studies also indicate that this
toxigenic Clostridium is usually sensitive in-vitro to vancomycin. When 125 mg to 500 mg of vanco
mycin were administered orally four times a day for 5 -1 0 or more days, there was a rapid ob
served disappearance of the toxin from faecal samples and a coincidental recovery from the diarrhea.
It should be noted that serious relapses have occurred up to one month after apparently successful
treatment. A relatively prolonged period of continuing observation is therefore recommended.
Precautions: Dalacin C Phosphate (clindamycin phosphate), like any drug, should be prescribed with
caution in atopic individuals. Dalacin C Phosphate must be diluted for intravenous administration.
(See Dosage and Administration)
The use of antibiotics occasionally results in overgrowth of nonsusceptible organisms - particularly
yeasts. Should superinfections occur, appropriate measures should be taken as dictated by the
clinical situation.
As with all antibiotics, perform culture and sensitivity studies in conjunction with drug therapy.
Since abnormalities of liver function tests have been noted occasionally in animals and man, periodic
liver function tests should be performed during prolonged therapy. Blood counts should also be
monitored,during extended therapy.
Dalacin C Phosphate may be used in anuretic patients. Since the serum half-life of clindamycin in
patients with impaired hepatic function is greater than that found in normal patients, the dose of
Dalacin C Phosphate should be appropriately decreased. Hemodialysisand peritoneal dialysis are not
effective means of removing the compound from the blood. Periodic serum levels should be deter
mined in patients with severe hepatic and renal insufficiency.
Adverse Reactions: Local
(a) Intramuscular Injections: Of 404 patients treated with Dalacin C Phosphate (clindamycin
phosphate) intramuscularly (with a solution containing 150 mg/ml), six (1.5%) demonstrated local
reactions as follows: Two complained of pain at the injection site, two demonstrated induration at
the injection site and two developed sterile absesses.
(b) Intravenous Infusions: Of 192 patients treated with Dalacin C Phosphate by intravenous infusion,
14 (7.3%) demonstrated local reactions. Eleven patients developed superficial thrombophlebitis and
one patient developed both superficial and deep thrombophlebitis. The majority of these cases
developed in conjuctionwiththe use of indwelling I.V.cathetersand it isdifticultto know howmuchthe
drug contributed to the irritation. Two patients developed localized erythema, swelling and pain at
the site of the infusion.
Systemic Side Effects: Twenty-eight patients of 596 treated with Dalacin C Phosphate (clindamycin
phosphate) by either the intramuscular or intravenous routes developed systemic side effects as follows:
Number o f Patients
Rash.............................................................................................................................................................. 7
Urticaria......................................................................................................................................................... 1
Pruritus......................................................................................................................................................... 1
Fever, Leucocytosis.................................................................................................................................... 1
Nausea, with or without vomiting.............................................................................................................. 1
Diarrhea (See also under 'Warnings")........................................................................................................ 4
Hypotension.................................................................................................................................................. 1
Hypertension................................................................................................................................................ 1
Shortness of Breath.................................................................................................................................... 1
Superinfection- ............................................................................................................................................ 4
Cardiac arrest- * .......................................................................................................................................... 1
Bad or bitter taste in m outh........................................................................................................................ 5

Clinical and Laboratory Findings: Patients treated during clinical trials of Dalacin C Phosphate
(clindamycin phosphate) were followed with clinical laboratory tests, including complete hematology,
urinalysisandliverand kidney function tests. Some of these tests were abnormal initially and returned
to normal during therapy with Dalacin C Phosphate, while others were normal initially and became
abnormal.during therapy. Overall evaluation of clinical laboratory values in these patients does no* indicate that Dalacin C Phosphate therapy has a toxic effect on the hematopoietic, hepatic or renal
"
systems. Transient elevations of serum transaminases have occured in some patients, but other liver r ,
function tests (alkaline phosphatase, serum bilirubin) have not shown any tendency to increase and
there have not been clinical signs of drug-induced hepatic toxicity.
4 J
Symptoms and Treatment of Overdosage: No cases of overdosage have been reported No specific . '
antidote is known. Doses as high as 1200 mg every six hours (4800 mg/day) by infusion for five days
have been given without adverse effects.

DOSAGE AND ADMINISTRATION
*
Adults
*V t
Intramuscular Injection: 600 mg/day in 2 equal doses.
Moderately severe infections: 600to1200m g/dayin2or3equaldoses.
’’
Severe infections: 1200 to 2400 mg/day in 2,3 or 4 equal doses. Intramuscular injections ot more than
600 mg into a single site are not recommended.
r
Intravenous Administration: Dalacin C Phosphate (clindamycin phosphate) must be diluted prior to
t
I.V. administration to a dilution of 300 mg in 50 mL of diluent (6mg/mL) or more, and infused in not le sj J
than 10 minutes. Administration of morethan 1200mg inasingle 1 hourinfusionisnotrecommended. i
Dalacin C Phosphate should not be injected intravenously undiluted as a bolus.
Moderately severe infections: 900 to 1800 mg/day by continuous drip or in 2 or 3 equal doses, each
1
infused over 20 minutes or longer.
A
Severe Infections: 1800 to 2700 mg/day by continuous drip or in 3 or 4 equal doses, each infused over i j
20 minutes or longer. In life-threatening infections, doses of 2700to 4800 mg/day by continuous drip or A
in 3 or 4 equal doses each infused over 20 minutes or longer may be given.
Dilution and infusion rates:
Time
"
^
Dose
Diluent
10 min.
300 mg
50 mL
20 min.
*•
600 mg
100 mL
30 min.
900 mg
150 mL
1200 mg
200 mL
45 min.
r- i
Alternatively, drug may be administered in the form of a single rapid infusion of the first dose followed
by continuous I.V. infusion as follows:
Maintenance
To maintain serum
Rapid
infusion rate
clindamycin levels
infusion rate
0.75 mg/min.
*
Above 4 mcg/mL
10m g/m in.for30m in.
1.00mg/min.
Above 5 mcg/mL
15m g/m in.for30m in.
1.25 mg/min.
J
Above 6 mcg/mL
20m g/m in.for30m in.

1
1

Children: (Over one month of age)
Intramuscular injection: 10 to 15 mg/kg/day in 2,3 or 4 equal doses.
Moderately severe infections: 15 to 20 mg/kg/day in 3 or 4 equal doses.
Severe infections: 20 to 30 mg/kg/day in 3 or 4 equal doses.
Intravenous Administration:
Moderately severe infections: 15 to 25 mg/kg/day by continuous drip or in 3 or 4 equal doses, each v
infused over 20 minutes or longer.
Severe infections: It is recommended that children be given no less than 300 mg/day regardless of body 4
weight. (Dilute Dalacin C Phosphate Sterile Solution in the same manneras for adults.)
'
Dilution and Compatibility:
y <
4 mL (600 mg) Dalacin C Phosphate when diluted with 1000 mL of the following commonly used in
fusion solutions was found to be physically compatible and demonstrated no significant change in pH,
or antimicrobial potency over a period of 24 hours:
*
Sodium chloride injection
Dextrose 5% in water
*
Dextrose 5% in saline
*
Dextrose 5% in Ringer s Solution
Dextrose 5% in half-strength saline plus 40 mEq potassium chloride
Dextrose 2'/2% in Lactated Ringer's Solution (Hartmann's Solution)
’y ^
Dalacin C Phosphate was not stable when added to Dextrose 5% in water plus vitamins. Therefore it is
not recommended that Dalacin C Phosphate be mixed with any infusion solution containing B vitamins*

^

Supplied:
Dalacin C Phosphate contains the following per mL of sterile solution:
Clindamycin phosphate equivalent to clindamycin base 150 mg
+
Benzyl alcohol 5 mg
Disodium edetate 0.5 mg
■>
Water for injection q.s.
When necessary the pH is adjusted with sodium hydroxide and/or hydrochloric acid to maintain a pH
range of 5.5 to 7.0.
Dalacin C Phosphate is available in 2 mL and 4 mL ampoules.
—A
NOTE: Do not store below 15°C.

i
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Product Monograph available upon request.
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R191
MARLEX MESH IMPROVES THE RESULTS OF INCISIONAL
HERNIA REPAIRS. P. Makarewicz, M. Al-Shehri, J. Freeman. Divi
sion o f General Surgery, Ottawa General Hospital, University of Ottawa,
Ottawa, Ont.

One percent of all abdominal surgery is complicated by a postopera
tive hernia and 8% of such repairs fail. Significant defects in muscle
and fascia or infection cause failure after simple closure. Reinforce
ment with prosthetic materials may reduce recurrence but increases risks.
We established a hernia follow-up clinic to study recurrence and com
plications in 116 patients with massive primary or recurrent hernias
repaired with (60) or without (56) Marlex. There were 68 women and
48 men aged 54 ± 14. The hernia was incisional in 91/116 (78%); 39
of these 91 (34%) were recurrent. There were 58 upper, 41 lower abdomi
nal hernias, 8 inguinal, 12 umbilical and 5 others. Thirty-six hernias
were massive (greater than 8 x 8 cm). Fifty-nine patients were obese,
25 had diabetes and 65 smoked. Postoperative drains were placed in
64/116; local antibiotics were used in 43/116 and systemic antibiotics
in 60/116. Patients were followed for 18 - 40 months. In the Marlex
group, 10/60 (17%) complained of pain without objective findings while
at least half of these were proven secondary to Prolene sutures subse
quently removed. Two patients developed wound sinus necessitating
removal of Marlex. Recurrent hernia occurred in 9/60 (15%). In those
repaired without Marlex, 9/56 (16%) complained of pain and recur
rence occurred in 22/56 (39%). There was a strong correlation between
recurrence versus obesity, diabetes or previous surgery.
Marlex mesh repair of abdominal hernias is advisable for all large
and/or recurrent hernias or in the presence of obesity. The recurrence
rate with Marlex is lower compared to primary repair (15 versus 39%).
Incisional pain is identical in patients with and without Marlex and may
be secondary to Prolene knot granulomas.

R193
PREVENTION OF INTRA-ABDOM INAL ABSCESSES W ITH
FIBRINOLYTIC AGENTS. O.D. Rotstein, J. Quinto, J. Kao. Depart
ment of Surgery, University o f Toronto, Toronto, Ont.

Fibrin deposition during peritonitis predisposes to subsequent abscess
formation by protecting bacteria from host defences. To determine
whether the use of intraperitoneal (ip) fibrinolytic agents could prevent
ip abscess formation, Wistar rats were implanted intraperitoneally with
fibrin clots (100 m g/dl) containing either B. fragilis (BF, 2 x 109/clot)
alone or E. coli (EC, 2 x 106) plus BF (2 x 108) and beginning at sur
gery, animals received daily 5 ml ip injections of either phosphatebuffered saline (PBS), trypsin (TRYP 1.0 mg/ml or 0.5 m g/m l) or
recombinant tissue plasminogen activator (t-PA, 0.25 m g/m l, Genentech Co). Abscess form ation and bacterial numbers were assessed at
5 days.
Treatment

B. fragilis0
Abscess formation

87% (n =
PBS
20% b (n =
TRYP (1 mg/ml)
TRYP (0.5 mg/ml) 60% (n =
0% (n =
t-PA

15)
20)
5)
15)

E. coli + B. fragilis
Mortality
Abscesses
8.3% (n = 12)
25% (n = 12)
16% (n = 12)
ND

90%
ll%b
18%b
ND

a: No mortalities occurred, b: p 0.01 versus PBS control, ND: not done.
The viable bacteria (log CFU/abscess) in BF abscesses were 7.7 ± 0.4
(n = 6) in the PBS group versus 4.8 ± 2.5 (n = 4) in the TRYP I
mg/ml group. In-vitro studies demonstrated no direct microbicidal
activity of TRYP or t-PA on BF or EC, suggesting that enhanced bac
terial clearance was responsible for reduced abscesses and bacterial num
bers. Controlled fibrinolysis at operation may be a useful adjunct to
surgery and antibiotics in preventing postoperative ip abscess formation.

R192
PRELIMINARY RESULTS OF COLOANAL ANASTOMOSIS. Denis
Bernard, Daniel Tasse, Ramses Wassef, Stephen Morgan. Department
of Surgery, University of Montreal, Division o f Gastrointestinal Sur
gery, Hopital St-Luc, Montreal, PQ

Coloanal anastomosis is the ultimate procedure to preserve the patients’
sphincters and avoid a permanent colostomy. Carcinomas (CA) of the
midrectum and sometimes of the lower third do not require excision
of the pelvic floor and sphincters for cure. Coloanal anastomosis was
achieved in 29 patients after rectal excision for CA in 23, for adenomas
in 4 and for 2 other conditions. Dukes’ staging of the CA were A: seven,
B: six, C: nine and resection was palliative in one. The mean distance
from the anus to the CA was 6.4 cm. A temporary defunctioning
colostomy was established in all. There were no deaths and 52% (n:
15) had postoperative complications (major: six, minor: nine). Mean
follow-up is now 29 months (9-61 months). Only one had pelvic recur
rence; one is alive with metastatic disease and one died of an unknown
cause at 30 months with no evidence of recurrent disease. All others
are alive and well. Colostomy was closed in all but two. Stenosis was
the most common long-term problem: it occurred in 13 and required
more than one dilatation in 8. Six months after the procedure the mean
number of daily bowel movements is 4.3; 95% are continent to solid
stools and 16% are incontinent to liquid stools or gas, but only one
would prefer re-establishment of a colostomy. In selected cases with
little or no extramural spread, we feel a resection and coloanal anasto
mosis is a good alternative with acceptable functional results and a low
rate of recurrent tumour comparable to complete rectal excision.

R194
LOBULAR CARCINOM A OF THE BREAST. W .J. Orrom, B.M .
Mielke, O.G. Thurston. Department of Surgery and Department of
Pathology, University o f Alberta Hospital, Edmonton, Alta.

Lobular carcinoma o f breast has distinct biological differences from
other breast cancers affecting treatment, follow-up and prognosis. This
study is a review of our experience with 22 cases of lobular carcinoma
in situ and 136 cases of invasive lobular carcinoma seen at the Univer
sity of Alberta Hospital, 1955 - 1985.
Lobular carcinoma totalled 10% of all breast cancers in this period.
When compared to patients with invasive duct carcinoma, those patients
with invasive lobular carcinoma were younger — 55 versus 58 years
(p < 0.01) and had a higher incidence of bilaterality — 20% versus
5% (p < 0.001). Actuarial survival was better for invasive lobular than
invasive duct cancers (p < 0.001). The mean age of patients with lobu
lar carcinoma in situ was 7 years younger than patients with invasive
lobular carcinoma (p < 0.01) whereas patients with duct carcinoma
in situ were similar in age to patients with invasive duct carcinoma. The
surgical treatment of invasive lobular carcinoma was evenly distributed
between radical, modified radical and simple mastectomy. There were
no survival differences between the three groups.
The results of this study indicate a biological behaviour to lobular
carcinoma that is significantly different than the more common duct
carcinoma. The younger age, improved prognosis and higher frequency
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of bilaterality in patients with lobular carcinoma have important impli
cations for treatment and follow-up. The 7-year lag between the insitu and invasive forms of lobular cancer is strong evidence that this
is a precursor lesion rather than a high-risk marker of invasive cancer.
This is in contrast to duct carcinoma, where the in-situ and invasive
forms appear virtually simultaneously.
R195
ENHANCEMENT OF CELLULAR KINETICS IN THE PROXIMAL
SM ALL INTESTINE OF THE RAT FOLLOWING RUMENECTOMY. R. Odze, B. Milmaker, P .H . Gordon. Lady Davis Research
Institute, Department of Surgery, Sir Mortimer B. Davis-Jewish General
H ospital, McGill University, Montreal, PQ

To determine the effect of excision of the rat rumen (forestomach) on
the cellular kinetics of the proximal small intestine, young male
Sprague-Dawley rats were randomly assigned to receive either control
gastrotom y (Group A) or rumenectomy (Group B). After preliminary
results indicated a proliferative response in Group B, the following two
surgical groups were added to differentiate if this effect is dependent
on luminal or extraluminal factors: pyloric ligation and gas
trojejunostomy (Group C) and rumenectomy, pyloric ligation and gas
trojejunostomy (Group D). Fourteen days following surgery each animal
received an intraperitoneal injection of 3H-thymidine and was
sacrificed 1 hour later. Radioautographic slides were prepared from
sections o f duodenum and jejunum for determination of crypt column
cell counts (CCC), villous column cell counts (VCC), crypt labelling
index (Li) and proliferative index (Pi). In the duodenum, the results
showed a CCC of 31.5 ± 0.3 (SEM) in Group A and 40.0 ± 0.4 in
Group B (p < 0.01). Bypassed duodenum from Groups C (32.5 ± 0.3)
and D (35.9 ± 0.4) showed no significant change in this parameter.
In the efferent jejunum, the CCC showed no difference between Group
A (30.9 ± 0.3) and B (33.1 ± 0.2) but significant increases were observed
in both Groups C (40.3 ± 0.5) and D (46.9 ± 0.4) when compared
to control (p < 0.01) and to each other (p < 0.05). The Li, Pi and
VCC showed little variation between any surgical group. These results
indicate that the intestinal mucosa in direct proximity to the stomach
exhibits a luminal dependent crypt cell hyperplastic response follow
ing excision of the rumen.
R196
RECONSTRUCTION OF THE TOTAL THORACIC ESOPHAGUS
WITH REVASCULARIZED JEJUNUM: A N EXPERIMENTAL
M ODEL. J. Hobson, G. Pliagas, G. DeRose, R. Finley. Division of
General Surgery and Division o f Vascular Surgery, Victoria Hospital,
University o f Western Ontario, London, Ont.

Historically, total esophageal reconstruction with pedicled jejunum has
proved to be unreliable. Ischemia of the proximal graft leads to anasto
motic leakage and increased morbidity and mortality. Augmentation
of the blood supply to the proximal jejunum should prevent these com
plications.
A canine model was used to assess this technique of total esophageal
reconstruction with autologous revascularized jejunum. Pedicled,
isoperistaltic jejunum is passed retrosternally to the neck and
anastomosed to the cervical esophagus and distally to the stomach. In
the experimental groups (n = 15) the proximal jejunal arcade is revas
cularized by anastomosing the artery to the side o f the common carotid
artery and vein to side of external jugular vein. The control group (n
= 6) had no revascularization.
Successful revascularization occurred in 14/15 experimental animals.
The esophagojejunal anastomosis leaked in 5/14 experimental (no stric
tures) and 6/6 control animals (p < 0.01). None of the control animals
were able to sustain an oral diet.
Using this technique, 10 other dogs (n = 10) underwent total thoracic
esophageal reconstruction with revascularized jejunum. Regional mesen
teric blood flow in the jejunum was measured using the radioactive
microsphere technique (1-125 and Cr-51). Blood flow to the jejunum
at the esophagojejunal anastomosis without revascularization measured
0.011 ± 0.009 ml/g/min. With revascularization jejunal blood flow
at the anastomosis measured 0.415 ± 0.129 m l/g/m in (p < 0.001).
Revascularization of the proximal jejunum in the neck does result
in a statistically significant increase in blood flow to the jejunum at
the esophagojejunal anastomosis and decreases the incidence of
esophagojejunal anastomotic leakage in the neck.
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R197
THE VALUE OF CURATIVE RESECTION FOR CARCINOMA OF
THE ESOPHAGUS. F. Rubens, F. Shamji, S. Brown, H. Sachs. Divi
sion of Cardiothoracic Surgery, University of Ottawa, Ottawa Civic
Hospital, Ottawa, Ont.

We managed 71 patients with esophageal cancer between December 1983
and February 1987. Thirty-two had squamous cell and 39 had adenocar
cinoma of which 13 arose in Barrett’s esophagus. Using predefined
criteria, 45 patients were considered operable. Thirty-seven of these were
deemed resectable; 29 of these were curative and 8 were palliative.
Twenty-one of the 29 patients who had curative resection are alive
1 to 36 months postoperatively (mean 20 months) whereas 6 of the 8
patients who had palliative resection died 1 to 13 months (mean 4.8
months) after surgery. Four of 45 operated patients died (8.9%); 3 of
these were amongst the palliative resection group. However, only 1/29
patients (3%) resected for cure died. The eight patients in the operable
but unresectable group lived 2 to 24 months (mean 9). Eight of 26 inoper
able patients are still alive 2 to 27 months (mean 11.5) after diagnosis.
O f the 32 patients with squamous cell cancer, 9 were inoperable or
unresectable and were treated with 5-FU and radiation. Four of nine
of these patients have survived longer than 13 months.
Conclusions: Curative resection of carcinoma of the esophagus results
in mean 20-month survivorship which is superior to palliative or nonresectional therapy and has an operative mortality of 1/29 (3%). Con
versely, palliative resection for carcinoma of the esophagus carries a
high operative mortality with a low survival. Combination chemoradiation therapy provides reasonable palliation for patients with inopera
ble squamous cell lesions.
R198
PALLIATIVE ND:YAG LASER THERAPY FOR OBSTRUCTING
ESOPHAGEAL CANCER. K. W oolfson, C.D. Mercer. Hotel Dieu
Hospilal, Kingston, Ont.

Nine patients with unresectable carcinoma of the esophagus (one
hypopharyngeal, one Barrett’s adenocarcinoma, two squamous cell
midesophageal and five adenocarcinoma of the gastroesophageal junc
tion), ranging in age from 41 to 87 years (mean 68 years) underwent
palliative vaporization of the tumour with the Nd:YAG Laser. Four
teen treatments were required in these patients. A maximum o f 7870
joules (J) of energy was used in a single session (mean 4400 J). Pulse
settings were energy 40 watts, pulse duration 0.5 seconds. Operative
time ranged from 5 to 48 minutes. No intraoperative complications
occurred. Postoperative morbidity occurred in two patients having previ
ously undergone radiotherapy. (Procedure-related morbidity rate was
14%.) One developed transient laryngeal edema requiring intubation
and one developed a tracheoesophageal fistula controlled with an internal
esophageal stent. Mean follow-up is 3 months (range 2 - 6 months).
Significant improvement of dysphagia occurred in seven patients and
one patient with a bleeding tumour was controlled with the laser. Two
patients had minimal transient relief of dysphagia. Two patients died
of metastatic disease during follow-up. The Nd:YAG Laser is an effec
tive alternative to internal esophageal stenting and palliative resection
or bypass in patients with obstructing esophageal malignancy.
R199
NORMOGLYCEMIA AFTER IMPLANTATION OF PURIFIED
ISLETS OF LANGERHANS IN DOGS. G.L. Warnock, R.V. Rajotte.
Department of Surgery and Department of Medicine, University of
Alberta, Edmonton, Alta.

To promote clinical transplantation, effective methods for the isola
tion of purified islets will be needed. Canine pancreata removed at total
pancreatectomy were cannulated via the ducts and perfused with collagenase solution (1900 U/ml) at 37°C until mucoid. The gland was
dissociated into a tissue suspension by teasing and trituration. Islets
were separated on ficoll with gradient densities of 1.045, 1.075 and 1.085,
which reduced the mean packed cell volume from 37 ± 2 to 1.1 ± 0.4
ml (± SEM, n = 15). Counts of islets identified at microscopy revealed
a recovery of 103.6 ± 12 X 103 per pancreas. Mean islet diameter was
128 ± 7 pm. Histology showed highly purified islets. A dose of > 3200
purified islets/kg body weight was autoimplanted into splenic veins
(six dogs) or embolized via the portal vein to the liver (five dogs). Por
tal venous pressure was unchanged in the former and rose transiently
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by 3.4 ± 1.3 cm H20 in the latter group. Mean fasting plasma glu
cose (PG, mg/dl) was 122 ± 4 at 1 week, 91 ± 6 at 1 month and 86
± 4 at 6 months. During glucose tolerance tests, K values were nondi
abetic (> 1.0) at 1.9 ± 0.2 (1 month) and 2.0 ± 0.3 (6 months). Six
months after splenic implantation, basal splenic vein insulin was 20 ±
4 mU/L versus 4 ± 1 in the artery; PG rose to > 350 after splenec
tomy and immunohistology showed intrasplenic islets. In four other
dogs, < 3200 islets/kg were refluxed into the spleen; PG rose to 235
± 16 at 1 week. In three apancreatic controls, PG was 337 + 9. These
data define the critical number of purified dog islets of constant size
which is necessary to induce prolonged normoglycemia. Sufficient pure
islets can be collected from a single dog pancreas to reverse diabetes
after implantation into the liver or spleen.

R200
THE OPERATING ROOM: AN UNEXPLOITED UNDERGRADU
ATE TEACHING RESOURCE. J.L. Provan, R. Cohen. Department
of Surgery, University of Toronto, Toronto, Ont.
During the 1985-86 clerkship at the University of Toronto, 236 students
completed the end-of-rotation Clerkship Assessment Form (CAF). The
CAF contains 27 closed-ended (1 to 5 scale) items that assess the qual
ity of the learning experience and the exposure to specific activities on
all surgical clerkship rotations. Analysis of these data (correlation coeffi
cients and stepwise multiple regression) revealed that six of the speci
fied activities correlated well to moderately well with perceived success
of the student’s learning experience, i.e., quality of time spent in the
OR (r = 0.68), amount of scut work the clerk had to do (r = 0.53),
frequency of review of histories and physical examinations (r = 0.46),
opportunity to follow patients admitted previously to the OR (r = 0.45),
amount of responsibility for patient care (r = 0.41) and the opportu
nity to follow patients postoperatively (r = 0.33). Stepwise regression
revealed that one activity, i.e., quality of time spent in the OR explained
most of the variance on the dependent variable (perceived success of
learning experience) for all surgical subspecialties: general surgery 45%
(total variance explained 56%), neurosurgery 41% (total explained 61%),
orthopedics 28% (total explained 51 %), thoracic 43% (total explained
50%), urology 51% (total explained 65%), plastic surgery 53% (total
explained 60%), and vascular surgery 44% (total explained 56%) at
p < 0.001 (for all). The results of this study indicate that the quality
of teaching students receive in the OR is important in determining the
success of a surgical clerkship as a learning experience. Clerkship coor
dinators need to give more attention to developing the OR as a struc
tured undergraduate learning experience.

R201
COMPLICATIONS OF HICKMAN-BROVIAC CATHETERS. M.J.
Monaghan, R.F. Pace. Department of Surgery, Queen’s University,
Kingston General Hospital, Kingston, Ont.
The use of indwelling Silastic central venous catheters (HickmanBroviac) has simplified many problems of long-term venous access. A
review of 103 catheters in 79 patients (12 192 patient days) has disclosed
a significant incidence of catheter-related morbidity, with occasional
mortality. The indications for catheter use were chemotherapy adminis
tration in 48, total parenteral nutrition in 19 and fluid or antibiotic
administration in 12 patients. Mean catheter use in successfully catheterized patients was 120.7 days (range 1 to 827 days) and 11 patients
required more than one catheter to complete therapy. Although 69%
(71/103) of catheters functioned satisfactorily until elective removal,
patient death or study conclusion, only 45% (46/103) were free from
complication. Catheter removal was necessary in 31% (32/103) because
of complications which did not respond to treatment, the most com
mon indications for premature removal being catheter occlusion (6),
subcutaneous tunnel infection (5) and catheter sepsis (10).
Although tunnel sepsis usually required catheter removal (5/7), the
more ominous onset of catheter sepsis could often be controlled with
intravenous antibiotics, and catheter removal was avoided in 14/24 cases.
Coagulase-negative staphylococci predominated in cases of catheter sep
sis (16/20 cases). Postoperative hemorrhage, venous thrombosis and
catheter sepsis each contributed to one patient death and resulted in
significant morbidity in surviving patients. Despite the high incidence

of complications associated with Hickman catheters, patient acceptance
was high, and their use facilitated treatment in a high-risk patient group.

R202
RESTORATIVE PROCTOCOLECTOMY FOR ULCERATIVE
COLITIS AND FAMILIAL POLYPOSIS — THE CALGARY
EXPERIENCE. J.A. Heine (R-II), J.M. Langevin, R.M. Preshaw,
W.D. Wong. Division of General Surgery, Department of Surgery,
Faculty of Medicine, University of Calgary, Calgary, Alta.
Fifty-five patients with ulcerative colitis (51 patients) or familial poly
posis (4 patients) have undergone restorative proctocolectomy employing
either an S or J ileal pouch-anal anastomosis. There were no postoper
ative deaths. Major complications included small-bowel obstruction
requiring laparotomy in two patients (4%) and pelvic abscess in three
patients (5.5%). Minor complications included small-bowel obstruc
tion managed conservatively in 10 patients (18%); “ pouchitis” in 11
patients (20%); and anastomotic stenosis in 12 patients (22%), requir
ing anal dilatation under general anesthesia in 5 patients (9%).
Patients were followed up for a mean of 14.7 months. Fifty-four
patients (98%) could defecate spontaneously and mean stool frequency
was 6.1 ± 1.9 bowel movements per 24-hour period. Four patients (7%)
were having nine or more bowel movements per 24-hour period. M ajor
daytime incontinence was a complaint of two patients (4%). Functional
outcome was judged to be good to excellent in 50 patients (91 %). These
results suggest that restorative proctocolectomy is a viable surgical alter
native in selected patients requiring surgical management of ulcerative
colitis or familial polyposis.

R203
SURGICAL TREATMENT OF CHRONIC PANCREATITIS (CP): 12
YEARS’ EXPERIENCE. B.G. Karam, M.J. Wexler. Department of
Surgery, Royal Victoria Hospital, McGill University, Montreal, PQ
Forty patients with cp underwent 42 operations between 1973 and 1984.
Intractable pain or symptomatic cysts were the primary indications. Fifty
percent were alcoholic, 23% diabetic and 18% had steatorrhea. All
patients had ERCP or operative pancreatogram. Selection of proce
dure was tailored to ductal pathology with attempts to preserve pan
creatic tissue. Late results were classified as A , B or C: “ A ” = com
plete relief of pain, no worsening of pancreatic function (pf); “ B” =
only occasional pain an d /o r controlled pf; “ C ” = failure to relieve
pain or poorly controlled pf. Mean follow-up was 5.6 years. Three
patients developed pancreatic carcinoma and four had late unrelated
deaths. Perioperative mortality and morbidity rates were 2.5% and 15%
respectively. Procedures and results are summarized:

Whipple or total pancreatectomy
40-80% distal resection ±
retrograde drainage (Duval)
Lateral pancreatojejunostomy
Internal cyst drainage
Sphincteroplasty Wirsung
Other

#

A

B

C

3
17

1
3

1
5

5

5
8
8
1

2
5
5

1

1
1

1

Relief of pain without iatrogenic worsening o f p f can be achieved
with 80% success and minimal morbidity and mortality, using a selec
tive approach based on the ductal pathology. Results are poorest when
m ajor resectional procedures are required.

R204
IMPROVED SURVIVAL WITH SURGICAL TREATMENT OF
PANCREATIC ABSCESS. R.G. Keith, J.R. Brow, H. Miller, J.
McKee, R. Reid. Department of Surgery, University of Toronto,
Toronto, Ont.
Twenty-two consecutive patients with pancreatic abscess were treated
by operation designed to preserve maximal pancreatic tissue. Infected
pseudocysts and aseptic necrosis were excluded from this study. All
patients presented with sustained sepsis and nutritional failure; 10
patients had single organ failure and 1 had multiple organ failure (MOF).
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Accurate localization of septic foci was obtained by diagnostic imag
ing; CT scanning proved superior to ultrasound (sensitivity 90%:45%).
Multiple abscesses were identified in 17 cases. Operation in each case
was extensive debridement and drainage of all suppurative necrosis and
abscess, specifically minimizing pancreatic resection. Postoperative
intensive care was supplemented by mechanical ventilation in 9 cases
and total parenteral nutrition in 15 cases.
There were only two deaths: 7 days from MOF; 60 days from
myocardial infarction. Both had multifocal sepsis, preoperative organ
failure but a short interval from diagnosis to operation (1:7 days).
Postoperative complications were common, correlating with multifo
cal sepsis, but not with interval from diagnosis to operation. Fifteen
patients developed 31 complications; 7 required reoperation, 2 for
residual abscesses.
Follow-up of pancreatic function in 20 survivors at mean duration
of 54 months documented preservation of endocrine (16/20 nondia
betic) and exocrine (17/20) function, which correlated with intact whole
organ on scanning (16/20).
Improved long-term survival is possible when debridement surgery
conserving pancreatic parenchyma is effectively combined with inten
sive perioperative care.

R205
THE RESTING ENERGY EXPENDITURE OF THE MORBIDLY
OBESE. L.K. Tin, M. Gagner, H .M . Shizgal, R.A. Forse, L.D.
MacLean. Royal Victoria Hospital, McGill University, Montreal, PQ

Previous reports on the resting energy expenditure (REE) of the mor
bidly obese are inconsistent. This study was undertaken to determine
the effects of obesity on the REE. In 18 morbidly obese patients, body
composition was determined by multiple isotope technique, and the REE
simultaneously measured by indirect calorimetry. Control data were
obtained in 16 normally nourished volunteers. Resting energy expen
diture was expressed as a function of body weight (BW), body surface
area (BSA) and body cell mass (BCM). The degree of obesity was deter
mined using an obesity index (OI) defined as body fat (FAT) per BCM
representing the amount of fat supported for a given BCM.
____________BCM_________ FAT______ REE
C ontrol 24.6 ± 1.6
Obese
30.7 ± 1.4*

16.7 ± 1.3
61.2 + 2.4*

REE/BW

R207
SUTURELESS BOWEL ANASTOMOSIS USING NDrYAG LASER.
C .D . Mercer, B. Pauli. Department of Surgery, Hotel Dieu Hospital,
Queen’s University, Kingston, Ont.

Phase 1: Nd:YAG Laser produced tissue-welded bowel anastomoses in
rabbits. A 0.5-cm enterotomy was closed using sutures or non-contact
laser energy. Small-bowel anastomoses (n = 84) were performed 15
cm apart; bursting pressure (BP) of the occluded anastomotic segment
was measured. Bursting pressures of laser anastomoses less than 300
J were weaker (p < 0.001) than sutured anastomoses. Bursting pres
sures of sutured and laser anastomoses using 300 - 500 J were similar.
Phase II: Enterotomies were closed with sutures or laser at 400 J. All
rabbits (n = 6) recovered without complication. At 7 or 14 days, all
anastomoses were intact. Bursting pressures of sutured (mean 203 ±
7 mm Hg) and laser anastomoses were not different (mean 200 ± 10
mm Hg). Histology demonstrated fibrous union at 7 days but incom
plete mucosal approximation with laser anastomosis. At 14 days, laser
anastomoses were indistinguishable from normal bowel.
Technique

N

Sutures
Non-contact laser

10
7
19
21
20
7

REE/BSA REE/BCM_________ OI

1427 ± 7421.6 ±
1961 ± 77*15.9 ±

0.7
0.5*

789 ± 24
870 ± 6*

*Significantly different from control by unpaired Student’s t-test.
Morbid obesity is associated with an increased REE not only due to
an increased BCM but also and separately due to the degree of obesity.
A multiple linear regression equation was developed and was found to
be significant (p < 0.0001, r = 0.89).
REE = 139.3 ± 47.0 (BCM) ± 180.5 (OI)
(p < 0.0001)
(p < 0.001)
These data indicate that morbid obesity is associated with a hypermetabolic state which is apparent when REE is expressed as a function
of BCM, the metabolically active component of the body. The REE
is related to the size of the BCM and the degree of obesity.

R206
POST NISSEN SYNDROME. D.E. Low, C.D. Mercer, E.C. James,
L.D. Hill. Virginia Mason Medical Center, Seattle, WA.

Introduction: Nissen fundoplication (NFP) is the most common
antireflux operation performed in North America. We reviewed 305
patients who had undergone 356 previous antireflux procedures but
required reoperation for recurrence or complication from 1964 to 1986.
The 116 patients who required reoperation following NFP were specif
ically examined for etiology of failure and complications. Results: Rea
sons for reoperation included recurrent reflux ± stricture (80%), severe
dysphagia (60%) and esophageal dysmotility (48%). Mean time inter
val between failed NFP and remedial surgery was 51.4 months, but mean
time to onset of recurrent symptoms was only 12.8 months. Prior to
the patient’s original NFP, dysphagia was present in 23% compared
to 60% of patients requiring remedial surgery. Analysis at operation
demonstrated the cause of NFP failure to be “ slipped Nissen” (48%),
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patulous repair (21%), complete (16%) and partial (13%) disruption,
in addition to life-threatening complications including gastrobronchial,
gastrocutaneous, gastropericardial and gastroaortic fistulas. Remedial
surgery was individualized; however, most patients underwent Hill
posterior gastropexy. Operative mortality was 2.6%. With a mean
follow-up of 19 months, the overall results were rated excellent/good
(86%), fair (11 %) and poor (3%). Summary: We suggest three reasons
for recurrent symptoms and complications following NFP. (1) The
procedure is done blindly with no attempt at intraoperative LES calibra
tion, (2) it relies on sutures placed in the esophageal muscularis, (3)
the wrap is not anchored and therefore is more prone to migration.
The popularity of the NFP should be tempered due to these weaknesses
in technique and increased risk of recurrence and serious complications.

56.6 ± 1.70.70 ± 0.05
64.7 ± 2.4*2.06 ± 0.10*

Energy (J) Mean BP ± SD (mm Hg)
—

100
200
300
400
500

65.6
29.1
41.3
50.2
64.0
65.0

±
±
±
±
±
±

15.3
6.5
11.9
20.9
25.7
25.8

Nd:YAG Laser tissue welding is an effective method of anastomosing
small-bowel enterotomies in rabbits.
R208
VOLVULUS OF THE COLON: EARLY LOCALIZATION OF SITE
AN ESSENTIAL STEP FOR PROPER MANAGEMENT. E. Farkouh,
M. Allard, H. Atlas, R. Denis. Department of Surgery, Sacre-Coeur
Hospital, University of Montreal, Montreal, PQ

This paper summarizes our experience with this uncommon and seri
ous form of intestinal obstruction over a period of 12 years, pointing
out the importance of early recognition of the bowel segment involved
for the selection of the appropriate treatment. Forty patients with colonic
volvulus form the basis of this study, 24 male and 16 female, average
age 59 years. They were divided into three groups according to site:
1. Sigmoid volvulus (n: 24): Deflation by rectosigmoidoscopy was
attempted on 20 patients. It was successful in 11 patients, and 5 of those
had eventually elective surgery at a later date. Nine patients where defla
tion failed had emergency surgery. Early in the series four patients had
emergency surgery without attempt of deflation endoscopy. The type
of operation used: sigmoid resection and anastomosis in eight, H art
m ann’s procedure in five and simple detorsion in five. In this group
the primary treatment recommended is deflation by rectosigmoidoscopy,
with elective surgery at a later date. 2. Cecal volvulus (n: 13): All patients
had emergency surgery, five had right hemicolectomy, six had detor
sion and cecostomy, and two had cecopexy. 3. Transverse colon vol
vulus (n: 3): Two patients had colon resection and anastomosis; and
one patient had resection and ileostomy.
Groups 2 and 3 should be recognized early and subjected to immedi
ate surgery to avoid early necrosis and perforation. In the three groups,
seven patients died postoperatively (mortality rate 17.5%).
To lower this high mortality rate associated with colonic volvulus,
early localization of the bowel segment involved and the immediate appli-
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cation of the appropriate treatment are essential. On the left side of
the colon deflation endoscopy should be the primary treatment, while
on the right side emergency surgery is the treatment of choice.

R209
IMMUNOSUPPRESSION WITH CYCLOSPORIN A (CsA) DOES
NOT AFFECT RESISTANCE TO MURINE HEPATITIS VIRUS
(MHV-3) IN A /J MICE. M. Abecassis, G.A. Levy, J.A . Falk, L.
Makowka, R.E. Falk. Department of Medicine and Department of Sur
gery, University of Toronto, Toronto, Ont.

It has been recently suggested that CsA is associated with a lower inci
dence of viral infections when compared to conventional immunosup
pressive therapy. These studies were designed to examine whether CsA
alters innate T-cell dependent resistance to MHV-3 infection in the fully
resistant A /J mouse. Mice, 6 - 8 weeks of age, were treated daily with
cyclophosphamide (CY — 75 mg/kg), methylprednisolone (MP — 500
mg/kg) or CsA (50 mg/kg) and were infected with MHV-3. Trough
serum CsA levels were measured by radioimmunoassay 12 hours
(4830 ± 650 ng/ml) and 24 hours (628 ± 315 ng/ml) following adminis
tration, and CsA, at this dosage, prevented rejection of allogeneic skin
grafts. Infected mice treated with CsA developed specific antibody (IgM
and IgG) to MHV-3 and demonstrated no biochemical or histologic
evidence of liver disease. In contrast, infected mice immunosuppreseed
with either CY or MP developed both histologic and biochemical evi
dence of fulminant hepatitis associated with failure to produce anti
body to MHV-3 and 100% mortality. These results suggest that CsA
does not alter innate resistance to MHV-3 in A /J mice, whereas
immunosuppression with either CY or MP results in conversion of
resistance to susceptibility. We conclude that the increased incidence
of viral infections associated with the use of CsA may be related to
the concomitant use of other immunosuppressive agents.

R210
UTILITY OF INTRAOPERATIVE ULTRASONOGRAPHY IN THE
SURGICAL TREATMENT OF HEPATIC TUMOURS. R. Lapointe,
M. Lafortune, L. Lapointe, R. Dery, P. Lavoie. Department of Sur
gery and Department of Radiology, Hopital Saint-Lue, Universite de
Montreal, Montreal, PQ

Intraoperative ultrasonography was performed in 14 patients with var
ious liver tumours: 9 colorectal metastasis, 3 nodular focal hyperpla
sia, 1 hepatoma and 1 primary hepatic cystadenocarcinoma. All patients
had preoperative work-up including ultrasonography of the liver as well
as computerized tomography of the liver (13 patients) and selective
hepatic arteriography (12 patients). At surgery, various kinds of liver
surgery were carried out on these 14 patients after inspection, palpa
tion and operative ultrasound examination of the liver had been per
formed; segmentectomy in 4, hepatic lobectomy in 4, subsegmentectomy in 2 and biopsy in 4. Intraoperative ultrasonography proved to
be a useful method not only for revealing and permitting guided biopsy
of unsuspected preoperative tumours deep in the hepatic parenchyma
but also for establishing the exact relationship between the vascular struc
tures and the tumour. It is therefore an important exploration mean
for therapeutic decision in liver surgery.

R211
SEPTIC STRESS AN D THE ADIPOCYTE BETA-1 ADRENERGIC
RECEPTOR. D. St. Vil, M. Gagner, R.A. Forse. Royal Victoria Hospi
tal, McGill University, Montreal, PQ

Catecholamine exposure results in down-regulation of beta-adrenergic
receptors (decreased response to stimulation in vitro). The object of
this study was to determine if there were differences in the downregulation of beta-1 receptors of adipose tissue from septic patients who
survived (SURV) and those who died (NON-SURV). The adipose tis
sue was biopsied from the abdominal wall and the intestinal mesentery
during open abdominal dressing for peritonitis. Normal tissue was biop
sied during elective surgery (Normal). Lipolysis was measured using
an in-vitro dual isotope technique and expressed below as the lipolysis
factor (LF). The beta-1 receptors were stimulated with isoproterenol
(ISO). The maximal LF at any concentration was recorded as the Vmax
The results are:

ISO
Mesentery
Normal
SURV
NON-SURV

5.3 ± 2.7
5.6 £ 5.6
18.0 ± 2.1*

22.1 £ 7.3
26.4 ± 9.3
16.4 ± 5.2

51.3 £ 9.0
43.7 ± 25.3
5.9 ± 2.3*

50.7 ± 4.5
38.3 £ 14.0
10.4 £ 8.4*

43.6 £ 5.8
34.0 £ 9.6
7.4 £ 6.2*

62.1 £ 7.9
53.4 £ 23.2
21.2 £ 0.4*

Abdominal wall
Normal
SURV
NON-SURV

7.6 ± 4.6
12.6 £ 4.9
0.3 ± 3.2*

17.8
27.7
14.2

40.5 £ 6.2
46.4 £ 15.3
16.5 ± 4.2*

39.1 £ 4.6
42.4 £ 15.3
20.4 £ 12.3*

40.0 £ 7.4
42.3 £ 9.2
7.1 £ 6.9*

48.4 £ 6.5
53.1 ± 23.2
25.5 £ 9.9*

± 4.4
£ 7.3
± 6.8

’ Significantly different from normal by analysis o f variance.

The LF at each ISO concentration and the Vmax were significantly
decreased in the NON-SURV, reflecting the degree of catecholamine
stimulation. The APACHE II and APS scores were similar between
SURV and NON-SURV. The data thus indicate that the beta-1 recep
tor of adipose tissue can provide an early measure of septic stress and
be an early indicator of septic outcome.

R212
RESULTS OF PARKS’ SPHINCTEROPLASTY FOR POST T R A U 
MATIC ANAL INCONTINENCE. S. Morgan, D. Bernard, D. Tasse,
R. Wassef. Department o f Surgery, University of M ontreal, Division
o f Gastrointestinal Surgery, Hopital St-Luc, Montreal, PQ

Surgical and obstetrical trauma is one o f the commonest causes of fecal
incontinence. Controversy still exists as to the type o f repair and the
need for a tem porary diverting colostomy. We report on 45 patients
(40 F, 5 M): 17 (38%) had one or more previous attempts at repair.
Duration of incontinence following obstetrical trauma averaged 13 years
versus 4 years following other traum a. Diverting colostomy was estab
lished in every patient either shortly after the traum a for .he inconti
nence or immediately before attempting repair and was closed 3 months
after the repair in every case. Sphincteroplasty was performed accord
ing to Parks’ technique by dissection o f the sphincters over half o f its
circumference, dividing the centre of the fibrotic ring, and doing an
overlapping type o f repair and leaving the wound open for secondintention healing. There was no mortality. Results for incontinence were
judged good to excellent in 82%, fair in 9% and failures in 9% (four
cases). Three o f the failures were repaired according to the same tech
nique and the result was excellent in two and fair in the other. Previous
reports mentioned three factors o f increased risk o f failure: age > 65,
previous repairs and over 10-year duration of incontinence. Assessment
of these risk factors reveals no difference in our results, possibly because
of the presence o f a colostomy. The rate of failures was significantly
higher in the first 15 cases (47%) than in the last 30 (3%) (p < 0.01).
Sphincter repair following Parks’ principles is sound; a colostomy is
recommended after major traum a or sepsis and should be considered
when risk factors of failure are present.

R213
THE RESULTS OF TREATMENT USING COMPOSITE RESEC
TION IN PATIENTS WITH SQUAMOUS CELL CARCINOM A OF
THE ORAL CAVITY FOLLOW ING FAILED IRRADIATION
THERAPY. R.E. Robins, S. Schlagentweit. Cancer Control Agency
of British Columbia and University o f British Columbia Medical School,
Vancouver, BC

In our institution, the majority of patients with T1 and T2 NO and
selected T3 and T4 NO squamous carcinoma of the oral cavity receive
irradiation as primary therapy. There is close follow-up and surgical
treatment for failure or recurrence. A retrospective study of 98 con
secutive patients undergoing composite resection from 1971 to 1983 was
done to determine and compare treatm ent results in those irradiated
(76) and the total group including non-irradiated (22) patients. In the
22 patients treated primarily by composite resection, 21 had T3 or T4
lesions. All were followed at least 2 years and 84% more than 3 years.
A computer-assisted analysis of the data was performed yielding product
limit and actuarial survival curves.
The commonest sites were floor of mouth (35), tongue (19) and lower
alveolus (19). There was no significant difference in the overall sur
vival between the irradiated and total group. The 2, 3 and 5 years’ sur
vival for all patients was 58%, 56% and 48%; for irradiated patients
56%, 54% and 47%. There was also no difference in the behaviour
of the irradiated group as compared to the total in comparison of tumour
size, positive margins or node status. In both groups, 25% had posi
tive margins at surgery. This was followed by ultimate failure as at 3
years there were no survivors with positive margins; for clear margins
there was 70% survival at 3 years and 61 % at 5 years. One-half of both
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groups had positive cervical nodes. Three and 5 years’ survival with
negative nodes was 65% and 61%; with positive nodes 46% and 37%.
The level o f nodal involvement was highly significant.

R214
SPECIFIC AND NONSPECIFIC IMMUNITY IN THE RESPONSE
TO PSEUDOMONAS INFECTION FOLLOWING THERMAL
INJURY. J.C. Marshall, H. Rode, D . Eshelby, J.L. Meakins, N.V.
Christou. Department o f Surgery, Royal Victoria Hospital, McGill
University, Montreal, PQ

The role of specific and nonspecific immune mechanisms in the response
to pulmonary infection with Pseudomonas following thermal injury was
studied in a rat model. Male Lou/Lewis rats (mean weight 320 g), presen
sitized to keyhole limpet hemocyanin (KLH), underwent a 30% TBSA
scald burn or sham burn. Twenty-four hours later, animals were
immunized IP with 10s heat-killed Pseudomonas aeruginosa. Seven
days following immunization, blood was drawn for assay of specific
anti-Pseudomonas IgG antibody using an ELISA to whole organisms,
then animals were challenged intratracheally with 2 x 10® CFU live
Pseudomonas. Animals were sacrificed 24 hours later, and the right
lung was homogenized for quantitation of residual numbers of viable
Pseudomonas. The mean diameter (mm) of the delayed-type hypersen
sitivity (DTH) response to recall skin testing with KLH was used as a
measure o f nonspecific immune responsiveness following the burn.
Specific anti -Pseudomonas IgG was expressed in units/ml measured
against a standard serum arbitrarily defined to have 10 U/ml of activity.
Results follow (mean ± SEM).

Group
Controls
Burn

24 h
DTH

72 h
DTH

6.8±0.3
1.8±0.5a

10.2±0.2
3.6±0.5a

1 wk
DTH

Amipseudo IgG

Log10 CFU
pseudo/ml

9.0 + 0.3 69.5±11.0
4.2±0.3a 61.5± 7.7b

1.97±0.1
2.30±0.1°

ap < 0.001, bNS, cp = 0.01.

A 30% TBSA burn injury produced marked and persistent impair
ment of nonspecific host defences; in contrast specific anti -Pseudomonas
antibody production was normal. Pulmonary clearance of a bacterial
challenge was depressed, despite an intact humoral immune response.

R215
SURGERY FOR CHRONIC CONSTIPATION. J. Engel, J. Duff, D.
Grant, B. Taylor. Department o f Surgery, University of Western
Ontario, London, Ont.

We reviewed 25 patients who underwent surgery between 1976 and 1986
for severe disabling constipation not controlled by laxative and enema
regimens. There were 22 females and 3 males with a mean age of 43
years (range 5-86). They had an average of 1.2 bowel movements per
week (range 0-7 ). Additional symptoms included abdominal bloating
22 (88%), abdominal pain 20 (80%), straining at stool for greater than
5 minutes 14 (56%) and nausea 14 (56%). The preoperative diagnosis
was colonic inertia in 23 (92%) and anal sphincter spasm in 2 (8%).
Barium enemas performed in 22 patients showed: no abnormality - 8,
megacolon - 7, dolichocolon - 6. Transit studies demonstrated colonic
inertia in 14 and outlet obstruction in 2 patients.
The following operations were performed: subtotal colectomy with
ileorectal anastomosis - 15 (60%), total colectomy with ileostomy - 4
(16%), subtotal colectomy with ileosigmoid anastomosis - 3 (12%),
extended internal sphincterotomy - 2 (8%) and partial colectomy with
cecorectal anastomosis - 1 (4%). The mean follow-up was 19 months
(range 1 - 6 0 months). Adhesive small-bowel obstruction occurred in
five (20%) patients; three required reoperation. Constipation was com
pletely relieved in 14 (56%) patients. Ten (40%) patients were improved:
7 (28%) required regular laxatives and 3 (12%) required occasional lax
atives. One patient remained constipated following an extended inter
nal sphincterotomy. No one suffered from disabling diarrhea.
We conclude that total colectomy alleviates disabling constipation
due to colonic inertia.
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R216
H U M A N COLONIC M UCIN IN INFLAM M ATORY A N D
NEOPLASTIC DISORDERS. B.E. Lukie. Department of Physiolog
ical Sciences, University o f Newcastle-Upon-Tyne, UK

A mucus alteration of unknown significance has been observed in
neoplastic and inflammatory disorders of the colon. The objective of
this work was to characterize the molecular size distribution of this
abnormal mucus. Mucus obtained from fresh colectomy specimens was
solubilized and analysed by Sepharose CL-2B gel filtration chromatog
raphy. Two glycoprotein peaks were regularly observed: a high molecular
weight peak (mucin) which eluted at the void volume and extended to
the initial included volume; a late-eluting low molecular weight peak
(LMWP) o f higher protein content. The distribution of glycoprotein
between these two peaks was unaffected by prior heating at 100°C for
10 minutes, incubation at 37°C for 48 hours or 10“ 3M phenylmethylsulfonyl fluoride. Both ulcerative colitis (UC) and cancer (CA) sam
ples showed an increase in LMWP protein content when compared to
a mucus from a patient with sigmoid volvulus. Mucin subunit which
elutes between the mucin and LMWP peaks was not seen in any of the
CA samples but was present in one of the two UC samples studied.
Thus, CA and UC mucus are associated with an increased protein con
tent of the LMWP. Mucin subunit formation was not detected in CA,
but may be a feature o f some cases of UC.

R217
MANAGEMENT OF MALIGNANT COLORECTAL POLYPS. D.
Bernard, S. Morgan, D. Tasse, R. Wassef. Department of Surgery,
University of Montreal, Division of Gastrointestinal Surgery, Hopital
St-Luc, Montreal, PQ

Management of patients with endoscopically removed malignant intes
tinal polyps remains controversial. The risk of residual disease, esti
mated at 10.1% by Wilcox (Cancer 1986; 57: 160-171) should be assessed
against the risk of a surgical operation. We report 30 cases of malig
nant polyps (7.3% of 409 colonoscopically removed adenomas). Four
teen contained carcinoma in situ and had no further treatment and 16
had invasive carcinoma (5 sessile, 11 pediculated). Among these 16, 5
were not submitted to surgery: because of old age in 1, minimal inva
sion in 3 and low rectal location in the other. Eleven (3 sessile, 8 pedic
ulated) underwent surgical resection and residual disease was present
in 3 (27%), 1 with positive nodes. Reported criteria of increased risk
of residual disease — CA in lymphatics or veins, incomplete excision,
tumour at resection margin, sessile and villous — were present in seven.
All three patients with residual disease had one or more of these criteria
in their malignant polyps. Evidence of residual disease (10.1%) in the
colonoscopy era studies comes from 14 series (Cancer 1986; 57:160-171),
such as this one, totalling 188 cases. The presence of criteria of increased
risk justifies surgical resection unless the patient is an otherwise poorer
operative risk.

R218
SCINTIGRAPHIC BALLOON PROCTOGRAPHY FOR ASSESS
MENT OF SEVERE CONSTIPATION. M .E. Pezim, J.H . Pember
ton, S.F. Phillips. Department of Surgery and Gastroenterology Unit,
Mayo Medical School, Rochester, MN

To determine why some constipated patients remain unchanged fol
lowing colectomy and ileorectal anastomosis, we examined the role of
the anorectal angle during defecation. Method: Fourteen subjects (5
healthy controls, 9 severely constipated patients) were studied at rest
and during defecation with an intrarectal balloon probe containing 5
mCi 99mT c0 4- in 70 ml water, imaged by gamma camera. Patients in
Group A (n = 5) often used digital evacuation or perineal compres
sion to facilitate defecation. Patients in Group B did not. Results: Group
A differed significantly from both controls and Group B by having a
more acute resting anorectal angle, and a reduced ability to straighten
the angle during defecation. In contrast, Group B resembled controls
in both resting and defecation anorectal angles.
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Table: Anorectal Angle (°) (Mean ± SEM)
Control
Group A
Group B

Rest

Defecate

Change

113 ± 4
101 ± 4*
118 ± 5

133 ± 5
109 ± 4
142 ± 6

20 ± 4
8 ± 2**
23 ± 2***

Feeding was started 3 days after Stamm and 24 hours after PEG,
initially elemental diet, progressed to non-digested liquid diet. “ Pull”
PEG requires removal and reinsertion of the scope, and drags oral bac
teria through abdominal wall which may account for peritubal infec
tions. Percutaneous endoscopic gastrostomy was less costly than Stamm;
“ push” PEG was simpler, faster and safer.

*Group A vs Group B rest; p = 0.02.
**Group A vs control change; p = 0.02.
***Group B vs control change; NS.
Conclusion: Scintigraphic balloon proctography differentiates consti
pated patients into two groups. Patients unable to straighten their
anorectal angle during defecation have an expulsion disorder which
would persist following colectomy. Those with normal anorectal angle
dynamics have a colonic motility disorder for which colectomy is
rational. Scintigraphic balloon proctography appears to be an impor
tant too! in selecting patients for appropriate surgical treatment.

R219
STRICTUREPLASTY FOR CROHN’S DISEASE. P.J. Whelan, F.G.
Saibil, L.B. Cohen, A .W . Harrison. Division of General Surgery and
Gastroenterology, Sunnybrook Medical Centre, University of Toronto,
Toronto, Ont.

The threat of short-bowel syndrome secondary to resectional surgery
for Crohn’s disease has led us to test the safety and efficacy of stric
tureplasty for the obstructive complications of C rohn’s disease.
In the past 21 months we performed strictureplasties on eight patients
with Crohn’s disease. The main indication for operation in all was
chronic obstruction. Six patients had a history of previous bypass and/or
resection.
Thirty-two strictureplasties have been carried out, encompassing 55
strictures. Two of the eight patients underwent limited resection con
currently with multiple strictureplasties.
The length of follow-up ranges from 4 to 21 months. One patient
has required reoperation for recurrence of an enterovesical fistula. Two
patients had evidence of postoperative leaks; both responded to con
servative management. All patients are able to ingest a full, normal diet
despite discontinuation of steroids. The nutritional status of all patients
has improved or continued in the normal ranges as determined by body
weight, serum protein and hemoglobin.
Strictureplasty is a safe and effective therapy for C rohn’s disease.

R221
EFFECTS OF PROLONGED INTESTINAL TRANSIT TIM E ON
BILIARY LIPIDS IN THE PIG. N . Causton, O. Thurston, K. Walker.
The Surgical-Medical Research Institute, University o f Alberta, Edmon
ton, Alta.

Previous studies indicate that cholesterol saturation of bile is associated
with prolonged intestinal transit time (so-called colonic stasis) charac
teristic of populations eating a low-fibre/high-refined-carbohydrate diet.
This study was undertaken to determine the effect o f prolonged intes
tinal time on biliary lipids (cholesterol, phospholipid and total bile salts).
Young domestic pigs weighing 10 - 30 kg had an antiperistaltic loop
of colon fashioned to prolong intestinal transit time mechanically, as
measured by the passage of radiopaque markers. Gallbladder bile for
determination o f biliary lipids was obtained by needle aspiration at
celiotomy prior to reversal of a 10- to 35-cm colonic segment and at
4 and 8 weeks after reversal. The number of animals studied at 0, 4
and 8 weeks was 19, 13 and 9 respectively. The animals were on a
cholesterol-free diet throughout the study.
Intestinal transit time in control animals was 53.5 ± 23.1 hours (x
± SEM) and was 175.2 ± 22.1 hours in animals with a reversed colonic
segment (p < 0.001). Cholesterol saturation index o f bile was 0.40 ±
0.03 in the control period and 0.38 ± 0.03 and 0.33 ± 0.02 at 4 and
8 weeks after colonic reversal. None of the observed differences was
statistically significant.
Under the conditions of this study a marked prolongation o f intesti
nal transit time did not increase the cholesterol saturation index o f gall
bladder bile. This result does not support the commonly held belief that
prolonged intestinal transit time is a factor leading to cholesterol gall
stone formation.

R220
PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (PEG) BY THE
“ PULL” A N D “ P U SH ” METHODS. M. Deitel, T. To, E. Spratt,
C. Burul. Department of Surgery and Department o f Nutritional
Sciences, University o f Toronto, St. Joseph’s Health Centre, Toronto,
Ont.

After 28 patients studied prospectively underwent PEG by the Ponsky
“ pull” technique, a subsequent 28 patients underwent PEG by the Rus
sell “ push” technique. These were compared with the prior 28 patients
retrospectively who had undergone Stamm gastrostomy as an indepen
dent operation by the same group of surgeons. All procedures were done
within a 4-year period. “Pul!” Method: After gastroscopic insuffla
tion, a suture or guidewire passed through a Medicut was snared and
secured to the end of a phlanged 14F mushroom tube which was pulled
retrograde out the abdominal wall. “Push” Method: Through a nee
dle, a guidewire was inserted over which a dilator-sheath was rotated;
the dilator was removed, and a lubricated 14F Foley was pushed through
the intragastric-viewed sheath which was peeled away.

R222
THE EFFECT OF CYCLOSPORINE ON LIVER REGENERATION.
R. Black, D. Grant, R. Zhong, W. Wall, P. Keown, J. D u ff. Depart
ment of Surgery and Department o f Medicine, University o f Western
Ontario, London, Ont.

Liver regeneration can be critical to the success of orthotopic liver trans
plantation when the donor organ has been compromised. Many drugs
interfere with liver regeneration. The present study examined effect of
oral cyclosporine (CsA) on liver regeneration. Thirty-two male SpragueDawley rats were placed into four groups after a standard 70% hepatectomy. The rats were sacrificed on the 10th postoperative day, and the
following were measured: hepatic regenerative rate (RR), total food
intake (FI) and the change in body weight (BW).
Treatment
Group
Group
Group
Group

1
2
3
4

Olive oil
CsA 10 m g /k g /d
CsA 20 m g /k g /d
Olive oil/pair-fed
with Group 4

RR
105%
104%
87 %*
86% *

BW

FI
186
159
124
124

g
g
g*
g*

+ 13%
+ 9%
- 5%*
- 3%*

Table: (n = 28 per group)

Stamm

“ Pull”
PEG

“Push”
PEG

Age (x ± SD yr):
Use: Neurologic diseases
Pharyngeal blockage
Cachexia, respiratory,
burn
No. under local anesthesia:
Time for procedure (min):
Wound infection:
Death within 30 days:

68 ± 12
15
3
10

69 ± 14
16
4
8

73 ± 15
14
6
8

* = p < 0.05 compared to Group 1.
The correlation coefficient between FI and RR was +0.75 (p < 0.001).

5
55 ± 7 p < 0.001
5
4

13
27 ± 8 p < 0.001
6
2

17
16 ± 3
0
2

We conclude: (1) there is a significant correlation between FI and
liver regeneration, (2) low-dose CsA does not impair liver regeneration,
(3) high-dose CsA indirectly impairs liver regeneration by inducing
anorexia.
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R223
LONG-TERM RESULTS OF ENDOSCOPIC SCLEROTHERAPY
FOR BLEEDING ESOPHAGEAL VARICES: EFFECTIVENESS,
COMPLICATIONS, AN D SURVIVAL. R.J. Tabah, M.J. Wexler,
A .P .H . McLean. Department of Surgery, Royal Victoria Hospital,
McGill University, Montreal, PQ

Endoscopic sclerotherapy as initial and primary treatment of sympto
matic esophageal varices in 77 consecutive, unselected patients over a
6-year period is reviewed in order to define the effectiveness, compli
cations and survival associated with this form of treatment. Each of
the 186 individual sclerotherapy sessions was performed through a
Williams overtube under general anesthesia. Alcoholic cirrhosis was
present in 69%. O f those with cirrhosis, 41 % were classified as Child’s

C. No specific additional treatment other than repeat sclerotherapy was
required in 58%. Only 23% ultimately required surgery for control of
recurrent variceal hemorrhage. The rate of rebleeding following an
individual sclerotherapy session was 29%. Forty-one percent of recur
rent bleeding occurred within 1 week following sclerotherapy. Com
plications directly attributable to sclerosis were generally mild and well
tolerated. These included superficial esophageal ulceration (11.8%) and
fever (25%). Deep esophageal ulceration was observed in 17% of
patients. Two deaths were directly attributable to sclerotherapy. Lifetable analysis resulted in a 3-year survival of 71%, 63% and 27% in
Child’s A, B and C patients managed under our protocol. Major causes
o f death included hepatic failure, sepsis and hemorrhage. We believe
that endoscopic sclerotherapy as performed under general anesthesia
is a safe, effective means of initial and long-term management of the
patient with bleeding esophageal varices.

Canadian Society for Vascular Surgery
R523
CAROTID ENDARTERECTOMY: LATE RESULTS. C.R. Lye.
University of Manitoba, Health Sciences Centre, Winnipeg, Man.

The late results of carotid endarterectomy have been assessed in a con
secutive series of 380 patients who underwent 444 carotid repairs between
1975 and 1986. Follow-up to date, subsequent stroke or death was
obtained in 357 patients (94%).
There were 49 late deaths (30 cardiac, 7 cerebral), with a 7-year
cumulative survival (life-table method) of 68.4%. There have been 18
late strokes (7 fatal), of which 3 were ipsilateral to the original repair.
Cumulative freedom from all stroke events (including operative stroke)
at 1, 4 and 7 years was 94%, 90% and 81% respectively. Freedom from
fatal or disabling stroke at the same intervals was 97%, 96% and 89%
respectively. Only three patients have experienced late disabling nonfatal strokes.
Late angiograms have been obtained in 53 patients and have demon
strated occlusion (5) and restenosis (6) o f the original repair as well as
marked progression of disease in the opposite carotid (13).
Repair of recurrent stenosis was carried out in four patients, two of
whom presented with recurrent symptoms. Late contralateral repair was
performed in 13 patients, 8 of whom were symptomatic.
Although many patients die with intercurrent coronary artery dis
ease, carotid endarterectomy can result in prolonged freedom from dis
abling stroke. Late recurrent stenosis is less frequent and troublesome
than contralateral disease progression.
R524
INFLUENCE OF SIZE ON SURVIVAL AFTER RUPTURED
ABDOMINAL AORTIC ANEURYSM REPAIR. J.L. Murphy, G.G.
Barber, N.V. McPhail, T.K. Scobie. Division of Vascular Surgery,
Ottawa Civic Hospital, Ottawa, Out.

One hundred and seventy-two consecutive patients underwent repair
of ruptured abdominal aortic aneurysms (AAA) between 1970 and 1985.
There were 146 males and 26 females with an average age of 69.8 years.
The overall mortality rate was 49.4%. Fourteen of 51 variables were
clinically and statistically important, the most significant being urine
output under 100 ml in the Operating Room, hypotension ( < 90 mm
Hg) in the OR, arrest, history of collapse and initial systolic BP (<
90 mm Hg). Discriminant analysis correctly classified 90.2% o f sur
vivors with a false ( + ) rate of 9.8% and 83.7% of nonsurvivors with
a false ( - ) rate of 16.3%. The principal contributors (F > 4) to the
prognostic formulae were parameters of shock, not age or associated
cardiopulmonary disease.
Size was documented in 133 aneurysms. Thirteen (9.8%) were less
than 6.0 cm and 23 (17.8%) were 6.0 cm or less, while the average size
of the larger (> 6.0 cm) AAA was 9.51 cm. The 13 smallest aneurysms
( < 6.0 cm) were correctly diagnosed initially in only 46.2% compared
to 76.7% overall (p < 0.05) and the time from arrival in the hospital
to the Operating Room was 6.71 versus 2.37 hours for the rest (p <
0.05). The mortality for these small aneurysms was 76.9% compared
to 45.0% for the remainder (p < 0.06). Small aneurysms were known
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to be present prior to rupture in 8/23 (34.8%) of cases, including 5/10
aneurysms measured at 6.0 cm.
This review confirms the continuing poor results after ruptured
abdominal aortic aneurysm repair and supports a more aggressive
approach to diagnosis and treatment including abdominal aortic
aneurysms between 4.0 and 6.0 cm in size.
R525
THE SELECTIVE MANAGEMENT OF SMALL ABDOMINAL
AORTIC ANEURYSM WITH SERIAL ULTRASOUND SIZING.
J.R . Gutelius, R. Pattenden, P.M . Brown. Division of Vascular Sur
gery, Department of Surgery, Queen’s University and Kingston General
Hospital, Kingston, Ont.

Management of the small asymptomatic abdominal aortic aneurysm
is controversial. The authors have attempted to clarify this problem
by a sizing program for all patients with asymptomatic aneurysms less
than 5.0 cm in diameter.
In the past 6 years, 163 patients have entered the sizing program.
After the initial ultrasound, repeat studies were done on a 6-month basis.
Operation was performed if the aneurysm became symptomatic,
increased more than 0.5 cm in diameter in 6 months, or reached 5 cm
in greatest AP or lateral diameter. Twenty-eight patients have required
surgery for symptoms (3), increase of greater than 0.5 cm in 6 months
(5), and size of greater than 5 cm in diameter (20). There were no oper
ative deaths and no patients ruptured prior to surgery. The operative
patients were followed a mean duration of 17 months prior to surgery
with a yearly increase in size of 1.1 cm.
One hundred thirty-five patients have been followed without surgery.
Eighty-five of these patients have had two or more documented sizings
with an average follow-up of 24 months. The mean yearly increase in
size in this group was 0.2 cm. No ruptures occurred and there were only
two deaths (CA of esophagus and myocardial infarction). Five patients
were lost to follow-up.
Abdominal aortic aneurysm with a diameter of less than 5.0 cm can
safely be followed. Even low-risk patients may be optimally managed
conservatively and followed with serial ultrasounds with minimal risk
o f rupture.
R526
POPLITEAL ANEURYSMS: AN INDEX OF GENERALIZED VAS
CULAR DISEASE. A.M . Thijssen, G.G. Barber, N.V. McPhail, T.K.
Scobie, C. Wm. Cole. Division of Vascular Surgery, Ottawa Civic
Hospital, Ottawa, Ont.

Experience with 59 popliteal aneurysms in 38 patients, accrued over
10 years, was reviewed. Information is complete for 31 patients (50 legs)
available for follow-up or who were followed until they died. Seven
patients were lost to follow-up after several months and are included
only so far as reliable information is known. Age at presentation ranged
from 93 to 39 with the median age of patients with unilateral aneurysms
being 5 years younger than those with bilateral disease (67 versus 72).
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There was only one female. Associated vascular pathology was noted
with increasing frequency as age progressed including the development
of a second popliteal aneurysm in patients presenting initially with
unilateral findings. Two such patients were found to have developed
an aneurysm in the opposite leg on subsequent follow-up 5 and 7 months
after initial treatment. Seventeen patients with unilateral popliteal
aneurysms remain asymptomatic with respect to the opposite leg, but
the follow-up experience is considerably shorter than for the group who
presented with bilateral disease. Initial management consisted of a bypass
graft in 34/59, immediate amputation in 9/59, while 16/59 unreconstructable but viable limbs were treated without surgical intervention.
Bypass material was ePTFE in 2/34 and saphenous vein in the
remainder. Thirty of 34 grafts were patent at last follow-up or were
determined to be patent at the time of death. Four grafts occluded, one
in the perioperative period and the others at 4, 5 and 32 months result
ing in three amputations, only one o f which was below-knee. These
data illustrate that popliteal aneurysms may serve as a gauge of gener
alized vascular disease, with a higher probability of occlusive as well
as aneurysmal disease in other vessels when bilateral.
Vascular Pathology Associated With Popliteal Aneurysms
No. of patients
Age (median)
Follow-up (median)
Ml
CABG
Stroke
AAA
Fem/iliac aneurysm

17 (unilateral)
67
21 (range 1-95 mo)
24 (%)
6
12
24
18

21 (bilateral)
72
35 (range 1-96 mo)
33 (%)
10
19
38
29

R527
THE RATE AND DISTRIBUTION OF BLOOD FLOW FOLLOW
ING PROLONGED SKELETAL MUSCLE ISCHEMIA. I. Forrest,
T. Lindsay, A. Romaschin, I). Mickle, P. Walker. Division of Vascu
lar Surgery, Toronto General Hospital, Toronto, Ont.
The pattern of muscle blood flow upon re-establishment of circulation
to the lower extremity, following an acute arterial occlusion, is unclear,
and yet may determine the extent o f resulting necrosis. The purpose
of this study was to document total blood flow and its distribution within
the muscle, following prolonged periods of ischemia. The bilateral canine
gracilis muscle preparation was used. Total blood flow was measured
by timed venous collections. Distribution of blood flow was determined
using a multiple microsphere technique. Measurements were made
preischemia and during the reperfusion phase at 3, 18, 33 and 48 minutes
following 4 (n = 8) and 5 (n = 8) hours of ischemia. Necrosis was
quantitated using nitroblue tetrazolium staining in conjunction with com
puterized planimetry. The muscles were divided into six slices and blood
flow to each slice, as well as to the alive and dead portions, was calcu
lated.
We demonstrated that preischemic flow is homogeneous through
out the muscle (4.4 ± 0.02 m l/m in/100 g). On reperfusion, total flow
was 6-10 times higher and the distribution was preferentially to the mid
dle slices. Blood flow in each slice was correlated to necrosis (r = 0.4)
(p < 0.05). The degree of reactive hyperemia was greater following
4 hours of ischemia than 5 hours (12.5 cc/m in/100 g versus 20.3
cc/min/100 g, p < 0.05) but there was no correlation between blood
flow to alive versus dead portions, in each slice (p = NS).
We conclude that upon reperfusion muscle blood flow is no longer
homogeneous. The rate of reactive hyperemia is inversely related to the
length of ischemia. The extent of returning blood flow may not be the
sole predictor of muscle viability.

cefamandole (CFM) during the surgical procedure. One gram of antibi
otic was infused over 1 5 - 2 0 minutes beginning 60 minutes prior to
surgery. Aortic blood (for preclotting the Dacron graft), a biopsy of
the aorta at the proximal anastomosis and soft tissue from the region
of the distal anastomosis were obtained at approximately 100, 115 and
150 minutes respectively, after initiating the antibiotic infusion. Results
are shown below:
Mean Concentration ± SE of Antibiotic (gg/ml Tissue Fluid)
Serum at
Tissue, distal
preclotting graft
A orta
anastomosis
(90-100 min)
(115-120 min) (140-150min)
Cefazolin, n = 16
Cefamandole, n = 7

43.3 ± 6.7
23.0 ± 4.9

16.0 ± 3.6
8.7 ± 1.9

15.2 ± 3.2
3.7 ± 0.8

Excluding isolates of S. hemolyticus, both CFZ and CFM were gener
ally bactericidal for CNS. However, CFM was two- to fourfold more
active on a weight basis with an MBCjo of 1.0 gg/ml whereas the
MBCgo for CFZ was 4 ng/ml. Despite lower serum and tissue concen
trations as compared to CFZ, CFM should be further evaluated as
prophylaxis during vascular graft procedures since serum or tissue concentration/MBC90 ratios suggest that CFM is an equivalent or superior
drug as compared to CFZ. The results of an ongoing randomized com
parison, including quantitative and qualitative cultures of graft material
will be presented.
R529
IS AORTOPROFUNDA BYPASS A SUCCESSFUL OPERATION
FOR MULTILEVEL OCCLUSIVE DISEASE? P.G. Kalman, M. Rae,
K.W. Johnston, P.M . Walker. Division of Vascular Surgery, Toronto
General Hospital, Toronto, Ont.
Proximal reconstruction is performed first in patients with combined
aortoiliac and femoropopliteal occlusive disease. Profundoplasty of vari
able length, however, may be required for providing adequate outflow.
The purpose of this study was to determine whether aortoprofunda
bypass is successful for multilevel occlusive disease. A ortoprofunda
bypass was performed in 121 patients for disabling claudication (66%)
and limb salvage (34°7o). The superficial femoral artery was occluded
in 73% and diseased but patent in 27%. Fifty-seven (47%) had bilateral
and 64 (53%) had unilateral profundoplasties — local in 16%, inter
mediate (past one perforator) in 40%, and extended (past three perfo
rators) in 44%. The cumulative graft patency, clinical success (patent
and clinically improved) and hemodynamic success (patent and improved
ankle/brachial index) were determined by life-table analysis (see table).
Cumulative (%)
at 5 years
G raft patency
Clinical success
Hemodynamic success

97% *+
77%*
67% +

Standard Error
(%)
1.3%
5.2%
5.9%

*, + p < 0.01, log rank test.
There was no significant difference in success when patients were
stratified for sex, preoperative grade (disabling claudication versus limb
salvage), type o f proximal anastomosis and extent of profundoplasty.
No patients underwent concomitant distal revascularization and only
four subsequent infrainguinal bypasses were required.
In conclusion, aortoprofunda bypass is a successful operation for
the management o f multilevel peripheral occlusive disease with very few
patients requiring subsequent distal revascularization. Despite continued
patency, gradual subjective and objective deterioration occurs secon
dary to progression of disease.

R528
EVALUATION OF CEFAZOLIN AND CEEAMANDOLE TISSUE
CONCENTRATIONS DURING AORTOFEMORAL BYPASS
GRAFT PROCEDURES. A. Downs, T. Louie, C. Lye, D. Howard,
G. Gray, H. Fong, W. Krulicki. Department of Medicine, Department
of Medical Microbiology and Department of Surgery, University of
Manitoba, Winnipeg, Man.

FACTORS INFLUENCING RESULTS OF 136 ARTERIAL RECON
STRUCTIONS FOR LOWER LIMB ISCHEMIA. F.M. Ameli, M.
Stein, J.L. Provan. University of Toronto, Division of Vascular Sur
gery, The Wellesley Hospital, Toronto, Ont.

Coagulase-negative staphylococci (CNS), primarily S. epidermidis, are
increasingly recognized as pathogens causing prosthetic graft infections.
We measured serum and tissue concentraions of cefazolin (CFZ) or

We present a 5-year follow-up study of 136 arterial reconstructions for
lower limb ischemia. A statistical analysis was performed using the stan
dard life-table analysis, the log rank test, the Krusbal-W allis analysis
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and the Spearman rank correlation coefficient. At 5 years of follow
up, cumulative patency rate (CPR), limb loss rate (LLR) and cumula
tive mortality were 52.3%, 15.8% and 30% respectively. The best predic
tors of long-term mortality were age (p = 0.018) and operative com
plications (p < 0.001). Over 5 years of follow-up CPRs were higher
for claudicants than for limb salvage cases (p = 0.037). At 5 years,
CPR of autogenous saphenous vein (ASV) grafts was 67.5% compared
to 38.2% for prosthetic grafts (p = 0.016). Autogenous saphenous vein
grafts had higher CPRs only for patients 64 years or younger (p =
0.007). For patients older than 64 years, ASV and prosthetic grafts had
similar CPRs. In patients with ASV grafts, good runoff was associated
with significantly higher CPRs compared to poor runoff (p = 0.041).
Claudicants lost only 2 limbs (3.9%) over the 5-year follow-up, com
pared to 12 lost limbs (14.5%) for limb salvage patients (p = 0.038).
Claudicants with ASV grafts had a 5-year LLR of 0% compared to
21.3% for limb salvage (p = 0.039). However, claudicants with
prosthetic grafts had a 5-year LLR of 17.8% compared to 20.1% for
limb salvage patients with prosthetic grafts (p = 0.356). Postoperative
smoking increased the probability of limb loss and adversely affected
CPRs.
In conclusion, LLRs and CPRs are affected by multiple interactions
with variables such as preoperative symptoms, graft material, age, runoff
and postoperative smoking.
R531
REOPERATION WITHIN TWO YEARS FOLLOWING AORTOFEMORAL BYPASS. J.G. Sladen, A. Gerein, J.L. Gilmour, T.
Maxwell, R. Wong. University of British Columbia, St. Paul’s Hos
pital, Vancouver, BC
This study was undertaken to assess the factors leading to early reoper
ation following aortofemoral grafting. All data were recorded prospec
tively. We analysed 269 consecutive primary aortofemoral grafts (523
limbs) operated during the 5-year period prior to Dec. 31, 1983. Includ
ing the initial hospitalization, 36 limbs (7%) had another lower extremity
vascular operation within 2 years. Hospital morbidity included throm
bosis with revision (2.2%), amputation (0.7%), and death (0.7%) which
compares favourably with the National Vascular Audit.
Precursors to reoperation were: occluded superficial femoral (12%),
gangrene (23%) and acute severe ischemia (40%). Operations performed
were: redo 1; thrombectomy 1; embolectomy 1; femoral crossover 5;
profundoplasty 1; femoropopliteal or tibial bypass 27. The reason for
secondary operation was classified as: technical 13; disease “ progress”
5; insufficient improvement 6; “ opposite” leg 2; questionable selec
tion or candidate for dilatation 10.
Inadequate management o f an isolated profundus outflow was the
commonest technical problem, preceding nine reoperations, five of these
for thrombosis. Reoperation varied from 9 to 33% by surgeon. Although
occlusion of the superficial femoral artery (SFA) is of statistical sig
nificance with regard to reoperation (p = 0.001), 88% of the limbs with
an occluded SFA did not require subsequent reconstruction within the
first 2 years. Early reoperation can be reduced by identifying high-risk
limbs and planning management and surgery more carefully in these
patients.

R532
REVASCULARIZATION FOR RENAL FAILURE. S.J. Brister, J.R.
Gutelius, P. Morrin, P.M. Brown. Department of Surgery, Kingston
General Hospital, Kingston, Ont.
Between 1982 and 1987, 10 patients from our institution have under
gone unilateral saphenous vein bypass (6), bilateral saphenous vein
bypass (2), endarterectomy (1) or renal artery reimplantation (1) for
renal failure. Six operations were done on an emergency basis for severe
oliguria or anuria. Four patients were done on an elective basis for soli
tary kidneys with high-grade arterial stenoses. Nine of 10 patients had
atherosclerotic renal artery stenosis or occlusion. One patient had
bilateral renal artery obstruction after rupture o f a high recurrent
abdominal aortic aneurysm. Eleven of 12 kidneys were greater than 10
cm in length with the remaining kidney being 8.9 cm. Operations empha
sized optimal exposure with rotation of viscera as required. Ischemic
times at surgery varied from 20 minutes to 1'h hours with renal cool
ing used in only one patient.
O f nine patients with atherosclerotic renal disease, two required tem
porary dialysis postoperatively because of severe ATN. The patient with
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occluded renal arteries secondary to his aneurysm repair 48 hours previ
ously did not recover renal function. Eight patients were discharged
with one late death attributed to pneumonia. In those discharged, creati
nine fell from a median of 720 \ i mol/L (range 160-1100) preoperatively
to 290 /rmol/L (180-470) postoperatively. No patients discharged
required dialysis.
Renal artery surgery for salvage may be done in those with severe
renal occlusive disease and normal size kidneys with a high degree of
success. Although operative mortality and morbidity is significant, the
possibility of relative normal renal function justifies the risks of renal
revascularization.
R533
AORTIC PROSTHETIC-ENTERIC FISTULA. A.R. Downs, C.R.
Lye, H. Fong. Department of Surgery, University of Manitoba, Health
Sciences Centre, Winnipeg, Man.
Aortic prosthetic-enteric fistula (APEF) is an uncommon but devastating
complication of abdominal aortic surgery. Over the past 10 years, 14
patients with APEF have been treated at our institution. There were
10 males and 4 females aged 50 to 82 years. The patients presented 3
weeks to 23 years after their initial graft placement. Four patients had
upper GI bleeding, 12 patients had melena. One patient presented with
anemia and unexplained fever. Massive bleeding in two patients required
emergency operation. Upper endoscopy was performed in eight patients.
In only one case was a diagnosis suspected. Aortography was done in
11 patients and was helpful in 3 patients, demonstrating two false
aneurysms and a leak into small bowel. An upper GI barium study was
done in four patients and demonstrated the lesion in two. The original
operation was for aortic aneurysm in nine patients. The proximal anasto
mosis was end-to-end in 10 patients. One patient was operated upon
for graft occlusion and the APEF was not discovered until postmor
tem. One patient had local repair of the duodenum and the aortic anasto
mosis. The remaining 12 patients had graft excision, omental patch and
an extra anatomical bypass. Four patients died in the postoperative
period and two patients died at 3 months and 4 months from aortic
disruption. Eight patients have survived up to 4 years.
R534
IN-VIVO EXCIMER LASER ABLATION: ACUTE AND CHRONIC
EFFECTS ON CANINE AORTA. D.L. Doyle, F. Litvack, W.S.
Grundfest, A. Hickey, M. Fishbein, J. Forrester. Cedars-Sinai Medi
cal Center, Los Angeles, CA
The lack of a fiberoptic delivery system has prevented in vivo excimer
laser ablation. This is the first report of the acute and chronic effect
of excimer laser on living arteries. We made 5 - 6 cm longitudinal
anterior arteriotomies in the infrarenal aortas of 17 dogs. In 13, a 125
mm2 rectangular segment of posterior intima was ablated by 85 ns
pulsed, 308 nm excimer energy delivered via a 600 /im core 2 m optical
waveguide. Four aortas were opened but not lased. Aortas were exa
mined by light and scanning electron microscopy at 0, 1, 2, 24, 48, 72,
106 hours; 1, 2, 3, 4 weeks.
Gross luminal thrombus developed in two control and one lased aorta.
No aneurysms or fistulae developed. Excimer produced no thermal
injury. Acutely, lased aortas had craters penetrating into the media.
At 24 - 72 hours there were red cells in the media, localized fibrin depo
sition and neutrophil infiltration. At 2 weeks the media had regener
ated and the intima partially re-endothelialized. At 3 - 4 weeks the intima
had completely healed and was indistinguishable from control.
In conclusion: (1) Excimer energy transmitted via fiberoptics precisely
ablates in vivo without thermal injury. (2) Ablated arteries heal by 3
weeks. (3) Excimer may be the technology of choice for laser angioplasty,
especially for small-calibre thin-walled vessels.
R535
IS FASCIOTOMY NECESSARY FOLLOWING REVASCULARIZA
TION FOR ACUTE ARTERIAL OCCLUSION? R. Corbisiero, A.
Graham, B. de Varennes, R. Baffour, J. Symes. Cardiovascular
Research Unit, McGill University, Montreal, PQ
Controversy exists as to the need for fasciotomy at the time of revas
cularization for acute arterial occlusion. To address this issue we deve
loped a unique canine model of compartment syndrome. Both hind limbs
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were completely devascularized at the popliteal level except for an iso
lated pedicle of anterior tibial artery and vein. The right limb served
as control while the left had both tibial vessels occluded for 8 hours
then released for 16. Anterior compartmental pressures (CMP) were
continuously monitored and popliteal venous effluent was collected for
CPK, K, lactate and pH. Transfascial Pc^TFPOj) measurements
were performed over the compartments. One hour after the onset of
reperfusion 35 mCi of technetium-99m pyrophosphate (TcPYP) was
injected systemically, and the uptake expressed as a ratio of the left
limb to the right (L/R). Muscle necrosis was also graded histologically
following the reperfusion period. In Group I (n = 7) no fasciotomy
was performed while Group II (n = 7) underwent fasciotomy before
reperfusion. Results: TFPo2 after arterial occlusion confirmed severe
ischemia in both groups (mean 4 mm Hg). Data 1 hour after reperfu
sion were:
CMP
(mm Hg)
Grp I
100
Grp It
15.7
*p < 0.0001

TFPOj
(mm Hg)

Lactate
(mg/dl)

CPK
(IU)

TcPYP
(L/R)

37 (± 8.5)
84.3 (±24.5)
*p < 0.005

22.85 (± 5 .5 )
14.67 (± 5 .7 )
*p < 0.01

5072 (±3794)
1426 (±923)
*p < 0.01

8.14 (± 2.7)
2.16 (± 1.3)
*p < 0.002

♦Student’s /-test.

Elevation of CMP due to reperfusion significantly increases the extent
of muscle necrosis following acute arterial ischemia. This study strongly
supports the use of prophylactic fasciotomy in this setting.

R536
EARLY EXPERIENCE WITH IN-SITU SAPHENOUS VEIN
BYPASS FOR LIMBS WITH CRITICAL ISCHEMIA. H. Fong, A.R.
Downs, C. Lye. Department of Surgery, University of Manitoba, Win
nipeg, Man.
Fifty-seven lower extremities in 55 patients (41 males, 14 females, mean
age 69 years) underwent in-situ saphenous vein bypass for critical ische
mia between 1985 and 1986. Indications for distal arterial reconstruc
tion were ischemic lesions 56% and rest pain 44%. Associated medical
conditions included hypertension 58%, angina 40%, old myocardial
infarction 37%, congestive heart failure 25%, diabetes 40% and chronic
smoker 68%. Regional anesthesia was used in 3/4 of patient group.
Status of tibial vessel run-off by angiography were one vessel 68%, two
vessels 25% and three vessels 7%. Proximal saphenous veins were
anastomosed to common femoral artery 54%, superficial femoral artery
35%, profunda femoral artery 4% and prosthetic graft 7%. Endarterec
tomies to common femoral and superficial arteries were performed in
nine extremities of which three had prosthetic patch angioplasty. Dis
tal anastomoses were performed below knee in 56 extremities of which
45% distal popliteal artery, 35% posterior tibial artery, 11% peroneal
artery and anterior tibial artery 7%. There were four deaths, mortality
rate 7%, of which three died of acute myocardial infarctions and one
of respiratory failure. Other complications included leg edema 89%,
wound complication 18%, acute graft occlusion 11% and acute hemor
rhage 7%. There were six early and six late graft occlusions of which
three extremities from each group required amputations respectively.
Overall cumulative patency was 82% in 30 days, 81% in 3 months, 75%
in 1 year and 72% in 2 years. We feel that for distal tibial arterial recon
struction, in-situ saphenous vein bypass is a good procedure with accept
able patency rate for limbs with critical ischemia.

R537
MANAGEMENT OF TRAUMATIC AORTIC DISRUPTION. C.
Cina, R. Maggisano. University of Toronto, Sunnybrook Medical
Centre, Toronto, Ont.
Fifteen patients have been managed for traumatic rupture of the aorta
at Sunnybrook Medical Centre in the last 6 years.
While classic teaching is to operate immediately, a more deliberate
plan of management was used. Cardiovascular hemodynamics were care
fully monitored and pharmacologic hypotension was maintained in an
intensive-care environment. Priorities for associated injuries were estab
lished and often their treatment preceded that of surgical repair of the
aorta. This was delayed until cardiorespiratory and CNS injuries were
improved. Neither pump nor shunt was used in the operative repair.
Six patients were not operated upon: two were dead on arrival; one

died of MI after 13 days; two refused operation (and are still alive);
one died waiting for operation. The average cross-clamping time was
36 ± 12 minutes. Tube-graft interposition was used in seven patients
and direct repair in two. The overall mortality rate of this management
approach is 23%, and the operative mortality 22%. One patient became
paraplegic and one had a left vocal cord paralysis.
Prior to this experience a comparable group of patients were managed
with urgent operative repair: three with direct cross-clamping and three
with cardiopulmonary bypass. The mortality rate was 85%.
We conclude that delaying surgical repair until major cardiopulmo
nary and CNS associated injuries resolve, will improve mortality and
possible morbidity.

R538
CATHETER INJURIES OF PERIPHERAL ARTERIES: MANAGE
MENT AND PREVENTION. T. Kieser, T. Wesley-James, G. Barber,
N. McPhail, T.K. Scobie. Division of Vascular Surgery/ Ottawa Civic
Hospital, Ottawa, Ont.
Fifty angiographic catheter injuries required surgical repair between 1977
and 1985,0.3% of 12 244 cardiac and 0.25% of 2858 peripheral angio
grams. Arteries involved included 21 common femoral, 10 superficial
femoral and 4 profunda femoral. Injuries were thrombosis in 25,
laceration-hematoma in 12, false aneurysms in 6, emboli in 5 and arterio
venous fistula in 2. M ajor pathological lesions were lacerationperforation in 24, intimal damage in 3, significant atherosclerosis in
9, hypoplastic arteries in 6 and no gross wall change in 8. Operative
repair was thrombectomy and patch angioplasty in 18, primary repair
in 9, thrombectomy in 8, formal bypass grafting and other procedures
in 16. Rethrombosis requiring reoperation occurred in five patients,
all of whom were successfully repaired. Four of 47 patients died.
Since common femoral artery catheterization is preferable to catheteri
zation of major branches, 100 patients were assessed at the time of elec
tive femoral artery surgery to demonstrate the level of common femoral
bifurcation. The area was marked by a transverse line laterally from
the pubic tubercle and in the groin skin crease. Ninety-one percent of
femoral bifurcations were below the pubic tubercle confirming the value
of this landmark for safe femoral artery catheterization.
The incidence of catheter injuries can be reduced by precise com
mon femoral artery puncture and the avoidance of atherosclerotic and
hypoplastic arteries. Results depend on prompt diagnosis and immedi
ate surgery, thrombectomy with patch angioplasty providing optimal
operative repair.

R539
RADIONUCLIDE ANGIOGRAPHY AT REST AND EXERCISE IN
PREDICTING CARDIAC OUTCOME IN PATIENTS UNDERGO
ING ABDOMINAL AORTIC RECONSTRUCTIVE SURGERY. W.P.
Joyce, J.L. Provan, F.M. Ameli, P. McEwan. University of Toronto,
Toronto, Ont.
Coronary artery disease (CAD) is the major cause of morbidity and
mortality in patients undergoing elective abdominal aortic surgery. To
identify this high-risk group o f patients preoperatively, we have selected
resting and exercise gated blood pool studies in 40 unselected and con
secutive patients undergoing infrarenal abdominal aortic reconstruc
tive surgery. Preoperatively, patients were allocated into two risk groups
depending upon their left ventricular ejection fraction at rest (EFR).
Patients with EFR < 50% (n = 11) were considered high risk and
patients with EFR > 50% (n = 29) were considered low risk. Evidence
of CAD was based on a history o f myocardial infarction (MI), conges
tive heart failure (CHF), or an abnormal preoperative ECG. Outcome
was defined only in terms o f cardiac complications and cardiac end
points were taken as death, MI, CHF and pulmonary edema. Only four
patients suffered a postoperative cardiac complication with one death
(mortality 2.0%). These four patients had aneurysmal disease and a
mean ejection fraction (EFR ± SD) of 27 + 5. Complications included
pulmonary edema in three patients and cardiorespiratory failure and
death in one patient. The clinical presence o f CAD was significant in
predicting outcome (p = 0.01) while information derived from stress
electrocardiograms and exercise gated blood pool studies were not. Our
preoperative assessment o f risk based on EFR < 50% was highly sig
nificant in predicting outcome (p = 0.0004) while EFR alone was the
best overall predictor of outcome (p = 0.0001).
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SURGEONS’ UPDATE

continued from page 232
that the timing would never be suitable
for an intervention. The debate in the
appeals court is expected by the QMA to
establish some criteria for the body that
represents physicians and for the timing
for changes.
The QMA recently released “ A New
Contract for Health Care in Quebec” ,
which says among other things, “ ...the
greater part of [health-related] expenses
is blamed on physicians; only in appear
ances can such an erroneous assumption
be explained, not with facts and
figures.... If we deduct the amount paid
in 1984 by the RAMQ [Regie de 1’Assur
ance Maladie du Quebec] for medical
services, that is $882 772 551, or 12% of
total expenses, we then obtain the total
amount of $6 337 665 449 for all other
expenses.
“ The Quebec physician is the one earn
ing the lowest gross average income in
Canada. In 1984, the gross average
income was 40% lower than the Canadian
average. Between 1971 and 1980, the con
sumer price index increased by 108.4%,
while the physician’s gross income was
raised by a mere 48%. His purchasing
power decreased by 30%; that of the
salaried worker increased by 15%.
“ ...our Quebec physicians should be
entitled to rates that compare to the
Canadian average, to an updating of fees
considering the technical difficulty, the
rising costs of insurance, etc. They should
be entitled to premiums for services ren
dered evenings, nights, weekends and
statutory holidays.”
Canada-wide statistics compiled by the
federal government lend some support to
the QMA’s contentions that the physi
cians in that province are the lowest paid
in the country. Criticized by medical
associations as being a reflection of utili
zation as much as differences in fees, the
indices are based on a sample of the most
highly utilized items in the schedules for
each specialty, the fees paid for consul
tations and an average price per service
weighted by use patterns and total serv
ices rendered. Using these statistics, the
government establishes a “ median” fee
for all services and gives it the value of
100, valuing accordingly the “ all-services
fee” for each province.

The indices for 1986 put Quebec’s
general surgeons, urologists, ophthalmol
ogists, and thoracic and cardiovascular
surgeons as the lowest paid for their
specialty in Canada.

New Chairman for General
Surgery, U of Ottawa
Mark Dover, FRCSC, was recently
appointed chairman for the division of
general surgery at the University of
Ottawa and chief of general surgery at the
Ottawa Civic Hospital. Dover received his
medical degree from the University of
Ottawa in 1955 and took postgraduate
training in Ottawa and New York.

M. Dover, MD, FRSCS

Casualties of War Treated
in Canada
Simon Wren, FRCSC, a general sur
geon in Kingston is chairman of the med
ical committee of the local chapter of the
Afghan Medical Relief Organization, and
for the past few months has been coor
dinating efforts in Canada to bring med

ical help to casualties of the freedom
fighting. He recently spoke to CJS about
his work: “ We have had two objectives:
one to transfer medical equipment to the
refugee camps in Pakistan and to bring
to Canada people who require reconstruc
tive surgery for injuries sustained during
the war.
“ At present at Hotel Dieu we have
taken four patients — the first was a man
who had chronic osteomyelitis caused by
a gunshot wound to the tibia; the second
had a malunion of the distal femur with
consequent problems in the knee joint (he
ended up with a fused knee). These
patients were handled here by two ortho
pedic surgeons, Michael Ashworth and
Douglas Hedden. The third patient was
a young girl who had injuries, I believe,
from stepping on a mine. Her foot and
ankle had healed but were malaligned and
she couldn’t walk well. She has been
treated with, in essence, an ankle and foot
fusion and her foot has been straightened.
The last one we treated here is a young
girl who sustained shrapnel injuries to the
head; she has retained some shrapnel in
the brain tissue and has a partial right
hemiparesis and partial aphasia. She’s
here for some of the problems associated
with the hemiparesis — problems to the
right arm and leg.”
Wren has arranged for treatm ent of
some of the patients elsewhere — in
Toronto at the Toronto General, Western
and St. Joseph’s hospitals.
“ All were patients in the refugee camps
in Pakistan,” he said. “ I am coordinat
ing the medical end of it; I get lists of
patients from Pakistan with explanations
of the problem; I relay the inform ation
to physicians who have elected to care for
such patients. All the care is voluntary.
The AMRO chapter has set up transla
tion and home care services so these
patients can be treated as outpatients.
“ The patients have adjusted well to a
life that is very foreign to them; all will
be going back after their care is complete.
The intergovernmental committee for
migration in Geneva coordinates the
travel of these people from the camps to
the various countries that are providing
assistance. The committee arranges exit
visas with the government in P akistan.”

A my C houinard
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BOOK REVIEW S
continued from page 271
work of a related symposium. Most of the
authors are well-respected, experienced physi
cians, renowned for their clinical expertise. The
text is divided into eight sections that include
historical considerations, surveillance and
detection, pathologic features, special diagnos
tic techniques, management, adjuvant therapy,
complications and follow-up procedures. The
text is supplemented by beautiful illustrations
and tables. The print is clear and easy to read.
Most of the book is well written. However,
the multiauthor format has resulted in a weak
and uneven style. Many of the chapters, par
ticularly on surgical technique and radiation
therapy, are of the “ how I do it” type. There
is frequently too little analysis of important
recent trials or too much analysis of lessimportant issues (e.g., the no-touch technique).
The chapters on radiotherapy are particularly
poor in that regard. The results of major adju
vant radiation studies are buried in the
chemotherapy section. In particular, the chap
ter dealing with preoperative radiotherapy and
sphincter preservation contributes nothing to
our knowledge. Similarly, there are two chap
ters, dealing with urologic and vascular com
plications, that are neither particularly com
mon nor unique to colorectal cancer surgery.
They seem, at best, to be filler. There are three
separate chapters on polyps by four authors
that, although not contradictory, are repetitive
and still leave the reader confused.
The descriptive chapters on surgical tech
niques are the strongest in the book. The chap
ters on dysplasia in ulcerative colitis, prolifer
ative defects and follow-up procedures are also
excellent.
Steele and Osteen have selected fewer (14)
contributors and used a much different format
for Colorectal Cancer. They have established
the controversial and key issues in each area
of colorectal cancer and have asked the con
tributors to provide all of the important rele
vant data, analyses of them and their conclu
sions. To a great extent they have been
successful.
The chapter on screening is particularly good
at eliminating the confusion created by a mul
titude of studies. The chapters on surgical treat
ment concentrate on the survival advantages
for particular techniques in a variety of situa
tions. The conclusions on management of anal
cancer are somewhat controversial but are well
supported. The section on polyps is a reasona
ble analysis of the literature but does omit
recent British literature which is at variance in
some respects with the author’s conclusions.
The chapters on radiation by Gunderson and
adjuvant therapy by Mayer are much clearer
in their interpretation of the literature than in
Colorectal Tumors and provide more of an
opportunity for the reader to evaluate their
conclusions.
The major weaknesses of the book lie in the
poor quality of editing and printing. The qual
ity of reproductions in the surgical treatment
section is particularly poor, and the tables are
at times too cluttered to be interpreted easily.
There are a number of grammatical and typo
graphic errors throughout the book.
In conclusion, both texts are comprehensive
studies of colorectal cancer. Beahrs and col
leagues have produced a generally well-written
text that would be of some use to the practis
ing general surgeon or resident. However, it
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has little to offer over and above standard Brit
ish and American textbooks of colorectal sur
gery. For the serious students of colorectal
cancer, particularly those involved in con
ducting clinical trials, Steele and Osteen have
produced the better book.
H a rtley S. S t e r n , m d , frcsc
Department of Surgery,
University of Toronto,
Mount Sinai Hospital,
Ste. 1142,
600 University Ave.,
Toronto, Ont.
M5G 1X5

DIAGNOSTIC PATIENT STUDIES IN SUR
GERY. Bernard Sigel. 449 pp. Illust. Lea
& Febiger, Philadelphia, 1986. $79.75.
ISBN 0-8121-0996-1.

This excellent, concise textbook of commonly
used diagnostic techniques provides rapid
access to and selection of the most appropri
ate test for a specific clinical situation. Many
specialists in the fields of surgery, radiology
and medicine have provided detailed reviews
of patient diagnostic studies, which are defined
as those “ requiring presence of the patient, not
only specimen sent to the laboratory” .
Diagnostic investigations are initially divided
into three groups: imaging, endoscopy and
function studies, but the book is divided into
two parts: part I — imaging and part II —
endoscopy, function studies and magnetic
resonance. This is somewhat confusing but for
tunately is the only weak point in this book.
Part I contains nine chapters, giving detailed
reviews of radiologic techniques, beginning
with an interesting introduction to the basics
and technique. This is followed by plain roent
genography of the skeleton, chest and the
abdomen. Then ultrasonography, computer
ized tomography and radionuclide scanning are
described. Finally, the more invasive luminal
contrast studies of hepatobiliary and gastroin
testinal systems and angiography are presented.
Whenever indicated, emphasis is placed on the
application of a particular study in trauma or
some other emergency situation. Each chap
ter is designed to present the background of
the technique, indications, principles of diag
nosis, complications and limitations of the test
related to technique as well as to the examiner.
Each overview is followed by a specific organ
study, again with emphasis on indications,
complications and limitations. In the chapter
on plain-film roentgenography, the controversy
regarding the use of preoperative chest x-rays
is discussed. The chapters on ultrasonography
and computerized tomography describe the
indications for synchronized percutaneous
biopsy. Percutaneous fine-needle biopsy is
elaborated upon in more detail in part II.
Part II consists of 10 chapters dealing with
the principles o f urologic, respiratory, upper
and lower gastrointestinal endoscopies. Two
chapters are devoted to the applications of
diagnostic laparoscopy and paracentesis, with
emphasis on trauma. Pulmonary function tests
are outlined with detailed discussions on the
indications, interpretation and even costeffectiveness. In the chapter on cardiac assess
ment, outlines of electrocardiography, cardiac
catheterization and invasive bedside monitor
ing techniques are presented. Continuous

esophageal pH monitoring, esophageal motil
ity studies and gastroduodenal function studies
are described. The efficacy of noninvasive vas
cular techniques and technical problems
associated with them in relation to both the
venous and arterial systems are well presented.
In the last chapter, applications for magnetic
resonance imaging are dealt with.
In all chapters, numerous well-selected
studies including controversial issues are
quoted. Each topic is supported with wellselected illustrations of normal or pathologic
states, sometimes with emphasis on diagnos
tic errors. The endoscopy chapters lack illus
trations, but these can be found in many text
books and atlases.
Each chapter lists references from the cur
rent literature as well as general reading on the
subject.
This textbook is not a manual and does not
pretend to teach one how to perform or inter
pret a particular study. However, it gives very
reliable reviews of most of the commonly used
techniques with their rationale, indications and
limitations. This book can be strongly recom
mended to all medical and surgical residents.
Surgeons, medical specialists and general prac
titioners may use it as a reference guide to help
them choose the proper study or to avoid inap
propriate and costly tests in a particular clini
cal situation.
J o el B. F r e e m a n , m d , fr c sc , facs
Professor of surgery,
University of Ottawa,
Ottawa General Hospital,
501 Smyth Rd.,
Ottawa, Ont.
K1H 8L6

FINE NEEDLE ASPIRATION FOR THE
CLINICIAN. Joseph A. Linsk and Sixten
Franzen. 337 pp. Illust. J.B. Lippincott
Company, Philadelphia, 1986. Price not
stated. ISBN 0-397-50678-3.

This book is based on the large experience of
a consultant clinical oncologist who is an expert
in fine-needle aspiration and works with a
highly experienced cytopathologist. The
authors rightly emphasize the lack of familiar
ity of many physicians with the use of fineneedle aspiration to solve clinical problems.
In the introductory chapter, the pictures and
text on technique are excellent and the hazards
of the procedure are well documented. The
remainder of the book is divided into sections
that catalogue practically all visible and pal
pable tumours in the human body, as well as
those that can be imaged by various techniques.
A short description of the clinical and patho
logical findings of each is given, and the poten
tial role of fine-needle aspiration in establish
ing the diagnosis is considered. The section on
the fine-needle aspiration of intrathoracic
lesions, intra-abdominal lesions, the transrectal and transvaginal approach to pelvic lesions,
and lesions of the skeletal system are of interest
only to specialists in these areas and usually
require the cooperation of an expert in diag
nostic imaging.
The chapter on the breast includes a section
on how masses may be discovered by a patient
and an extensive section on the technique of
clinical examination, both of which are not
really germane to the central theme.

VOLUME 30, NO. 4, JU L Y 1987 / THE CANADIAN JOURNAL OF SURGERY

The authors continually mention the impor
tance of experience in the use o f the technique
by the clinican and the interpretation of the
slides by the pathologist. However, they fail
to give any indication of the percentages of
false-negative and false-positive results in their
own experience or in that from other clinics,
which have been well documented in the liter
ature. In the primary surgical treatment of
breast cancer, they imply that positive cytologic
findings may preclude the need for frozensection confirmation of the diagnosis of cancer
before embarking on a primary surgical proce
dure. Most surgeons would forcefully disagree
with this because false-positive findings have
been reported.
This book contain^ a lot of extraneous infor
mation which clouds the clarity of its message.
It is not recommended for the average physi
cian. It is a good reference for any person who
is interested in developing his or her expertise
in the technique of fine-needle cytology to help
elucidate the diagnosis of palpable lumps in any
area of the body.

Leo Mahoney , md , frcsc , facs
Associate professor of surgery,
University of Toronto,
Ste. 405,
55 Queen St. E,
Toronto, Ont.
M5C 1R6
UPPER EXTREMITY REPLANTATION.
Basic Principles, Surgical Technique, and
Strategy. Viktor E. Meyer. 121 pp. Illust.
Churchill Livingstone, Edinburgh; Aca
demic Press Canada, Don Mills, Ont.,
1985. $58. ISBN 0-443-08448-3.

The author of this book on upper-extremity
replantation has had extensive experience in the
last decade in the management of patients with
amputations of the finger, hand and forearm.
The book presents a balanced, logical, thought
ful approach to the subject, which is one of
the most complex in hand surgery. There are
many problems in the management of ampu
tations. Patient selection, operative technique
and postoperative care are among the most
important considerations and one chapter is
devoted to each of these. O f particular note
is the chapter on personnel and organizational
requirements for a replantation centre. This
chapter should be seriously considered by any
one thinking of doing solo replantation. Dr.
Meyer’s team consists of four surgeons who
can provide not only 24-hour service, but can
back each other up for long procedures and
assist in taking patients back to the operating
room for revisions.
The chapter on indications is a most impor
tant one and presents a balanced conservative
approach with which I am in nearly complete
agreement.
Surgical technique is well covered, with
strong emphasis on skeletal fixation, which it
rightly deserves. This chapter emphasizes tech
nical principles and provides us with technical
details that the author favours. Most replan
tation centres would agree with the majority
of the techniques used, but might favour a freetissue transfer rather than a groin flap for
major soft-tissue defects associated with upper
limb replantation. Early mobilization and
edema control by elevation is considerably eas
ier with a free flap.

SESAP V Critique
ITEM 315

This patient has an imperforate anus, better termed anorectal atresia with a
rectourethral fistula. Patients with high-lying defects located above the leva
tor sling mechanism are prone to urinary tract infection, primarily because of
associated genitourinary malformations. In such patients the risk of infection
prior to definitive pull-through operation and division of the rectourethral fistula
is about 60%. Some patients have only sporadic difficulty, but others, partic
ularly those with neurogenic bladders, develop chronic problems. In one series
of 200 patients with various anatomic types of imperforate anus, 40% had some
form of anomaly of the urinary tract, neurogenic bladder, significant urinary
tract infection, or other forms of urinary complications. Metabolic acidosis
may result from poorly functioning kidneys, further compromised by urinary
tract infection. The reflux of urine through the fistula into the distal limb of
the colostomy also causes acidosis, Chloride ions from the urine are reabsorbed
through the bowel muscosa. Severe degrees of recurrent acidosis would neces
sitate division of the fistula with or without completion of the rectoplasty.
E
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The section on postoperative care could be
stronger. The author stresses the importance
o f postoperative therapy but allows only one
page for discussion o f postoperative therapy
for the hand.
The reporting o f results is a difficult area and
the author is to be congratulated for his efforts.
He has used the classification o f Chen; unfor
tunately, this includes the patient’s return to
work, a factor that depends upon motivation,
social support systems and the pre-injury job
and does not really give us the information we
would like — grip and pinch strength, manual
dexterity, tactile gnosis and psychological adap
tation to the injury. Nevertheless, the results
section is useful, as it gives some idea of the
levels o f amputations and types o f amputation
injuries that are most likely to result in suc
cessful replantation.
The book is written in a lucid style and the
illustrations are excellent. Overall, it is a major
addition to the microvascular literature and is
necessary reading for all surgeons who are
practising in this field, and residents who are
training in hand surgery.

Ralph T. Manktelow , md , frcsc
Division o f Plastic Surgery,
EN 10-236,
Toronto General Hospital,
200 Elizabeth St.,
Toronto, Ont.
M5G 2C4
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x 2" $100.00. $6.00 charge (first insertion only) for CJS box numbers. Display rates
available on request.
Copy should be mailed to the Canadian Journal o f Surgery, PO Box 8650, Ottawa,
Ontario K1G 0G8.
GENERAL SURGEON: MB — Prospective partner
required to replace retiring surgeon. The group
services a productive economically stable region
of 180 000, located in a university city of 42 000.
Excellent schools, recreational and cultural facili
ties. The clinic having a modern laboratory, x-ray
and other diagnostic services is located adjacent
to a 220-bod acute care hospital. Interest in chest
or vascular surgery an asset but not essential.
Canadian fellowship is required. Contact: Mr. A.J.
Lockhart, Administrator, Box 280, Brandon, MB
R7A 5Z2.
-S 8 7 -5 3

GENERAL SURGEON: ON — required immedi
ately to serve the com m unity of Arnprior and
surrounding area. Sole practice draws from a
com munity population of 6000 and a catch
ment area of approxim ately 14 000. Current
medical sta ff includes 9 GPs, 3 of w hich are
GP anesthetists. Also available are weekly on
site radiologic services for ultrasound and bar
ium stud ies. A rn p rio r ho spital is fu lly
accredited w ith 50 acute and 20 chronic care
beds. We have 2 fully equipped operating
rooms and an additional cysto/ortho room.
Prospective candidates should have some
training in orthopedic w ork as well as do emer
gency and repeat ceasarean sections. Arnpri
or is s itu a te d on th e O tta w a River
approximately 70 km from dow ntow n Otta
wa. Our com m unity offers excellent schools
and recreational areas including golf courses,
a curling club, a com munity sports centre w ith
ski hills nearby. A ttra ctive grant available to
assist w ith relocation and/or establishment of
practice. For further inform ation please con
tact: R.J. Kedrosky, Administrator, Arnprior &
District Memorial Hospital, 350 John St., N.,
Arnprior, ON K7S 3H4. Tel. (613) 623-3166.
-S 8 7 -4 5
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GENERAL SURGEON: BC — required to move to
the beautiful Sunshine Coast and relieve the local
surgeon during his holidays. This is 10-12 weeks
a year. Ideal position for a general surgeon near
ing retirement. Apply to: Dr. E.J. Paetkau, Box
6 3 8 , Schelt, BC VON 3A 0.
- S 8 7 -5 4

230, 231

SPECIALIST AND/OR CARDIOLOGIST: ON This exclusive seven storey building is located
across from the Sutton Place Hotel at 984 Bay
Street, corner of Bay and Wellesley. Currently we
are 80% leased requiring only a few selected spe
cialists to fill out a full com plim ent. The building
houses a large research oriented fam ily practice,
numerous specialists as w ell as radiology, ultra
sound, pharmacy, laboratory, nuclear medicine
and sports medicine facilities including tw o oper
ating suites used prim arily for cosmetic related
surgery. For further leasing information call:
Geoffrey Smith, (416) 24 3-90 10.
-S 8 7 -5 6

UNIVERSITY OF BRITISH COLUMBIA - Head, for
the Department of Surgery in the Faculty of Medi
cine at the University of British Columbia, (subject
to final budgetary approval). The person appointed
would be responsible for directing and developing
the teaching, research and service programs of the
department. A candidate should hold a specialty
qualification in surgery and have substantial aca
demic and clinical experience. Starting date and
salary are subject to negotiation. The University
of British Columbia offers equal opportunity for
employment to qualified male and female candi
dates. In accordance w ith Canadian immigration
requirements, this ad is directed to Canadian
citizens and permanent residents and preference
will be given to these individuals. Applications, ac
companied by a detailed curriculum vitae and the
names of three individuals for references should
be directed to: Dr. Andrew Eisen, Associate Dean,
Faculty of Medicine, Room 317, Instructional
Resources Centre, University of British Columbia,
21 94 Health Sciences Mall, Vancouver, BC
V6T 1W5.
-S 8 7 -5 2

GENERAL SURGEON: US — required to practise
in a 53-bed hospital and w ork in an office w ith a
cardiologist and general practice physician. Board
certified or board eligible. Located in east central
Alabama. Office rent free for 6 months. Please re
ply to: Dr. Cecil P. Horn, PO Box 398, Ashland,
Al 36251.
—S87-55

CLINICAL FELLOWSHIP: ON - position in
orthopedic surgery for 1 year period beginning
July 1, 1988. We have fellowships available
in joint reconstruction, spine surgery, sports
medicine and knee surgery, hand surgery and
rehabilitation, each involving some aspect of
trauma, due to Sunnybrook being the home of
The Regional Trauma Unit. If interested please
forward a letter of application stating your par
ticular orthopedic interest, and include a copy
of your curriculum vitae to: Dr. J. Schatzker,
Chief, Division of Orthopedic Surgery, Room
D5505, Sunnybrook Medical Centre, 2075
Bayview Ave., Toronto, ON M4N 3M5. Please
also state w hether you w ill be self-funded or
require support from Sunnybrook Medical
Centre.
-S 8 7 -4 6

MICROSURGICAL COURSE: - The Department
o f Surgery, M cM aster University is now offering
one week, on-going courses in microsurgery, us
ing animal facilities and videotapes. These courses
are for anyone interested in small vessel anasto
mosis, nerve repairs, vas and fallopian tube recon
structions. The laboratory is organized to guide
you through the basic microsurgical techniques to
more advanced tasks w ith the help o f an assis
tant on a one-to-one basis. Please call: Dr. A. Thoma at (416) 52 3-0 0 1 9 for further information.

-S86-23
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MORE C O N F I D E N C E IN A N T I T H R O M B O T I C THERAP Y

New Guidelines for
Antithrombotic Therapy
In Surgical Cases
The American College of Chest Physi
cians and the National Heart, Lung and
Blood Institute recently issued new
guidelines for antithrombotic therapy.1
There were four Grade A recom
mendations for the use of warfarin
(Coumadin®) in surgical oases. In each
of these four (and other Grade A and B
recommendations for Coumadin®) a PT
ratio of 1.2-1.5 (rabbit brain) was
emphasized for clinical efficacy and
reduced side-effects risk.

INDICATIONS: Elective hip surgery/
surgery for fractured
hips.

CONDITION: Bioprosthetic heart valves.

all patients with bioprosthetic heart valves
in the mitral position be treated for the first
three months after valve insertion with less
intense warfarin . . ."
"

patients undergoing elective hip surgery
should be pretreated prophylactically with
adjusted-dose heparin or moderate-dose war
farin sodium . .
patients undergoing surgery for fractured
hips should be treated prophylactically with
moderate-dose warfarin.
.

■ •

INDICATION: Prophylaxis of venous
thromboembolism.

"It is strongly recommended that the
therapeutic range for prophylaxis . . . in highrisk medical or surgical patients should be
equivalent to an INR of2.0-3.0(corresponding
rabbit brain thromboplastin ratio 1.2-1.5)."

re believe these recommendations ff
will be of value to practicing physicians.

James E Dolen. M D . F C C P , Jock H,rsh. M D . F R C P C . C o -C ha.rm e n A C C P -N H L B I Conference on Antithrombotic Therapy

CONDITION: Prophylaxis of venous
thromboembolism.

OUMADIN

*-

®

(warfarin sodium)

"It is recommended that anticoagulant therapy
should be continued for three months using
oral anticoagulants to prolong prothrombin
tim e. . ."
1. Chest 1986;89(2);1S-106S

for Antithrombotic Therapy
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Meet some members
of our family
...n o w comes the
Even Greater Stapler

Now a monofilament suture
that is easy to handle and tie

Soft supple, flexible
Resists kinki
eknot
Yields secure
Strong

Ultra Light Compact
disposable skin stapler
•
•
•
•
•

the manageable monofilament

Automatically released staples
Improved staple visibility
Proven reliability
Allows for excellent accuracy
Quality stapler supplied inexpensively

FO RAD I
YOUC.

THE SMOOTH ONE

RENCE
FEEL

NEW PRE-CYDE

(Chtortiexidne Gluconate)

ew Pre-Cyde is the only
germicidal antiseptic hand
wash that combines all the
effectiveness of chlorhexidine
with a gentle emollient to
sooth the skin.

N

Pre-Cyde's broad antibacterial
spectrum makes it an excellent
bactericidal and fungicidal

DEXON PLUS
Excellent knot security plus superior handling
and smoother tissue passage.

Pre-Cyde is safe, virtually
Irritating,
pleasant
difference

quality professional products from
DAVIS+GECK
Cyanamid Canada Inc.
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Atria North, 2255 Sheppard Avenue East, Willowdale, (Ontario) M2J 4Y5
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